<!doctype html>
<html lang="en-us">
<head>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta charset="utf-8">
<title data-react-helmet="true">Editorial board - Autoimmunity Reviews | ScienceDirect.com by Elsevier</title>
<meta data-react-helmet="true" name="SDTech" content="Proudly brought to you by the SD Technology team in London, Dayton, and Amsterdam" /><meta data-react-helmet="true" name="description" content="Read the latest articles of Autoimmunity Reviews at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature" /><meta data-react-helmet="true" name="robots" content="INDEX,FOLLOW,NOARCHIVE,NOCACHE,NOODP,NOYDIR" />
<link data-react-helmet="true" rel="alternate" type="application/rss+xml" href="https://rss.sciencedirect.com/publication/science/15689972" title="RSS" /><link data-react-helmet="true" rel="canonical" href="https://www.sciencedirect.com/journal/autoimmunity-reviews/about/editorial-board" />
<link rel="shortcut icon" href="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/103/images/favSD.ico" type="image/x-icon">
<link rel="icon" href="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/103/images/favSD.ico" type="image/x-icon">
<link href="https://sdfestaticassets-eu-west-1.sciencedirectassets.com" rel="dns-prefetch">
<link href="https://sdfestaticassets-eu-west-1.sciencedirectassets.com" rel="preconnect" crossorigin="anonymous">
<link href="https://smetrics.elsevier.com" rel="dns-prefetch">
<link href="https://smetrics.elsevier.com" rel="preconnect" crossorigin="anonymous">
<link href="https://assets.adobedtm.com" rel="dns-prefetch">
<link href="https://assets.adobedtm.com" rel="preconnect" crossorigin="anonymous">
<link rel="stylesheet" href="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/prod/7ba758f35c085605b3a44408553251401be17045-jhp/style.css" />
<script data-cfasync="false">(function newRelicBrowserProSPA() {
  ;
  window.NREUM || (NREUM = {});
  NREUM.init = {
    privacy: {
      cookies_enabled: true
    },
    ajax: {
      deny_list: ["bam-cell.nr-data.net"]
    }
  };
  ;
  NREUM.loader_config = {
    accountID: "2128461",
    trustKey: "2038175",
    agentID: "1118783207",
    licenseKey: "7ac4127487",
    applicationID: "1080562708"
  };
  ;
  NREUM.info = {
    beacon: "bam.nr-data.net",
    errorBeacon: "bam.nr-data.net",
    licenseKey: "7ac4127487",
    applicationID: "1080562708",
    sa: 1
  };
  ; /*! For license information please see nr-loader-spa-1.238.0.min.js.LICENSE.txt */
  (() => {
    "use strict";

    var e,
      t,
      r = {
        5763: (e, t, r) => {
          r.d(t, {
            P_: () => f,
            Mt: () => p,
            C5: () => s,
            DL: () => v,
            OP: () => T,
            lF: () => D,
            Yu: () => y,
            Dg: () => h,
            CX: () => c,
            GE: () => b,
            sU: () => _
          });
          var n = r(8632),
            i = r(9567);
          const o = {
              beacon: n.ce.beacon,
              errorBeacon: n.ce.errorBeacon,
              licenseKey: void 0,
              applicationID: void 0,
              sa: void 0,
              queueTime: void 0,
              applicationTime: void 0,
              ttGuid: void 0,
              user: void 0,
              account: void 0,
              product: void 0,
              extra: void 0,
              jsAttributes: {},
              userAttributes: void 0,
              atts: void 0,
              transactionName: void 0,
              tNamePlain: void 0
            },
            a = {};
          function s(e) {
            if (!e) throw new Error("All info objects require an agent identifier!");
            if (!a[e]) throw new Error("Info for ".concat(e, " was never set"));
            return a[e];
          }
          function c(e, t) {
            if (!e) throw new Error("All info objects require an agent identifier!");
            a[e] = (0, i.D)(t, o), (0, n.Qy)(e, a[e], "info");
          }
          var u = r(7056);
          const d = () => {
              const e = {
                blockSelector: "[data-nr-block]",
                maskInputOptions: {
                  password: !0
                }
              };
              return {
                allow_bfcache: !0,
                privacy: {
                  cookies_enabled: !0
                },
                ajax: {
                  deny_list: void 0,
                  block_internal: !0,
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                distributed_tracing: {
                  enabled: void 0,
                  exclude_newrelic_header: void 0,
                  cors_use_newrelic_header: void 0,
                  cors_use_tracecontext_headers: void 0,
                  allowed_origins: void 0
                },
                session: {
                  domain: void 0,
                  expiresMs: u.oD,
                  inactiveMs: u.Hb
                },
                ssl: void 0,
                obfuscate: void 0,
                jserrors: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                metrics: {
                  enabled: !0
                },
                page_action: {
                  enabled: !0,
                  harvestTimeSeconds: 30
                },
                page_view_event: {
                  enabled: !0
                },
                page_view_timing: {
                  enabled: !0,
                  harvestTimeSeconds: 30,
                  long_task: !1
                },
                session_trace: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                harvest: {
                  tooManyRequestsDelay: 60
                },
                session_replay: {
                  enabled: !1,
                  harvestTimeSeconds: 60,
                  sampleRate: .1,
                  errorSampleRate: .1,
                  maskTextSelector: "*",
                  maskAllInputs: !0,
                  get blockClass() {
                    return "nr-block";
                  },
                  get ignoreClass() {
                    return "nr-ignore";
                  },
                  get maskTextClass() {
                    return "nr-mask";
                  },
                  get blockSelector() {
                    return e.blockSelector;
                  },
                  set blockSelector(t) {
                    e.blockSelector += ",".concat(t);
                  },
                  get maskInputOptions() {
                    return e.maskInputOptions;
                  },
                  set maskInputOptions(t) {
                    e.maskInputOptions = {
                      ...t,
                      password: !0
                    };
                  }
                },
                spa: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                }
              };
            },
            l = {};
          function f(e) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            if (!l[e]) throw new Error("Configuration for ".concat(e, " was never set"));
            return l[e];
          }
          function h(e, t) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            l[e] = (0, i.D)(t, d()), (0, n.Qy)(e, l[e], "config");
          }
          function p(e, t) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            var r = f(e);
            if (r) {
              for (var n = t.split("."), i = 0; i < n.length - 1; i++) if ("object" != typeof (r = r[n[i]])) return;
              r = r[n[n.length - 1]];
            }
            return r;
          }
          const g = {
              accountID: void 0,
              trustKey: void 0,
              agentID: void 0,
              licenseKey: void 0,
              applicationID: void 0,
              xpid: void 0
            },
            m = {};
          function v(e) {
            if (!e) throw new Error("All loader-config objects require an agent identifier!");
            if (!m[e]) throw new Error("LoaderConfig for ".concat(e, " was never set"));
            return m[e];
          }
          function b(e, t) {
            if (!e) throw new Error("All loader-config objects require an agent identifier!");
            m[e] = (0, i.D)(t, g), (0, n.Qy)(e, m[e], "loader_config");
          }
          const y = (0, n.mF)().o;
          var w = r(385),
            A = r(6818);
          const x = {
              buildEnv: A.Re,
              bytesSent: {},
              queryBytesSent: {},
              customTransaction: void 0,
              disabled: !1,
              distMethod: A.gF,
              isolatedBacklog: !1,
              loaderType: void 0,
              maxBytes: 3e4,
              offset: Math.floor(w._A?.performance?.timeOrigin || w._A?.performance?.timing?.navigationStart || Date.now()),
              onerror: void 0,
              origin: "" + w._A.location,
              ptid: void 0,
              releaseIds: {},
              session: void 0,
              xhrWrappable: "function" == typeof w._A.XMLHttpRequest?.prototype?.addEventListener,
              version: A.q4,
              denyList: void 0
            },
            E = {};
          function T(e) {
            if (!e) throw new Error("All runtime objects require an agent identifier!");
            if (!E[e]) throw new Error("Runtime for ".concat(e, " was never set"));
            return E[e];
          }
          function _(e, t) {
            if (!e) throw new Error("All runtime objects require an agent identifier!");
            E[e] = (0, i.D)(t, x), (0, n.Qy)(e, E[e], "runtime");
          }
          function D(e) {
            return function (e) {
              try {
                const t = s(e);
                return !!t.licenseKey && !!t.errorBeacon && !!t.applicationID;
              } catch (e) {
                return !1;
              }
            }(e);
          }
        },
        9567: (e, t, r) => {
          r.d(t, {
            D: () => i
          });
          var n = r(50);
          function i(e, t) {
            try {
              if (!e || "object" != typeof e) return (0, n.Z)("Setting a Configurable requires an object as input");
              if (!t || "object" != typeof t) return (0, n.Z)("Setting a Configurable requires a model to set its initial properties");
              const r = Object.create(Object.getPrototypeOf(t), Object.getOwnPropertyDescriptors(t)),
                o = 0 === Object.keys(r).length ? e : r;
              for (let a in o) if (void 0 !== e[a]) try {
                "object" == typeof e[a] && "object" == typeof t[a] ? r[a] = i(e[a], t[a]) : r[a] = e[a];
              } catch (e) {
                (0, n.Z)("An error occurred while setting a property of a Configurable", e);
              }
              return r;
            } catch (e) {
              (0, n.Z)("An error occured while setting a Configurable", e);
            }
          }
        },
        6818: (e, t, r) => {
          r.d(t, {
            Re: () => i,
            gF: () => o,
            q4: () => n
          });
          const n = "1.238.0",
            i = "PROD",
            o = "CDN";
        },
        385: (e, t, r) => {
          r.d(t, {
            FN: () => a,
            IF: () => u,
            Nk: () => l,
            Tt: () => s,
            _A: () => o,
            il: () => n,
            pL: () => c,
            v6: () => i,
            w1: () => d
          });
          const n = "undefined" != typeof window && !!window.document,
            i = "undefined" != typeof WorkerGlobalScope && ("undefined" != typeof self && self instanceof WorkerGlobalScope && self.navigator instanceof WorkerNavigator || "undefined" != typeof globalThis && globalThis instanceof WorkerGlobalScope && globalThis.navigator instanceof WorkerNavigator),
            o = n ? window : "undefined" != typeof WorkerGlobalScope && ("undefined" != typeof self && self instanceof WorkerGlobalScope && self || "undefined" != typeof globalThis && globalThis instanceof WorkerGlobalScope && globalThis),
            a = "" + o?.location,
            s = /iPad|iPhone|iPod/.test(navigator.userAgent),
            c = s && "undefined" == typeof SharedWorker,
            u = (() => {
              const e = navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);
              return Array.isArray(e) && e.length >= 2 ? +e[1] : 0;
            })(),
            d = Boolean(n && window.document.documentMode),
            l = !!navigator.sendBeacon;
        },
        1117: (e, t, r) => {
          r.d(t, {
            w: () => o
          });
          var n = r(50);
          const i = {
            agentIdentifier: "",
            ee: void 0
          };
          class o {
            constructor(e) {
              try {
                if ("object" != typeof e) return (0, n.Z)("shared context requires an object as input");
                this.sharedContext = {}, Object.assign(this.sharedContext, i), Object.entries(e).forEach(e => {
                  let [t, r] = e;
                  Object.keys(i).includes(t) && (this.sharedContext[t] = r);
                });
              } catch (e) {
                (0, n.Z)("An error occured while setting SharedContext", e);
              }
            }
          }
        },
        8e3: (e, t, r) => {
          r.d(t, {
            L: () => d,
            R: () => c
          });
          var n = r(8325),
            i = r(1284),
            o = r(4322),
            a = r(3325);
          const s = {};
          function c(e, t) {
            const r = {
              staged: !1,
              priority: a.p[t] || 0
            };
            u(e), s[e].get(t) || s[e].set(t, r);
          }
          function u(e) {
            e && (s[e] || (s[e] = new Map()));
          }
          function d() {
            let e = arguments.length > 0 && void 0 !== arguments[0] ? arguments[0] : "",
              t = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : "feature";
            if (u(e), !e || !s[e].get(t)) return a(t);
            s[e].get(t).staged = !0;
            const r = [...s[e]];
            function a(t) {
              const r = e ? n.ee.get(e) : n.ee,
                a = o.X.handlers;
              if (r.backlog && a) {
                var s = r.backlog[t],
                  c = a[t];
                if (c) {
                  for (var u = 0; s && u < s.length; ++u) l(s[u], c);
                  (0, i.D)(c, function (e, t) {
                    (0, i.D)(t, function (t, r) {
                      r[0].on(e, r[1]);
                    });
                  });
                }
                delete a[t], r.backlog[t] = null, r.emit("drain-" + t, []);
              }
            }
            r.every(e => {
              let [t, r] = e;
              return r.staged;
            }) && (r.sort((e, t) => e[1].priority - t[1].priority), r.forEach(e => {
              let [t] = e;
              a(t);
            }));
          }
          function l(e, t) {
            var r = e[1];
            (0, i.D)(t[r], function (t, r) {
              var n = e[0];
              if (r[0] === n) {
                var i = r[1],
                  o = e[3],
                  a = e[2];
                i.apply(o, a);
              }
            });
          }
        },
        8325: (e, t, r) => {
          r.d(t, {
            A: () => c,
            ee: () => u
          });
          var n = r(8632),
            i = r(2210),
            o = r(5763);
          class a {
            constructor(e) {
              this.contextId = e;
            }
          }
          var s = r(3117);
          const c = "nr@context:".concat(s.a),
            u = function e(t, r) {
              var n = {},
                s = {},
                d = {},
                f = !1;
              try {
                f = 16 === r.length && (0, o.OP)(r).isolatedBacklog;
              } catch (e) {}
              var h = {
                on: g,
                addEventListener: g,
                removeEventListener: function (e, t) {
                  var r = n[e];
                  if (!r) return;
                  for (var i = 0; i < r.length; i++) r[i] === t && r.splice(i, 1);
                },
                emit: function (e, r, n, i, o) {
                  !1 !== o && (o = !0);
                  if (u.aborted && !i) return;
                  t && o && t.emit(e, r, n);
                  for (var a = p(n), c = m(e), d = c.length, l = 0; l < d; l++) c[l].apply(a, r);
                  var f = b()[s[e]];
                  f && f.push([h, e, r, a]);
                  return a;
                },
                get: v,
                listeners: m,
                context: p,
                buffer: function (e, t) {
                  const r = b();
                  if (t = t || "feature", h.aborted) return;
                  Object.entries(e || {}).forEach(e => {
                    let [n, i] = e;
                    s[i] = t, t in r || (r[t] = []);
                  });
                },
                abort: l,
                aborted: !1,
                isBuffering: function (e) {
                  return !!b()[s[e]];
                },
                debugId: r,
                backlog: f ? {} : t && "object" == typeof t.backlog ? t.backlog : {}
              };
              return h;
              function p(e) {
                return e && e instanceof a ? e : e ? (0, i.X)(e, c, () => new a(c)) : new a(c);
              }
              function g(e, t) {
                n[e] = m(e).concat(t);
              }
              function m(e) {
                return n[e] || [];
              }
              function v(t) {
                return d[t] = d[t] || e(h, t);
              }
              function b() {
                return h.backlog;
              }
            }(void 0, "globalEE"),
            d = (0, n.fP)();
          function l() {
            u.aborted = !0, u.backlog = {};
          }
          d.ee || (d.ee = u);
        },
        5546: (e, t, r) => {
          r.d(t, {
            E: () => n,
            p: () => i
          });
          var n = r(8325).ee.get("handle");
          function i(e, t, r, i, o) {
            o ? (o.buffer([e], i), o.emit(e, t, r)) : (n.buffer([e], i), n.emit(e, t, r));
          }
        },
        4322: (e, t, r) => {
          r.d(t, {
            X: () => o
          });
          var n = r(5546);
          o.on = a;
          var i = o.handlers = {};
          function o(e, t, r, o) {
            a(o || n.E, i, e, t, r);
          }
          function a(e, t, r, i, o) {
            o || (o = "feature"), e || (e = n.E);
            var a = t[o] = t[o] || {};
            (a[r] = a[r] || []).push([e, i]);
          }
        },
        3239: (e, t, r) => {
          r.d(t, {
            bP: () => s,
            iz: () => c,
            m$: () => a
          });
          var n = r(385);
          let i = !1,
            o = !1;
          try {
            const e = {
              get passive() {
                return i = !0, !1;
              },
              get signal() {
                return o = !0, !1;
              }
            };
            n._A.addEventListener("test", null, e), n._A.removeEventListener("test", null, e);
          } catch (e) {}
          function a(e, t) {
            return i || o ? {
              capture: !!e,
              passive: i,
              signal: t
            } : !!e;
          }
          function s(e, t) {
            let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2],
              n = arguments.length > 3 ? arguments[3] : void 0;
            window.addEventListener(e, t, a(r, n));
          }
          function c(e, t) {
            let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2],
              n = arguments.length > 3 ? arguments[3] : void 0;
            document.addEventListener(e, t, a(r, n));
          }
        },
        3117: (e, t, r) => {
          r.d(t, {
            a: () => n
          });
          const n = (0, r(4402).Rl)();
        },
        4402: (e, t, r) => {
          r.d(t, {
            Ht: () => u,
            M: () => c,
            Rl: () => a,
            ky: () => s
          });
          var n = r(385);
          const i = "xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";
          function o(e, t) {
            return e ? 15 & e[t] : 16 * Math.random() | 0;
          }
          function a() {
            const e = n._A?.crypto || n._A?.msCrypto;
            let t,
              r = 0;
            return e && e.getRandomValues && (t = e.getRandomValues(new Uint8Array(31))), i.split("").map(e => "x" === e ? o(t, ++r).toString(16) : "y" === e ? (3 & o() | 8).toString(16) : e).join("");
          }
          function s(e) {
            const t = n._A?.crypto || n._A?.msCrypto;
            let r,
              i = 0;
            t && t.getRandomValues && (r = t.getRandomValues(new Uint8Array(31)));
            const a = [];
            for (var s = 0; s < e; s++) a.push(o(r, ++i).toString(16));
            return a.join("");
          }
          function c() {
            return s(16);
          }
          function u() {
            return s(32);
          }
        },
        7056: (e, t, r) => {
          r.d(t, {
            Bq: () => n,
            Hb: () => o,
            oD: () => i
          });
          const n = "NRBA",
            i = 144e5,
            o = 18e5;
        },
        7894: (e, t, r) => {
          function n() {
            return Math.round(performance.now());
          }
          r.d(t, {
            z: () => n
          });
        },
        7243: (e, t, r) => {
          r.d(t, {
            e: () => o
          });
          var n = r(385),
            i = {};
          function o(e) {
            if (e in i) return i[e];
            if (0 === (e || "").indexOf("data:")) return {
              protocol: "data"
            };
            let t;
            var r = n._A?.location,
              o = {};
            if (n.il) t = document.createElement("a"), t.href = e;else try {
              t = new URL(e, r.href);
            } catch (e) {
              return o;
            }
            o.port = t.port;
            var a = t.href.split("://");
            !o.port && a[1] && (o.port = a[1].split("/")[0].split("@").pop().split(":")[1]), o.port && "0" !== o.port || (o.port = "https" === a[0] ? "443" : "80"), o.hostname = t.hostname || r.hostname, o.pathname = t.pathname, o.protocol = a[0], "/" !== o.pathname.charAt(0) && (o.pathname = "/" + o.pathname);
            var s = !t.protocol || ":" === t.protocol || t.protocol === r.protocol,
              c = t.hostname === r.hostname && t.port === r.port;
            return o.sameOrigin = s && (!t.hostname || c), "/" === o.pathname && (i[e] = o), o;
          }
        },
        50: (e, t, r) => {
          function n(e, t) {
            "function" == typeof console.warn && (console.warn("New Relic: ".concat(e)), t && console.warn(t));
          }
          r.d(t, {
            Z: () => n
          });
        },
        2587: (e, t, r) => {
          r.d(t, {
            N: () => c,
            T: () => u
          });
          var n = r(8325),
            i = r(5546),
            o = r(8e3),
            a = r(3325);
          const s = {
            stn: [a.D.sessionTrace],
            err: [a.D.jserrors, a.D.metrics],
            ins: [a.D.pageAction],
            spa: [a.D.spa],
            sr: [a.D.sessionReplay, a.D.sessionTrace]
          };
          function c(e, t) {
            const r = n.ee.get(t);
            e && "object" == typeof e && (Object.entries(e).forEach(e => {
              let [t, n] = e;
              void 0 === u[t] && (s[t] ? s[t].forEach(e => {
                n ? (0, i.p)("feat-" + t, [], void 0, e, r) : (0, i.p)("block-" + t, [], void 0, e, r), (0, i.p)("rumresp-" + t, [Boolean(n)], void 0, e, r);
              }) : n && (0, i.p)("feat-" + t, [], void 0, void 0, r), u[t] = Boolean(n));
            }), Object.keys(s).forEach(e => {
              void 0 === u[e] && (s[e]?.forEach(t => (0, i.p)("rumresp-" + e, [!1], void 0, t, r)), u[e] = !1);
            }), (0, o.L)(t, a.D.pageViewEvent));
          }
          const u = {};
        },
        2210: (e, t, r) => {
          r.d(t, {
            X: () => i
          });
          var n = Object.prototype.hasOwnProperty;
          function i(e, t, r) {
            if (n.call(e, t)) return e[t];
            var i = r();
            if (Object.defineProperty && Object.keys) try {
              return Object.defineProperty(e, t, {
                value: i,
                writable: !0,
                enumerable: !1
              }), i;
            } catch (e) {}
            return e[t] = i, i;
          }
        },
        1284: (e, t, r) => {
          r.d(t, {
            D: () => n
          });
          const n = (e, t) => Object.entries(e || {}).map(e => {
            let [r, n] = e;
            return t(r, n);
          });
        },
        4351: (e, t, r) => {
          r.d(t, {
            P: () => o
          });
          var n = r(8325);
          const i = () => {
            const e = new WeakSet();
            return (t, r) => {
              if ("object" == typeof r && null !== r) {
                if (e.has(r)) return;
                e.add(r);
              }
              return r;
            };
          };
          function o(e) {
            try {
              return JSON.stringify(e, i());
            } catch (e) {
              try {
                n.ee.emit("internal-error", [e]);
              } catch (e) {}
            }
          }
        },
        3960: (e, t, r) => {
          r.d(t, {
            K: () => a,
            b: () => o
          });
          var n = r(3239);
          function i() {
            return "undefined" == typeof document || "complete" === document.readyState;
          }
          function o(e, t) {
            if (i()) return e();
            (0, n.bP)("load", e, t);
          }
          function a(e) {
            if (i()) return e();
            (0, n.iz)("DOMContentLoaded", e);
          }
        },
        8632: (e, t, r) => {
          r.d(t, {
            EZ: () => u,
            Qy: () => c,
            ce: () => o,
            fP: () => a,
            gG: () => d,
            mF: () => s
          });
          var n = r(7894),
            i = r(385);
          const o = {
            beacon: "bam.nr-data.net",
            errorBeacon: "bam.nr-data.net"
          };
          function a() {
            return i._A.NREUM || (i._A.NREUM = {}), void 0 === i._A.newrelic && (i._A.newrelic = i._A.NREUM), i._A.NREUM;
          }
          function s() {
            let e = a();
            return e.o || (e.o = {
              ST: i._A.setTimeout,
              SI: i._A.setImmediate,
              CT: i._A.clearTimeout,
              XHR: i._A.XMLHttpRequest,
              REQ: i._A.Request,
              EV: i._A.Event,
              PR: i._A.Promise,
              MO: i._A.MutationObserver,
              FETCH: i._A.fetch
            }), e;
          }
          function c(e, t, r) {
            let i = a();
            const o = i.initializedAgents || {},
              s = o[e] || {};
            return Object.keys(s).length || (s.initializedAt = {
              ms: (0, n.z)(),
              date: new Date()
            }), i.initializedAgents = {
              ...o,
              [e]: {
                ...s,
                [r]: t
              }
            }, i;
          }
          function u(e, t) {
            a()[e] = t;
          }
          function d() {
            return function () {
              let e = a();
              const t = e.info || {};
              e.info = {
                beacon: o.beacon,
                errorBeacon: o.errorBeacon,
                ...t
              };
            }(), function () {
              let e = a();
              const t = e.init || {};
              e.init = {
                ...t
              };
            }(), s(), function () {
              let e = a();
              const t = e.loader_config || {};
              e.loader_config = {
                ...t
              };
            }(), a();
          }
        },
        7956: (e, t, r) => {
          r.d(t, {
            N: () => i
          });
          var n = r(3239);
          function i(e) {
            let t = arguments.length > 1 && void 0 !== arguments[1] && arguments[1],
              r = arguments.length > 2 ? arguments[2] : void 0,
              i = arguments.length > 3 ? arguments[3] : void 0;
            return void (0, n.iz)("visibilitychange", function () {
              if (t) return void ("hidden" == document.visibilityState && e());
              e(document.visibilityState);
            }, r, i);
          }
        },
        1214: (e, t, r) => {
          r.d(t, {
            em: () => b,
            u5: () => j,
            QU: () => O,
            _L: () => I,
            Gm: () => H,
            Lg: () => L,
            BV: () => G,
            Kf: () => K
          });
          var n = r(8325),
            i = r(3117);
          const o = "nr@original:".concat(i.a);
          var a = Object.prototype.hasOwnProperty,
            s = !1;
          function c(e, t) {
            return e || (e = n.ee), r.inPlace = function (e, t, n, i, o) {
              n || (n = "");
              const a = "-" === n.charAt(0);
              for (let s = 0; s < t.length; s++) {
                const c = t[s],
                  u = e[c];
                d(u) || (e[c] = r(u, a ? c + n : n, i, c, o));
              }
            }, r.flag = o, r;
            function r(t, r, n, s, c) {
              return d(t) ? t : (r || (r = ""), nrWrapper[o] = t, function (e, t, r) {
                if (Object.defineProperty && Object.keys) try {
                  return Object.keys(e).forEach(function (r) {
                    Object.defineProperty(t, r, {
                      get: function () {
                        return e[r];
                      },
                      set: function (t) {
                        return e[r] = t, t;
                      }
                    });
                  }), t;
                } catch (e) {
                  u([e], r);
                }
                for (var n in e) a.call(e, n) && (t[n] = e[n]);
              }(t, nrWrapper, e), nrWrapper);
              function nrWrapper() {
                var o, a, d, l;
                try {
                  a = this, o = [...arguments], d = "function" == typeof n ? n(o, a) : n || {};
                } catch (t) {
                  u([t, "", [o, a, s], d], e);
                }
                i(r + "start", [o, a, s], d, c);
                try {
                  return l = t.apply(a, o);
                } catch (e) {
                  throw i(r + "err", [o, a, e], d, c), e;
                } finally {
                  i(r + "end", [o, a, l], d, c);
                }
              }
            }
            function i(r, n, i, o) {
              if (!s || t) {
                var a = s;
                s = !0;
                try {
                  e.emit(r, n, i, t, o);
                } catch (t) {
                  u([t, r, n, i], e);
                }
                s = a;
              }
            }
          }
          function u(e, t) {
            t || (t = n.ee);
            try {
              t.emit("internal-error", e);
            } catch (e) {}
          }
          function d(e) {
            return !(e && e instanceof Function && e.apply && !e[o]);
          }
          var l = r(2210),
            f = r(385);
          const h = {},
            p = f._A.XMLHttpRequest,
            g = "addEventListener",
            m = "removeEventListener",
            v = "nr@wrapped:".concat(n.A);
          function b(e) {
            var t = function (e) {
              return (e || n.ee).get("events");
            }(e);
            if (h[t.debugId]++) return t;
            h[t.debugId] = 1;
            var r = c(t, !0);
            function i(e) {
              r.inPlace(e, [g, m], "-", o);
            }
            function o(e, t) {
              return e[1];
            }
            return "getPrototypeOf" in Object && (f.il && y(document, i), y(f._A, i), y(p.prototype, i)), t.on(g + "-start", function (e, t) {
              var n = e[1];
              if (null !== n && ("function" == typeof n || "object" == typeof n)) {
                var i = (0, l.X)(n, v, function () {
                  var e = {
                    object: function () {
                      if ("function" != typeof n.handleEvent) return;
                      return n.handleEvent.apply(n, arguments);
                    },
                    function: n
                  }[typeof n];
                  return e ? r(e, "fn-", null, e.name || "anonymous") : n;
                });
                this.wrapped = e[1] = i;
              }
            }), t.on(m + "-start", function (e) {
              e[1] = this.wrapped || e[1];
            }), t;
          }
          function y(e, t) {
            let r = e;
            for (; "object" == typeof r && !Object.prototype.hasOwnProperty.call(r, g);) r = Object.getPrototypeOf(r);
            for (var n = arguments.length, i = new Array(n > 2 ? n - 2 : 0), o = 2; o < n; o++) i[o - 2] = arguments[o];
            r && t(r, ...i);
          }
          var w = "fetch-",
            A = w + "body-",
            x = ["arrayBuffer", "blob", "json", "text", "formData"],
            E = f._A.Request,
            T = f._A.Response,
            _ = "prototype";
          const D = {};
          function j(e) {
            const t = function (e) {
              return (e || n.ee).get("fetch");
            }(e);
            if (!(E && T && f._A.fetch)) return t;
            if (D[t.debugId]++) return t;
            function r(e, r, i) {
              var o = e[r];
              "function" == typeof o && (e[r] = function () {
                var e,
                  r = [...arguments],
                  a = {};
                t.emit(i + "before-start", [r], a), a[n.A] && a[n.A].dt && (e = a[n.A].dt);
                var s = o.apply(this, r);
                return t.emit(i + "start", [r, e], s), s.then(function (e) {
                  return t.emit(i + "end", [null, e], s), e;
                }, function (e) {
                  throw t.emit(i + "end", [e], s), e;
                });
              });
            }
            return D[t.debugId] = 1, x.forEach(e => {
              r(E[_], e, A), r(T[_], e, A);
            }), r(f._A, "fetch", w), t.on(w + "end", function (e, r) {
              var n = this;
              if (r) {
                var i = r.headers.get("content-length");
                null !== i && (n.rxSize = i), t.emit(w + "done", [null, r], n);
              } else t.emit(w + "done", [e], n);
            }), t;
          }
          const C = {},
            N = ["pushState", "replaceState"];
          function O(e) {
            const t = function (e) {
              return (e || n.ee).get("history");
            }(e);
            return !f.il || C[t.debugId]++ || (C[t.debugId] = 1, c(t).inPlace(window.history, N, "-")), t;
          }
          var S = r(3239);
          const P = {},
            R = ["appendChild", "insertBefore", "replaceChild"];
          function I(e) {
            const t = function (e) {
              return (e || n.ee).get("jsonp");
            }(e);
            if (!f.il || P[t.debugId]) return t;
            P[t.debugId] = !0;
            var r = c(t),
              i = /[?&](?:callback|cb)=([^&#]+)/,
              o = /(.*)\.([^.]+)/,
              a = /^(\w+)(\.|$)(.*)$/;
            function s(e, t) {
              if (!e) return t;
              const r = e.match(a),
                n = r[1];
              return s(r[3], t[n]);
            }
            return r.inPlace(Node.prototype, R, "dom-"), t.on("dom-start", function (e) {
              !function (e) {
                if (!e || "string" != typeof e.nodeName || "script" !== e.nodeName.toLowerCase()) return;
                if ("function" != typeof e.addEventListener) return;
                var n = (a = e.src, c = a.match(i), c ? c[1] : null);
                var a, c;
                if (!n) return;
                var u = function (e) {
                  var t = e.match(o);
                  if (t && t.length >= 3) return {
                    key: t[2],
                    parent: s(t[1], window)
                  };
                  return {
                    key: e,
                    parent: window
                  };
                }(n);
                if ("function" != typeof u.parent[u.key]) return;
                var d = {};
                function l() {
                  t.emit("jsonp-end", [], d), e.removeEventListener("load", l, (0, S.m$)(!1)), e.removeEventListener("error", f, (0, S.m$)(!1));
                }
                function f() {
                  t.emit("jsonp-error", [], d), t.emit("jsonp-end", [], d), e.removeEventListener("load", l, (0, S.m$)(!1)), e.removeEventListener("error", f, (0, S.m$)(!1));
                }
                r.inPlace(u.parent, [u.key], "cb-", d), e.addEventListener("load", l, (0, S.m$)(!1)), e.addEventListener("error", f, (0, S.m$)(!1)), t.emit("new-jsonp", [e.src], d);
              }(e[0]);
            }), t;
          }
          const k = {};
          function H(e) {
            const t = function (e) {
              return (e || n.ee).get("mutation");
            }(e);
            if (!f.il || k[t.debugId]) return t;
            k[t.debugId] = !0;
            var r = c(t),
              i = f._A.MutationObserver;
            return i && (window.MutationObserver = function (e) {
              return this instanceof i ? new i(r(e, "fn-")) : i.apply(this, arguments);
            }, MutationObserver.prototype = i.prototype), t;
          }
          const z = {};
          function L(e) {
            const t = function (e) {
              return (e || n.ee).get("promise");
            }(e);
            if (z[t.debugId]) return t;
            z[t.debugId] = !0;
            var r = t.context,
              i = c(t),
              a = f._A.Promise;
            return a && function () {
              function e(r) {
                var n = t.context(),
                  o = i(r, "executor-", n, null, !1);
                const s = Reflect.construct(a, [o], e);
                return t.context(s).getCtx = function () {
                  return n;
                }, s;
              }
              f._A.Promise = e, Object.defineProperty(e, "name", {
                value: "Promise"
              }), e.toString = function () {
                return a.toString();
              }, Object.setPrototypeOf(e, a), ["all", "race"].forEach(function (r) {
                const n = a[r];
                e[r] = function (e) {
                  let i = !1;
                  [...(e || [])].forEach(e => {
                    this.resolve(e).then(a("all" === r), a(!1));
                  });
                  const o = n.apply(this, arguments);
                  return o;
                  function a(e) {
                    return function () {
                      t.emit("propagate", [null, !i], o, !1, !1), i = i || !e;
                    };
                  }
                };
              }), ["resolve", "reject"].forEach(function (r) {
                const n = a[r];
                e[r] = function (e) {
                  const r = n.apply(this, arguments);
                  return e !== r && t.emit("propagate", [e, !0], r, !1, !1), r;
                };
              }), e.prototype = a.prototype;
              const n = a.prototype.then;
              a.prototype.then = function () {
                var e = this,
                  o = r(e);
                o.promise = e;
                for (var a = arguments.length, s = new Array(a), c = 0; c < a; c++) s[c] = arguments[c];
                s[0] = i(s[0], "cb-", o, null, !1), s[1] = i(s[1], "cb-", o, null, !1);
                const u = n.apply(this, s);
                return o.nextPromise = u, t.emit("propagate", [e, !0], u, !1, !1), u;
              }, a.prototype.then[o] = n, t.on("executor-start", function (e) {
                e[0] = i(e[0], "resolve-", this, null, !1), e[1] = i(e[1], "resolve-", this, null, !1);
              }), t.on("executor-err", function (e, t, r) {
                e[1](r);
              }), t.on("cb-end", function (e, r, n) {
                t.emit("propagate", [n, !0], this.nextPromise, !1, !1);
              }), t.on("propagate", function (e, r, n) {
                this.getCtx && !r || (this.getCtx = function () {
                  if (e instanceof Promise) var r = t.context(e);
                  return r && r.getCtx ? r.getCtx() : this;
                });
              });
            }(), t;
          }
          const M = {},
            B = "setTimeout",
            F = "setInterval",
            U = "clearTimeout",
            q = "-start",
            Z = "-",
            V = [B, "setImmediate", F, U, "clearImmediate"];
          function G(e) {
            const t = function (e) {
              return (e || n.ee).get("timer");
            }(e);
            if (M[t.debugId]++) return t;
            M[t.debugId] = 1;
            var r = c(t);
            return r.inPlace(f._A, V.slice(0, 2), B + Z), r.inPlace(f._A, V.slice(2, 3), F + Z), r.inPlace(f._A, V.slice(3), U + Z), t.on(F + q, function (e, t, n) {
              e[0] = r(e[0], "fn-", null, n);
            }), t.on(B + q, function (e, t, n) {
              this.method = n, this.timerDuration = isNaN(e[1]) ? 0 : +e[1], e[0] = r(e[0], "fn-", this, n);
            }), t;
          }
          var W = r(50);
          const X = {},
            Q = ["open", "send"];
          function K(e) {
            var t = e || n.ee;
            const r = function (e) {
              return (e || n.ee).get("xhr");
            }(t);
            if (X[r.debugId]++) return r;
            X[r.debugId] = 1, b(t);
            var i = c(r),
              o = f._A.XMLHttpRequest,
              a = f._A.MutationObserver,
              s = f._A.Promise,
              u = f._A.setInterval,
              d = "readystatechange",
              l = ["onload", "onerror", "onabort", "onloadstart", "onloadend", "onprogress", "ontimeout"],
              h = [],
              p = f._A.XMLHttpRequest = function (e) {
                const t = new o(e),
                  n = r.context(t);
                try {
                  r.emit("new-xhr", [t], n), t.addEventListener(d, (a = n, function () {
                    var e = this;
                    e.readyState > 3 && !a.resolved && (a.resolved = !0, r.emit("xhr-resolved", [], e)), i.inPlace(e, l, "fn-", A);
                  }), (0, S.m$)(!1));
                } catch (e) {
                  (0, W.Z)("An error occurred while intercepting XHR", e);
                  try {
                    r.emit("internal-error", [e]);
                  } catch (e) {}
                }
                var a;
                return t;
              };
            function g(e, t) {
              i.inPlace(t, ["onreadystatechange"], "fn-", A);
            }
            if (function (e, t) {
              for (var r in e) t[r] = e[r];
            }(o, p), p.prototype = o.prototype, i.inPlace(p.prototype, Q, "-xhr-", A), r.on("send-xhr-start", function (e, t) {
              g(e, t), function (e) {
                h.push(e), a && (m ? m.then(w) : u ? u(w) : (v = -v, y.data = v));
              }(t);
            }), r.on("open-xhr-start", g), a) {
              var m = s && s.resolve();
              if (!u && !s) {
                var v = 1,
                  y = document.createTextNode(v);
                new a(w).observe(y, {
                  characterData: !0
                });
              }
            } else t.on("fn-end", function (e) {
              e[0] && e[0].type === d || w();
            });
            function w() {
              for (var e = 0; e < h.length; e++) g(0, h[e]);
              h.length && (h = []);
            }
            function A(e, t) {
              return t;
            }
            return r;
          }
        },
        7825: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.ajax;
        },
        6660: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.jserrors;
        },
        3081: (e, t, r) => {
          r.d(t, {
            gF: () => o,
            mY: () => i,
            t9: () => n,
            vz: () => s,
            xS: () => a
          });
          const n = r(3325).D.metrics,
            i = "sm",
            o = "cm",
            a = "storeSupportabilityMetrics",
            s = "storeEventMetrics";
        },
        4649: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.pageAction;
        },
        7633: (e, t, r) => {
          r.d(t, {
            Dz: () => i,
            OJ: () => a,
            qw: () => o,
            t9: () => n
          });
          const n = r(3325).D.pageViewEvent,
            i = "firstbyte",
            o = "domcontent",
            a = "windowload";
        },
        9251: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.pageViewTiming;
        },
        3614: (e, t, r) => {
          r.d(t, {
            BST_RESOURCE: () => i,
            END: () => s,
            FEATURE_NAME: () => n,
            FN_END: () => u,
            FN_START: () => c,
            PUSH_STATE: () => d,
            RESOURCE: () => o,
            START: () => a
          });
          const n = r(3325).D.sessionTrace,
            i = "bstResource",
            o = "resource",
            a = "-start",
            s = "-end",
            c = "fn" + a,
            u = "fn" + s,
            d = "pushState";
        },
        7836: (e, t, r) => {
          r.d(t, {
            BODY: () => x,
            CB_END: () => E,
            CB_START: () => u,
            END: () => A,
            FEATURE_NAME: () => i,
            FETCH: () => _,
            FETCH_BODY: () => v,
            FETCH_DONE: () => m,
            FETCH_START: () => g,
            FN_END: () => c,
            FN_START: () => s,
            INTERACTION: () => f,
            INTERACTION_API: () => d,
            INTERACTION_EVENTS: () => o,
            JSONP_END: () => b,
            JSONP_NODE: () => p,
            JS_TIME: () => T,
            MAX_TIMER_BUDGET: () => a,
            REMAINING: () => l,
            SPA_NODE: () => h,
            START: () => w,
            originalSetTimeout: () => y
          });
          var n = r(5763);
          const i = r(3325).D.spa,
            o = ["click", "submit", "keypress", "keydown", "keyup", "change"],
            a = 999,
            s = "fn-start",
            c = "fn-end",
            u = "cb-start",
            d = "api-ixn-",
            l = "remaining",
            f = "interaction",
            h = "spaNode",
            p = "jsonpNode",
            g = "fetch-start",
            m = "fetch-done",
            v = "fetch-body-",
            b = "jsonp-end",
            y = n.Yu.ST,
            w = "-start",
            A = "-end",
            x = "-body",
            E = "cb" + A,
            T = "jsTime",
            _ = "fetch";
        },
        5938: (e, t, r) => {
          r.d(t, {
            W: () => o
          });
          var n = r(5763),
            i = r(8325);
          class o {
            constructor(e, t, r) {
              this.agentIdentifier = e, this.aggregator = t, this.ee = i.ee.get(e, (0, n.OP)(this.agentIdentifier).isolatedBacklog), this.featureName = r, this.blocked = !1;
            }
          }
        },
        9144: (e, t, r) => {
          r.d(t, {
            j: () => m
          });
          var n = r(3325),
            i = r(5763),
            o = r(5546),
            a = r(8325),
            s = r(7894),
            c = r(8e3),
            u = r(3960),
            d = r(385),
            l = r(50),
            f = r(3081),
            h = r(8632);
          function p() {
            const e = (0, h.gG)();
            ["setErrorHandler", "finished", "addToTrace", "inlineHit", "addRelease", "addPageAction", "setCurrentRouteName", "setPageViewName", "setCustomAttribute", "interaction", "noticeError", "setUserId", "setApplicationVersion"].forEach(t => {
              e[t] = function () {
                for (var r = arguments.length, n = new Array(r), i = 0; i < r; i++) n[i] = arguments[i];
                return function (t) {
                  for (var r = arguments.length, n = new Array(r > 1 ? r - 1 : 0), i = 1; i < r; i++) n[i - 1] = arguments[i];
                  let o = [];
                  return Object.values(e.initializedAgents).forEach(e => {
                    e.exposed && e.api[t] && o.push(e.api[t](...n));
                  }), o.length > 1 ? o : o[0];
                }(t, ...n);
              };
            });
          }
          var g = r(2587);
          function m(e) {
            let t = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : {},
              m = arguments.length > 2 ? arguments[2] : void 0,
              v = arguments.length > 3 ? arguments[3] : void 0,
              {
                init: b,
                info: y,
                loader_config: w,
                runtime: A = {
                  loaderType: m
                },
                exposed: x = !0
              } = t;
            const E = (0, h.gG)();
            y || (b = E.init, y = E.info, w = E.loader_config), (0, i.Dg)(e, b || {}), (0, i.GE)(e, w || {}), y.jsAttributes ??= {}, d.v6 && (y.jsAttributes.isWorker = !0), (0, i.CX)(e, y);
            const T = (0, i.P_)(e);
            A.denyList = [...(T.ajax?.deny_list || []), ...(T.ajax?.block_internal ? [y.beacon, y.errorBeacon] : [])], (0, i.sU)(e, A), p();
            const _ = function (e, t) {
              t || (0, c.R)(e, "api");
              const h = {};
              var p = a.ee.get(e),
                g = p.get("tracer"),
                m = "api-",
                v = m + "ixn-";
              function b(t, r, n, o) {
                const a = (0, i.C5)(e);
                return null === r ? delete a.jsAttributes[t] : (0, i.CX)(e, {
                  ...a,
                  jsAttributes: {
                    ...a.jsAttributes,
                    [t]: r
                  }
                }), A(m, n, !0, o || null === r ? "session" : void 0)(t, r);
              }
              function y() {}
              ["setErrorHandler", "finished", "addToTrace", "inlineHit", "addRelease"].forEach(e => h[e] = A(m, e, !0, "api")), h.addPageAction = A(m, "addPageAction", !0, n.D.pageAction), h.setCurrentRouteName = A(m, "routeName", !0, n.D.spa), h.setPageViewName = function (t, r) {
                if ("string" == typeof t) return "/" !== t.charAt(0) && (t = "/" + t), (0, i.OP)(e).customTransaction = (r || "http://custom.transaction") + t, A(m, "setPageViewName", !0)();
              }, h.setCustomAttribute = function (e, t) {
                let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2];
                if ("string" == typeof e) {
                  if (["string", "number"].includes(typeof t) || null === t) return b(e, t, "setCustomAttribute", r);
                  (0, l.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t, "> was provided."));
                } else (0, l.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e, "> was provided."));
              }, h.setUserId = function (e) {
                if ("string" == typeof e || null === e) return b("enduser.id", e, "setUserId", !0);
                (0, l.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e, "> was provided."));
              }, h.setApplicationVersion = function (e) {
                if ("string" == typeof e || null === e) return b("application.version", e, "setApplicationVersion", !1);
                (0, l.Z)("Failed to execute setApplicationVersion. Expected <String | null>, but got <".concat(typeof e, ">."));
              }, h.interaction = function () {
                return new y().get();
              };
              var w = y.prototype = {
                createTracer: function (e, t) {
                  var r = {},
                    i = this,
                    a = "function" == typeof t;
                  return (0, o.p)(v + "tracer", [(0, s.z)(), e, r], i, n.D.spa, p), function () {
                    if (g.emit((a ? "" : "no-") + "fn-start", [(0, s.z)(), i, a], r), a) try {
                      return t.apply(this, arguments);
                    } catch (e) {
                      throw g.emit("fn-err", [arguments, this, e], r), e;
                    } finally {
                      g.emit("fn-end", [(0, s.z)()], r);
                    }
                  };
                }
              };
              function A(e, t, r, i) {
                return function () {
                  return (0, o.p)(f.xS, ["API/" + t + "/called"], void 0, n.D.metrics, p), i && (0, o.p)(e + t, [(0, s.z)(), ...arguments], r ? null : this, i, p), r ? void 0 : this;
                };
              }
              function x() {
                r.e(111).then(r.bind(r, 7438)).then(t => {
                  let {
                    setAPI: r
                  } = t;
                  r(e), (0, c.L)(e, "api");
                }).catch(() => (0, l.Z)("Downloading runtime APIs failed..."));
              }
              return ["actionText", "setName", "setAttribute", "save", "ignore", "onEnd", "getContext", "end", "get"].forEach(e => {
                w[e] = A(v, e, void 0, n.D.spa);
              }), h.noticeError = function (e, t) {
                "string" == typeof e && (e = new Error(e)), (0, o.p)(f.xS, ["API/noticeError/called"], void 0, n.D.metrics, p), (0, o.p)("err", [e, (0, s.z)(), !1, t], void 0, n.D.jserrors, p);
              }, d.il ? (0, u.b)(() => x(), !0) : x(), h;
            }(e, v);
            return (0, h.Qy)(e, _, "api"), (0, h.Qy)(e, x, "exposed"), (0, h.EZ)("activatedFeatures", g.T), _;
          }
        },
        3325: (e, t, r) => {
          r.d(t, {
            D: () => n,
            p: () => i
          });
          const n = {
              ajax: "ajax",
              jserrors: "jserrors",
              metrics: "metrics",
              pageAction: "page_action",
              pageViewEvent: "page_view_event",
              pageViewTiming: "page_view_timing",
              sessionReplay: "session_replay",
              sessionTrace: "session_trace",
              spa: "spa"
            },
            i = {
              [n.pageViewEvent]: 1,
              [n.pageViewTiming]: 2,
              [n.metrics]: 3,
              [n.jserrors]: 4,
              [n.ajax]: 5,
              [n.sessionTrace]: 6,
              [n.pageAction]: 7,
              [n.spa]: 8,
              [n.sessionReplay]: 9
            };
        }
      },
      n = {};
    function i(e) {
      var t = n[e];
      if (void 0 !== t) return t.exports;
      var o = n[e] = {
        exports: {}
      };
      return r[e](o, o.exports, i), o.exports;
    }
    i.m = r, i.d = (e, t) => {
      for (var r in t) i.o(t, r) && !i.o(e, r) && Object.defineProperty(e, r, {
        enumerable: !0,
        get: t[r]
      });
    }, i.f = {}, i.e = e => Promise.all(Object.keys(i.f).reduce((t, r) => (i.f[r](e, t), t), [])), i.u = e => "nr-spa.1097a448-1.238.0.min.js", i.o = (e, t) => Object.prototype.hasOwnProperty.call(e, t), e = {}, t = "NRBA-1.238.0.PROD:", i.l = (r, n, o, a) => {
      if (e[r]) e[r].push(n);else {
        var s, c;
        if (void 0 !== o) for (var u = document.getElementsByTagName("script"), d = 0; d < u.length; d++) {
          var l = u[d];
          if (l.getAttribute("src") == r || l.getAttribute("data-webpack") == t + o) {
            s = l;
            break;
          }
        }
        s || (c = !0, (s = document.createElement("script")).charset = "utf-8", s.timeout = 120, i.nc && s.setAttribute("nonce", i.nc), s.setAttribute("data-webpack", t + o), s.src = r), e[r] = [n];
        var f = (t, n) => {
            s.onerror = s.onload = null, clearTimeout(h);
            var i = e[r];
            if (delete e[r], s.parentNode && s.parentNode.removeChild(s), i && i.forEach(e => e(n)), t) return t(n);
          },
          h = setTimeout(f.bind(null, void 0, {
            type: "timeout",
            target: s
          }), 12e4);
        s.onerror = f.bind(null, s.onerror), s.onload = f.bind(null, s.onload), c && document.head.appendChild(s);
      }
    }, i.r = e => {
      "undefined" != typeof Symbol && Symbol.toStringTag && Object.defineProperty(e, Symbol.toStringTag, {
        value: "Module"
      }), Object.defineProperty(e, "__esModule", {
        value: !0
      });
    }, i.p = "https://js-agent.newrelic.com/", (() => {
      var e = {
        801: 0,
        92: 0
      };
      i.f.j = (t, r) => {
        var n = i.o(e, t) ? e[t] : void 0;
        if (0 !== n) if (n) r.push(n[2]);else {
          var o = new Promise((r, i) => n = e[t] = [r, i]);
          r.push(n[2] = o);
          var a = i.p + i.u(t),
            s = new Error();
          i.l(a, r => {
            if (i.o(e, t) && (0 !== (n = e[t]) && (e[t] = void 0), n)) {
              var o = r && ("load" === r.type ? "missing" : r.type),
                a = r && r.target && r.target.src;
              s.message = "Loading chunk " + t + " failed.\n(" + o + ": " + a + ")", s.name = "ChunkLoadError", s.type = o, s.request = a, n[1](s);
            }
          }, "chunk-" + t, t);
        }
      };
      var t = (t, r) => {
          var n,
            o,
            [a, s, c] = r,
            u = 0;
          if (a.some(t => 0 !== e[t])) {
            for (n in s) i.o(s, n) && (i.m[n] = s[n]);
            if (c) c(i);
          }
          for (t && t(r); u < a.length; u++) o = a[u], i.o(e, o) && e[o] && e[o][0](), e[o] = 0;
        },
        r = self["webpackChunk:NRBA-1.238.0.PROD"] = self["webpackChunk:NRBA-1.238.0.PROD"] || [];
      r.forEach(t.bind(null, 0)), r.push = t.bind(null, r.push.bind(r));
    })(), (() => {
      var e = i(50);
      class t {
        addPageAction(t, r) {
          (0, e.Z)("Call to agent api addPageAction failed. The session trace feature is not currently initialized.");
        }
        setPageViewName(t, r) {
          (0, e.Z)("Call to agent api setPageViewName failed. The page view feature is not currently initialized.");
        }
        setCustomAttribute(t, r, n) {
          (0, e.Z)("Call to agent api setCustomAttribute failed. The js errors feature is not currently initialized.");
        }
        noticeError(t, r) {
          (0, e.Z)("Call to agent api noticeError failed. The js errors feature is not currently initialized.");
        }
        setUserId(t) {
          (0, e.Z)("Call to agent api setUserId failed. The js errors feature is not currently initialized.");
        }
        setApplicationVersion(t) {
          (0, e.Z)("Call to agent api setApplicationVersion failed. The agent is not currently initialized.");
        }
        setErrorHandler(t) {
          (0, e.Z)("Call to agent api setErrorHandler failed. The js errors feature is not currently initialized.");
        }
        finished(t) {
          (0, e.Z)("Call to agent api finished failed. The page action feature is not currently initialized.");
        }
        addRelease(t, r) {
          (0, e.Z)("Call to agent api addRelease failed. The agent is not currently initialized.");
        }
      }
      var r = i(3325),
        n = i(5763);
      const o = Object.values(r.D);
      function a(e) {
        const t = {};
        return o.forEach(r => {
          t[r] = function (e, t) {
            return !1 !== (0, n.Mt)(t, "".concat(e, ".enabled"));
          }(r, e);
        }), t;
      }
      var s = i(9144);
      var c = i(5546),
        u = i(385),
        d = i(8e3),
        l = i(5938),
        f = i(3960);
      class h extends l.W {
        constructor(e, t, r) {
          let n = !(arguments.length > 3 && void 0 !== arguments[3]) || arguments[3];
          super(e, t, r), this.auto = n, this.abortHandler, this.featAggregate, this.onAggregateImported, n && (0, d.R)(e, r);
        }
        importAggregator() {
          let t = arguments.length > 0 && void 0 !== arguments[0] ? arguments[0] : {};
          if (this.featAggregate || !this.auto) return;
          const r = u.il && !0 === (0, n.Mt)(this.agentIdentifier, "privacy.cookies_enabled");
          let o;
          this.onAggregateImported = new Promise(e => {
            o = e;
          });
          const a = async () => {
            let n;
            try {
              if (r) {
                const {
                  setupAgentSession: e
                } = await i.e(111).then(i.bind(i, 3228));
                n = e(this.agentIdentifier);
              }
            } catch (t) {
              (0, e.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.", t);
            }
            try {
              if (!this.shouldImportAgg(this.featureName, n)) return (0, d.L)(this.agentIdentifier, this.featureName), void o(!1);
              const {
                  lazyFeatureLoader: e
                } = await i.e(111).then(i.bind(i, 8582)),
                {
                  Aggregate: r
                } = await e(this.featureName, "aggregate");
              this.featAggregate = new r(this.agentIdentifier, this.aggregator, t), o(!0);
            } catch (t) {
              (0, e.Z)("Downloading and initializing ".concat(this.featureName, " failed..."), t), this.abortHandler?.(), o(!1);
            }
          };
          u.il ? (0, f.b)(() => a(), !0) : a();
        }
        shouldImportAgg(e, t) {
          return e !== r.D.sessionReplay || !!n.Yu.MO && !1 !== (0, n.Mt)(this.agentIdentifier, "session_trace.enabled") && (!!t?.isNew || !!t?.state.sessionReplay);
        }
      }
      var p = i(7633),
        g = i(7894);
      class m extends h {
        static featureName = p.t9;
        constructor(e, t) {
          let i = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          if (super(e, t, p.t9, i), ("undefined" == typeof PerformanceNavigationTiming || u.Tt) && "undefined" != typeof PerformanceTiming) {
            const t = (0, n.OP)(e);
            t[p.Dz] = Math.max(Date.now() - t.offset, 0), (0, f.K)(() => t[p.qw] = Math.max((0, g.z)() - t[p.Dz], 0)), (0, f.b)(() => {
              const e = (0, g.z)();
              t[p.OJ] = Math.max(e - t[p.Dz], 0), (0, c.p)("timing", ["load", e], void 0, r.D.pageViewTiming, this.ee);
            });
          }
          this.importAggregator();
        }
      }
      var v = i(1117),
        b = i(1284);
      class y extends v.w {
        constructor(e) {
          super(e), this.aggregatedData = {};
        }
        store(e, t, r, n, i) {
          var o = this.getBucket(e, t, r, i);
          return o.metrics = function (e, t) {
            t || (t = {
              count: 0
            });
            return t.count += 1, (0, b.D)(e, function (e, r) {
              t[e] = w(r, t[e]);
            }), t;
          }(n, o.metrics), o;
        }
        merge(e, t, r, n, i) {
          var o = this.getBucket(e, t, n, i);
          if (o.metrics) {
            var a = o.metrics;
            a.count += r.count, (0, b.D)(r, function (e, t) {
              if ("count" !== e) {
                var n = a[e],
                  i = r[e];
                i && !i.c ? a[e] = w(i.t, n) : a[e] = function (e, t) {
                  if (!t) return e;
                  t.c || (t = A(t.t));
                  return t.min = Math.min(e.min, t.min), t.max = Math.max(e.max, t.max), t.t += e.t, t.sos += e.sos, t.c += e.c, t;
                }(i, a[e]);
              }
            });
          } else o.metrics = r;
        }
        storeMetric(e, t, r, n) {
          var i = this.getBucket(e, t, r);
          return i.stats = w(n, i.stats), i;
        }
        getBucket(e, t, r, n) {
          this.aggregatedData[e] || (this.aggregatedData[e] = {});
          var i = this.aggregatedData[e][t];
          return i || (i = this.aggregatedData[e][t] = {
            params: r || {}
          }, n && (i.custom = n)), i;
        }
        get(e, t) {
          return t ? this.aggregatedData[e] && this.aggregatedData[e][t] : this.aggregatedData[e];
        }
        take(e) {
          for (var t = {}, r = "", n = !1, i = 0; i < e.length; i++) t[r = e[i]] = x(this.aggregatedData[r]), t[r].length && (n = !0), delete this.aggregatedData[r];
          return n ? t : null;
        }
      }
      function w(e, t) {
        return null == e ? function (e) {
          e ? e.c++ : e = {
            c: 1
          };
          return e;
        }(t) : t ? (t.c || (t = A(t.t)), t.c += 1, t.t += e, t.sos += e * e, e > t.max && (t.max = e), e < t.min && (t.min = e), t) : {
          t: e
        };
      }
      function A(e) {
        return {
          t: e,
          min: e,
          max: e,
          sos: e * e,
          c: 1
        };
      }
      function x(e) {
        return "object" != typeof e ? [] : (0, b.D)(e, E);
      }
      function E(e, t) {
        return t;
      }
      var T = i(8632),
        _ = i(4402),
        D = i(4351);
      var j = i(7956),
        C = i(3239),
        N = i(9251);
      class O extends h {
        static featureName = N.t;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, N.t, r), u.il && ((0, n.OP)(e).initHidden = Boolean("hidden" === document.visibilityState), (0, j.N)(() => (0, c.p)("docHidden", [(0, g.z)()], void 0, N.t, this.ee), !0), (0, C.bP)("pagehide", () => (0, c.p)("winPagehide", [(0, g.z)()], void 0, N.t, this.ee)), this.importAggregator());
        }
      }
      var S = i(3081);
      class P extends h {
        static featureName = S.t9;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, S.t9, r), this.importAggregator();
        }
      }
      var R = i(6660);
      class I {
        constructor(e, t, r, n) {
          this.name = "UncaughtError", this.message = e, this.sourceURL = t, this.line = r, this.column = n;
        }
      }
      class k extends h {
        static featureName = R.t;
        #e = new Set();
        constructor(e, t) {
          let n = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, R.t, n);
          try {
            this.removeOnAbort = new AbortController();
          } catch (e) {}
          this.ee.on("fn-err", (e, t, n) => {
            this.abortHandler && !this.#e.has(n) && (this.#e.add(n), (0, c.p)("err", [this.#t(n), (0, g.z)()], void 0, r.D.jserrors, this.ee));
          }), this.ee.on("internal-error", e => {
            this.abortHandler && (0, c.p)("ierr", [this.#t(e), (0, g.z)(), !0], void 0, r.D.jserrors, this.ee);
          }), u._A.addEventListener("unhandledrejection", e => {
            this.abortHandler && (0, c.p)("err", [this.#r(e), (0, g.z)(), !1, {
              unhandledPromiseRejection: 1
            }], void 0, r.D.jserrors, this.ee);
          }, (0, C.m$)(!1, this.removeOnAbort?.signal)), u._A.addEventListener("error", e => {
            this.abortHandler && (this.#e.has(e.error) ? this.#e.delete(e.error) : (0, c.p)("err", [this.#n(e), (0, g.z)()], void 0, r.D.jserrors, this.ee));
          }, (0, C.m$)(!1, this.removeOnAbort?.signal)), this.abortHandler = this.#i, this.importAggregator();
        }
        #i() {
          this.removeOnAbort?.abort(), this.#e.clear(), this.abortHandler = void 0;
        }
        #t(e) {
          return e instanceof Error ? e : void 0 !== e?.message ? new I(e.message, e.filename || e.sourceURL, e.lineno || e.line, e.colno || e.col) : new I("string" == typeof e ? e : (0, D.P)(e));
        }
        #r(e) {
          let t = "Unhandled Promise Rejection: ";
          if (e?.reason instanceof Error) try {
            return e.reason.message = t + e.reason.message, e.reason;
          } catch (t) {
            return e.reason;
          }
          if (void 0 === e.reason) return new I(t);
          const r = this.#t(e.reason);
          return r.message = t + r.message, r;
        }
        #n(e) {
          return e.error instanceof Error ? e.error : new I(e.message, e.filename, e.lineno, e.colno);
        }
      }
      var H = i(2210);
      let z = 1;
      const L = "nr@id";
      function M(e) {
        const t = typeof e;
        return !e || "object" !== t && "function" !== t ? -1 : e === u._A ? 0 : (0, H.X)(e, L, function () {
          return z++;
        });
      }
      function B(e) {
        if ("string" == typeof e && e.length) return e.length;
        if ("object" == typeof e) {
          if ("undefined" != typeof ArrayBuffer && e instanceof ArrayBuffer && e.byteLength) return e.byteLength;
          if ("undefined" != typeof Blob && e instanceof Blob && e.size) return e.size;
          if (!("undefined" != typeof FormData && e instanceof FormData)) try {
            return (0, D.P)(e).length;
          } catch (e) {
            return;
          }
        }
      }
      var F = i(1214),
        U = i(7243);
      class q {
        constructor(e) {
          this.agentIdentifier = e;
        }
        generateTracePayload(e) {
          if (!this.shouldGenerateTrace(e)) return null;
          var t = (0, n.DL)(this.agentIdentifier);
          if (!t) return null;
          var r = (t.accountID || "").toString() || null,
            i = (t.agentID || "").toString() || null,
            o = (t.trustKey || "").toString() || null;
          if (!r || !i) return null;
          var a = (0, _.M)(),
            s = (0, _.Ht)(),
            c = Date.now(),
            u = {
              spanId: a,
              traceId: s,
              timestamp: c
            };
          return (e.sameOrigin || this.isAllowedOrigin(e) && this.useTraceContextHeadersForCors()) && (u.traceContextParentHeader = this.generateTraceContextParentHeader(a, s), u.traceContextStateHeader = this.generateTraceContextStateHeader(a, c, r, i, o)), (e.sameOrigin && !this.excludeNewrelicHeader() || !e.sameOrigin && this.isAllowedOrigin(e) && this.useNewrelicHeaderForCors()) && (u.newrelicHeader = this.generateTraceHeader(a, s, c, r, i, o)), u;
        }
        generateTraceContextParentHeader(e, t) {
          return "00-" + t + "-" + e + "-01";
        }
        generateTraceContextStateHeader(e, t, r, n, i) {
          return i + "@nr=0-1-" + r + "-" + n + "-" + e + "----" + t;
        }
        generateTraceHeader(e, t, r, n, i, o) {
          if (!("function" == typeof u._A?.btoa)) return null;
          var a = {
            v: [0, 1],
            d: {
              ty: "Browser",
              ac: n,
              ap: i,
              id: e,
              tr: t,
              ti: r
            }
          };
          return o && n !== o && (a.d.tk = o), btoa((0, D.P)(a));
        }
        shouldGenerateTrace(e) {
          return this.isDtEnabled() && this.isAllowedOrigin(e);
        }
        isAllowedOrigin(e) {
          var t = !1,
            r = {};
          if ((0, n.Mt)(this.agentIdentifier, "distributed_tracing") && (r = (0, n.P_)(this.agentIdentifier).distributed_tracing), e.sameOrigin) t = !0;else if (r.allowed_origins instanceof Array) for (var i = 0; i < r.allowed_origins.length; i++) {
            var o = (0, U.e)(r.allowed_origins[i]);
            if (e.hostname === o.hostname && e.protocol === o.protocol && e.port === o.port) {
              t = !0;
              break;
            }
          }
          return t;
        }
        isDtEnabled() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.enabled;
        }
        excludeNewrelicHeader() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.exclude_newrelic_header;
        }
        useNewrelicHeaderForCors() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !1 !== e.cors_use_newrelic_header;
        }
        useTraceContextHeadersForCors() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.cors_use_tracecontext_headers;
        }
      }
      var Z = i(7825),
        V = ["load", "error", "abort", "timeout"],
        G = V.length,
        W = n.Yu.REQ,
        X = n.Yu.XHR;
      class Q extends h {
        static featureName = Z.t;
        constructor(e, t) {
          let i = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, Z.t, i), (0, n.OP)(e).xhrWrappable && (this.dt = new q(e), this.handler = (e, t, r, n) => (0, c.p)(e, t, r, n, this.ee), (0, F.u5)(this.ee), (0, F.Kf)(this.ee), function (e, t, i, o) {
            function a(e) {
              var t = this;
              t.totalCbs = 0, t.called = 0, t.cbTime = 0, t.end = E, t.ended = !1, t.xhrGuids = {}, t.lastSize = null, t.loadCaptureCalled = !1, t.params = this.params || {}, t.metrics = this.metrics || {}, e.addEventListener("load", function (r) {
                _(t, e);
              }, (0, C.m$)(!1)), u.IF || e.addEventListener("progress", function (e) {
                t.lastSize = e.loaded;
              }, (0, C.m$)(!1));
            }
            function s(e) {
              this.params = {
                method: e[0]
              }, T(this, e[1]), this.metrics = {};
            }
            function c(t, r) {
              var i = (0, n.DL)(e);
              i.xpid && this.sameOrigin && r.setRequestHeader("X-NewRelic-ID", i.xpid);
              var a = o.generateTracePayload(this.parsedOrigin);
              if (a) {
                var s = !1;
                a.newrelicHeader && (r.setRequestHeader("newrelic", a.newrelicHeader), s = !0), a.traceContextParentHeader && (r.setRequestHeader("traceparent", a.traceContextParentHeader), a.traceContextStateHeader && r.setRequestHeader("tracestate", a.traceContextStateHeader), s = !0), s && (this.dt = a);
              }
            }
            function d(e, r) {
              var n = this.metrics,
                i = e[0],
                o = this;
              if (n && i) {
                var a = B(i);
                a && (n.txSize = a);
              }
              this.startTime = (0, g.z)(), this.listener = function (e) {
                try {
                  "abort" !== e.type || o.loadCaptureCalled || (o.params.aborted = !0), ("load" !== e.type || o.called === o.totalCbs && (o.onloadCalled || "function" != typeof r.onload) && "function" == typeof o.end) && o.end(r);
                } catch (e) {
                  try {
                    t.emit("internal-error", [e]);
                  } catch (e) {}
                }
              };
              for (var s = 0; s < G; s++) r.addEventListener(V[s], this.listener, (0, C.m$)(!1));
            }
            function l(e, t, r) {
              this.cbTime += e, t ? this.onloadCalled = !0 : this.called += 1, this.called !== this.totalCbs || !this.onloadCalled && "function" == typeof r.onload || "function" != typeof this.end || this.end(r);
            }
            function f(e, t) {
              var r = "" + M(e) + !!t;
              this.xhrGuids && !this.xhrGuids[r] && (this.xhrGuids[r] = !0, this.totalCbs += 1);
            }
            function h(e, t) {
              var r = "" + M(e) + !!t;
              this.xhrGuids && this.xhrGuids[r] && (delete this.xhrGuids[r], this.totalCbs -= 1);
            }
            function p() {
              this.endTime = (0, g.z)();
            }
            function m(e, r) {
              r instanceof X && "load" === e[0] && t.emit("xhr-load-added", [e[1], e[2]], r);
            }
            function v(e, r) {
              r instanceof X && "load" === e[0] && t.emit("xhr-load-removed", [e[1], e[2]], r);
            }
            function b(e, t, r) {
              t instanceof X && ("onload" === r && (this.onload = !0), ("load" === (e[0] && e[0].type) || this.onload) && (this.xhrCbStart = (0, g.z)()));
            }
            function y(e, r) {
              this.xhrCbStart && t.emit("xhr-cb-time", [(0, g.z)() - this.xhrCbStart, this.onload, r], r);
            }
            function w(e) {
              var t,
                r = e[1] || {};
              if ("string" == typeof e[0] ? 0 === (t = e[0]).length && u.il && (t = "" + u._A.location.href) : e[0] && e[0].url ? t = e[0].url : u._A?.URL && e[0] && e[0] instanceof URL ? t = e[0].href : "function" == typeof e[0].toString && (t = e[0].toString()), "string" == typeof t && 0 !== t.length) {
                t && (this.parsedOrigin = (0, U.e)(t), this.sameOrigin = this.parsedOrigin.sameOrigin);
                var n = o.generateTracePayload(this.parsedOrigin);
                if (n && (n.newrelicHeader || n.traceContextParentHeader)) if (e[0] && e[0].headers) s(e[0].headers, n) && (this.dt = n);else {
                  var i = {};
                  for (var a in r) i[a] = r[a];
                  i.headers = new Headers(r.headers || {}), s(i.headers, n) && (this.dt = n), e.length > 1 ? e[1] = i : e.push(i);
                }
              }
              function s(e, t) {
                var r = !1;
                return t.newrelicHeader && (e.set("newrelic", t.newrelicHeader), r = !0), t.traceContextParentHeader && (e.set("traceparent", t.traceContextParentHeader), t.traceContextStateHeader && e.set("tracestate", t.traceContextStateHeader), r = !0), r;
              }
            }
            function A(e, t) {
              this.params = {}, this.metrics = {}, this.startTime = (0, g.z)(), this.dt = t, e.length >= 1 && (this.target = e[0]), e.length >= 2 && (this.opts = e[1]);
              var r,
                n = this.opts || {},
                i = this.target;
              "string" == typeof i ? r = i : "object" == typeof i && i instanceof W ? r = i.url : u._A?.URL && "object" == typeof i && i instanceof URL && (r = i.href), T(this, r);
              var o = ("" + (i && i instanceof W && i.method || n.method || "GET")).toUpperCase();
              this.params.method = o, this.txSize = B(n.body) || 0;
            }
            function x(e, t) {
              var n;
              this.endTime = (0, g.z)(), this.params || (this.params = {}), this.params.status = t ? t.status : 0, "string" == typeof this.rxSize && this.rxSize.length > 0 && (n = +this.rxSize);
              var o = {
                txSize: this.txSize,
                rxSize: n,
                duration: (0, g.z)() - this.startTime
              };
              i("xhr", [this.params, o, this.startTime, this.endTime, "fetch"], this, r.D.ajax);
            }
            function E(e) {
              var t = this.params,
                n = this.metrics;
              if (!this.ended) {
                this.ended = !0;
                for (var o = 0; o < G; o++) e.removeEventListener(V[o], this.listener, !1);
                t.aborted || (n.duration = (0, g.z)() - this.startTime, this.loadCaptureCalled || 4 !== e.readyState ? null == t.status && (t.status = 0) : _(this, e), n.cbTime = this.cbTime, i("xhr", [t, n, this.startTime, this.endTime, "xhr"], this, r.D.ajax));
              }
            }
            function T(e, t) {
              var r = (0, U.e)(t),
                n = e.params;
              n.hostname = r.hostname, n.port = r.port, n.protocol = r.protocol, n.host = r.hostname + ":" + r.port, n.pathname = r.pathname, e.parsedOrigin = r, e.sameOrigin = r.sameOrigin;
            }
            function _(e, t) {
              e.params.status = t.status;
              var r = function (e, t) {
                var r = e.responseType;
                return "json" === r && null !== t ? t : "arraybuffer" === r || "blob" === r || "json" === r ? B(e.response) : "text" === r || "" === r || void 0 === r ? B(e.responseText) : void 0;
              }(t, e.lastSize);
              if (r && (e.metrics.rxSize = r), e.sameOrigin) {
                var n = t.getResponseHeader("X-NewRelic-App-Data");
                n && (e.params.cat = n.split(", ").pop());
              }
              e.loadCaptureCalled = !0;
            }
            t.on("new-xhr", a), t.on("open-xhr-start", s), t.on("open-xhr-end", c), t.on("send-xhr-start", d), t.on("xhr-cb-time", l), t.on("xhr-load-added", f), t.on("xhr-load-removed", h), t.on("xhr-resolved", p), t.on("addEventListener-end", m), t.on("removeEventListener-end", v), t.on("fn-end", y), t.on("fetch-before-start", w), t.on("fetch-start", A), t.on("fn-start", b), t.on("fetch-done", x);
          }(e, this.ee, this.handler, this.dt), this.importAggregator());
        }
      }
      var K = i(3614);
      const {
        BST_RESOURCE: Y,
        RESOURCE: J,
        START: ee,
        END: te,
        FEATURE_NAME: re,
        FN_END: ne,
        FN_START: ie,
        PUSH_STATE: oe
      } = K;
      var ae = i(7836);
      const {
        FEATURE_NAME: se,
        START: ce,
        END: ue,
        BODY: de,
        CB_END: le,
        JS_TIME: fe,
        FETCH: he,
        FN_START: pe,
        CB_START: ge,
        FN_END: me
      } = ae;
      var ve = i(4649);
      class be extends h {
        static featureName = ve.t;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, ve.t, r), this.importAggregator();
        }
      }
      new class extends t {
        constructor(t) {
          let r = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : (0, _.ky)(16);
          super(), u._A ? (this.agentIdentifier = r, this.sharedAggregator = new y({
            agentIdentifier: this.agentIdentifier
          }), this.features = {}, this.desiredFeatures = new Set(t.features || []), this.desiredFeatures.add(m), Object.assign(this, (0, s.j)(this.agentIdentifier, t, t.loaderType || "agent")), this.start()) : (0, e.Z)("Failed to initial the agent. Could not determine the runtime environment.");
        }
        get config() {
          return {
            info: (0, n.C5)(this.agentIdentifier),
            init: (0, n.P_)(this.agentIdentifier),
            loader_config: (0, n.DL)(this.agentIdentifier),
            runtime: (0, n.OP)(this.agentIdentifier)
          };
        }
        start() {
          const t = "features";
          try {
            const n = a(this.agentIdentifier),
              i = [...this.desiredFeatures];
            i.sort((e, t) => r.p[e.featureName] - r.p[t.featureName]), i.forEach(t => {
              if (n[t.featureName] || t.featureName === r.D.pageViewEvent) {
                const i = function (e) {
                  switch (e) {
                    case r.D.ajax:
                      return [r.D.jserrors];
                    case r.D.sessionTrace:
                      return [r.D.ajax, r.D.pageViewEvent];
                    case r.D.sessionReplay:
                      return [r.D.sessionTrace];
                    case r.D.pageViewTiming:
                      return [r.D.pageViewEvent];
                    default:
                      return [];
                  }
                }(t.featureName);
                i.every(e => n[e]) || (0, e.Z)("".concat(t.featureName, " is enabled but one or more dependent features has been disabled (").concat((0, D.P)(i), "). This may cause unintended consequences or missing data...")), this.features[t.featureName] = new t(this.agentIdentifier, this.sharedAggregator);
              }
            }), (0, T.Qy)(this.agentIdentifier, this.features, t);
          } catch (r) {
            (0, e.Z)("Failed to initialize all enabled instrument classes (agent aborted) -", r);
            for (const e in this.features) this.features[e].abortHandler?.();
            const n = (0, T.fP)();
            return delete n.initializedAgents[this.agentIdentifier]?.api, delete n.initializedAgents[this.agentIdentifier]?.[t], delete this.sharedAggregator, n.ee?.abort(), delete n.ee?.get(this.agentIdentifier), !1;
          }
        }
        addToTrace(t) {
          (0, e.Z)("Call to agent api addToTrace failed. The page action feature is not currently initialized.");
        }
        setCurrentRouteName(t) {
          (0, e.Z)("Call to agent api setCurrentRouteName failed. The spa feature is not currently initialized.");
        }
        interaction() {
          (0, e.Z)("Call to agent api interaction failed. The spa feature is not currently initialized.");
        }
      }({
        features: [Q, m, O, class extends h {
          static featureName = re;
          constructor(e, t) {
            if (super(e, t, re, !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2]), !u.il) return;
            const n = this.ee;
            let i;
            (0, F.QU)(n), this.eventsEE = (0, F.em)(n), this.eventsEE.on(ie, function (e, t) {
              this.bstStart = (0, g.z)();
            }), this.eventsEE.on(ne, function (e, t) {
              (0, c.p)("bst", [e[0], t, this.bstStart, (0, g.z)()], void 0, r.D.sessionTrace, n);
            }), n.on(oe + ee, function (e) {
              this.time = (0, g.z)(), this.startPath = location.pathname + location.hash;
            }), n.on(oe + te, function (e) {
              (0, c.p)("bstHist", [location.pathname + location.hash, this.startPath, this.time], void 0, r.D.sessionTrace, n);
            });
            try {
              i = new PerformanceObserver(e => {
                const t = e.getEntries();
                (0, c.p)(Y, [t], void 0, r.D.sessionTrace, n);
              }), i.observe({
                type: J,
                buffered: !0
              });
            } catch (e) {}
            this.importAggregator({
              resourceObserver: i
            });
          }
        }, P, be, k, class extends h {
          static featureName = se;
          constructor(e, t) {
            if (super(e, t, se, !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2]), !u.il) return;
            if (!(0, n.OP)(e).xhrWrappable) return;
            try {
              this.removeOnAbort = new AbortController();
            } catch (e) {}
            let r,
              i = 0;
            const o = this.ee.get("tracer"),
              a = (0, F._L)(this.ee),
              s = (0, F.Lg)(this.ee),
              c = (0, F.BV)(this.ee),
              d = (0, F.Kf)(this.ee),
              l = this.ee.get("events"),
              f = (0, F.u5)(this.ee),
              h = (0, F.QU)(this.ee),
              p = (0, F.Gm)(this.ee);
            function m(e, t) {
              h.emit("newURL", ["" + window.location, t]);
            }
            function v() {
              i++, r = window.location.hash, this[pe] = (0, g.z)();
            }
            function b() {
              i--, window.location.hash !== r && m(0, !0);
              var e = (0, g.z)();
              this[fe] = ~~this[fe] + e - this[pe], this[me] = e;
            }
            function y(e, t) {
              e.on(t, function () {
                this[t] = (0, g.z)();
              });
            }
            this.ee.on(pe, v), s.on(ge, v), a.on(ge, v), this.ee.on(me, b), s.on(le, b), a.on(le, b), this.ee.buffer([pe, me, "xhr-resolved"], this.featureName), l.buffer([pe], this.featureName), c.buffer(["setTimeout" + ue, "clearTimeout" + ce, pe], this.featureName), d.buffer([pe, "new-xhr", "send-xhr" + ce], this.featureName), f.buffer([he + ce, he + "-done", he + de + ce, he + de + ue], this.featureName), h.buffer(["newURL"], this.featureName), p.buffer([pe], this.featureName), s.buffer(["propagate", ge, le, "executor-err", "resolve" + ce], this.featureName), o.buffer([pe, "no-" + pe], this.featureName), a.buffer(["new-jsonp", "cb-start", "jsonp-error", "jsonp-end"], this.featureName), y(f, he + ce), y(f, he + "-done"), y(a, "new-jsonp"), y(a, "jsonp-end"), y(a, "cb-start"), h.on("pushState-end", m), h.on("replaceState-end", m), window.addEventListener("hashchange", m, (0, C.m$)(!0, this.removeOnAbort?.signal)), window.addEventListener("load", m, (0, C.m$)(!0, this.removeOnAbort?.signal)), window.addEventListener("popstate", function () {
              m(0, i > 1);
            }, (0, C.m$)(!0, this.removeOnAbort?.signal)), this.abortHandler = this.#i, this.importAggregator();
          }
          #i() {
            this.removeOnAbort?.abort(), this.abortHandler = void 0;
          }
        }],
        loaderType: "spa"
      });
    })();
  })();
})()</script>
<script type="4a85e47efd71a21c1bf3c9f1-text/javascript">
        var gptadslots = [];
        var googletag = googletag || {};
        googletag.cmd = googletag.cmd || [];
      </script>
<script type="4a85e47efd71a21c1bf3c9f1-text/javascript">
        var targetServerState = JSON.stringify({"4D6368F454EC41940A4C98A6@AdobeOrg":{"sdid":{"supplementalDataIDCurrent":"6442A8F599359E40-5D87C047B00AED93","supplementalDataIDCurrentConsumed":{"payload:target-global-mbox":true},"supplementalDataIDLastConsumed":{}}}});
      </script>
<script type="4a85e47efd71a21c1bf3c9f1-text/javascript"> window.appData = window.appData || []; </script><script src="https://assets.adobedtm.com/4a848ae9611a/032db4f73473/launch-a6263b31083f.min.js" async type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script type="4a85e47efd71a21c1bf3c9f1-text/javascript">
      if (window.newrelic) {
        window.newrelic.setCustomAttribute('visitorType', 'ae:ANON_GUEST')
      }
    </script>
<script type="text/x-mathjax-config">
          MathJax.Hub.Config({
            messageStyle: 'none',
            displayAlign: 'left',
            "fast-preview": {
              disabled: true
            },
            CommonHTML: { linebreaks: { automatic: true } },
            PreviewHTML: { linebreaks: { automatic: true } },
            'HTML-CSS': { linebreaks: { automatic: true } },
            SVG: {
              scale: 90,
              linebreaks: { automatic: true }
            }
          });
        </script>
<script async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=MML_SVG" type="4a85e47efd71a21c1bf3c9f1-text/javascript">
        </script>
</head>
<body>
<div class="skip-link-menu js-skip-link-menu " data-reactroot><a class="anchor skip-link js-skip-link anchor-default" href="#journal-title"><span class="anchor-text">Skip to <!-- -->main content</span></a></div>
<div class="js-ad-banner" data-reactroot><script type="4a85e47efd71a21c1bf3c9f1-text/javascript">googletag.cmd.push(function() {
    gptadslots[1]= googletag
      .defineSlot('/6053/els.sdguest/ISSN15689972', [[728,90]], 'Leaderboard')
      .addService(googletag.pubads());
    googletag.pubads().collapseEmptyDivs();
    googletag.pubads().enableAsyncRendering();
    googletag.enableServices();
  })</script><div id="Leaderboard" style="text-align:center"><script type="4a85e47efd71a21c1bf3c9f1-text/javascript">googletag.cmd.push(function() { googletag.display('Leaderboard'); });</script><div style="color:#5c5c5c;font-size:10px;font-weight:700">ADVERTISEMENT</div></div></div>
<div id="react-root" class="u-light-theme"><div data-iso-key="_0"><style data-styled="true" data-styled-version="5.2.1">.htzoGy:hover .button-link-text{border-bottom-color:#FFFFFF !important;}/*!sc*/
data-styled.g1[id="sc-bdfBwQ"]{content:"htzoGy,"}/*!sc*/
.gARavv{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}/*!sc*/
data-styled.g6[id="sc-jSgupP"]{content:"gARavv,"}/*!sc*/
.KkBYC{display:none;}/*!sc*/
.KkBYC .cover-image-bg{border-bottom:0;-webkit-transition:none;transition:none;}/*!sc*/
.KkBYC .anchor:hover .anchor-text{border-bottom-color:#FFFFFF !important;}/*!sc*/
@media only screen and (min-width:62em){.KkBYC{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:11rem;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;width:8rem;}.KkBYC .anchor-text{border-bottom:0;}.KkBYC .cover-image{border:0;box-shadow:-3px 7px 12px 0 rgba(80,80,80,0.2);}}/*!sc*/
data-styled.g7[id="sc-gKsewC"]{content:"KkBYC,"}/*!sc*/
.fxMpMn{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex:1;-ms-flex:1;flex:1;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;width:100%;}/*!sc*/
@media only screen and (min-width:62em){.fxMpMn{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;margin:3.1rem 0 0;min-height:6.3rem;}}/*!sc*/
@media only screen and (min-width:75em){.fxMpMn{margin:3.1rem 0 0 1.8rem;}}/*!sc*/
.fxMpMn .title-img-link{margin-right:1.6rem;}/*!sc*/
data-styled.g8[id="sc-iBPRYJ"]{content:"fxMpMn,"}/*!sc*/
.fIQOJW{-webkit-flex:1;-ms-flex:1;flex:1;max-width:100%;min-width:0;padding:0.8rem;}/*!sc*/
data-styled.g9[id="sc-fubCfw"]{content:"fIQOJW,"}/*!sc*/
.elsBX{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;text-overflow:ellipsis;}/*!sc*/
@media only screen and (min-width:62em){.elsBX{overflow-x:visible;white-space:normal;}}/*!sc*/
.elsBX #journal-title{max-width:-webkit-max-content !important;max-width:-moz-max-content !important;max-width:max-content !important;display:inherit;}/*!sc*/
data-styled.g10[id="sc-pFZIQ"]{content:"elsBX,"}/*!sc*/
.gcNVAO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border-top:#FFFFFF solid 1px;}/*!sc*/
@media only screen and (min-width:62em){.gcNVAO{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:none;}}/*!sc*/
data-styled.g13[id="sc-iqHYGH"]{content:"gcNVAO,"}/*!sc*/
.gXoCQi{margin-left:auto;padding:0.8rem;}/*!sc*/
@media only screen and (min-width:62em){.gXoCQi{padding:0 0.8rem;}}/*!sc*/
data-styled.g14[id="sc-crrsfI"]{content:"gXoCQi,"}/*!sc*/
.kPFoEJ{margin-left:0.8rem;padding-left:1.6rem;border-left:#FFFFFF solid 1px;}/*!sc*/
data-styled.g15[id="sc-dQppl"]{content:"kPFoEJ,"}/*!sc*/
.leEssE{background:#146826;width:100%;grid-column:1/4;grid-row:1;position:relative;}/*!sc*/
@media only screen and (min-width:62em){.leEssE{grid-column:2/4;background:linear-gradient(180deg,#fff 0%,#fff 50px,#146826 50px,#146826 100%);}}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.leEssE{-ms-grid-column:2;-ms-grid-column-span:2;-ms-grid-row:1;}}/*!sc*/
data-styled.g16[id="sc-bqyKva"]{content:"leEssE,"}/*!sc*/
.gpzaOu{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
data-styled.g18[id="sc-hBEYos"]{content:"gpzaOu,"}/*!sc*/
.cMnmlX{border:none !important;padding:0px !important;outline-offset:8px !important;}/*!sc*/
data-styled.g20[id="sc-fFubgz"]{content:"cMnmlX,"}/*!sc*/
.csaSwa{display:none;border-right:1px solid rgb(220,220,220);}/*!sc*/
@media only screen and (min-width:75em){.csaSwa{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}}/*!sc*/
data-styled.g21[id="sc-bkzZxe"]{content:"csaSwa,"}/*!sc*/
.jOyJaT{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;list-style:none;}/*!sc*/
data-styled.g22[id="sc-idOhPF"]{content:"jOyJaT,"}/*!sc*/
.jYScwr{list-style:none;}/*!sc*/
data-styled.g24[id="sc-hHftDr"]{content:"jYScwr,"}/*!sc*/
.dBKBdm{padding-left:0.9rem;margin:0.9rem 0 0.9rem 0;}/*!sc*/
.dBKBdm .link-anchor{-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.dBKBdm.active{border-left:rgb(255,108,0) solid 2px;}/*!sc*/
data-styled.g25[id="sc-dmlrTW"]{content:"dBKBdm,"}/*!sc*/
.gyEvgg{background-color:#fafafa;position:absolute;width:320px;left:-320px;padding:1.1rem 1.4rem 0 1.4rem;z-index:1000;height:100vh;visibility:hidden;-webkit-transition:visibility 0.2s,left 0.2s;transition:visibility 0.2s,left 0.2s;}/*!sc*/
.gyEvgg.visible{left:0;visibility:visible;}/*!sc*/
.gyEvgg .accordion-panel{border:none !important;}/*!sc*/
.gyEvgg .accordion-panel .accordion-panel-title{color:black !important;}/*!sc*/
.gyEvgg .accordion-panel button[aria-expanded="true"]{font-weight:bold;}/*!sc*/
.gyEvgg .accordion-nav-container{-webkit-overflow-scrolling:touch;overflow-y:auto;height:40vh;}/*!sc*/
@media only screen and (min-height:600px){.gyEvgg .accordion-nav-container{height:45vh;}}/*!sc*/
@media only screen and (min-height:680px){.gyEvgg .accordion-nav-container{height:50vh;}}/*!sc*/
@media only screen and (min-height:1024px){.gyEvgg .accordion-nav-container{height:60vh;}}/*!sc*/
data-styled.g26[id="sc-kfzAmx"]{content:"gyEvgg,"}/*!sc*/
.nwOmR{height:100%;border-top:white 1px solid;}/*!sc*/
data-styled.g27[id="sc-fKFyDc"]{content:"nwOmR,"}/*!sc*/
.eoGpMS{display:none;}/*!sc*/
@media only screen and (min-width:62em){.eoGpMS{display:block;border-top:solid 1px rgb(185,185,185);padding-top:0.8rem;}}/*!sc*/
data-styled.g28[id="sc-bBXqnf"]{content:"eoGpMS,"}/*!sc*/
.kYvpjU{z-index:99;height:100%;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;cursor:text;}/*!sc*/
.kYvpjU .reset-search-button{display:none;}/*!sc*/
.kYvpjU .submit-search-button{display:none;}/*!sc*/
.kYvpjU.focused{background-color:rgb(245,245,245);border:0;-webkit-transition:background-color .3s ease;transition:background-color .3s ease;width:100%;position:relative;}/*!sc*/
.kYvpjU.focused .search-icon{display:none;}/*!sc*/
.kYvpjU.focused .reset-search-button{display:inline;}/*!sc*/
.kYvpjU.focused .submit-search-button{display:block;}/*!sc*/
.kYvpjU.focused .inline-search-input{background-color:rgb(245,245,245);-webkit-transition:background-color .3s ease;transition:background-color .3s ease;}/*!sc*/
.kYvpjU.focused .advanced-search-link{display:none;}/*!sc*/
@media only screen and (min-width:36em){.kYvpjU.focused .advanced-search-link{display:block;}}/*!sc*/
.kYvpjU.focused .advanced-search-link::before{content:"|";margin-right:1.4rem;margin-left:1.4rem;}/*!sc*/
data-styled.g29[id="sc-iwyYcG"]{content:"kYvpjU,"}/*!sc*/
.fcxfHF{border:none;font-family:inherit;padding-right:0.6rem;width:100%;}/*!sc*/
.fcxfHF:focus{outline:none;width:85%;}/*!sc*/
.fcxfHF::-webkit-input-placeholder{color:rgb(46,46,46);}/*!sc*/
.fcxfHF::-moz-placeholder{color:rgb(46,46,46);}/*!sc*/
.fcxfHF:-ms-input-placeholder{color:rgb(46,46,46);}/*!sc*/
.fcxfHF::placeholder{color:rgb(46,46,46);}/*!sc*/
.fcxfHF only screen and (min-width:48em){width:40%;}/*!sc*/
.fcxfHF only screen and (min-width:62em){width:85%;}/*!sc*/
data-styled.g30[id="sc-cxFLnm"]{content:"fcxfHF,"}/*!sc*/
.hDnWTA{grid-row:3;grid-column:1/4;max-width:100%;}/*!sc*/
@media only screen and (min-width:36em){.hDnWTA{grid-column:1/4;grid-row:2;white-space:nowrap;}.hDnWTA .nav-mobile-menu-button{font-size:0.9rem;width:108px;height:100%;}.hDnWTA .nav-mobile-menu-button.nav-mobile-menu-button{-webkit-flex:none;-ms-flex:none;flex:none;}.hDnWTA .banner-search-container{padding-right:0.8rem;}}/*!sc*/
@media only screen and (min-width:75em){.hDnWTA{grid-column:2/4;}.hDnWTA .mobile-nav{display:none !important;}}/*!sc*/
.hDnWTA .search-container{width:100%;-webkit-flex:3;-ms-flex:3;flex:3;}/*!sc*/
@media only screen and (min-width:48em){.hDnWTA .search-container{width:calc(100% - 379px);}}/*!sc*/
.hDnWTA .nav-search-container{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:100%;}/*!sc*/
.hDnWTA.search-mode .mobile-nav{display:none !important;}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.hDnWTA{-ms-grid-column:2;-ms-grid-column-span:2;-ms-grid-row:2;}.hDnWTA .search-input::-ms-clear{display:none;}}/*!sc*/
data-styled.g31[id="sc-lmoMRL"]{content:"hDnWTA,"}/*!sc*/
.csKSbf{-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;border-right:solid 1px rgb(220,220,220);font-size:0.8rem !important;overflow-x:hidden;padding:0.6rem;text-align:center;text-overflow:ellipsis;width:100%;background-color:rgb(46,46,46);color:rgb(255,255,255);display:inherit !important;position:relative;z-index:50;}/*!sc*/
.csKSbf:hover.sc-iJuUWI:hover{color:rgb(255,255,255);}/*!sc*/
.csKSbf:hover .anchor-text{border-bottom-color:rgb(255,108,0) !important;}/*!sc*/
.csKSbf:focus-visible{outline-offset:0px !important;}/*!sc*/
@media only screen and (min-width:48em){.csKSbf{background-color:rgb(255,255,255);font-size:1rem;}}/*!sc*/
data-styled.g32[id="sc-iJuUWI"]{content:"csKSbf,"}/*!sc*/
.dcoGjl{border-left:solid 1px rgb(220,220,220);}/*!sc*/
@media only screen and (min-width:36em){.dcoGjl{margin-left:3px;background-color:rgb(255,255,255);-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}.dcoGjl.dcoGjl{color:rgb(46,46,46);}.dcoGjl:hover.sc-ezrdKe:hover{color:rgb(46,46,46);}}/*!sc*/
data-styled.g34[id="sc-ezrdKe"]{content:"dcoGjl,"}/*!sc*/
.kGVTpd{grid-row:2;grid-column:1/4;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border-top:solid 1px rgb(255,255,255);color:rgb(255,255,255);width:100%;margin-left:auto;}/*!sc*/
@media only screen and (min-width:36em){.kGVTpd{max-width:20.85rem;}}/*!sc*/
@media only screen and (min-width:62em){.kGVTpd{grid-column:2/4;grid-row:2;}}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.kGVTpd{-ms-grid-column:2;-ms-grid-column-span:2;-ms-grid-row:2;}}/*!sc*/
data-styled.g35[id="sc-bYEvPH"]{content:"kGVTpd,"}/*!sc*/
.dSrBAr{position:relative;}/*!sc*/
data-styled.g36[id="sc-kLgntA"]{content:"dSrBAr,"}/*!sc*/
.cpKXNF{background:white;display:grid;border-bottom:#146826 solid 1px;}/*!sc*/
@media only screen and (min-width:36em){.cpKXNF{grid-template-columns:minmax(0,auto) minmax(auto,calc(100% - 250px)) minmax(auto,250px) minmax(0,auto);}}/*!sc*/
@media only screen and (min-width:62em){.cpKXNF{grid-auto-rows:auto 60px;grid-template-columns:minmax(0,auto) minmax(auto,998px) minmax(auto,282px) minmax(0,auto);}}/*!sc*/
.cpKXNF::before{background:linear-gradient(180deg,#fff 0%,#fff 50px,#146826 50px,#146826 100%);content:"";}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.cpKXNF::before{display:block;}}/*!sc*/
.cpKXNF::after{background:linear-gradient(180deg,#fff 0%,#fff 50px,#146826 50px,#146826 100%);content:"";}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.cpKXNF::after{display:block;position:absolute;width:calc((100% - 1280px) / 2);height:calc(100% - 61px);left:calc(100% - (100% - 1280px) / 2);}}/*!sc*/
@media screen and (-ms-high-contrast:active),(-ms-high-contrast:none){.cpKXNF{display:-ms-grid;-ms-grid-rows:auto 60px;-ms-grid-columns:minmax(0,1fr) minmax(1fr,998px) minmax(1fr,282px) minmax(0,1fr);}}/*!sc*/
data-styled.g37[id="sc-iktFzd"]{content:"cpKXNF,"}/*!sc*/
</style><div class="app sd-flex-container"><div class="sd-flex-content"><header id="gh-cnt"><div id="gh-main-cnt" class="u-flex-center-ver u-position-relative u-padding-s-hor u-padding-l-hor-from-xl"><a id="gh-branding" class="u-flex-center-ver" href="/" aria-label="ScienceDirect home page" data-aa-region="header" data-aa-name="ScienceDirect"><img class="gh-logo" src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/24/images/elsevier-non-solus-new-grey.svg" alt="Elsevier logo" height="48" width="54" /><svg xmlns="http://www.w3.org/2000/svg" version="1.1" height="15" viewBox="0 0 190 23" role="img" class="gh-wordmark u-margin-s-left" aria-labelledby="gh-wm-science-direct" focusable="false" aria-hidden="true" alt="ScienceDirect Wordmark"><title id="gh-wm-science-direct">ScienceDirect</title><g><path fill="#EB6500" d="M3.81 6.9c0-1.48 0.86-3.04 3.7-3.04 1.42 0 3.1 0.43 4.65 1.32l0.13-2.64c-1.42-0.63-2.97-0.96-4.78-0.96 -4.62 0-6.6 2.44-6.6 5.45 0 5.61 8.78 6.14 8.78 9.93 0 1.48-1.15 3.04-3.86 3.04 -1.72 0-3.4-0.56-4.72-1.39l-0.36 2.64c1.55 0.76 3.57 1.06 5.15 1.06 4.26 0 6.7-2.48 6.7-5.51C12.59 11.49 3.81 10.76 3.81 6.9M20.27 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.15-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.68 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.14 0-4.55-1.71-4.55-5.91C17.93 10.2 20.01 9.18 20.27 9.01"></path><rect x="29.42" y="6.97" fill="#EB6500" width="2.54" height="14.95"></rect><path fill="#EB6500" d="M30.67 0.7c-0.92 0-1.65 0.92-1.65 1.81 0 0.93 0.76 1.85 1.65 1.85 0.89 0 1.68-0.96 1.68-1.88C32.35 1.55 31.56 0.7 30.67 0.7M48.06 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.88-1.95-4.88-5.51v-0.49H48.06M39.91 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C38.56 10.27 39.71 9.37 39.91 9.18zM58.82 6.57c-2.24 0-3.63 1.12-4.85 2.61l-0.4-2.21h-2.34l0.13 1.19c0.1 0.76 0.13 1.78 0.13 2.97v10.79h2.54V11.88c0.69-0.96 2.15-2.48 2.48-2.64 0.23-0.13 1.29-0.4 2.08-0.4 2.28 0 2.48 1.15 2.54 3.43 0.03 1.19 0.03 3.17 0.03 3.17 0.03 3-0.1 6.47-0.1 6.47h2.54c0 0 0.07-4.49 0.07-6.96 0-1.48 0.03-2.97-0.1-4.46C63.31 7.43 61.49 6.57 58.82 6.57M72.12 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.15-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.68 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.15 0-4.55-1.71-4.55-5.91C69.77 10.2 71.85 9.18 72.12 9.01M92.74 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.88-1.95-4.88-5.51v-0.49H92.74M84.59 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C83.24 10.27 84.39 9.37 84.59 9.18zM103.9 1.98h-7.13v19.93h6.83c7.26 0 9.77-5.68 9.77-10.03C113.37 7.33 110.93 1.98 103.9 1.98M103.14 19.8h-3.76V4.1h4.09c5.38 0 6.96 4.39 6.96 7.79C110.43 16.87 108.19 19.8 103.14 19.8zM118.38 0.7c-0.92 0-1.65 0.92-1.65 1.81 0 0.93 0.76 1.85 1.65 1.85 0.89 0 1.69-0.96 1.69-1.88C120.07 1.55 119.28 0.7 118.38 0.7"></path><rect x="117.13" y="6.97" fill="#EB6500" width="2.54" height="14.95"></rect><path fill="#EB6500" d="M130.2 6.6c-1.62 0-2.87 1.45-3.4 2.74l-0.43-2.37h-2.34l0.13 1.19c0.1 0.76 0.13 1.75 0.13 2.9v10.86h2.54v-9.51c0.53-1.29 1.72-3.7 3.17-3.7 0.96 0 1.06 0.99 1.06 1.22l2.08-0.6V9.18c0-0.03-0.03-0.17-0.06-0.4C132.8 7.36 131.91 6.6 130.2 6.6M145.87 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.89-1.95-4.89-5.51v-0.49H145.87M137.72 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C136.37 10.27 137.52 9.37 137.72 9.18zM153.23 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.14-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.69 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.15 0-4.55-1.71-4.55-5.91C150.89 10.2 152.97 9.18 153.23 9.01M170 19.44c-0.92 0.36-1.72 0.69-2.51 0.69 -1.16 0-1.58-0.66-1.58-2.34V8.95h3.93V6.97h-3.93V2.97h-2.48v3.99h-2.71v1.98h2.71v9.67c0 2.64 1.39 3.73 3.33 3.73 1.15 0 2.54-0.39 3.43-0.79L170 19.44M173.68 5.96c-1.09 0-2-0.87-2-1.97 0-1.1 0.91-1.97 2-1.97s1.98 0.88 1.98 1.98C175.66 5.09 174.77 5.96 173.68 5.96zM173.67 2.46c-0.85 0-1.54 0.67-1.54 1.52 0 0.85 0.69 1.54 1.54 1.54 0.85 0 1.54-0.69 1.54-1.54C175.21 3.13 174.52 2.46 173.67 2.46zM174.17 5.05c-0.09-0.09-0.17-0.19-0.25-0.3l-0.41-0.56h-0.16v0.87h-0.39V2.92c0.22-0.01 0.47-0.03 0.66-0.03 0.41 0 0.82 0.16 0.82 0.64 0 0.29-0.21 0.55-0.49 0.63 0.23 0.32 0.45 0.62 0.73 0.91H174.17zM173.56 3.22l-0.22 0.01v0.63h0.22c0.26 0 0.43-0.05 0.43-0.34C174 3.28 173.83 3.21 173.56 3.22z"></path></g></svg></a><div class="gh-nav-cnt u-hide-from-print"><div class="gh-nav-links-container gh-nav-links-container-h u-hide-from-print gh-nav-content-container"><nav aria-label="links" class="gh-nav gh-nav-links gh-nav-h"><ul class="gh-nav-list u-list-reset"><li class="gh-nav-item gh-move-to-spine"><a class="anchor gh-nav-action anchor-default" href="/browse/journals-and-books" data-aa-region="header" data-aa-name="Journals &amp; Books"><span class="anchor-text">Journals &amp; Books</span></a></li></ul></nav><nav aria-label="utilities" class="gh-nav gh-nav-utilities gh-nav-h"><ul class="gh-nav-list u-list-reset"><li class="gh-move-to-spine gh-help-button gh-help-icon gh-nav-item"><div class="popover" id="gh-help-icon-popover"><div id="popover-trigger-gh-help-icon-popover"><input type="hidden" /><button class="button-link gh-nav-help-icon gh-icon-btn button-link-primary button-link-icon-only" type="button" aria-expanded="false" aria-label="ScienceDirect Support Center links"><svg focusable="false" viewBox="0 0 114 128" aria-hidden="true" alt="ScienceDirect help page" width="21.375" height="24" class="icon icon-help gh-icon"><path d="m57 8c-14.7 0-28.5 5.72-38.9 16.1-10.38 10.4-16.1 24.22-16.1 38.9 0 30.32 24.68 55 55 55 14.68 0 28.5-5.72 38.88-16.1 10.4-10.4 16.12-24.2 16.12-38.9 0-30.32-24.68-55-55-55zm0 1e1c24.82 0 45 20.18 45 45 0 12.02-4.68 23.32-13.18 31.82s-19.8 13.18-31.82 13.18c-24.82 0-45-20.18-45-45 0-12.02 4.68-23.32 13.18-31.82s19.8-13.18 31.82-13.18zm-0.14 14c-11.55 0.26-16.86 8.43-16.86 18v2h1e1v-2c0-4.22 2.22-9.66 8-9.24 5.5 0.4 6.32 5.14 5.78 8.14-1.1 6.16-11.78 9.5-11.78 20.5v6.6h1e1v-5.56c0-8.16 11.22-11.52 12-21.7 0.74-9.86-5.56-16.52-16-16.74-0.39-0.01-0.76-0.01-1.14 0zm-4.86 5e1v1e1h1e1v-1e1h-1e1z"></path></svg></button></div></div></li><li class="gh-search-toggle gh-nav-item search-button-link"><a class="anchor button-link-primary gh-nav-action gh-icon-btn anchor-default anchor-icon-only" href="/search" data-aa-button="search-in-header-opened-from-jrnl_about" aria-label="Search ScienceDirect" role="button"><svg focusable="false" viewBox="0 0 100 128" aria-hidden="true" alt="Search" width="18.75" height="24" class="icon icon-search gh-icon"><path d="m19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6l-26.32-26.32c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96s-21.17 4.25-28.88 11.96c-7.72 7.71-11.97 17.97-11.97 28.88s4.25 21.17 11.97 28.88c7.71 7.71 17.97 11.96 28.88 11.96 9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03"></path></svg></a></li></ul></nav></div></div><div class="gh-profile-container gh-move-to-spine u-hide-from-print"><a class="link-button link-button-secondary link-button-small u-margin-s-right link-button-text-only" href="/user/register?targetURL=%2Fjournal%2Fautoimmunity-reviews%2Fabout%2Feditorial-board" id="gh-cta-btn" data-aa-region="header" data-aa-name="Register"><span class="link-button-text">Register</span></a><a class="link-button link-button-primary link-button-small link-button-text-only" href="/user/login?targetURL=%2Fjournal%2Fautoimmunity-reviews%2Fabout%2Feditorial-board&amp;from=globalheader" id="gh-signin-btn" data-aa-region="header" data-aa-name="Sign in"><span class="link-button-text">Sign in</span></a></div><div id="gh-mobile-menu" class="mobile-menu u-hide-from-print"><div class="gh-hamburger u-fill-grey7 u-margin-m-left"><button class="button-link u-flex-center-ver button-link-primary button-link-icon-only" type="button" aria-label="Toggle mobile menu" aria-expanded="false"><svg class="gh-hamburger-svg-el gh-hamburger-closed" role="img" aria-hidden="true" height="18" width="40"><path d="M0 14h40v2H0zm0-7h40v2H0zm0-7h40v2H0z"></path></svg></button></div><div id="gh-overlay" class="mobile-menu-overlay u-overlay u-display-none" role="button" tabindex="-1"></div><div id="gh-drawer" aria-label="Mobile menu" class role="navigation"></div></div></div></header><div class="page-container"><main><div class="sc-kLgntA dSrBAr"><div><section class="sc-iktFzd cpKXNF js-container-section"><div class="sc-bqyKva leEssE"><div class="sc-jSgupP gARavv"><div color="#FFFFFF" class="sc-gKsewC KkBYC"><a class="anchor js-cover-image-link anchor-default" href="/journal/autoimmunity-reviews" usageZone="jrnl_banner"><span class="anchor-text"><img src="https://ars.els-cdn.com/content/image/X15689972.jpg" alt="Go to journal home page - Autoimmunity Reviews" class="cover-image-large cover-image js-cover-image" /></span></a></div><div class="sc-iBPRYJ fxMpMn"><div class="sc-fubCfw fIQOJW"><h1 class="sc-pFZIQ elsBX js-title-text u-text-light u-h2" style="color:#FFFFFF"><a class="anchor js-title-link anchor-default anchor-has-background-color anchor-has-inherit-color" href="/journal/autoimmunity-reviews" usageZone="jrnl_banner" id="journal-title"><span class="anchor-text">Autoimmunity Reviews</span></a></h1><div class="open-statement sc-jrAGrp js-open-statement" style="color:#FFFFFF"><div class="open-statement-item u-display-inline-block"><button class="button-link sc-bdfBwQ htzoGy js-open-access-link button-link-secondary u-text-left" type="button" id="openStatement-supports" color="#FFFFFF" aria-expanded="false"><span class="button-link-text"><span class="js-open-statement-text open-statement-text" style="color:#FFFFFF">Supports <span class="u-text">open access</span></span></span></button></div></div></div><div class="sc-iqHYGH gcNVAO"><div class="sc-crrsfI gXoCQi js-cite-score metric"><button class="button-link sc-bdfBwQ htzoGy button-link button-link-secondary u-text-left" type="button" color="#FFFFFF" aria-expanded="false"><span class="button-link-text"><span style="color:#FFFFFF" class="text-l u-display-block">23.3</span><span style="color:#FFFFFF" class="text-xs ">CiteScore</span></span></button></div><div class="sc-crrsfI gXoCQi sc-dQppl kPFoEJ js-impact-factor metric"><button class="button-link sc-bdfBwQ htzoGy button-link button-link-secondary u-text-left" type="button" color="#FFFFFF" aria-expanded="false"><span class="button-link-text"><span style="color:#FFFFFF" class="text-l u-display-block">13.6</span><span style="color:#FFFFFF" class="text-xs ">Impact Factor</span></span></button></div></div></div></div></div><div class="sc-lmoMRL hDnWTA js-banner-links text-s"><div class="nav-search-container"><nav class="sc-bkzZxe csaSwa banner-nav" aria-label="Navigation"><ul class="sc-idOhPF jOyJaT js-banner-nav-list" aria-label="journal navigation"><li class="u-margin-l-right"><div><button type="button" class="button sc-fFubgz cMnmlX button-secondary expandable-nav-item" aria-disabled="false" aria-haspopup="true" aria-expanded="false"><span class="button-text"><div class="sc-hBEYos gpzaOu label"><span class="u-clr-black">Articles &amp; Issues</span><svg focusable="false" viewBox="0 0 92 128" height="20" width="20" aria-hidden="true" class="icon icon-navigate-down"><path d="m1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></div></span></button></div></li><li class="u-margin-l-right"><div><button type="button" class="button sc-fFubgz cMnmlX button-secondary expandable-nav-item" aria-disabled="false" aria-haspopup="true" aria-expanded="false"><span class="button-text"><div class="sc-hBEYos gpzaOu label"><span class="u-clr-black">About</span><svg focusable="false" viewBox="0 0 92 128" height="20" width="20" aria-hidden="true" class="icon icon-navigate-down"><path d="m1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></div></span></button></div></li><li class="u-margin-l-right"><div><button type="button" class="button sc-fFubgz cMnmlX button-secondary expandable-nav-item" aria-disabled="false" aria-haspopup="true" aria-expanded="false"><span class="button-text"><div class="sc-hBEYos gpzaOu label"><span class="u-clr-black">Publish</span><svg focusable="false" viewBox="0 0 92 128" height="20" width="20" aria-hidden="true" class="icon icon-navigate-down"><path d="m1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></div></span></button></div></li><li class="u-margin-l-right"><div class="u-padding-xs-ver"><a class="anchor anchor-default anchor-has-inherit-color" href="https://www.elsevier.com/journals/autoimmunity-reviews/1568-9972/subscribe?subscriptiontype=personal&amp;dgcid=SD_ecom_referral_journals" target="_blank"><span class="anchor-text">Order journal</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></div></li></ul></nav><nav class="mobile-nav"><div class="sc-fKFyDc nwOmR nav-mobile-container"><button type="button" class="button nav-mobile-menu-button button-primary button-icon-left" aria-disabled="false" data-aa-button="aa-mobile-menu"><svg focusable="false" viewBox="25 0 25 21" width="24" height="24" preserveAspectRatio="xMinYMax" class="icon icon-hamburger"><path d="M0 14h40v2H0zm0-7h40v2H0zm0-7h40v2H0z"></path></svg><span class="button-text">Menu</span></button><div class="sc-kfzAmx gyEvgg slide-out-menu hidden"><div class="accordion-nav-container"><ol class="accordion-container u-font-sans nav-items" role="tablist"><li class="accordion-panel"><button id="512526-accordion-tab-0" type="button" class="u-display-flex icon-right accordion-panel-title u-padding-s-ver u-text-left" tabindex="0" role="tab" aria-expanded="true" aria-selected="true" aria-controls="512526-accordion-panel-0" data-aa-button="aa-mobile-menu-articles-&amp;-issues"><div><span class="accordion-title">Articles &amp; Issues</span></div><svg focusable="false" viewBox="0 0 92 128" width="17.25" height="24" class="icon icon-navigate-up accordion-icon navigate-up"><path d="m46 46l-38 38-7-7 45-45 45 45-7 7z"></path></svg></button><div id="512526-accordion-panel-0" class="accordion-panel-content u-padding-xs-ver" role="tabpanel" aria-labelledby="512526-accordion-tab-0"><ul class="sc-hHftDr jYScwr"><li class="sc-dmlrTW dBKBdm link"><a class="link-anchor u-clr-black" href="/journal/autoimmunity-reviews/vol/23/issue/5" target="_self">Latest issue</a></li><li class="sc-dmlrTW dBKBdm link"><a class="link-anchor u-clr-black" href="/journal/autoimmunity-reviews/issues" target="_self">All issues</a></li><li class="sc-dmlrTW dBKBdm link"><a class="link-anchor u-clr-black" href="/journal/autoimmunity-reviews/articles-in-press" target="_self">Articles in press</a></li><li class="sc-dmlrTW dBKBdm link"><a class="link-anchor u-clr-black" href="/journal/autoimmunity-reviews/special-issues" target="_self">Special issues and article collections</a></li><li class="sc-dmlrTW dBKBdm link"><div class="sc-bBXqnf eoGpMS"></div><span><button class="button-alternative js-link js-follow-link button-alternative-primary" href type="button"><span class="button-alternative-text">Sign in to set up alerts</span></button></span></li><li class="sc-dmlrTW dBKBdm link"><button class="button-alternative js-rss-link-button rss-link-button button-alternative-primary" type="button"><span class="button-alternative-text">RSS</span></button></li></ul></div></li><li class="accordion-panel"><button id="512526-accordion-tab-1" type="button" class="u-display-flex icon-right accordion-panel-title u-padding-s-ver u-text-left" tabindex="0" role="tab" aria-expanded="false" aria-selected="true" aria-controls="512526-accordion-panel-1" data-aa-button="aa-mobile-menu-about"><div><span class="accordion-title">About</span></div><svg focusable="false" viewBox="0 0 92 128" width="17.25" height="24" class="icon icon-navigate-down accordion-icon"><path d="m1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></li><li class="accordion-panel"><button id="512526-accordion-tab-2" type="button" class="u-display-flex icon-right accordion-panel-title u-padding-s-ver u-text-left" tabindex="0" role="tab" aria-expanded="false" aria-selected="true" aria-controls="512526-accordion-panel-2" data-aa-button="aa-mobile-menu-publish"><div><span class="accordion-title">Publish</span></div><svg focusable="false" viewBox="0 0 92 128" width="17.25" height="24" class="icon icon-navigate-down accordion-icon"><path d="m1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></li></ol><div class="u-padding-xs-ver"><a class="anchor anchor-default anchor-has-inherit-color" href="https://www.elsevier.com/journals/autoimmunity-reviews/1568-9972/subscribe?subscriptiontype=personal&amp;dgcid=SD_ecom_referral_journals" target="_blank"><span class="anchor-text">Order journal</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></div></div></div></div></nav><div class="search-container"><div class="sc-iwyYcG kYvpjU banner-search-container u-padding-m-left mobile-search"><button class="button-link reset-search-button button-link-primary button-link-icon-only" type="button" aria-label="Reset"><svg focusable="false" viewBox="0 0 54 128" aria-hidden="true" width="10.125" height="24" class="icon icon-navigate-left"><path d="m1 61l45-45 7 7-38 38 38 38-7 7z"></path></svg></button><svg focusable="false" viewBox="0 0 100 128" width="18.75" height="24" class="icon icon-search search-icon u-fill-blue"><path d="m19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6l-26.32-26.32c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96s-21.17 4.25-28.88 11.96c-7.72 7.71-11.97 17.97-11.97 28.88s4.25 21.17 11.97 28.88c7.71 7.71 17.97 11.96 28.88 11.96 9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03"></path></svg><form class="search-form u-padding-m-left" action="/search#submit" role="search" aria-label="Search in this journal" data-aa-region="aa-jhp-search" style="width:100%"><input name="qs" class="sc-cxFLnm fcxfHF inline-search-input" title="search" placeholder="Search in this journal" value /><input type="hidden" name="pub" value="Autoimmunity Reviews" /><input type="hidden" name="cid" value="272276" /><input type="hidden" name="origin" value="jrnl_about" /><input type="hidden" name="zone" value="qSearch" /><button aria-hidden="true" style="display:none" type="submit" data-aa-button="journal-search-submit">Submit search</button></form><span class="submit-search-button-wrap" tabindex="-1"><button type="button" class="button submit-search-button button-primary button-icon-only" aria-disabled="false" data-aa-button="journal-search-submit" aria-label="Search"><svg focusable="false" viewBox="0 0 100 128" aria-hidden="true" width="18.75" height="24" class="icon icon-search"><path d="m19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6l-26.32-26.32c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96s-21.17 4.25-28.88 11.96c-7.72 7.71-11.97 17.97-11.97 28.88s4.25 21.17 11.97 28.88c7.71 7.71 17.97 11.96 28.88 11.96 9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03"></path></svg></button></span></div></div></div></div><div class="sc-bYEvPH kGVTpd"><a class="anchor sc-iJuUWI csKSbf sc-ezrdKe dcoGjl js-gfa anchor-default anchor-has-inherit-color" href="/journal/autoimmunity-reviews/publish/guide-for-authors" background="#146826"><span class="anchor-text">Guide for authors</span></a></div></section></div></div><div class="about-page-container"><div class="left-pane"><ul class="sections"><li><button class="button-link type u-text-left button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">Aims and scope</span></button></li><li><button class="button-link type u-text-left selected button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">Editorial board</span></button></li><li><button class="button-link type u-text-left button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">News</span></button></li><li><button class="button-link type u-text-left button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">Announcements</span></button></li><li><button class="button-link type u-text-left button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">Conferences</span></button></li><li><button class="button-link type u-text-left button-link-primary button-link-icon-left" type="button" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">Highlighted Articles</span></button></li></ul><ul class="sub-list"></ul><span class="divider"></span><div class="editorial-board-by-country"><h3 class="editorial-board-by-country-title u-h4">Editorial board by country/region<!-- --> </h3><div class="editors-by-country-text u-margin-s-ver text-s">64<!-- --> editors and editorial board members in <!-- -->19<!-- --> <!-- -->countries/regions</div><ol class="editors-by-country-ordered-list"><li class="country-list-item">Italy<!-- --> (<!-- -->11<!-- -->)</li><li class="country-list-item">United States of America<!-- --> (<!-- -->10<!-- -->)</li><li class="country-list-item">Israel<!-- --> (<!-- -->8<!-- -->)</li></ol><button class="button-link editorial-board-country-distribution-more-details u-margin-m-top button-link-secondary button-link-icon-left" type="button" data-aa-button="aa-editors-by-country-distribution-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="6" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">See more editors by country/region</span></button><div data-focus-guard="true" tabindex="-1" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div><div data-focus-lock-disabled="disabled"><div class="slide-out" style="height:0" role="dialog" aria-label="Slideout panel"><div class="header-container"><h2 class="title-slideout u-h3 u-text-light" tabindex="-1">Editorial board by country/region</h2><button type="button" class="button close-button js-close-button button-anchor" aria-disabled="false" aria-label="close panel"><span class="button-text"><svg focusable="false" viewBox="0 0 70 128" width="13.125" height="24" class="icon icon-cross"><path d="m68.94 36.12l-6.94-7.12-27 27-27-27-7 7 27 27-27 27 7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></span></button></div><div class="editors-by-country-text u-margin-s-ver text-s">64<!-- --> editors and editorial board members in <!-- -->19<!-- --> <!-- -->countries/regions</div><ul class="editors-by-country-unordered-list"><li class="country-list-item">Italy<!-- --> (<!-- -->11<!-- -->)</li><li class="country-list-item">United States of America<!-- --> (<!-- -->10<!-- -->)</li><li class="country-list-item">Israel<!-- --> (<!-- -->8<!-- -->)</li><li class="country-list-item">United Kingdom<!-- --> (<!-- -->5<!-- -->)</li></ul><div class="all-the-rest-editors-by-country u-padding-s-ver">Brazil<!-- --> (4)<!-- -->, <!-- -->France<!-- --> (4)<!-- -->, <!-- -->Germany<!-- --> (3)<!-- -->, <!-- -->Greece<!-- --> (3)<!-- -->, <!-- -->Japan<!-- --> (3)<!-- -->, <!-- -->Portugal<!-- --> (2)<!-- -->, <!-- -->Russian Federation<!-- --> (2)<!-- -->, <!-- -->Spain<!-- --> (2)<!-- -->, <!-- -->Australia<!-- -->, <!-- -->Belgium<!-- -->, <!-- -->China<!-- -->, <!-- -->Colombia<!-- -->, <!-- -->Hungary<!-- -->, <!-- -->Latvia<!-- -->, <!-- -->Mexico</div></div></div><div data-focus-guard="true" tabindex="-1" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div></div><span class="divider"></span></div><div class="right-pane" tabindex="-1"><div class="title"><div class="section-heading-wrapper u-margin-l-ver"><h2 class="section-heading u-h3" style="--border-color:#146826">Editorial board</h2></div></div><div class="item"><div class="inner"><div class="u-margin-xl-top u-clr-grey8"><div class="u-margin-xl-bottom"><h3 class="u-clr-black js-editor-group-role u-margin-s-bottom">Co-Editors in Chief</h3><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0158e000000lI45AAE&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1696336710004" alt="Photo of A. Perl, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">A. Perl, MD, PhD</h4><p class="js-affiliation branded text-s">SUNY Upstate Medical University, Syracuse, New York, United States of America</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000002c0nUIAQ&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1707477977921" alt="Photo of D. Bogdanos" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">D. Bogdanos</h4><p class="js-affiliation branded text-s">University of Thessaly, Faculty of Medicine, Larisa, Greece</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div></div><div class="u-margin-xl-bottom"><h3 class="u-clr-black js-editor-group-role u-margin-s-bottom">Editorial Board Members</h3><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">A.K. Abbas</h4><p class="js-affiliation branded text-s">University of California San Francisco, San Francisco, California, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. Alarcón Riquelme</h4><p class="js-affiliation branded text-s">Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Granada, Spain</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">H. Amital</h4><p class="js-affiliation branded text-s">Meir Medical Center, Kfar Sava, Israel</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L00000024aKQAQ&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1656429462891" alt="Photo of J. M. Anaya Cabrera, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">J. M. Anaya Cabrera, MD, PhD</h4><p class="js-affiliation branded text-s">LifeFactors Zona Franca SAS, Rionegro, Colombia</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mY9oQAE&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1663974941481" alt="Photo of Coelho Andrade, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">Coelho Andrade, MD, PhD</h4><p class="js-affiliation branded text-s">Federal University of Sao Paulo, SAO PAULO, Brazil</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">S. Appenzeller, MD,PhD</h4><p class="js-affiliation branded text-s">State University of Campinas, CAMPINAS, São Paulo, Brazil</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">T. Atsumi</h4><p class="js-affiliation branded text-s">Hokkaido University, Sapporo, Japan</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">Balbir-Gurman, MD</h4><p class="js-affiliation branded text-s">Rambam Health Care Campus; Rappaport, Faculty of Medicine, Haifa, Israel</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">R. Birk</h4><p class="js-affiliation branded text-s">Ariel University, Department of Health Systems Management, Ariel, Israel</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">O. Bitsadze, Md</h4><p class="js-affiliation branded text-s">I M Sechenov First Moscow State Medical University, Moskva, Russian Federation</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000002c0nUIAQ&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1707477977921" alt="Photo of D. Bogdanos" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">D. Bogdanos</h4><p class="js-affiliation branded text-s">University of Thessaly, Faculty of Medicine, Larisa, Greece</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">S. Bombardieri</h4><p class="js-affiliation branded text-s">University of Pisa, Pisa, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">R. Cervera</h4><p class="js-affiliation branded text-s">University of Barcelona, Faculty of Medicine and Health Sciences, Barcelona, Spain</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">E. K. L. Chan</h4><p class="js-affiliation branded text-s">University of Florida, Gainesville, Florida, United States of America</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">J. Chapman</h4><p class="js-affiliation branded text-s">Sheba Medical Center, Tel Aviv, Israel</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mUTVQA2&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1663707191667" alt="Photo of P. Churilov, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">P. Churilov, MD, PhD</h4><p class="js-affiliation branded text-s">St Petersburg University, Sankt Peterburg, Russian Federation</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">K. Conrad</h4><p class="js-affiliation branded text-s">TU Dresden, Dresden, Germany</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L00000023KLQAY&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1656338957919" alt="Photo of E. Cutolo, MD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">E. Cutolo, MD</h4><p class="js-affiliation branded text-s">University of Genoa, Genova, Italy</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">D. D'Cruz</h4><p class="js-affiliation branded text-s">St Thomas' Hospital, London, United Kingdom</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mYQkQAM&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1664034990367" alt="Photo of M. G. Danieli, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">M. G. Danieli, MD, PhD</h4><p class="js-affiliation branded text-s">Polytechnic University of Marche, Department of Clinical and Molecular Sciences, Ancona, Italy</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">C. Dias</h4><p class="js-affiliation branded text-s">Medintern Association, Porto, Portugal</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">A. Doria, Professor of Rheumatology</h4><p class="js-affiliation branded text-s">University of Padua, Padova, Italy</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">C. Edwards</h4><p class="js-affiliation branded text-s">, United Kingdom</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">K. Elkon</h4><p class="js-affiliation branded text-s">University of Washington, Seattle, Washington, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. G. von Herrath, MD</h4><p class="js-affiliation branded text-s">La Jolla Institute for Immunology, La Jolla, California, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">G. Hughes</h4><p class="js-affiliation branded text-s">King's College London, London, United Kingdom</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">L.J. Jara</h4><p class="js-affiliation branded text-s">CMN La Raza Specialty Hospital, Ciudad de México, Mexico</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">D. Jayne</h4><p class="js-affiliation branded text-s">, United Kingdom</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M.A. Khamashta</h4><p class="js-affiliation branded text-s">St Thomas' Hospital, London, United Kingdom</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000miBfQAI&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1665205940398" alt="Photo of T. Koike, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">T. Koike, MD, PhD</h4><p class="js-affiliation branded text-s">Hokkaido University, Sapporo, Japan</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">O. Koren</h4><p class="js-affiliation branded text-s">Bar-Ilan University The Azrieli, Faculty of Medicine, Ramat Gan, Israel</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhbmQAA&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1665137127052" alt="Photo of A. Lerner, M.D., MHA" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">A. Lerner, M.D., MHA</h4><p class="js-affiliation branded text-s">Ariel University, Ari'el, Israel</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">R.A. Levy</h4><p class="js-affiliation branded text-s">Rio de Janeiro State University, RIO DE JANEIRO, Brazil</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. Li</h4><p class="js-affiliation branded text-s">Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. Mahler</h4><p class="js-affiliation branded text-s">INOVA Diagnostics Inc, San Diego, California, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">E. Matsuura</h4><p class="js-affiliation branded text-s">Okayama University, Okayama, Japan</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhOdQAI&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1665129700223" alt="Photo of P.L. Meroni, MD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">P.L. Meroni, MD</h4><p class="js-affiliation branded text-s">University of Milan, Milano, Italy</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">P. Miossec, MD, PhD</h4><p class="js-affiliation branded text-s">University Claude Bernard Lyon 1, Villeurbanne, France</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000005G4j9IAC&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1713192453660" alt="Photo of F. Morand, M.B., B.S.; PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">F. Morand, M.B., B.S.; PhD</h4><p class="js-affiliation branded text-s">Monash University, Clayton, Victoria, Australia</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. Mosca, MD, PhD</h4><p class="js-affiliation branded text-s">University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">Mouthon</h4><p class="js-affiliation branded text-s">Hospital Cochin, Paris, France</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">S. Muller, PhD</h4><p class="js-affiliation branded text-s">National Centre for Scientific Research, Paris, France</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mV9bQAE&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1663762228188" alt="Photo of M. F. Murovska, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">M. F. Murovska, MD, PhD</h4><p class="js-affiliation branded text-s">Riga Stradins University Institute of Microbiology and Virology, Rīga, Latvia</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhB5QAI&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1665077884365" alt="Photo of C. Perricone, M.D., Ph.D." class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">C. Perricone, M.D., Ph.D.</h4><p class="js-affiliation branded text-s">University of Perugia, Perugia, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">R. Perricone</h4><p class="js-affiliation branded text-s">University of Rome Tor Vergata, Roma, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">C. Putterman</h4><p class="js-affiliation branded text-s">Albert Einstein College of Medicine, Bronx, New York, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">G. Riemekasten</h4><p class="js-affiliation branded text-s">University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">C. Salvarani</h4><p class="js-affiliation branded text-s">Reggio Emilia Local Agency - IRCCS Advanced Technologies and Care Models in Oncology, Reggio Emilia, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">P. Sarzi-Puttini</h4><p class="js-affiliation branded text-s">Regional Health Care and Social Agency Fatebenefratelli Sacco, Milano, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M. Scheinberg</h4><p class="js-affiliation branded text-s">Sociedade Beneficente Israelita Brasileira Albert Einstein, SAO PAULO, São Paulo, Brazil</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">J. Scher</h4><p class="js-affiliation branded text-s">New York University Grossman School of Medicine, New York, New York, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">R. E. Schmidt†</h4><p class="js-affiliation branded text-s">Hannover Medical School, Hannover, Germany</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mjhSQAQ&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1665486886019" alt="Photo of V. Somers, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">V. Somers, PhD</h4><p class="js-affiliation branded text-s">Biomedical Research Institute, Diepenbeek, Belgium</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">M-J. R. Sousa, PhD</h4><p class="js-affiliation branded text-s">New University of Lisbon Comprehensive Health Research Centre National School of Public Health, Lisboa, Portugal</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mUfHQAU&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1663736942167" alt="Photo of Z. Szekanecz, PhD, DSc" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">Z. Szekanecz, PhD, DSc</h4><p class="js-affiliation branded text-s">University of Debrecen, Debrecen, Hungary</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mULMQA2&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1663699289348" alt="Photo of M. Tektonidou, MD, PhD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">M. Tektonidou, MD, PhD</h4><p class="js-affiliation branded text-s">National and Kapodistrian University of Athens First, Department of Propaedeutic and Internal Medicine, Athens, Greece</p><button class="button-link editor-bio text-s u-margin-hor-xs u-display-block button-link-primary button-link-icon-left" type="button" data-aa-button="aa-editor-bio-expand" tabindex="0"><svg focusable="false" viewBox="0 0 54 128" width="10.125" height="24" class="icon icon-navigate-right"><path d="m1 99l38-38-38-38 7-7 45 45-45 45z"></path></svg><span class="button-link-text">View full biography</span></button></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">A. Tincani</h4><p class="js-affiliation branded text-s">Regional Health Care and Social Agency Civil Hospitals of Brescia, Brescia, Italy</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">Y. Tomer, MD</h4><p class="js-affiliation branded text-s">Albert Einstein College of Medicine, Bronx, New York, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">E. Toubi</h4><p class="js-affiliation branded text-s">Bnai Zion Medical Center, Haifa, Israel</p></div></div><div class="row editor-group u-margin-l-ver"><img src="https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mdBGQAY&amp;oid=00D1t000000qIy5EAE&amp;lastMod=1664526848497" alt="Photo of C. Tsokos, MD" class="col-xs-4 u-display-inline-block editor-img js-editor-img u-margin-s-right" /><div class="col-xs-20 u-display-inline-block "><h4 class="js-editor-name">C. Tsokos, MD</h4><p class="js-affiliation branded text-s">Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">A. Tzioufas</h4><p class="js-affiliation branded text-s">National and Kapodistrian University of Athens, Athens, Greece</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">P. Youinou</h4><p class="js-affiliation branded text-s">Brest University Hospital Centre, Brest, France</p></div></div><div class="row editor-group u-margin-l-ver"><div class="col-xs-20 u-display-inline-block  img-placeholder"><h4 class="js-editor-name">G Zandman-Goddard</h4><p class="js-affiliation branded text-s">, Israel</p></div></div></div><div data-focus-guard="true" tabindex="-1" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div><div data-focus-lock-disabled="disabled"><div class="slide-out" style="height:0" role="dialog" aria-label="Slideout panel"><div class="header-container"><button type="button" class="button close-button js-close-button button-anchor" aria-disabled="false" aria-label="close panel"><span class="button-text"><svg focusable="false" viewBox="0 0 70 128" width="13.125" height="24" class="icon icon-cross"><path d="m68.94 36.12l-6.94-7.12-27 27-27-27-7 7 27 27-27 27 7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></span></button></div><p class="editor-bio-slide-out-panel-text branded"></p></div></div><div data-focus-guard="true" tabindex="-1" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div><p class="disclaimer">All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. Elsevier remains neutral with regard to any jurisdictional claims.</p></div></div></div></div></div></main></div></div><footer role="contentinfo" class="els-footer u-bg-white text-xs u-padding-s-hor u-padding-m-hor-from-sm u-padding-l-hor-from-md u-padding-l-ver u-margin-l-top u-margin-xl-top-from-sm u-margin-l-top-from-md"><div class="els-footer-elsevier u-margin-m-bottom u-margin-0-bottom-from-md u-margin-s-right u-margin-m-right-from-md u-margin-l-right-from-lg"><a class="anchor anchor-default anchor-icon-only" href="https://www.elsevier.com/" target="_blank" aria-label="Elsevier home page (opens in a new tab)" rel="nofollow"><img class="footer-logo" src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/47/images/elsevier-non-solus-new-with-wordmark.svg" alt="Elsevier logo with wordmark" height="64" width="58" loading="lazy" /></a></div><div class="els-footer-content"><div class="u-remove-if-print"><ul class="els-footer-links u-margin-xs-bottom" style="list-style:none"><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="https://www.elsevier.com/solutions/sciencedirect" target="_blank" id="els-footer-about-science-direct" rel="nofollow"><span class="anchor-text">About ScienceDirect</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="/user/institution/login?targetURL=%2Fjournal%2Fautoimmunity-reviews%2Fabout%2Feditorial-board" id="els-footer-remote-access" rel="nofollow"><span class="anchor-text">Remote access</span></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="https://sd-cart.elsevier.com/?" target="_blank" id="els-footer-shopping-cart" rel="nofollow"><span class="anchor-text">Shopping cart</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="http://elsmediakits.com" target="_blank" id="els-footer-advertise" rel="nofollow"><span class="anchor-text">Advertise</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="https://service.elsevier.com/app/contact/supporthub/sciencedirect/" target="_blank" id="els-footer-contact-support" rel="nofollow"><span class="anchor-text">Contact and support</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions" target="_blank" id="els-footer-terms-condition" rel="nofollow"><span class="anchor-text">Terms and conditions</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li><li><a class="anchor u-display-block u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-default" href="https://www.elsevier.com/legal/privacy-policy" target="_blank" id="els-footer-privacy-policy" rel="nofollow"><span class="anchor-text">Privacy policy</span><svg focusable="false" viewBox="0 0 78 128" aria-label="Opens in new window" width="1em" height="1em" class="icon icon-arrow-up-right arrow-external-link"><path d="m4 36h57.07l-59.5 59.5 7.07 7.08 59.36-59.36v56.78h1e1v-74h-74z"></path></svg></a></li></ul></div><p id="els-footer-cookie-message" class="u-remove-if-print">Cookies are used by this site. <!-- --> <button class="button-link ot-sdk-show-settings cookie-btn button-link-primary" type="button" id="ot-sdk-btn"><span class="button-link-text"><strong>Cookie Settings</strong></span></button></p><p id="els-footer-copyright">All content on this site: Copyright © <!-- -->2024<!-- --> Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply.</p></div><div class="els-footer-relx u-margin-0-top u-margin-m-top-from-xs u-margin-0-top-from-md"><a class="anchor anchor-default anchor-icon-only" href="https://www.relx.com/" target="_blank" aria-label="RELX home page (opens in a new tab)" id="els-footer-relx" rel="nofollow"><img loading="lazy" src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/60/images/logo-relx-tm.svg" width="93" height="20" alt="RELX group home page" /></a></div></footer></div></div>
<script type="application/json" data-iso-key="_0">"{\"adobeTarget\":{\"visitorState\":{\"4D6368F454EC41940A4C98A6@AdobeOrg\":{\"sdid\":{\"supplementalDataIDCurrent\":\"6442A8F599359E40-5D87C047B00AED93\",\"supplementalDataIDCurrentConsumed\":{\"payload:target-global-mbox\":true},\"supplementalDataIDLastConsumed\":{}}}},\"journal-compare-cta-link-server-side-mbox\":{\"variation\":false}},\"articlesInPress\":{},\"config\":{\"client\":{\"arsBaseUrl\":\"https://ars.els-cdn.com\",\"cdnAssetsHost\":\"https://sdfestaticassets-eu-west-1.sciencedirectassets.com\",\"publishingTimelineMetricsUnit\":\"day\",\"title\":{\"maxLines\":3},\"query\":{\"articlesInPress\":{\"page\":1,\"pageSize\":8},\"latestPublishedArticles\":{\"pageSize\":8,\"documentSubtype\":\"jhpType\",\"order\":\"asc\"},\"latestArticles\":{\"pageSize\":3,\"documentSubtype\":\"jhpType\",\"order\":\"desc\"},\"latestIssues\":{\"size\":6,\"return\":[\"cover-date-text\",\"issn\",\"hub-stage\",\"pages\",\"vol-issue-supplement-text\",\"uri-lookup\",\"title-editors-group\"]},\"specialIssues\":{\"page\":1,\"pageSize\":4}},\"pages\":{\"arp\":\"\",\"ahp\":\"\",\"ihp\":\"\",\"jhp\":\"\",\"sap\":\"\",\"srp\":\"\",\"notFound\":\"/science/error\",\"doi\":\"https://dx.doi.org\",\"compare\":\"\"},\"analytics\":{\"jhp\":{\"enabled\":true,\"pageName\":\"home\",\"environment\":\"prod\"},\"aimsAndScope\":{\"enabled\":true,\"pageName\":\"about:aims-and-scope\",\"environment\":\"prod\"},\"editorialBoard\":{\"enabled\":true,\"pageName\":\"about:editorial-board\",\"environment\":\"prod\"},\"about\":{\"enabled\":true,\"pageName\":\"about\",\"environment\":\"prod\"},\"insights\":{\"enabled\":true,\"pageName\":\"insights\",\"environment\":\"prod\"},\"guideForAuthors\":{\"enabled\":true,\"pageName\":\"guide-for-authors\",\"environment\":\"prod\"},\"openAccessOptions\":{\"enabled\":true,\"pageName\":\"open-access-options\",\"environment\":\"prod\"}},\"outputComponentErrors\":false,\"usageInfo\":false,\"editorsByCountry\":true,\"submitQueenEnabled\":true,\"cookiePreferenceCenter\":true,\"apcComparisonTool\":false,\"compareCTA\":true,\"enableErmsEditorialBoard\":false,\"enableJifaAimsAndScope\":false,\"requestPath\":\"/journal/autoimmunity-reviews/about/editorial-board\",\"identity\":{},\"canonicalBaseUrl\":\"https://www.sciencedirect.com\",\"baseUrl\":\"//www.sciencedirect.com\",\"ip\":\"80.113.54.144\",\"mobileUserAgent\":false,\"cfIpCountryCode\":\"NL\"},\"headerFooter\":{\"helpUrl\":\"https://service.elsevier.com/app/answers/detail/a_id/25950/supporthub/sciencedirect/\",\"contactUrl\":\"https://service.elsevier.com/app/contact/supporthub/sciencedirect/\",\"userName\":\"\",\"userEmail\":\"\",\"orgName\":\"ScienceDirect Guests\",\"webUserId\":\"12975512\",\"libraryBanner\":null,\"shib_regUrl\":\"\",\"tick_regUrl\":\"\",\"recentInstitutions\":[],\"canActivatePersonalization\":false,\"hasInstitutionalAssociation\":false,\"hasMultiOrg\":false,\"userType\":\"GUEST\",\"userAnonymity\":\"ANON_GUEST\",\"allowCart\":true,\"environment\":\"prod\",\"cdnAssetsHost\":\"https://sdfestaticassets-eu-west-1.sciencedirectassets.com\",\"contextualSupportHubUrls\":[{\"text\":\"What can I do on a journal home page?\",\"href\":\"https://service.elsevier.com/app/answers/detail/a_id/25950/supporthub/sciencedirect/\",\"aaName\":\"What can I do on a journal home page?\"}],\"cookieBanner\":true},\"userPdfStatus\":{\"preventUserTransactionalAccess\":false,\"preventUserDocumentDelivery\":true,\"allowUserCreditCardPurchase\":true,\"blockFullTextForAnonymousAccess\":false},\"userAnalyticsIdentity\":{\"accountId\":\"ae:228598\",\"accountName\":\"ae:ScienceDirect Guests\",\"userId\":\"ae:12975512\",\"accessType\":\"ae:ANON_GUEST\"},\"journalAlertsIdentity\":{\"webUserId\":\"12975512\"},\"usageEventIdentity\":{\"accessType\":\"GUEST\",\"primary\":\"(12975512,U|291352,D|228598,A|3,P|2,PL)(SDFE,CON|e9cf439225bc2043ad3a7c30a5f6e032c6e0gxrqb,SSO|ANON_GUEST,ACCESS_TYPE)\",\"sessId\":\"0d2de889-e4fc-4133-80ac-9261e73cc91c\",\"utt\":\"53e7ff40aa59f81e2f865429998625b2835779a-mp0x\"},\"alerts\":{\"jsonWebToken\":\"eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJ4LXNkZmUtdXNlci1pcCI6IjgwLjExMy41NC4xNDQiLCJ4LXNkZmUtdXNlci1pZCI6IjEyOTc1NTEyIiwiaWF0IjoxNzE2MjA2MjIyLCJpc3MiOiJNYW5hZ2UtTXktQWxlcnRzIiwianRpIjoiZTljZjQzOTIyNWJjMjA0M2FkM2E3YzMwYTVmNmUwMzJjNmUwZ3hycWIifQ.LmQUPIeng-m08OAjpcdPAVL_Ip6_fyd1wyK2Z-v-Nc0\",\"journalAlertStatus\":false}},\"latestIssues\":{},\"latestPublishedArticles\":{},\"mostDownloadedArticles\":{},\"namespace\":\"aimsAndScope\",\"rssModal\":{\"isOpen\":false},\"specialIssues\":{},\"titleMetadata\":{\"isFetching\":false,\"copyright\":\"Copyright © 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.\",\"externalSerial\":true,\"thirdParty\":false,\"allowVia\":true,\"editorCountries\":[{\"Country_Code\":\"AU\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Australia\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"BE\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Belgium\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"BR\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Brazil\",\"Editor_Count\":\"4\"},{\"Country_Code\":\"CN\",\"Journal_PTS\":\"AUTREV\",\"country\":\"China\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"CO\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Colombia\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"FR\",\"Journal_PTS\":\"AUTREV\",\"country\":\"France\",\"Editor_Count\":\"4\"},{\"Country_Code\":\"DE\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Germany\",\"Editor_Count\":\"3\"},{\"Country_Code\":\"GR\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Greece\",\"Editor_Count\":\"3\"},{\"Country_Code\":\"HU\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Hungary\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"IL\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Israel\",\"Editor_Count\":\"8\"},{\"Country_Code\":\"IT\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Italy\",\"Editor_Count\":\"11\"},{\"Country_Code\":\"JP\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Japan\",\"Editor_Count\":\"3\"},{\"Country_Code\":\"LV\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Latvia\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"MX\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Mexico\",\"Editor_Count\":\"1\"},{\"Country_Code\":\"PT\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Portugal\",\"Editor_Count\":\"2\"},{\"Country_Code\":\"RU\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Russian Federation\",\"Editor_Count\":\"2\"},{\"Country_Code\":\"ES\",\"Journal_PTS\":\"AUTREV\",\"country\":\"Spain\",\"Editor_Count\":\"2\"},{\"Country_Code\":\"GB\",\"Journal_PTS\":\"AUTREV\",\"country\":\"United Kingdom\",\"Editor_Count\":\"5\"},{\"Country_Code\":\"US\",\"Journal_PTS\":\"AUTREV\",\"country\":\"United States of America\",\"Editor_Count\":\"10\"}],\"abstractsAndIndexes\":[\"PubMed/Medline\",\"Science Citation Index Expanded\",\"Biosciences Information Services\",\"Chemical Abstracts\"],\"subjectIds\":[\"291693\",\"291903\"],\"topCitedArticles\":[{\"pii\":\"S1568997221000550\",\"numcitedby\":326},{\"pii\":\"S1568997221000392\",\"numcitedby\":161},{\"pii\":\"S1568997221000227\",\"numcitedby\":136},{\"pii\":\"S1568997221002020\",\"numcitedby\":132},{\"pii\":\"S1568997220303165\",\"numcitedby\":128},{\"pii\":\"S1568997221002226\",\"numcitedby\":126},{\"pii\":\"S1568997221002998\",\"numcitedby\":102},{\"pii\":\"S1568997220303220\",\"numcitedby\":99}],\"sampleIssueAvail\":false,\"personalOrder\":\"https://www.elsevier.com/journals/autoimmunity-reviews/1568-9972/subscribe?subscriptiontype=personal\",\"xcrTimeStamp\":\"2024-05-19T15:58:49.348673Z\",\"isGuideForAuthors\":true,\"latestIssue\":\"/vol/23/issue/5\",\"coverImage\":{\"attachment\":[{\"attachmentEid\":\"1-s2.0-S1568997224X00038-cov200h.gif\",\"fileBasename\":\"cov200h\",\"extension\":\"gif\",\"filename\":\"cov200h.gif\",\"ucsLocator\":[\"https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1568997224X00038/cover/DOWNSAMPLED200/image/gif/fa55618a3a241a5996b4313342c80157/cov200h.gif\"],\"attachmentType\":\"IMAGE-COVER-H200\",\"filesize\":\"16239\",\"pixelHeight\":\"200\",\"pixelWidth\":\"150\"},{\"attachmentEid\":\"1-s2.0-S1568997224X00038-cov150h.gif\",\"fileBasename\":\"cov150h\",\"extension\":\"gif\",\"filename\":\"cov150h.gif\",\"ucsLocator\":[\"https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1568997224X00038/cover/DOWNSAMPLED150/image/gif/9dacef24087d6912bceb5392eef2dadd/cov150h.gif\"],\"attachmentType\":\"IMAGE-COVER-H150\",\"filesize\":\"10392\",\"pixelHeight\":\"150\",\"pixelWidth\":\"113\"}]},\"issn\":\"15689972\",\"aimsAndScope\":\"&lt;em&gt;Autoimmunity Reviews&lt;/em&gt; will publish up-to-date, structured reviews on diverse topics in &lt;strong&gt;autoimmunity&lt;/strong&gt;, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a \\\"take-home\\\" message.&lt;br /&gt;&lt;br /&gt; Articles will principally be invited by the &lt;a href=\\\"https://www.journals.elsevier.com/autoimmunity-reviews/editorial-board/\\\"&gt;Editors-in-Chief&lt;/a&gt; upon the recommendations of the international Editorial Board, and will cover all fields of &lt;strong&gt;autoimmunology&lt;/strong&gt;, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the &lt;strong&gt;pathophysiology&lt;/strong&gt; and &lt;strong&gt;mechanisms&lt;/strong&gt; of &lt;strong&gt;disorders&lt;/strong&gt; as well as &lt;strong&gt;genomics&lt;/strong&gt; and &lt;strong&gt;proteomics&lt;/strong&gt;; clinical contributions will focus upon the diseases, novel therapies and clinical associations. &lt;br /&gt;&lt;br /&gt; &lt;strong&gt;Benefits to authors&lt;/strong&gt;&lt;br /&gt; We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our &lt;a href=\\\"https://www.elsevier.com/authors/author-services\\\"&gt; author services &lt;/a&gt;. &lt;br /&gt;&lt;br /&gt;Please see our &lt;a href=\\\"https://www.elsevier.com/journals/autoimmunity-reviews/1568-9972/guide-for-authors\\\"&gt;Guide for Authors&lt;/a&gt; for information on article submission. If you require any further information or help, please visit our &lt;a href=\\\"https://service.elsevier.com/app/home/supporthub/publishing/\\\"&gt;Support Center&lt;/a&gt;\",\"issnManifestations\":[{\"issn\":\"1873-0183\",\"type\":\"Electronic\"},{\"issn\":\"1568-9972\",\"type\":\"Print\"}],\"topViewedDownloaded\":[{\"period\":\"90\"}],\"institutionalOrder\":\"https://www.elsevier.com/journals/autoimmunity-reviews/1568-9972/subscribe?subscriptiontype=institutional\",\"smallCoverUrl\":\"https://ars.els-cdn.com/content/image/S15689972.gif\",\"articlePublishingCharge\":{\"listPrice\":4990},\"cid\":\"272276\",\"topSocialArticles\":[{\"pii\":\"S156899722100094X\"},{\"pii\":\"S1568997221002597\"},{\"pii\":\"S1568997223000216\"},{\"pii\":\"S1568997220303220\"},{\"pii\":\"S156899722100269X\"},{\"pii\":\"S1568997222000544\"},{\"pii\":\"S1568997221001373\"},{\"pii\":\"S1568997221001579\"}],\"monthlyGraphs\":[{\"citations\":{\"enabled_for_homepages\":false,\"name\":\"Citations\"}},{\"social_media\":{\"enabled_for_homepages\":false,\"name\":\"Social Media\"}},{\"mendeley_captures\":{\"enabled_for_homepages\":false,\"name\":\"Mendeley Captures\"}},{\"downloads\":{\"enabled_for_homepages\":false,\"name\":\"Downloads\"}}],\"displayName\":\"Autoimmunity Reviews\",\"hasAip\":true,\"title\":\"autoimmunity-reviews\",\"largeCoverUrl\":\"https://ars.els-cdn.com/content/image/X15689972.jpg\",\"transBlock\":false,\"openAccess\":{\"oaStatus\":\"\",\"oaArticleCount\":167,\"openArchiveStatus\":false,\"openArchiveArticleCount\":0,\"openAccessStartDate\":\"\",\"oaAllowsAuthorPaid\":true},\"productAvailable\":true,\"backgroundColor\":\"#146826\",\"scopusSourceId\":\"20689\",\"hasSpecialIssue\":true,\"editorialBoard\":{\"groups\":[{\"role\":\"Co-Editors in Chief\",\"members\":[{\"affiliation\":\"SUNY Upstate Medical University, Syracuse, New York, United States of America\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0158e000000lI45AAE&oid=00D1t000000qIy5EAE&lastMod=1696336710004\",\"name\":\"A. Perl, MD, PhD\",\"biography\":\"Andras Perl received his MD and PhD from Semmelweis University in Budapest, Hungary. He held faculty positions at Semmelweis, the University of Rochester, and the State University of New York (SUNY) in Buffalo and Syracuse. He has been Professor of Medicine, Microbiology and Immunology, and Biochemistry and Molecular Biology since 1997, Chief of Rheumatology since 2001, and SUNY Distinguished Professor since 2017. His laboratory discovered mitochondrial hyperpolarization (MHP), a source of mitochondrial oxidative stress and a checkpoint of T-cell activation and death signal processing. His team has identified disease susceptibility genes that regulate mitochondrial homeostasis, autophagy, activation of the mechanistic target of rapamycin (mTOR) pathway, and cell death signal processing in mouse models and patients with autoimmunity, cancer, metabolic diseases. He has initiated successful clinical trials in patients with systemic lupus erythematosus (SLE) blocking mTOR with N-acetylcysteine or sirolimus. He has published over 200 original peer-reviewed papers in leading medical and scientific journals, authored chapters in rheumatology and immunology textbooks, trained over 60 MD/PhD and PhD students and postdoctoral and rheumatology fellows. His laboratory has been continuously funded by the National Institutes of Health since 1996. He has been listed among the Best Doctors in America since 2007.\"},{\"affiliation\":\"University of Thessaly, Faculty of Medicine, Larisa, Greece\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000002c0nUIAQ&oid=00D1t000000qIy5EAE&lastMod=1707477977921\",\"name\":\"D. Bogdanos\",\"biography\":\"Dimitrios P. Bogdanos, MBA, MPA, LLM, MD, PhD is a Professor of Medicine and Autoimmune Diseases. He is the Director and Chairman of the Department of Rheumatology and Clinical Immunology, University of Thessaly Medical School and the Director of the Rheumatology Clinic, University General Hospital of Larissa, Greece. He is also the Director of the Laboratories of Rheumatology, Clinical Immunology and Autoimmune Diseases, Faculty of Medicine, University of Thessaly. Professor Bogdanos has studied medicine in Aristotle University of Thessaloniki and obtained a joint PhD from University College London/King&rsquo;s College London in UK. He has specialized medicine and clinical immunology and obtained a license to practice in UK.&lt;br&gt;He is a one of the very few Greeks who are regular members of the Academy of Sciences. &lt;br&gt;His main focus is the translational research and clinical management of patients with autoimmune rheumatic and organ specific autoimmune diseases. He has published extensively (&gt;350 papers in Pubmed) on research and clinical aspects of autoimmunity. &nbsp;He has published more than 35 books, chapters in books on autoimmunity.&lt;br&gt;He is the Editor of Autoimmunity Reviews, the most prestigious scientific journal of Autoimmunity in the world. For his research he has been awarded more than 35 national and international prizes (UK, USA, Germany), awards, distinctions, and honors over the last 25 years. &nbsp;&lt;br&gt;&nbsp;&lt;br&gt;MBA: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&eta;&nu; &Delta;&iota;&omicron;ί&kappa;&eta;&sigma;&eta; &Epsilon;&pi;&iota;&chi;&epsilon;&iota;&rho;ή&sigma;&epsilon;&omega;&nu;&lt;br&gt;&Mu;PA: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&eta;&nu; &Delta;&eta;&mu;ό&sigma;&iota;&alpha; &Delta;&iota;&omicron;ί&kappa;&eta;&sigma;&eta;&lt;br&gt;LLM: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&omicron; &Epsilon;&mu;&pi;&omicron;&rho;&iota;&kappa;ό &Delta;ί&kappa;&alpha;&iota;&omicron; &lt;br&gt;MD: Medical Degree (&Alpha;&Pi;&Theta;)&lt;br&gt;PhD: &Delta;&iota;&delta;&alpha;&kappa;&tau;&omicron;&rho;&iota;&kappa;ό &sigma;&tau;&eta;&nu; &Alpha;&nu;&omicron;&sigma;&omicron;&pi;&alpha;&theta;&omicron;&lambda;&omicron;&gamma;ί&alpha; (University of London)&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;\"}]},{\"role\":\"Editorial Board Members\",\"members\":[{\"affiliation\":\"University of California San Francisco, San Francisco, California, United States of America\",\"name\":\"A.K. Abbas\"},{\"affiliation\":\"Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Granada, Spain\",\"name\":\"M. Alarcón Riquelme\"},{\"affiliation\":\"Meir Medical Center, Kfar Sava, Israel\",\"name\":\"H. Amital\"},{\"affiliation\":\"LifeFactors Zona Franca SAS, Rionegro, Colombia\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L00000024aKQAQ&oid=00D1t000000qIy5EAE&lastMod=1656429462891\",\"name\":\"J. M. Anaya Cabrera, MD, PhD\",\"biography\":\"Chief Scientific Officer at LifeFactors, Colombia. \\nFounder and former director of the Center for Autoimmune Diseases Research (CREA), at the University of Rosario, in Bogota, Colombia, where he also created the Translational Medicine Chair. He received his M.D. degree from the Universidad del Rosario, developed his Residency in Rheumatology at the University of Paris V, and obtained a Postgraduate Diploma in Immunology at the Institute Pasteur of Paris. He served as &ldquo;Chef de Clinique&rdquo; at the Gui de Chaulliac Hospital, University of Montpellier, France. At the University of Texas Health Science Center in San Antonio, TX, USA, he performed as a Postdoctoral Research Fellow in Clinical Immunology. He received his Ph.D. degree in Biology from the University of Antioquia, Colombia, after completing a fellowship at the Medical Genetics Branch, NIH, Bethesda, and working as a Research Associate at the Oklahoma Medical Research Foundation, USA. He a member of the National Academy of Medicine of Colombia. \\nHis research is focused on the search and discovery of common mechanisms of autoimmune diseases (that is, the autoimmune tautology). He has coauthored more than 350 scientific papers and coedited 15 books on immunology and autoimmunity.\"},{\"affiliation\":\"Federal University of Sao Paulo, SAO PAULO, Brazil\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mY9oQAE&oid=00D1t000000qIy5EAE&lastMod=1663974941481\",\"name\":\"Coelho Andrade, MD, PhD\",\"biography\":\"Luis Andrade is currently a Professor of the Department of Medicine, Division of Rheumatology, at The Federal University of Sao Paulo in Brazil. He received his M.D. degree from Federal University of Minas Gerais and his Ph.D. degree in Rheumatology from Escola Paulista de Medicina, both in Brazil. He received his post-doctoral degree in the field of molecular and cellular biology of autoantibodies from the Scripps Research Institute in the USA under supervising of Professor Eng M. Tan. Luis Andrade is the Chair of the IUIS Quality and Assessment Committee (https://iuis.org/committees/qas/members/), Chair of the Laboratory Advisory Board of the Brazilian Society of Rheumatology and Co-coordinator (with Professor Edward Chan) of the ICAP (International Consensus on ANA Patterns). He is a former Chair of the Autoantibody Standardizing Subcommittee (www.autoab.org) affiliated with the IUIS and member of the American College of Rheumatology, the Brazilian Society of Rheumatology and the Brazilian Society of Clinical Pathology and Laboratory Medicine.  He serves in the editorial board of a variety of journals in the area of autoimmunity and rheumatology. His research interests have focused on studies on the fields of autoantibodies, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, capillaroscopy, and molecular biology of autoantigens and autoimmune rheumatic diseases. More recently, he concentrates on the fields of autoantibody testing and standardization as well as the interface between autoimmunity and immunodeficiency.\"},{\"affiliation\":\"State University of Campinas, CAMPINAS, São Paulo, Brazil\",\"name\":\"S. Appenzeller, MD,PhD\",\"biography\":\"I am an Adult and Pediateic Rheumatoligist. My research interest is to investigate neuropsychiatric manifestations in rheumatic disease and identify biomarkers associated with its occurrence.\"},{\"affiliation\":\"Hokkaido University, Sapporo, Japan\",\"name\":\"T. Atsumi\"},{\"affiliation\":\"Rambam Health Care Campus; Rappaport, Faculty of Medicine, Haifa, Israel\",\"name\":\"Balbir-Gurman, MD\",\"biography\":\"Alexandra Balbir-Gurman, Clinical Associate Professor has been Director of the B. Shine Rheumatology Institute at Rambam Health Care Campus since 2006. \\nDr. Balbir-Gurman graduated State Medical University, Chernivtsi, Ukraine in 1979. After receiving a medical degree, she worked as a family physician, internist and cardio-rheumatologist at a municipal hospital in Chernivtsi. She immigrated to Israel in 1989. Dr Balbir-Gurman completed her Residency in Internal Medicine (1990-1994) in the Department of Internal Medicine at B&rsquo;nai Zion Hospital. She completed rheumatology fellowship in Rheumatology Department at Rambam (1994-1997) and has been a Senior Rheumatologist since 1997. In 2000, she performed clinical fellowship in The Connective Tissue Diseases Unit at Royal Free Hospital (London) under Prof. C. Black and C. Denton. \\nProf. Balbir-Gurman is Clinical Associate Professor and Head of Rheumatology Department at the Rappaport Faculty of Medicine-Technion, Haifa. Prof. Balbir-Gurman was a member of the Executive Committee of the Israeli Society of Rheumatology for eight years; she is a member of international rheumatology organizations ACR and EULAR; she is a Counselor of the Scleroderma Research Group (EUSTAR). Prof. Balbir-Gurman maintains the largest Israeli scleroderma patients' registry, and operates a busy scleroderma clinic and a multidisciplinary fibro-vascular clinic for patients with respiratory problems and rheumatic diseases. She has published articles in the field of scleroderma, myositis, vasculitis, rheumatoid arthritis, biological therapies, and the use of US in rheumatic diseases. Prof. Balbir-Gurman has organized several musculo-skeletal US courses for Israeli rheumatologists. Every two years she organizes an International Rheumatology Scientific Conference at Rambam. Prof. Balbir-Gurman took part in more than 35 RCT in the field of rheumatology as a site-principal investigator at Rambam. Prof. Balbir-Gurman serves as Editorial Board Member of medical journals: IMAJ and Autoimmunity Reviews.\"},{\"affiliation\":\"Ariel University, Department of Health Systems Management, Ariel, Israel\",\"name\":\"R. Birk\"},{\"affiliation\":\"I M Sechenov First Moscow State Medical University, Moskva, Russian Federation\",\"name\":\"O. Bitsadze, Md\"},{\"affiliation\":\"University of Thessaly, Faculty of Medicine, Larisa, Greece\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000002c0nUIAQ&oid=00D1t000000qIy5EAE&lastMod=1707477977921\",\"name\":\"D. Bogdanos\",\"biography\":\"Dimitrios P. Bogdanos, MBA, MPA, LLM, MD, PhD is a Professor of Medicine and Autoimmune Diseases. He is the Director and Chairman of the Department of Rheumatology and Clinical Immunology, University of Thessaly Medical School and the Director of the Rheumatology Clinic, University General Hospital of Larissa, Greece. He is also the Director of the Laboratories of Rheumatology, Clinical Immunology and Autoimmune Diseases, Faculty of Medicine, University of Thessaly. Professor Bogdanos has studied medicine in Aristotle University of Thessaloniki and obtained a joint PhD from University College London/King&rsquo;s College London in UK. He has specialized medicine and clinical immunology and obtained a license to practice in UK.&lt;br&gt;He is a one of the very few Greeks who are regular members of the Academy of Sciences. &lt;br&gt;His main focus is the translational research and clinical management of patients with autoimmune rheumatic and organ specific autoimmune diseases. He has published extensively (&gt;350 papers in Pubmed) on research and clinical aspects of autoimmunity. &nbsp;He has published more than 35 books, chapters in books on autoimmunity.&lt;br&gt;He is the Editor of Autoimmunity Reviews, the most prestigious scientific journal of Autoimmunity in the world. For his research he has been awarded more than 35 national and international prizes (UK, USA, Germany), awards, distinctions, and honors over the last 25 years. &nbsp;&lt;br&gt;&nbsp;&lt;br&gt;MBA: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&eta;&nu; &Delta;&iota;&omicron;ί&kappa;&eta;&sigma;&eta; &Epsilon;&pi;&iota;&chi;&epsilon;&iota;&rho;ή&sigma;&epsilon;&omega;&nu;&lt;br&gt;&Mu;PA: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&eta;&nu; &Delta;&eta;&mu;ό&sigma;&iota;&alpha; &Delta;&iota;&omicron;ί&kappa;&eta;&sigma;&eta;&lt;br&gt;LLM: &Mu;&epsilon;&tau;&alpha;&pi;&tau;&upsilon;&chi;&iota;&alpha;&kappa;ό &sigma;&tau;&omicron; &Epsilon;&mu;&pi;&omicron;&rho;&iota;&kappa;ό &Delta;ί&kappa;&alpha;&iota;&omicron; &lt;br&gt;MD: Medical Degree (&Alpha;&Pi;&Theta;)&lt;br&gt;PhD: &Delta;&iota;&delta;&alpha;&kappa;&tau;&omicron;&rho;&iota;&kappa;ό &sigma;&tau;&eta;&nu; &Alpha;&nu;&omicron;&sigma;&omicron;&pi;&alpha;&theta;&omicron;&lambda;&omicron;&gamma;ί&alpha; (University of London)&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;&lt;/br&gt;\"},{\"affiliation\":\"University of Pisa, Pisa, Italy\",\"name\":\"S. Bombardieri\"},{\"affiliation\":\"University of Barcelona, Faculty of Medicine and Health Sciences, Barcelona, Spain\",\"name\":\"R. Cervera\"},{\"affiliation\":\"University of Florida, Gainesville, Florida, United States of America\",\"name\":\"E. K. L. Chan\",\"biography\":\"&nbsp; (url &nbsp;http://edward-chan.dental.ufl.edu/)&nbsp;Link to editor's website\"},{\"affiliation\":\"Sheba Medical Center, Tel Aviv, Israel\",\"name\":\"J. Chapman\"},{\"affiliation\":\"St Petersburg University, Sankt Peterburg, Russian Federation\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mUTVQA2&oid=00D1t000000qIy5EAE&lastMod=1663707191667\",\"name\":\"P. Churilov, MD, PhD\",\"biography\":\"Born June 10th, 1956 in Far North of Russia, Graduated from St Petersburg State Paediatric Medical University (1979) cum laude. Chairman of Pathology Dept, Faculty of Medicine, Deputy-Head of the Laboratory of Mosaic of Autoimmunity, St. Petersburg State University, Leading Research Scientist of the St. Petersburg Research Institute of Phthisiopulmonology, Member of International Academy of Sciences (Health and Ecology), Corresponding Member of International Higher School Academy of Sciences, Associate Professor. Author of Textbook of Pathophysiology in 3 volumes (6 editions for 17 years in Russia), also published about 40 monographs and handbooks in Pathophysiology, Immunology and Endocrinology, in History of Medicine and over 700 other academic papers. Member of International Society for Pathophysiology (ISP), laureate of ISP2006 Peking Congress Award for best poster presentation, winner of II All-Union competition on the best research in Pathophysiology, co-editor of Russian edition of &ldquo;Diabetes A to Z&rdquo; Encyclopedia of American Medical Association. Co-editor and co-author of the international &ldquo;Guide on Autoimmune Diseases for General Medical Practice&rdquo; (2017). Co-author of the first in Russia bilingual electronic manual in Immunology and Immunopathology, scientific editor of Manual in Military Field Surgery, scientific editor and co-author of the most recent Russian manual in shock and polytrauma, author of several monographs in obesity, Manual in Adolescent Endocrinology, monographs in stress and neuroses and in systemic disorders of connective tissue.  Published in Russia and abroad several papers in innovative interdisciplinary teaching of Pathophysiology intermingled with other medical disciplines. Co-developer and Dean of the first English medium M.D. Program in the history of Russian Medical School, for this contribution awarded the honorable diploma of the Senate of State of New York. Twice published a textbook and audio guide in English for Medical Students (2012, 2018). Was a participant of medical ecological expeditions through the areas contaminated after Chernobyl disaster and other nuclear accidents, was a scientific consultant of documentary film &laquo;Och stjarnans namn var Malort&raquo; (Malmerfilm production, Sweden) about medical sequels of nuclear disasters. Awarded with M.V. Lomonosov Medal from Russian Academy of Ecology &ldquo;for contribution into Ecological Medicine&rdquo; (2019), N. Paulescu Jubilee Medal from Academy of Sciences of Moldova &ldquo;for contribution in diabetes studies&rdquo; and E.I. Schwartz Medal from Association of Molecular Medicine &ldquo;for contribution into Molecular Pathology&rdquo; (2020). Laureate of St. Petersburg University Prize &ldquo;For best teaching skills&rdquo;. Certificates of honors: from Russian Federal Ministry of Education and Science &ldquo;for long successful teaching and research career&rdquo;, from St. Petersburg State University &ldquo;for scientific contribution&rdquo; , &ldquo;for teaching skills&rdquo; , &ldquo;for outstanding contribution in international academic relations&rdquo;, from St. Petersburg Orthodox Theological Academy (for research aimed at human health protection), visiting professorship of Harbin Medical University  and 4th Chinese Military Medical University of Xian . Editorial board member in 9 academic journals (5 Russian and 4 Foreign ones). Member of Central Pathophysiology Teaching and Methodological Board of Russian Medical Schools Teaching and Methodological Union, expert of Federal Directorate od Scientific and Technological Programs of Russian Federation Development, Foreign member of the Board of Governors of the Ukrainian Society of Pathophysiologists. Married, has 3 adult children, one grandson and few hobbies: Philosophy, Poetry, Visual Arts, Sinology, Football and Gardening.\"},{\"affiliation\":\"TU Dresden, Dresden, Germany\",\"name\":\"K. Conrad\"},{\"affiliation\":\"University of Genoa, Genova, Italy\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L00000023KLQAY&oid=00D1t000000qIy5EAE&lastMod=1656338957919\",\"name\":\"E. Cutolo, MD\",\"biography\":\"Prof. Maurizio Cutolo (MC) is Professor of Rheumatology  and Internal Medicine, Director of Research Laboratories, Academic Division of Clinical Rheumatology and Postgraduate School of Rheumatology, University of Genoa. \\nMC actually is Deputy Chair of Department of Internal Medicine - University of Genoa. MC is former President of both the European Alliance of Associations for Rheumatology (EULAR) (2013&ndash;2015) and the International League of Associations for Rheumatology (ILAR-2015), MC is Advisor of the EULAR Education Committee. \\nMC serves as Deputy-Chair of the European network on Rare and Complex Connective Tissue Disease (ReCONNET-ERN). MC is the founder and Chairman of the SG on &ldquo;Neuroimmune Endocrinology on RMDs&rdquo; and cochair of SG on &ldquo;Microcirculation in RMDs&rdquo; at EULAR. He is Associate Editor of Clin Exp Rheumatol and editorial board member of the Editorial Board of Ann Rheum Dis, RMDopen and other Journalsl. \\nMC and his TEAM, are involved in the following fields of research: systemic sclerosis, capillaroscopy in rheumatic diseases; role of sex hormones in the immune response and rheumatic diseases; the endocrine system of D vit; the chronotherapy of rheumatoid arthritis with night glucocorticoids; synovial macrophages as targets for biologicals in rheumatoid arthritis; chronic inflammation and cancer; and the role of biosimilars in rheumatic diseases.  MC is author-coauthor of more than 695 publications (PUB MED) and his H index is 88 (Scopus).\"},{\"affiliation\":\"St Thomas' Hospital, London, United Kingdom\",\"name\":\"D. D'Cruz\"},{\"affiliation\":\"Polytechnic University of Marche, Department of Clinical and Molecular Sciences, Ancona, Italy\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mYQkQAM&oid=00D1t000000qIy5EAE&lastMod=1664034990367\",\"name\":\"M. G. Danieli, MD, PhD\",\"biography\":\"Associate Professor in Internal Medicine at Medical School, and Director of the Postgraduate School of Allergology and Clinical Immunology, the Polytechnic University of Marche. Senior Assistant at Clinica Medica, a tertiary referral clinic at Ospedale Regionale, Ancona, Italy, where patients are clinically followed and are enrolled into ongoing research studies. Main interests: immune system disorders such as autoimmune diseases (mainly SLE and myositis) and Inborn Errors of Immunity, and related therapeutic modalities such as intravenous or subcutaneous immunoglobulin both in autoimmune and immunodeficiency diseases.  From 2018, the Responsible of the Immunology Rare Diseases Clinic at Ospedale Regionale, Ancona and from 2019, responsible for the PDTA Clinical pathway for patients with Primary Immunodeficiency of Marche Region.\\nAs for teaching at Polytechnic University of Marche, Immune System Disorders at School of Medicine (5th Year Medical Students),\"},{\"affiliation\":\"Medintern Association, Porto, Portugal\",\"name\":\"C. Dias\"},{\"affiliation\":\"University of Padua, Padova, Italy\",\"name\":\"A. Doria, Professor of Rheumatology\",\"biography\":\"Andrea Doria, MD, is Professor of Rheumatology and Director of Postgraduate School on Rheumatology at the Department of Medicine, Padua University School of Medicine, Italy, and Chief of Rheumatology Unit at Padua University Hospital. \\nThe unit he leads is a tertiary referral rheumatological centre, of prominence within Italy, for the diagnosis and management of patients affected with difficult-to-treat rheumatological conditions, which has been recently recognized as EULAR Center of Excellence in Rheumatology 2022-2027.\\nHe was recently appointed President elect of the Italian Society of Rheumatology. In 2016 he founded the European Lupus Society (SLEuro) and was the first President of the Executive Committee. He is a member of the Lupus Academy Steering Committee and the The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC)\\nProfessor Doria has organised over 10 international conferences on autoimmunity. He was the Chair of the 10th European Lupus Meeting, held in Venice (Italy) 5&ndash;8th October 2016 and the Chair of the 14th International Congress on Systemic Lupus Erythematosus held in virtual format from 6th to 9th October 2021. \\nProfessor Doria was involved as &ldquo;expert&rdquo; in the EUropean League Against Rheumatism (EULAR) Standing Committee for the development of clinical and therapeutic recommendations in SLE. \\nProfessor Doria participates on the editorial boards of several Rheumatology and Immunology journals: Lupus, Autoimmunity, Clinical and Experimental Rheumatology, Autoimmunity Reviews, Journal of Autoimmunity, Experimental Biology and Medicine\"},{\"affiliation\":\", United Kingdom\",\"name\":\"C. Edwards\"},{\"affiliation\":\"University of Washington, Seattle, Washington, United States of America\",\"name\":\"K. Elkon\"},{\"affiliation\":\"La Jolla Institute for Immunology, La Jolla, California, United States of America\",\"name\":\"M. G. von Herrath, MD\"},{\"affiliation\":\"King's College London, London, United Kingdom\",\"name\":\"G. Hughes\"},{\"affiliation\":\"CMN La Raza Specialty Hospital, Ciudad de México, Mexico\",\"name\":\"L.J. Jara\"},{\"affiliation\":\", United Kingdom\",\"name\":\"D. Jayne\"},{\"affiliation\":\"St Thomas' Hospital, London, United Kingdom\",\"name\":\"M.A. Khamashta\"},{\"affiliation\":\"Hokkaido University, Sapporo, Japan\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000miBfQAI&oid=00D1t000000qIy5EAE&lastMod=1665205940398\",\"name\":\"T. Koike, MD, PhD\",\"biography\":\"Education: 1972  M.D.\\n Hokkaido University School of Medicine, Sapporo Japan\\n1972-1975  Residency:\\n Hokkaido University School of Medicine, Sapporo Japan\\n1975-1978  Research Fellow, Department of Pathology, Hokkaido University School of Medicine, Sapporo, Japan\\n1978-1980  Postdoctoral Research Fellow, Department of Medicine, University of California, San Francisco, USA\\n1980- 1981  Assistant Professor, Department of Pathology, Kyoto University Faculty of Medicine, Kyoto, Japan\\n1982-1991  Assistant Professor, Department of Medicine, Chiba University School of Medicine, Chiba, Japan\\n1992-2011  Professor Department of Medicine II, Hokkaido University Graduate School of Medicine\\n2011-present Professor Emeritus  Hokkaido University,  Supreme Advisor, Hokkaido Medical Center for Rheumatic Diseases\"},{\"affiliation\":\"Bar-Ilan University The Azrieli, Faculty of Medicine, Ramat Gan, Israel\",\"name\":\"O. Koren\",\"biography\":\"&lt;p&gt;&lt;URL&gt;&lt;HREF&gt;&lt;/HREF&gt;&lt;HTXT&gt;Link to editor's website&lt;/HTXT&gt;&lt;/URL&gt;&lt;/p&gt;\"},{\"affiliation\":\"Ariel University, Ari'el, Israel\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhbmQAA&oid=00D1t000000qIy5EAE&lastMod=1665137127052\",\"name\":\"A. Lerner, M.D., MHA\",\"biography\":\"1976\\t\\tTel Aviv University, Tel Aviv, Israel                      \\t                                         M.D\\n1977-1982\\t\\tCarmel Medical Center, Haifa, Israel\\t         \\t                                  Certified Pediatrician\\n1982-4\\t\\tState University of New York, New York, U.S.A.                      Certified Pediatric Gastroenterology \\n1986-7\\t            Rambam Medical Center, Haifa, Israel                                           Certified Gastroenterologist\\n2005-2015       Head, Pediatric Gastroenterology Unit, Carmel Medical Center \\n2004-5            State University of North Carolina, Chapel Hill, N.C, U.S.A                      Visiting Professor   \\n2014-2020       Aesku.Kipp Research Institute, Wendelsheim, Germany                          Visiting Professor\\n2020-               The Zabludowicz Research Center for Autoimmune Diseases.\\t                                                                               \\nCurrent academic position:\\n 2020- Chaim Sheba Medical Center, The Zabludowicz Research Center for Autoimmune Diseases, Tel- Hashomer, Israel, 2021-Ariel University, Ariel, Israel.\\nScientific interests: Mucosal immunology, autoimmunity, diagnostic serology, Celiac disease, nutritional deficiencies, industrial food additives, intestinal permeability, microbial transglutaminase, microbiome/ dysbiome/ virome, gluten, and gliadin peptides.                                           \\nNo of peer-reviewed scientific publications: 350\"},{\"affiliation\":\"Rio de Janeiro State University, RIO DE JANEIRO, Brazil\",\"name\":\"R.A. Levy\"},{\"affiliation\":\"Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China\",\"name\":\"M. Li\"},{\"affiliation\":\"INOVA Diagnostics Inc, San Diego, California, United States of America\",\"name\":\"M. Mahler\"},{\"affiliation\":\"Okayama University, Okayama, Japan\",\"name\":\"E. Matsuura\"},{\"affiliation\":\"University of Milan, Milano, Italy\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhOdQAI&oid=00D1t000000qIy5EAE&lastMod=1665129700223\",\"name\":\"P.L. Meroni, MD\",\"biography\":\"Dr. Pier Luigi Meroni graduated from the University of Milan, Medical School. He has been trained in Internal Medicine and then in Clinical Immunology. He was nominated Full Professor in Internal Medicine in 2001 and Rheumatology in 2005. \\nHis clinical and scientific works have been focused mainly on autoimmune/rheumatic diseases, in particular, he investigated the pathogenic mechanisms responsible for systemic lupus erythematosus and anti-phospholipid syndrome. He has published more than 650 papers in peer-reviewed journals. He has authored and edited 7 books and written 50 book chapters. h-index: 84 (Scopus), 156 (Google Scholar) (n. 10 TIS,Top_Italian_Scientists_Biomedical_Sciences).\\nHis editorial activity is characterized by his inclusion on the editorial board of several journals in the field of rheumatology and autoimmunity.\\nHe organized several international scientific meetings. Dr. Meroni received the Roussel Prize in 1997 (Rome) for studies on the age-associated immune deficit, the EULAR Prize in 2005 (Vienna) for the seminal research on the infectious etiology of anti-phospholipid syndrome, and the AESKU Prize for life contribution to autoimmunity (2014 Nice). He was the first Italian-nominated Master of the American College of Rheumatology in 2014.\\nHe has been Chairman and then a member of the IUIS/WHO/AF/CDC Committee for the standardization of diagnostic tests for rheumatic diseases, Italian Representative of EASI (European Autoimmunity Standardization Initiative), founder of the IFCC Working Group Harmonization Autoimmune Serology Testing and president of the FIRMA (Forum Interdisciplinary Ricerca Malattie Autoimmune).\"},{\"affiliation\":\"University Claude Bernard Lyon 1, Villeurbanne, France\",\"name\":\"P. Miossec, MD, PhD\"},{\"affiliation\":\"Monash University, Clayton, Victoria, Australia\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=015Tl000005G4j9IAC&oid=00D1t000000qIy5EAE&lastMod=1713192453660\",\"name\":\"F. Morand, M.B., B.S.; PhD\",\"biography\":\"Professor Eric Morand is Dean of the Sub-Faculty of Clinical and Molecular Medicine, Monash University, and Director of Rheumatology at Monash Health. He graduated from Medicine at Monash University, trained in rheumatology in Australia and at the Royal National Hospital for Rheumatic Diseases, UK and took his PhD at Monash University. \\n\\nHis laboratory research has focussed on glucocorticoid-induced mechanisms in the immune system, with the goal of leveraging natural mechanisms of glucocorticoid action to discover a safe replacement for them. His clinical research focuses on systemic lupus erythematosus, including clinical measurement, outcome predictors, trials, mechanisms, and biomarkers. \\n\\nPast awards include the Parr Prize of the Australian Rheumatology Association and the William E Paul Distinguished Innovator Award and Global Team Science Award of the Lupus Research Alliance (US). In 2021 he was inducted into the Honour Roll of Monash University; in 2022 he was awarded Fellowship of the Australian Academy of Health and Medical Sciences, the Victoria Prize for Science and Innovation, and the Evelyn V. Hess Award of the Lupus Foundation of America.\"},{\"affiliation\":\"University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy\",\"name\":\"M. Mosca, MD, PhD\",\"biography\":\"Marta Mosca is Professor of Rheumatology at the University of Pisa and Head of the Rheumatology Unit at the Azienda Ospedaliera Universitaria Pisana, Italy. At the University of Pisa, prof Mosca is also the Director of Fellowship Training Program in Rheumatology.\\nSince December 2016 she is the Coordinator of the European Reference Network on &ldquo;Rare and Hereditary Connective and Musculoskeletal Diseases&rdquo; (RECONNET) promoted by the European Commission.\\nShe is also the coordinator of the European Commission Program INTEGRATE, which aims at integrating the physician and the patients&rsquo; point of view in SLE. Professor Mosca is a member of the Scientific Advisory Board of LUPUS EUROPE.\\nSince November 2019 she is member of the Systemic Lupus Erythematosus International Collaborating Clinics Group.\\nProfessor Mosca has participated in the development of EULAR recommendations for the management of SLE, for women&rsquo;s health, for the management of antiphospholipid syndrome in adults and has coordinated the Development of recommendations for monitoring SLE patients in in clinical practice and in observational studies. She was a member of the EULAR-ACR steering committee for the development of Classification Criteria for SLE.\"},{\"affiliation\":\"Hospital Cochin, Paris, France\",\"name\":\"Mouthon\"},{\"affiliation\":\"National Centre for Scientific Research, Paris, France\",\"name\":\"S. Muller, PhD\"},{\"affiliation\":\"Riga Stradins University Institute of Microbiology and Virology, Rīga, Latvia\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mV9bQAE&oid=00D1t000000qIy5EAE&lastMod=1663762228188\",\"name\":\"M. F. Murovska, MD, PhD\",\"biography\":\"Dr. Modra Murovska (https://orcid.org/0000-0003-0971-1784) obtained her MD at the Riga Medical Institute/Medical Academy of Latvia, Faculty of Paediatrics, and her PhD at the All-Union Cancer Research Centre, USSR Academy of Medical Sciences in Moscow, Russia. She was visiting scientist (Japanese Society for the Promotion of Science fellowship holder) at the Kochi Medical School, at the National Cancer Centre Research Institute, and at the Institute of Atomic Diseases of Nagasaki University Medical School, Japan in 1986-1987 and in 1989-1990. In 1993-1994 she was Nordic Medical Council fellowship holder and visiting scientist at the Department of Virology, the National Veterinary Institute, Uppsala, Sweden; in 1998 guest researcher at the Department of Medical Sciences, Uppsala University (Scholarship of the Swedish Institute), in 2001 guest researcher at the Department of Haematology, University of Cambridge. Currently she is Associate Professor of Riga Stradi&#326;&scaron; University and Lead Researcher at the Institute of Microbiology and Virology, Riga Stradi&#326;&scaron; University. Since 2012 she is Full Member of the Latvian Academy of Sciences, in 2000 she had got American Society for Microbiology Morrison Rogosa Award. She is/was principal investigator in numerous regional and international (Mutual Funds Taiwan-Latvia-Lithuania Cooperation, FP7 and Horizon 2020) research projects, more than 90 publications in last 10 years in the International peer-reviewed journals.\"},{\"affiliation\":\"University of Perugia, Perugia, Italy\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mhB5QAI&oid=00D1t000000qIy5EAE&lastMod=1665077884365\",\"name\":\"C. Perricone, M.D., Ph.D.\"},{\"affiliation\":\"University of Rome Tor Vergata, Roma, Italy\",\"name\":\"R. Perricone\"},{\"affiliation\":\"Albert Einstein College of Medicine, Bronx, New York, United States of America\",\"name\":\"C. Putterman\"},{\"affiliation\":\"University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany\",\"name\":\"G. Riemekasten\"},{\"affiliation\":\"Reggio Emilia Local Agency - IRCCS Advanced Technologies and Care Models in Oncology, Reggio Emilia, Italy\",\"name\":\"C. Salvarani\"},{\"affiliation\":\"Regional Health Care and Social Agency Fatebenefratelli Sacco, Milano, Italy\",\"name\":\"P. Sarzi-Puttini\"},{\"affiliation\":\"Sociedade Beneficente Israelita Brasileira Albert Einstein, SAO PAULO, São Paulo, Brazil\",\"name\":\"M. Scheinberg\"},{\"affiliation\":\"New York University Grossman School of Medicine, New York, New York, United States of America\",\"name\":\"J. Scher\"},{\"affiliation\":\"Hannover Medical School, Hannover, Germany\",\"name\":\"R. E. Schmidt†\"},{\"affiliation\":\"Biomedical Research Institute, Diepenbeek, Belgium\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mjhSQAQ&oid=00D1t000000qIy5EAE&lastMod=1665486886019\",\"name\":\"V. Somers, PhD\",\"biography\":\"Veerle Somers is a Full Professor of Molecular Biology and Dean of the Faculty of Medicine and Life Sciences at Hasselt University. She is head of the disease markers program at the Biomedical Research Institute (BIOMED), biobank coordinator at the Clinical Research Center (CRC) of Hasselt University. Her main research interests focus on B cell analysis, biomarker discovery and characterization in autoimmune and neurologic diseases such as multiple sclerosis, spinal cord injury, autism, rheumatoid arthritis and axial spondyloarthritis. Veerle Somers has a strong background in immunology and oncology including expertise in molecular and cellular biology, biobanking and cDNA phage display. Veerle Somers has strong experience in translation of results to biotechnology/biopharmaceutical companies.\"},{\"affiliation\":\"New University of Lisbon Comprehensive Health Research Centre National School of Public Health, Lisboa, Portugal\",\"name\":\"M-J. R. Sousa, PhD\"},{\"affiliation\":\"University of Debrecen, Debrecen, Hungary\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mUfHQAU&oid=00D1t000000qIy5EAE&lastMod=1663736942167\",\"name\":\"Z. Szekanecz, PhD, DSc\",\"biography\":\"Professor Zolt&aacute;n Szekanecz, MD, PhD, graduated from the University of Debrecen, Hungary in 1988. He then specialized in internal medicine, rheumatology and immunology. He has been the Head of the Department of Rheumatology at University of Debrecen since 2001.\\nProfessor Szekanecz&rsquo;s major research interests are rheumatoid arthritis (RA) and its comorbidities including vascular alterations in rheumatic diseases, pathogenesis of bone destruction and secondary cancer in rheumatic diseases (oncorheumatology). He is also intested in the molecular mechanisms and clinical effects of targeted therapies including their effects on comorbidities. He has published more than 320 papers in international journals, authored 12 books and published over 100 book chapters. His cumulative impact factor is over 1,000, citations over 19,000 and H-index over 70. \\nProfessor Szekanecz is the current vice-president of EULAR, past president of the Hungarian Society of Rheumatology, a member of four international and 10 Hungarian societies, founding editor of Immunology Quarterly, editorial board member of Arthritis Res Ther, Autoimmunity Rev, Joint Bone Spine and RMD Open and performs review services for 20 journals. He has been involved in more than 100 clinical trials in the field of RA, spondyloarthritis, osteoarthritis, osteoporosis, scleroderma and lupus.\"},{\"affiliation\":\"National and Kapodistrian University of Athens First, Department of Propaedeutic and Internal Medicine, Athens, Greece\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mULMQA2&oid=00D1t000000qIy5EAE&lastMod=1663699289348\",\"name\":\"M. Tektonidou, MD, PhD\",\"biography\":\"Maria Tektonidou is Professor of Internal Medicine &amp; Rheumatology, Head of Rheumatology Unit and Head of National Center of Expertise for Rare and Complex Connective Tissue and Musculoskeletal Diseases at the First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Greece. \\nFrom 2009 to 2019, she worked (1-2 monthly visits/year) as a Guest Researcher at the NIAMS/NIH. Dr. Tektonidou is a member of the Executive Committee of the &lsquo;AntiPhospholipid Syndrome (APS) Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) (2014-present), and of the &lsquo;European Lupus Society-SLEuro&rsquo; (2018-present). She is a member of the &lsquo;European Forum on Antiphospholipid Antibodies&rsquo; and the &ldquo;EULAR Systemic Lupus Erythematosus (SLE) study group&rdquo;, and she is leading the &lsquo;EULAR Antiphospholipid syndrome study group&rdquo;.  She has participated as an expert in the &lsquo;Task Force on Non-criteria APS Manifestations and on Catastrophic APS&rsquo; and the Task force group for &lsquo;Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients&rsquo;, the &lsquo;EULAR recommendations for the management of SLE with neuropsychiatric manifestations&rsquo;, the &lsquo;Joint EULAR/ERA-EDTA recommendations for the management of adult and paediatric lupus nephritis&rsquo;, the &lsquo;EULAR recommendations for women, health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with SLE and/or APS&rsquo; and the &ldquo;2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus&rdquo;. \\nShe chaired the &lsquo;2019 EULAR Recommendations for the management of APS in adults&rsquo; (2019), and co-chaired the &ldquo;EULAR recommendations for the cardiovascular management of RMDs including SLE and APS&rdquo; (2022). She is currently chairing the &quot;Development and validation of a EULAR diseases activity index in APS&quot;. She has participated as clinical investigator in clinical trials on Rheumatoid arthritis, spondyloarthritis, SLE and APS and she was invited speaker in several European and International meetings.\\nDr. Tektonidou&rsquo;s major research interests include the epidemiology, clinical manifestations and management, health-related quality of life, and long-term outcomes of patients with systemic autoimmune diseases, especially APS and SLE. She has over 200 peer-reviewed publications in international journals and book chapters with 14500 citations and h-index 51 (Google Scholar). She is in the editorial board of three international journals and served as a reviewer for more than 60 international journals.\"},{\"affiliation\":\"Regional Health Care and Social Agency Civil Hospitals of Brescia, Brescia, Italy\",\"name\":\"A. Tincani\"},{\"affiliation\":\"Albert Einstein College of Medicine, Bronx, New York, United States of America\",\"name\":\"Y. Tomer, MD\"},{\"affiliation\":\"Bnai Zion Medical Center, Haifa, Israel\",\"name\":\"E. Toubi\"},{\"affiliation\":\"Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America\",\"imageUrl\":\"https://relx-elsevier-erms--c.documentforce.com/servlet/servlet.ImageServer?id=0154L000000mdBGQAY&oid=00D1t000000qIy5EAE&lastMod=1664526848497\",\"name\":\"C. Tsokos, MD\"},{\"affiliation\":\"National and Kapodistrian University of Athens, Athens, Greece\",\"name\":\"A. Tzioufas\"},{\"affiliation\":\"Brest University Hospital Centre, Brest, France\",\"name\":\"P. Youinou\"},{\"affiliation\":\", Israel\",\"name\":\"G Zandman-Goddard\"}]}]},\"isOpenAccessOptions\":true,\"contentTypeCode\":\"JL\",\"hasAboutPage\":true,\"journalMetrics\":{\"bannerMetrics\":{\"impactFactor\":{\"value\":13.6,\"year\":2022},\"citeScore\":{\"value\":23.3,\"year\":2022,\"url\":\"https://www.scopus.com/sourceid/20689\"}},\"journalInsights\":[{\"metricKey\":\"time_to_1st_decision\",\"label\":\"Time to first decision\",\"value\":19.081042,\"order\":0,\"unit\":\"day\",\"centralTendencyFunction\":\"median\"},{\"metricKey\":\"review_time\",\"label\":\"Review time\",\"value\":19.46565,\"order\":1,\"unit\":\"day\",\"centralTendencyFunction\":\"median\"},{\"metricKey\":\"acceptance_speed\",\"label\":\"Submission to acceptance\",\"value\":19.465648,\"order\":2,\"unit\":\"day\",\"centralTendencyFunction\":\"median\"},{\"metricKey\":\"publication_time\",\"label\":\"Acceptance to publication\",\"value\":2.70845,\"order\":3,\"unit\":\"day\",\"centralTendencyFunction\":\"median\"},{\"metricKey\":\"publication_options\",\"label\":\"Publication Options\",\"value\":{\"2018\":{\"subscription_articles\":141,\"open_access_articles\":12,\"total_articles\":153},\"2019\":{\"subscription_articles\":110,\"open_access_articles\":8,\"total_articles\":118},\"2020\":{\"subscription_articles\":112,\"open_access_articles\":16,\"total_articles\":128},\"2021\":{\"subscription_articles\":109,\"open_access_articles\":15,\"total_articles\":124},\"2022\":{\"subscription_articles\":90,\"open_access_articles\":16,\"total_articles\":106}},\"order\":5}]}},\"marketingContent\":{\"isFetching\":false,\"elements\":{\"news\":{\"label\":\"News\",\"items\":[{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:25.292041609\",\"contentId\":177193,\"publishDate\":\"2018-02-06T10:40:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tSelected by the Prof. M. Eric Gershwin (Editor-in-Chief Journal of Autoimmunity) and Prof. Yehuda Shoenfeld (Editor-in-Chief Autoimmunity Reviews)&lt;/p&gt;\",\"url\":\"editors-choice-a-selection-of-articles-relevant-to-the-11th\",\"lastModifiedDate\":\"2021-03-20T17:21:14.34Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://autoimmunity.kenes.com/2018/Pages/default.aspx\\\" target=\\\"_blank\\\"&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/0teg1eav/banner-08140144.jpg\\\"&gt;&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tWe are pleased to present you a selection of articles published between the end of 2016 till now in the&nbsp;&lt;a href=\\\"https://www.journals.elsevier.com/journal-of-autoimmunity\\\" target=\\\"_blank\\\"&gt;&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;&nbsp;&lt;/a&gt;and&nbsp;&lt;a href=\\\"https://www.journals.elsevier.com/autoimmunity-reviews\\\" target=\\\"_blank\\\"&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;&lt;/a&gt;. These articles were carefully selected by the Prof. M. Eric Gershwin (Editor-in-Chief&nbsp;&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;) and Prof. Yehuda Shoenfeld (Editor-in-Chief&nbsp;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;) and are highly relevant to the 11th&nbsp;ICA 2018 program.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tWe hope you enjoy their selection, and consider the Journal of Autoimmunity for your next publication.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;The articles are freely available on Science Direct until August 6, 2018&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S0896841117304389\\\" target=\\\"_blank\\\"&gt;Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 86, January 2018, Pages 1-8&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S0896841117306844\\\" target=\\\"_blank\\\"&gt;Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Available online 4 January 2018&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S0896841117307540\\\" target=\\\"_blank\\\"&gt;Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Available online 16 December 2017&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841116302049\\\" target=\\\"_blank\\\"&gt;Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 76, January 2017, Pages 115-122&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S0896841116301354\\\" target=\\\"_blank\\\"&gt;Current trends in autoimmunity and the nervous system&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 75, December 2016, Pages 20-29&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997217302288\\\" target=\\\"_blank\\\"&gt;Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 16, Issue 11, November 2017, Pages 1109-1114&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S156899721730201X\\\" target=\\\"_blank\\\"&gt;How I treat patients with systemic sclerosis in clinical practice&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 16, Issue 10, October 2017, Pages 1024-1028&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997216301756\\\" target=\\\"_blank\\\"&gt;From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 11, November 2016, Pages 1054-1061&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997216301628\\\" target=\\\"_blank\\\"&gt;Pregnancy in patients with autoimmune disease: A reality in 2016&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 10, October 2016, Pages 975-977&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997216301367\\\" target=\\\"_blank\\\"&gt;Biosimilars from a practicing rheumatologist perspective: An overview&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 9, September 2016, Pages 911-916&lt;/p&gt;\",\"type\":\"news\",\"title\":\"Editor&#39;s choice: A selection of articles relevant to the 11th International Congress on Autoimmunity, May 16-20, 2018 Lisbon, Portugal\",\"displayDate\":\"6 February 2018\"},{\"summary\":\"Articles selected by Prof. Yehuda Shoenfeld\",\"published\":true,\"url\":\"editors-choice-for-autoimmunity-reviews\",\"LAST_PROCESSED\":\"2024-05-19T23:05:23.929963717\",\"contentId\":174612,\"publishDate\":\"2017-04-18T00:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tArticles selected by Prof. Yehuda Shoenfeld&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/ilgbogq5/editors-choice-for-autoimmunity-21095733.jpg\",\"lastModifiedDate\":\"2021-03-20T11:45:07.227Z\",\"description\":\"&lt;p&gt;\\r\\n\\tThese top articles, published in&lt;em&gt;&nbsp;Autoimmunity Reviews&lt;/em&gt;&nbsp;have been selected for you by the Editor-in-Chief Prof. Yehuda Shoenfeld.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tRead for free on ScienceDirect, until 19 July 2017.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216302798\\\" target=\\\"_blank\\\"&gt;Anti-endothelial cell antibodies in vasculitis: A systematic review&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tPaul Legendre, Alexis R&eacute;gent, Mathilde Thiebault, Luc Mouthon&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 16, Issue 2, February 2017, Pages 146&ndash;153&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&ldquo;AECAs have been detected in a wide range of pathological conditions, including systemic vasculitis. There is a great deal of evidence that AECAs play pathogenic roles in vasculitis, in EC activation and induction of apoptosis. None of the identified target antigens of AECAs is specific for ECs, and EC-specific target antigens of AECAs in systemic vasculitis remain to be identified. Further studies are needed to standardize the detection of AECAs and define their most relevant targets.&rdquo;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301975\\\" target=\\\"_blank\\\"&gt;Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tM. Alvarado-Cardenas, et al.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 12, December 2016, Pages 1161&ndash;1166&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&ldquo;In summary, a new distinctive IFL pattern (HALIP) detectable on triple rat IFL autoimmune serology screening is associated with anti-HMGCR autoantibody positivity and statin associated autoimmune myopathy. Awareness of this pattern may help to detect statin associated autoimmune myopathy.&rdquo;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301628\\\" target=\\\"_blank\\\"&gt;Pregnancy in patients with autoimmune disease: A reality in 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tA. Tincani, F. Dall&#39;Ara, M.G. Lazzaroni, R. Reggia, L. Andreoli&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 10, October 2016, Pages 975&ndash;977&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&ldquo;Risk assessment of maternal and/or fetal complications during pregnancy is necessary during preconception counseling. In addition to pregnancy risk factors identified for the general healthy population, risks related to the specific rheumatic disease should be carefully assessed. Based on clinical, laboratory, and general work-up, individual risk can be stratified. Changes in drug treatment and the frequency of monitoring should be adjusted to such individual risk, ensuring an optimal pregnancy management for both the foetus and the mother. The puerperium is also a critical period for maternal disease flare and should be monitored and managed according to the mother&#39;s desire for breastfeeding.&rdquo;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tInterested in reading more autoimmunity articles? &lt;a href=\\\"https://www.journals.elsevier.com/journal-of-autoimmunity/news/editors-choice-for-journal-of-autoimmunity\\\"&gt;View the Editor&#39;s Choice from&nbsp;&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;&nbsp;Reviews, selected by Prof. M. Eric Gershwin.&lt;/a&gt;&lt;/p&gt;\",\"type\":\"news\",\"title\":\"Editor’s Choice for Autoimmunity Reviews\",\"displayDate\":\"18 April 2017\"},{\"summary\":\"Text by: M. Eric Gershwin (Editor-in-Chief of Journal of Autoimmunity) Yehuda Shoenfeld (Editor-in-Chief of Autoimmunity Reviews)\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:04:13.59967345\",\"contentId\":171499,\"publishDate\":\"2016-02-29T00:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tText by:&lt;br&gt;\\r\\n\\tYehuda Shoenfeld (Editor-in-Chief of Autoimmunity Reviews)&lt;br&gt;\\r\\n\\tM. Eric Gershwin (Editor-in-Chief of Journal of Autoimmunity)&lt;/p&gt;\",\"url\":\"articles-selection-for-10th-international-autoimmunity\",\"lastModifiedDate\":\"2021-03-20T00:46:43.18Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;img src=\\\"https://api.journals.elsevier.com/media/vcfnqmla/autojnls-01091957.jpg\\\"&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"#1\\\"&gt;&lt;strong&gt;Go to the Articles Selection, which is free access until 1 June 2016&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Congress of Autoimmunity&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThe theme of both this and the previous 9th Congresses of Autoimmunity have centered on presentation of cutting-edge scientific papers whose focus is to improve the care of our patients with autoimmunity.&nbsp; Each Congress has become more and more sophisticated with increasing use of technology and further involvement of scientists in many disciplines.&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tAt the heart of the Congress, however, remains the patient.&nbsp; Autoimmunity has hit a wall.&nbsp; Although we have made enormous strides in dissecting the incredible promiscuous nature of the immune response, the reality is that we still lack precise understanding of etiology.&nbsp; The study of genetics, although yielding enormous amount of data and bioinformatics, has not led to any major breakthroughs.&nbsp; The introduction of biologics has certainly been a major stride for some autoimmune diseases such as rheumatoid arthritis, but has failed in many others, such as systemic lupus erythematosus.&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tOn the other hand, the first textbook of autoimmunity was not published until 1963 by Ian Mackay and Sir Macfarland Burnet; that textbook recognized only a limited number of autoimmune diseases.&nbsp; We now know that there are more than 100 autoimmune diseases and all of them are distinctive and all may involve different etiologies and different effector pathways.&nbsp; In other words, at present there is no one size fits all.&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tMany immunologists have made the analogy of the immune response to Greek mythology and, in particular, to Achilles.&nbsp; Achilles became immortal because his mother scorched remnants of mortality with fire.&nbsp; However, this immortality did not include his heel and, as is well known, he eventually died of a poisoned arrow directed at this heel.&nbsp; It is an interesting analogy for immunologists between immunity and autoimmunity.&nbsp; All animals have an immune system and of course its sophistication increases with evolution.&nbsp; With such sophistication come increasing errors and these of course include immunodeficiency, but also autoimmunity.&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Articles Selection&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThe following list of papers was extracted from approximately the last 18 months of&nbsp;&lt;em&gt;Autoimmunity Results&nbsp;&lt;/em&gt;and is intended to highlight the breadth of the immune response.&nbsp; Off course, it includes cutting-edge papers in many fields that are being presented at this meeting.&nbsp; In&nbsp;&lt;em&gt;Autoimmunity Results&lt;/em&gt;, as in the Congress, the far-reaching goal is outstanding scholarship and ultimately translation of original investigation to improve patient care.&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThis is the 10th Congress.&nbsp; Will there be a 100th Congress and what will mankind, the immune response, and autoimmune diseases look like in 300 years?&nbsp; We wish we knew.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a name=\\\"1\\\"&gt;&lt;/a&gt; &lt;strong&gt;ARTICLE SELECTION&nbsp;&lt;em&gt;AUTOIMMUNITY REVIEWS&lt;/em&gt;:&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000245\\\" target=\\\"_blank\\\"&gt;Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAaron Lerner, Torsten Matthias&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 6, June 2015, Pages 479&ndash;489&lt;br&gt;\\r\\n\\tOpen access&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214003012\\\" target=\\\"_blank\\\"&gt;Churg&ndash;Strauss syndrome&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAntonio Grecoa, Maria Ida Rizzob, Armando De Virgilioa, Andrea Galloc, Massimo Fusconia, Giovanni Ruoppoloa, Giancarlo Altissimid, Marco De Vincentiisa&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 4, April 2015, Pages 341&ndash;348&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997213001043\\\" target=\\\"_blank\\\"&gt;Innate and adaptive immunity in inflammatory bowel disease&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAlessandra Geremiaa, Paolo Biancheri, Philip Allana, Gino R. Corazza, Antonio Di Sabatino&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 13, Issue 1, January 2014, Pages 3&ndash;10&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214000986\\\" target=\\\"_blank\\\"&gt;Adult-onset Still&#39;s disease&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tMathieu Gerfaud-Valentina, Yvan Jamilloux, Jean Iwaz, Pascal S&egrave;ve&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 13, Issue 7, July 2014, Pages 708&ndash;722&lt;br&gt;\\r\\n\\tOpen access&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214002808\\\" target=\\\"_blank\\\"&gt;Zinc and its role in immunity and inflammation&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tPaola Bonaventura, Giulia Benedetti, Francis Albar&egrave;de, Pierre Miossec&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 4, April 2015, Pages 277&ndash;285&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214002845\\\" target=\\\"_blank\\\"&gt;T cell responses in psoriasis and psoriatic arthritis&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tMarco Diani, Gianfranco Altomare, Eva Reali&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&nbsp;&lt;/em&gt;Volume 14, Issue 4, April 2015, Pages 286&ndash;292&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214000196\\\" target=\\\"_blank\\\"&gt;Hashimoto thyroiditis: Clinical and diagnostic criteria&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tP. Catureglia, A. De Remigis, N.R. Rose&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&nbsp;&lt;/em&gt;Volume 13, Issues 4&ndash;5, April&ndash;May 2014, Pages 391&ndash;397&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721400055X\\\" target=\\\"_blank\\\"&gt;Diagnosis and classification of celiac disease and gluten sensitivity&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tElio Tonutti, Nicola Bizzaro&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&nbsp;&lt;/em&gt;Volume 13, Issues 4&ndash;5, April&ndash;May 2014, Pages 472&ndash;476&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000269\\\" target=\\\"_blank\\\"&gt;Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tFabrizio Cantini, Carlotta Nannini, Laura Niccoli, Florenzo Iannone, Giovanni Delogu, Giacomo Garlaschi, Alessandro Sanduzzi, Andrea Matucci, Francesca Prignano, Michele Conversano, Delia Goletti&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 6, June 2015, Pages 503&ndash;509&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721300181X\\\" target=\\\"_blank\\\"&gt;Complex regional pain syndrome: A comprehensive and critical review&lt;/a&gt;&lt;br&gt;\\r\\n\\tA.T. Borchers, M.E. Gershwin&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 13, Issue 3, March 2014, Pages 242&ndash;265&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721400024X\\\" target=\\\"_blank\\\"&gt;Revised diagnostic criteria of multiple sclerosis&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tRon Milo, Ariel Miller&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 13, Issues 4&ndash;5, April&ndash;May 2014, Pages 518&ndash;524&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000701\\\" target=\\\"_blank\\\"&gt;Google-driven search for big data in autoimmune geoepidemiology: Analysis of 394,827 patients with systemic autoimmune diseases&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tManuel Ramos-Casals, Pilar Brito-Zer&oacute;n, Belchin Kostov, Antoni Sis&oacute;-Almirall, Xavier Bosch, David Buss, Antoni Trilla, John H. Stone, Munther A. Khamashta, Yehuda Shoenfeld&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 8, August 2015, Pages 670&ndash;679&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000282\\\" target=\\\"_blank\\\"&gt;Citrullination and autoimmunity&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tGuido Valesini, Maria C. Gerardi, Cristina Iannuccelli, Viviana A. Pacucci, Monica Pendolino, Yehuda Shoenfeld&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 6, June 2015, Pages 490&ndash;497&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000324\\\" target=\\\"_blank\\\"&gt;Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tJan Damoiseaux, Luis E. Andrade, Marvin J. Fritzler, Yehuda Shoenfeld&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 14, Issue 6, June 2015, Pages 555&ndash;563&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214002249\\\" target=\\\"_blank\\\"&gt;Regulatory T-cells in autoimmune diseases: Challenges, controversies and&mdash;yet&mdash;unanswered questions&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tCharlotte R. Grant, Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani, Maria Serena Longhi&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&nbsp;&lt;/em&gt;Volume 14, Issue 2, February 2015, Pages 105&ndash;116&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997214000652\\\" target=\\\"_blank\\\"&gt;14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tDoruk Erkan, Cassyanne L. Aguiar, Danieli Andrade, Hannah Cohen, Maria J. Cuadrado, Adriana Danowski, Roger A. Levy, Thomas L. Ortel, Anisur Rahman, Jane E. Salmon, Maria G. Tektonidou, Rohan Willis, Michael D. Lockshin&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt;&nbsp;Volume 13, Issue 6, June 2014, Pages 685&ndash;696&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;ARTICLE SELECTION&nbsp;&lt;em&gt;JOURNAL OF AUTOIMMUNITY&lt;/em&gt;:&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000256\\\" target=\\\"_blank\\\"&gt;A T cell extrinsic mechanism by which IL-2 dampens Th17 differentiation&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAna C. Anderson, Jenna M. Sullivan, Dewar J. Tan, David H. Lee, Vijay K. Kuchroo&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 59, May 2015, Pages 38&ndash;42&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841114001309\\\" target=\\\"_blank\\\"&gt;Clinical features and pathobiology of Ebolavirus infectionReview Article&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAftab A. Ansari&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 55, December 2014, Pages 1-9&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000608\\\" target=\\\"_blank\\\"&gt;Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tWilliam A. Figgett, Devy Deliyanti, Kirsten A. Fairfax, Pin Shie Quah, Jennifer L. Wilkinson-Berka, Fabienne Mackay&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 61, July 2015, Pages 9&ndash;16&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300226\\\" target=\\\"_blank\\\"&gt;Immunogenetics of systemic lupus erythematosus: A comprehensive review&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tYogita Ghodke-Puranik, Timothy. B. Niewold&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 64, November 2015, Pages 125&ndash;136&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000906\\\" target=\\\"_blank\\\"&gt;Natural Th17 cells are critically regulated by functional medullary thymic microenvironments&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tWilliam E. Jenkinson, Nicholas I. McCarthy, Emma E. Dutton, Jennifer E. Cowan, Sonia M. Parnell, Andrea J. White, Graham Anderson&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 63, September 2015, Pages 13&ndash;22&lt;br&gt;\\r\\n\\tOpen access&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300160\\\" target=\\\"_blank\\\"&gt;Regulatory dendritic cells in autoimmunity: A comprehensive review&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tJuan Liu, Xuetao Cao&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 63, September 2015, Pages 1&ndash;12&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300548\\\" target=\\\"_blank\\\"&gt;Risk factors in autism: Thinking outside the brain&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tLauren Matelski, Judy Van de Water&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Available online 22 December 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841114001759\\\" target=\\\"_blank\\\"&gt;Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tEmanual Maverakis, Kyoungmi Kim, Michiko Shimoda, M. Eric Gershwin, Forum Patel, Reason Wilken, Siba Raychaudhuri, L. Renee Ruhaak, Carlito B. Lebrilla&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 57, February 2015, Pages 1&ndash;13&lt;br&gt;\\r\\n\\tOpen access&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300068\\\" target=\\\"_blank\\\"&gt;Type I and II interferon signatures in Sjogren&#39;s syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren&#39;s related lymphomagenesis&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAdrianos Nezos, Fotini Gravani, Anna Tassidou, Efstathia K. Kapsogeorgou, Michael Voulgarelis, Michael Koutsilieris, Mary K. Crow, Clio P. Mavragani&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity,&lt;/em&gt;&nbsp;Volume 63, September 2015, Pages 47&ndash;58&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300470\\\" target=\\\"_blank\\\"&gt;Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tAmr H. Sawalha, Mikhail G. Dozmorov&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Available online 20 October 2015&lt;br&gt;\\r\\n\\tOpen access&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300330\\\" target=\\\"_blank\\\"&gt;The genetics of human autoimmune disease: A perspective on progress in the field and future directions&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tMichael F. Seldin&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 64, November 2015, Pages 1&ndash;12&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300494\\\" target=\\\"_blank\\\"&gt;Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tNamir Shaabani, Vishal Khairnar, Vikas Duhan, Fan Zhou, Rita Ferrer Tur, Dieter H&auml;ussinger, Mike Recher, Alexei V. Tumanov, Cornelia Hardt, Daniel Pinschewer, Urs Christen, Philipp A. Lang, Nadine Honke,&nbsp; Karl S. Lang&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Available online 7 November 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115300408\\\" target=\\\"_blank\\\"&gt;The effects of RelB deficiency on lymphocyte development and function&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tNigel Sharfe, Daniele Merico, Ariana Karanxha, Carly Macdonald, Harjit Dadi, Bo Ngan, Jo-Anne Herbrick, Chaim M. Roifman&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 65, December 2015, Pages 90&ndash;100&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000566\\\" target=\\\"_blank\\\"&gt;Rituximab in anti-GBM disease: A retrospective study of 8 patients&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tMaxime Touzot, Johanne Poisson, Stanislas Faguer, David Ribes, Pascal Cohen, Loic Geffray, Nadia Anguel, Helene Fran&ccedil;ois, Alexandre Karras, Patrice Cacoub, Antoine Durrbach, David Saadoun&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 60, June 2015, Pages 74&ndash;79&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000876\\\" target=\\\"_blank\\\"&gt;Efficacy of anti-TNF alpha in severe and/or refractory Beh&ccedil;et&#39;s disease: Multicenter study of 124 patients&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tH. Vallet, S. Riviere, A. Sanna, A. Deroux, G. Moulis, O. Addimanda, C. Salvarani, M. Lambert, P. Bielefeld, P. Seve, J. Sibilia, Jl Pasquali, Jb Fraison, I. Marie, L. Perard, L. Bouillet, F. Cohen, D. Sene, Y. Schoindre, O. Lidove, P. Le Hoang, E. Hachulla, O. Fain, X. Mariette, T. Papo, B. Wechsler, B. Bodaghi, M. Resche Rigon, P. Cacoub, D. Saadoun&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 62, August 2015, Pages 67&ndash;74&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;&lt;a data-mce-=\\\"\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S0896841115000384\\\" target=\\\"_blank\\\"&gt;Cutting edge: FasL+ immune cells promote resolution of fibrosis&lt;/a&gt;&lt;/em&gt;&lt;br&gt;\\r\\n\\tShulamit B. Wallach-Dayan, Liron Elkayam, Regina Golan-Gerstl, Jenya Konikov, Philip Zisman, Mark Richter Dayan, Nissim Arish, Raphael Breuer&lt;br&gt;\\r\\n\\t&lt;em&gt;Journal of Autoimmunity&lt;/em&gt;, Volume 59, May 2015, Pages 67&ndash;76&lt;/p&gt;\",\"type\":\"news\",\"title\":\"The Current State of Autoimmunity: Introduction to the 10th International Congress on Autoimmunity, April 6-10, 2016 Leipzig, Germany\",\"displayDate\":\"29 February 2016\"}]},\"announcements\":{\"label\":\"Announcements\",\"items\":[{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:10:59.411237553\",\"contentId\":201540,\"publishDate\":\"2021-08-07T12:00:00Z\",\"intro\":\"&lt;p&gt;Autoimmunity Reviews pledges its commitment to improving diversity on the editorial team.&lt;/p&gt;\",\"url\":\"inclusion-and-diversity-pledge-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-08-11T09:33:45.603Z\",\"description\":\"&lt;p&gt;Autoimmunity Reviews pledges its commitment to improving diversity on the editorial team. In 2021 and 2022 we will be aiming to increase the proportion of currently underrepresented groups. This sits within Elsevier’s broader ongoing &lt;a href=\\\"https://www.elsevier.com/inclusion-and-diversity\\\"&gt; inclusion &amp; diversity&lt;/a&gt; efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation.&lt;/p&gt;\\n&lt;p&gt;We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.&lt;/p&gt;\",\"type\":\"announcements\",\"title\":\"Inclusion and diversity pledge - Autoimmunity Reviews\",\"displayDate\":\"7 August 2021\"}]},\"conferences\":{\"label\":\"Conferences\",\"items\":[{\"published\":true,\"location\":\"Altis Grand Hotel, Lisbon, Portugal\",\"endDate\":\"2024-09-11T12:00:00Z\",\"url\":\"18th-vaccine-congress\",\"allDay\":true,\"expiryDate\":\"2024-09-11T12:00:00Z\",\"LAST_PROCESSED\":\"2024-05-19T23:27:06.648472193\",\"contentId\":303288,\"startDate\":\"2024-09-08T12:00:00Z\",\"publishDate\":\"2024-04-24T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;strong&gt;Conference deadlines&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Abstract submission deadline for oral presentations – 3 May 2024&lt;br&gt;Author notification deadline – 10 June 2024&lt;br&gt;Author registration deadline – 12 July 2024&lt;br&gt;Early bird deadline – 12 July 2024&lt;/p&gt;\",\"lastModifiedDate\":\"2024-04-24T15:14:37.527Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/mngdv1if/vaccine18-banner.png\\\" alt=\\\"Vaccine\\\"&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Conference deadlines&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Abstract submission deadline for oral presentations – 3 May 2024&lt;br&gt;Author notification deadline – 10 June 2024&lt;br&gt;Author registration deadline – 12 July 2024&lt;br&gt;Early bird deadline – 12 July 2024&lt;/p&gt;\\n&lt;p&gt;Join leading experts at the &lt;strong&gt;18&lt;/strong&gt;&lt;strong&gt;&lt;sup&gt;th&lt;/sup&gt; Vaccine Congress, &lt;/strong&gt;8-11 September 2024, Altis Grand Hotel, Lisbon, Portugal who will share their knowledge on the current developments and discoveries in the field.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.elsevier.com/events/conferences/all/vaccine-congress/committee-and-speakers\\\"&gt;View the speakers&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Conference topics&lt;/strong&gt;&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;Computational Design of New Vaccines (AI): AI Approaches in Vaccine Development&lt;/li&gt;\\n&lt;li&gt;Vaccines against STIs&lt;/li&gt;\\n&lt;li&gt;Controlled Human Infection Models in Vaccine Development and Evaluation&lt;/li&gt;\\n&lt;li&gt;Immunisation of Special Risk Groups&lt;/li&gt;\\n&lt;li&gt;Socio Political Implications of Vaccination and Vaccine Policy&lt;/li&gt;\\n&lt;li&gt;Vaccines against Mosquito and Tick Borne Diseases&lt;/li&gt;\\n&lt;li&gt;Veterinary Vaccines&lt;/li&gt;\\n&lt;li&gt;One Health&lt;/li&gt;\\n&lt;li&gt;Vaccines against Respiratory Diseases (Influenza/Covid)&lt;/li&gt;\\n&lt;li&gt;Maternal Immunization&lt;/li&gt;\\n&lt;li&gt;Vaccine Hesitancy&lt;/li&gt;\\n&lt;li&gt;Vaccines for Neglected Diseases&lt;/li&gt;\\n&lt;li&gt;RSV&lt;/li&gt;\\n&lt;li&gt;Hot Topics&lt;/li&gt;\\n&lt;li&gt;One Health in Complex Settings (OHICS) / Fragile Environments&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.elsevier.com/events/conferences/all/vaccine-congress\\\"&gt;For more information, visit the website.&lt;/a&gt;&lt;/p&gt;\",\"type\":\"conferences\",\"title\":\"18th Vaccine Congress\",\"displayDate\":\"8 September - 11 September 2024\"}]},\"highlighted-articles\":{\"label\":\"Highlighted Articles\",\"items\":[{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:25:34.615404588\",\"contentId\":289716,\"publishDate\":\"2023-12-21T12:00:00Z\",\"intro\":\"&lt;p&gt;Idiopathic Inflammatory Myopathies (IIMs) are a group of chronic and disabling diseases, whose elusive exact aetiopathogenesis has impaired the development of effective therapeutic strategies. Associated numerous comorbidities make treatment even more complex.&lt;/p&gt;\",\"url\":\"highlighted-article-november-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-12-22T14:30:55.53Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997223001891\\\"&gt;Idiopathic inflammatory myopathies – The burden of disease: Cohort analysis focusing on damage and comorbidities &lt;/a&gt;&lt;br&gt;&lt;em&gt;&lt;span class=\\\"given-name\\\"&gt;Ana Campar&lt;/span&gt;, &lt;span class=\\\"given-name\\\"&gt;Inês Alves&lt;/span&gt;, &lt;span class=\\\"given-name\\\"&gt;Ana Martins da Silva&lt;/span&gt;, &lt;span class=\\\"given-name\\\"&gt;Fátima Farinha&lt;/span&gt;, &lt;span class=\\\"given-name\\\"&gt;Carlos Vasconcelos &lt;/span&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Idiopathic Inflammatory Myopathies (IIMs) are a group of chronic and disabling diseases, whose elusive exact aetiopathogenesis has impaired the development of effective therapeutic strategies. Associated numerous comorbidities make treatment even more complex.&lt;/p&gt;\\n&lt;p&gt;Survival rates of these patients have increased in recent decades, but a high burden of disease with poor quality of life, mainly caused by damage and comorbidities, remains. While comorbidities accumulation is the major factor for poor quality of life, damage severity is the main predictor for mortality. Beyond improved immunosuppressive therapeutic strategies to reduce steroids needs’, routine screening and management of comorbidities is an essential partner to lead to a comprehensive care of myositis patients and effective improvement of their quality of life.&lt;/p&gt;\\n&lt;p&gt;Lack of awareness for IIMs results in a huge delay in initial diagnosis and contributes for damage accrual. Medical records need to be updated concerning comorbidities and damage, and evaluation of functional limitation to access the real impact of disease in patients’ daily lives.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/cbnpqfhy/ana-campar.bmp\\\" alt=\\\"Ana Campar\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Ana Campar is Medical doctor (graduated assistant) of Clinical Immunology in Centro Hospitalar Universitário do Porto, Invited Assistant in School of Medicine and Biomedical Sciences Abel Salazar of University of Porto, Researcher, PhD Student Fellow in Institute for Research and Innovation of University of Porto, and invited Review Editor for Frontiers in Immunology journal. Published &gt; 25 articles in peer-reviewed indexed scientific medical journals, supervised 7 master dissertations and has received 2 awards in the Immunology field. Participates and/or participated as Co-Principal Investigator (Co-PI) in 8 projects and is Principal Investigator in 3 projects. Has been part of organizing committees of several autoimmune national congresses and participated either as lecturer or moderator of several round tables in these congresses.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - November 2023 - Autoimmunity Reviews\",\"displayDate\":\"21 December 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:25:24.169305841\",\"contentId\":288405,\"publishDate\":\"2023-12-13T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997223001799\\\"&gt;Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors&lt;/a&gt;&lt;br&gt;&lt;br&gt;Felix S. Seibert, Ulrik Stervbo, Lea Wiemers, Sarah Skrzypczyk, Maximillian Hogeweg, Sebastian Bertram, Julia Kurek, Moritz Anft, Timm H. Westhoff, Nina Babel&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Volume 22, Issue 11, November 2023, 103445&lt;/em&gt;&lt;/p&gt;\",\"url\":\"highlighted-article-october-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-12-13T07:06:42.263Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The prevalence of Long-COVID is increasing, with neurological sequelae drawing major clinical attention. Scientific data enlightening the immune pathogenesis of neurological/psychiatric symptoms of Long-COVID is limited. In addition, there are conflicting data on the association between certain autoantibodies (AAb) to G-protein coupled receptors (GPCR) and Long-COVID, which might be caused by several differences in analyzed Long-COVID cohorts, including inflammatory stage. In the present study, we analyzed AAb and inflammatory markers in three different patient cohorts including Long-COVID cohort, individuals with prior SARS-CoV-2 infection without persisting symptoms and apparently healthy controls with no known history of a SARS-CoV-2 infection. The long-COVID cohort was characterized by AAb pattern targeting certain GPCR that mainly regulate autonomous nervous system and vasoconstriction. Concentrations of AAb correlated with intensity of neurological disorders including psychomotor speed, visual search, attention, and fatigue demonstrating a potential (immuno)therapeutic target.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/ck5bly2q/babel-profile-picture.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Nina Babel is head of the Center for Translational Medicine and Immune Diagnostics Laboratory at the Ruhr University Bochum and Principal Investigator at the BIH Center for Regenerative Therapies, Charité. She studied medicine and received her clinical training in internal medicine, nephrology and immunology at Charité.&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/11xdzeyb/westhoff-profile-picture.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Timm Westhoff is Chair of Internal Medicine Clinic of Ruhr University Bochum with a focus on Nephrology and Hypertension. He studied medicine at Ruhr-University Bochum and worked at Charité before taking the Chair of Internal Medicine in Bochum. Babel and Westhoff have conducted several studies on antiviral immunity in COVID-19 high-risk populations resulting in more than 50 publications on SARS-CoV-2-specific cellular immunity.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2023 - Autoimmunity Reviews\",\"displayDate\":\"13 December 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:25:03.316605739\",\"contentId\":285372,\"publishDate\":\"2023-11-15T12:00:00Z\",\"intro\":\"&lt;p style=\\\"text-align: left;\\\"&gt;Autoimmune diseases (ADs) are caused by an immune-mediated attack on body’s own tissues and organs resulting from the insufficient self-tolerance. Although the prevalence of ADs has been investigated in several geographical areas, a global overview is lacking. This study using worldwide data extracted from GBD 2019 described current situation and analyzed temporal trends of prevalence for RA, IBD, MS and psoriasis at global, continental, and national levels. A strong heterogeneity in prevalence of ADs across 204 countries was detected, with an aggregation in Europe and America. Furthermore, there were distinct temporal trends of ADs over the last 30 years across the world, suggesting potential gaps in the prevention, management, and treatment for ADs. These results collectively highlighted the strong distributive inequities of ADs worldwide, which may be instructive for better understanding the epidemiology of these diseases, appropriately allocating medical resources, as well as making relevant health policies.&lt;/p&gt;\",\"url\":\"highlighted-article-august-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-11-15T13:55:26.187Z\",\"description\":\"&lt;p&gt;About the research:&lt;/p&gt;\\n&lt;p&gt;Autoimmune diseases (ADs) are caused by an immune-mediated attack on body’s own tissues and organs resulting from the insufficient self-tolerance. Although the prevalence of ADs has been investigated in several geographical areas, a global overview is lacking. This study using worldwide data extracted from GBD 2019 described current situation and analyzed temporal trends of prevalence for RA, IBD, MS and psoriasis at global, continental, and national levels. A strong heterogeneity in prevalence of ADs across 204 countries was detected, with an aggregation in Europe and America. Furthermore, there were distinct temporal trends of ADs over the last 30 years across the world, suggesting potential gaps in the prevention, management, and treatment for ADs. These results collectively highlighted the strong distributive inequities of ADs worldwide, which may be instructive for better understanding the epidemiology of these diseases, appropriately allocating medical resources, as well as making relevant health policies.&lt;/p&gt;\\n&lt;p&gt;About the authors:&lt;/p&gt;\\n&lt;table border=\\\"0\\\" cellpadding=\\\"8\\\" style=\\\"width: 100%; border-collapse: collapse;\\\"&gt;\\n&lt;tbody&gt;\\n&lt;tr&gt;\\n&lt;td style=\\\"width: 140px;\\\"&gt;&lt;strong&gt;&lt;img style=\\\"float: left; margin-right: 8px;\\\" src=\\\"https://api.journals.elsevier.com/media/jnhnjkss/fan-cao.png\\\" alt=\\\"Fan Cao\\\"&gt;&lt;/strong&gt;&lt;/td&gt;\\n&lt;td&gt;&lt;strong&gt;Fan Cao&lt;/strong&gt; MMed, Major in Ophthalmology, Member of the Global Burden of Disease Collaborator Network. His studies mainly focused on two fields: 1) Epidemiology of autoimmune and rheumatic diseases; 2) Basis and clinical transformation of autoimmune eye diseases. He has 18 publications with a H index of 9. He has received a great deal of honors for his academic work at the university.&lt;/td&gt;\\n&lt;/tr&gt;\\n&lt;tr&gt;\\n&lt;td style=\\\"width: 140px;\\\"&gt;&lt;strong&gt;&lt;img style=\\\"float: left; margin-right: 8px;\\\" src=\\\"https://api.journals.elsevier.com/media/km3emvms/han-feng-pan.png\\\" alt=\\\"Hai-Feng Pan\\\"&gt;&lt;/strong&gt;&lt;/td&gt;\\n&lt;td&gt;&lt;strong&gt;Hai-Feng Pan&lt;/strong&gt; MD, PhD, Professor in Epidemiology, Member of the Global Burden of Disease Collaborator Network, Doctoral supervisor and postdoctoral co-supervisor, Vice Dean in School of Public Health, Anhui Medical University. Associate editor of the International Journal of Rheumatic Diseases, Associate editor of Frontiers in Public Health, Editorial board Member of Current Pharmaceutical Design. His studies mainly focused on epidemiology and pathogenesis of rheumatic and musculoskeletal diseases. He has more than 400 publications with a H index of 44. In 2023, he ranked third in the national ranking of academic influence of scholars in the field of rheumatology and immunology.&lt;/td&gt;\\n&lt;/tr&gt;\\n&lt;/tbody&gt;\\n&lt;/table&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - August 2023 - Autoimmunity Reviews\",\"displayDate\":\"15 November 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:24:38.745105051\",\"contentId\":282480,\"publishDate\":\"2023-10-16T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997223001386?via%3Dihub\\\" data-anchor=\\\"?via%3Dihub\\\"&gt;From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies&lt;/a&gt;&lt;br&gt;&lt;br&gt;Marc Xipell, Gema M. Lledó, Allyson C. Egan, Farah Tamirou, Cristina Serrano del Castillo, Jordi Rovira, José A. Gómez-Puerta, Adriana García-Herrera, Ricard Cervera, Andreas Kronbichler, David R.W. Jayne, Hans-Joachim Anders, Frédéric Houssiau, Gerard Espinosa, Luis F. Quintana &lt;/p&gt;\",\"url\":\"highlighted-article-september-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-10-16T11:44:07.443Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the research:&lt;br&gt;&lt;/strong&gt;&lt;br&gt;Systemic lupus erythematosus is a disease that requires multidisciplinary management. From a renal perspective, this includes the vision not only of the nephrologist, but also of the immunologist, pathologist, rheumatologist, internist, nursing, among others. The improvement in knowledge of the disease in recent years, as well as the development of new therapies and clinical trials, has improved the prognosis of the disease. In the field of lupus nephritis, these advances have become more evident when clinical trial designs have been approached precisely from this multidisciplinary perspective, leading to the approval of new therapies. In this review we frame them conceptually, from the general pathogenic mechanisms of the disease to the current therapeutic alternatives. Our main objective was to integrate precisely this holistic but accurate vision of the disease, integrating the knowledge of various specialists in disease management, from international reference centers.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;&lt;br&gt;About the Author:&lt;br&gt;&lt;/strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/dm0ayawr/dr-luis-f-quintana.png\\\" alt=\\\"Dr Luis. F Quintana\\\"&gt;&lt;br&gt;Luis F. Quintana MD, PhD, is the Head of the Clinical Nephrology section at the Hospital Clínic de Barcelona. This section is member of the European Rare Kidney Disease Reference Network and is endorsed by the national health system as a Reference Center for Complex Glomerular Diseases (CSUR). Dr. Quintana is Full Professor of the Department of Medicine at the University of Barcelona, ​​where he coordinates the subject of kidney diseases in the Master in Autoimmune diseases. His publications are more than 100 and he served as an invited speaker around the world. Many of his students/fellows have followed academic career in Spain and Latin America.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - September 2023 - Autoimmunity Reviews\",\"displayDate\":\"16 October 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:23:12.365156087\",\"contentId\":272677,\"publishDate\":\"2023-06-22T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1568997223000484&amp;data=05%7C01%7Ca.ebenezer%40elsevier.com%7Cd94f43cded9f44fd7c4e08db6db1668c%7C9274ee3f94254109a27f9fb15c10675d%7C0%7C0%7C638224381608203578%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=GEmxxro%2BNNynJZwYBgRvB8k92NLU%2FHsC%2B2lMDME0GEA%3D&amp;reserved=0\\\"&gt;Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Shiri Keret&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Doron Rimar&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Pauline Lansiaux&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Erik Feldman&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Alain Lescoat&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Neta Milman&lt;/span&gt;&lt;/span&gt;, &lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Dominique Farge&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;\",\"url\":\"highlighted-article-april-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-06-23T17:15:42.403Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the research:&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;In 2016, a fruitful and warm collaboration has been established between the French Autoimmune Diseases and Stem Cell Therapy (www.mathec.com) group directed by Prof D.Farge and the rheumatology day care center in Bnai Zion medical center, directed by Prof D.Rimar in Haifa, Israel. This enabled us to set up the first stem cell transplantation (SCT) program for systemic sclerosis (SSc) in Israel. While our two teams were planning a collaborative study involving RNA sequencing in SSc patients before and after autologous hematopoietic SCT, we needed to have a deeper analysis of this complex field before diving in. This manuscript is a Franco-Israeli collaborative effort towards a better understanding of the opportunities that RNA sequencing holds with regard to personalized medicine. We walked in the footsteps that allowed to describe the molecular subtypes, the unsupervised to supervised machine learning and the importance of evaluating the molecular subsets in patients peripheral blood.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Authors:&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/uhydo135/doron.jpg?width=212&amp;height=191&amp;mode=max\\\" alt=\\\"\\\" width=\\\"212\\\" height=\\\"191\\\"&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Doron Rimar is Professor of Rheumatology at the Technion institute of technology. He is the director of the rheumatology day care center, systemic sclerosis clinics and capillaroscopy service in Bnai Zion medical center. Prof Rimar leads the first pioneer program of autologous stem cell transplantation for systemic sclerosis in Israel.&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/s24oi1j2/dominique.jpg?width=185&amp;height=278&amp;mode=max\\\" alt=\\\"\\\" width=\\\"185\\\" height=\\\"278\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Dominique Farge is Professor of Internal Medicine since 1994, head of the &lt;a href=\\\"http://www.mathec.com/\\\"&gt;MATHEC&lt;/a&gt; reference center for stem cell therapy in autoimmune diseases at St-Louis AP-HP and Pari- Cité University and adjunct Professor at McGill University since 2017. As co-founder of &lt;a href=\\\"http://www.eustar.org/\\\"&gt;EUSTAR&lt;/a&gt; , past-chair of the &lt;a href=\\\"http://www.ebmt.org/\\\"&gt;ADWP-EBMT&lt;/a&gt;  and current vice-president Europe of &lt;a href=\\\"http://www.isctglobal.org/\\\"&gt;ISCT&lt;/a&gt; , she has long-standing commitment in scleroderma, and contributed as Editor to 4 books, including “Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases” in 2022 &lt;a href=\\\"https://doi.org/10.1201/9781315151366%20\\\"&gt;https://doi.org/10.1201/9781315151366 &lt;/a&gt;, with 500&lt;em&gt; peer&lt;/em&gt;-reviewed articles.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - April 2023 - Autoimmunity Reviews\",\"displayDate\":\"22 June 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:21:44.007321598\",\"contentId\":263075,\"publishDate\":\"2023-03-16T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Immunoflurescence is a common laboratory method for autoantibodies detection (For ANA-Hep2 it is considered as the golden standard). Immunoflurescence is essential to supplement clinical findings in the diagnosis of autoimmune diseases, so the typical autoantibodies indicating or supporting the initial diagnosis are noted. My idea, was to show the less common autoantibodies, that till now, don’t have known clinical significance, and very often neglected in the final reporting. However, these less common autoantibodies could be the signal for an autoimmune process, thus the monitoring of their presence and relation to patient's symptoms, even mild or looking as non-specific, is necessary.&lt;/p&gt;\",\"url\":\"highlighted-article-march-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-03-16T06:03:26.947Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a href=\\\"https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1568997222002336%3Fvia%253Dihub&amp;data=05%7C01%7Cs.yuvanjaline%40elsevier.com%7Ccaa74ed71ce442c134a508db1ceb096c%7C9274ee3f94254109a27f9fb15c10675d%7C0%7C0%7C638135568198100641%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000%7C%7C%7C&amp;sdata=WTE%2B93J2TfFA%2Bsbcty30mddxn7CDCNIVdg2FU0TRXY0%3D&amp;reserved=0\\\"&gt;Uncommon types of autoantibodies – Detection and clinical associations&lt;/a&gt;&lt;br&gt;&lt;/strong&gt;&lt;em&gt;&lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Małgorzata Staruszkiewicz&lt;/span&gt;&lt;/span&gt;,&lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Anna Pituch-Noworolska&lt;/span&gt;&lt;/span&gt;,&lt;span class=\\\"react-xocs-alternative-link\\\"&gt;&lt;span class=\\\"given-name\\\"&gt;Szymon Skoczen&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Immunoflurescence is a common laboratory method for autoantibodies detection (For ANA-Hep2 it is considered as the golden standard). Immunoflurescence is essential to supplement clinical findings in the diagnosis of autoimmune diseases, so the typical autoantibodies indicating or supporting the initial diagnosis are noted. My idea, was to show the less common autoantibodies, that till now, don’t have known clinical significance, and very often neglected in the final reporting. However, these less common autoantibodies could be the signal for an autoimmune process, thus the monitoring of their presence and relation to patient's symptoms, even mild or looking as non-specific, is necessary.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;img src=\\\"media/hx0eafgf/malgorzata-staruszkiewicz.jpg?width=198&amp;height=198&amp;mode=max\\\" alt=\\\"\\\" width=\\\"200\\\" height=\\\"200\\\"&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Malgorzata Staruszkiewicz&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;I have an M.Sc. in Medical Analytics from the Farmaceutical Department of Jagiellonian University Medical College.&lt;br&gt;After graduation, I worked in the biotechnology and pharmaceutical fields, that gave me the privilege of participating in different international trainings, namely IFA. I used my knowledge and experience, to further train laboratory staff, and solve complex issues in various laboratories across Poland.&lt;br&gt;Currently, I am working at the University Children’s Hospital in Cracow.&lt;br&gt;I am interested in pathogenesis, immunology, diagnostic auto-antibody tests, pathophysiology and the treatment of autoimmune diseases. My special interests are autoantibodies in pregnant women and autoantibodies in children with PANDAS syndrome.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - March 2023 - Autoimmunity Reviews\",\"displayDate\":\"16 March 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:21:24.580199303\",\"contentId\":260103,\"publishDate\":\"2023-02-17T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222002063?via%3Dihub\\\" data-anchor=\\\"?via%3Dihub\\\"&gt;Autoimmune pre-disease&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;em&gt;Katja Bieber, Jennifer E. Hundt, Xinhua Yu, Marc Ehlers, Frank Petersen, Christian M. Karsten, Jörg Köhl, Khalaf Kridin, Kathrin Kalies, Anika Kasprick, Stephanie Goletz, Jens Y. Humrich, Rudolf A. Manz, Axel Künstner, Christoph M. Hammers, Reza Akbarzadeh, Hauke Busch, Christian D. Sadik, Tanja Lange, Hanna Grasshoff, Ralf J. Ludwig&lt;/em&gt;&lt;br&gt;&lt;br&gt;&lt;/p&gt;\",\"url\":\"highlighted-article-february-2023-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-02-20T07:23:21.78Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The idea for the review stemmed from the long-noticed observation that autoimmune diseases develop over years. Despite this notion, the processes that define the transition from health to autoimmunity, and from autoimmunity to clinically manifest autoimmune disease, are, however relatively poorly defined. Identification of (modifiable) pathways to alter this transition would be the basis for prophylactic interventions in individuals at risk to develop autoimmune diseases. In our article we summarized the current insights into these pathways&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/0qufslcb/bewerbungsfoto-passbild.jpg?width=200&amp;height=261&amp;mode=max\\\" alt=\\\"\\\" width=\\\"200\\\" height=\\\"261\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Ralf Ludwig is a trained dermatologist and is Director of the Lübeck Institute of Experimental Dermatology. His research interests focus on translational research in chronic, non-communicable inflammatory skin diseases, with an emphasis on pemphigus and pemphigoid diseases. He is a member of several national and international research consortia and is the spokesperson of the DFG-funded Research Training Group “Autoimmune Pre-Disease” (GRK 2633). Here, over 25 PhD candidates work to define and modulate autoimmune pre-disease&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - February 2023 - Autoimmunity Reviews\",\"displayDate\":\"17 February 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:20:39.460265769\",\"contentId\":254790,\"publishDate\":\"2023-01-03T12:00:00Z\",\"intro\":\"&lt;p&gt;Lupus nephritis, a complication of the autoimmune disorder systemic lupus erythematosus (SLE), leads to end stage kidney disease in 10-20% of patients.&lt;/p&gt;\",\"url\":\"highlighted-article-december-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2023-01-03T12:25:49.31Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the Article:&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Lupus nephritis, a complication of the autoimmune disorder systemic lupus erythematosus (SLE), leads to end stage kidney disease in 10-20% of patients. The high demand for new therapeutic targets is boosting research and will likely change the lupus field with new potential therapies, such as complement inhibition therapies.&lt;/p&gt;\\n&lt;p&gt;Monocytes and macrophages appear to have a central role in lupus pathology, since they are abundant in glomerular lesions and murine lupus models have shown disease attenuation when macrophages were targeted. However, recent single cell analyses show that kidney macrophages in lupus nephritis have heterogeneous subtypes with various disease promoting or immunomodulating functions. Those developments inspired this review to investigate the role of macrophages in lupus pathogenesis, associated chemokines, the role of complement and to explore this knowledge, focusing on monocytes and macrophages as therapeutic targets in lupus nephritis.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Authors:&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/ghqbi40v/photo_autoimmunity.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Marc Hilhorst, &lt;/strong&gt;MD, PhD, nephrologist at Amsterdam UMC, the Netherlands. His research focuses on immune-mediated kidney diseases and kidney transplantation.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Lianne Kwant&lt;/strong&gt; BSc, medical student and student researcher in Nephrology at Amsterdam University Medical Centers (UMC), the Netherlands. After acquiring a bachelor’s degree in Veterinary medicine, she switched to human medicine and devoted her master thesis to macrophages in lupus nephritis, after which she continued her research together with clinical rotations.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Yosta Vegting&lt;/strong&gt; MD, PhD candidate Nephrology-Immunology at Amsterdam UMC, the Netherlands. Her research currently focuses on the role of monocytes and macrophages in ANCA-associated glomerulonephritis as well as in lupus nephritis, investigating the complement system, inflammation and fibrosis.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - December 2022 - Autoimmunity Reviews\",\"displayDate\":\"3 January 2023\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:19:41.393560476\",\"contentId\":245481,\"publishDate\":\"2022-10-26T12:00:00Z\",\"intro\":\"&lt;p&gt;Psoriasis: Interplay between dysbiosis and host immune system&lt;/p&gt;\",\"url\":\"highlighted-article-october-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2022-10-26T17:27:48.467Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222001392\\\"&gt;Psoriasis: Interplay between dysbiosis and host immune system&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Bhupinder Kapoor, Monica Gulati, Pooja Rani, Reena Gupta&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;As someone from the profession of pharmaceutical sciences, you are often expected to share your opinion about their drug regimen. One of our colleagues, who had suddenly developed a fulminant psoriasis, was put on a combination regimen of chemotherapy and irradiation. She experienced remission-recurrence cycles and started developing symptoms of hepatic failure. We were then requested to do find some safer therapies. During this exercise, we came across a few reports wherein Fecal Microbiota Transplant (FMT) had been used for treatment of psoriasis. We found it quite interesting and explored it further. To our surprise, FMT has been reported to be effective in almost all auto-immune disorders. Though not explored fully, it seemed to offer a solution to some problems considered incurable hitherto. As the literature is very sparse, we had to look for all evident connections between microbiota alteration in psoriasis, restoration after therapy and therapeutic effects of therapy.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/nmnloxc2/bhupinder-kapoor.png\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Bhupinder Kapoor&lt;/strong&gt; PhD, Professor, Lovely Professional University, India.&lt;/p&gt;\\n&lt;p&gt;With an expertise in the physico-chemical and physico-mechanical properties of vesicular and complex delivery systems, he has authored more than 60 publications with a cumulative impact factor of &gt;300, total citations &gt;800; h-index 16.  His current research focuses on drug delivery and targeting, nanomedicine, and nutraceuticals.&lt;br&gt;&lt;br&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/n32fwlj4/monica-gulati.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Monica Gulati&lt;/strong&gt; PhD, Professor, Lovely Professional University, India.&lt;/p&gt;\\n&lt;p&gt;Her research forte is enhancing bio-performance of drug molecules, phytochemicals, probiotics, metabiotics and other biotherapeutics using conventional and novel dosage forms especially in the area of colon targeting. Her publications are more than 200 (citations &gt;3400, h-index &gt;30).&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2022 - Autoimmunity Reviews\",\"displayDate\":\"26 October 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:19:10.725701828\",\"contentId\":242361,\"publishDate\":\"2022-09-20T12:00:00Z\",\"intro\":\"&lt;p&gt;Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis&lt;/p&gt;\",\"url\":\"highlighted-article-august-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2022-09-20T10:15:16.243Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222000994\\\"&gt;Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Ricardo Ramírez-Morales, Elyzabeth Bermúdez-Benítez, Laura-Aline Martínez-Martínez, Manuel Martínez-Lavín&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;br&gt;&lt;/em&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Our longstanding fibromyalgia research leads us to propose dorsal root ganglia as the key neural hub where different stressors could be converted in neuropathic pain. Dorsal root ganglia could be also involved on the mechanisms leading to myalgic encephalomyelitis.  A pilot postmortem inquest of 4 myalgic encephalomyelitis patients disclosed dorsal root ganglia inflammation in 3 of them.   There is controversy on fibromyalgia and myalgic encephalomyelitis alikeness. Our systematic review was intended to enlighten this issue.&lt;/p&gt;\\n&lt;p&gt;Myalgic encephalomyelitis and fibromyalgia diagnoses overlapped in 47.3% of the reported cases. Nevertheless the overwhelming majority of the original articles used the old 1990 Wolfe et al fibromyalgia classification criteria. Theoretically, the clinical overlap between  these two illnesses could be even higher if future studies  use the new Wolfe et al fibromyalgia diagnostic criteria that incorporates three key myalgic encephalomyelitis features namely fatigue, waking unrefreshed, and dyscognition.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/khfdaut3/manuel-marti-nez-lavi-n.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Dr. Martínez-Lavín is Chief of Rheumatology Department at the National Institute of Cardiology in Mexico. He is Master of the American College of Rheumatology. His research group originally described the followingl fibromyalgia anomalies.&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;Autonomic dysfunction using heart rate variability analyses.&lt;/li&gt;\\n&lt;li&gt;Stress as key driving force.&lt;/li&gt;\\n&lt;li&gt;COMT enzyme and adrenergic receptor genetic alterations.&lt;/li&gt;\\n&lt;li&gt;Norepinephrine-evoked pain in fibromyalgia.&lt;/li&gt;\\n&lt;li&gt;Fibromyalgia as a sympathetically-maintained neuropathic pain syndrome.&lt;/li&gt;\\n&lt;li&gt;Small fiber neuropathy using corneal confocal microscopy.&lt;/li&gt;\\n&lt;li&gt;Dorsal root ganglia as the site where stress becomes pain.&lt;/li&gt;\\n&lt;li&gt;Complexity science paradigms to untangle fibromyalgia conundrum.&lt;/li&gt;\\n&lt;li&gt;Fibromyalgia in Frida Kahlo’s life and art.&lt;/li&gt;\\n&lt;/ul&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - August 2022 - Autoimmunity Reviews\",\"displayDate\":\"20 September 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:19:14.776184324\",\"contentId\":242385,\"publishDate\":\"2022-09-20T12:00:00Z\",\"intro\":\"&lt;p&gt;Seronegative autoimmune diseases: A challenging diagnosis&lt;/p&gt;\",\"url\":\"highlighted-article-september-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2022-09-20T12:42:31.563Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222001136\\\"&gt;Seronegative autoimmune diseases: A challenging diagnosis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, Matteo Gastaldi, Serena Bugatti, Mario Rotondi, Paola Ilaria Bianchi, Antonella Gentile, Luca Chiovato, Carlomaurizio Montecucco, Gino Roberto Corazza, Antonio Di Sabatino&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;br&gt;&lt;/em&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Autoimmune diseases (AID) comprise more than 100 disorders, and their early recognition is key for preventing complications. For most of these conditions, disease-specific serum autoantibodies are currently being used for making -or at least for addressing- a definitive diagnosis. Nonetheless, in a minority of cases, patients with AID may not show any autoantibody, a condition that is referred to as seronegative AID. Suboptimal laboratory accuracy, concomitant immunosuppressive therapy, immunodeficiencies, antigen exhaustion, and immunosenescence are the main responsible for seronegativity. Among AID, autoimmune gastritis, celiac disease, autoimmune liver disease, rheumatoid arthritis, autoimmune encephalitis, myasthenia gravis, Sjögren’s syndrome, antiphospholipid syndrome, and autoimmune thyroid diseases may all present as seronegative AID, thus making it challenging for making a diagnosis in clinical practice. In this review, we discuss the causes of seronegativity in those AID and how to overcome this obstacle in clinical practice.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/22dj45do/picture-prof-di-sabatino.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Prof. Antonio Di Sabatino is a Full Professor of Internal Medicine at University of Pavia, Italy, and Head of the Internal Medicine Unit at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. He has an extensive experience in mucosal immunology and management of immuno-mediated gastrointestinal disorders (h-index 55, 329 papers).&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/jzjf1ndi/foto-marco-lenti-2021.jpg\\\" alt=\\\"\\\" width=\\\"150\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Dr. Marco Vincenzo Lenti is an Assistant Professor of Internal Medicine at University of Pavia, Italy and a Gastroenterology Consultant at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. He is a clinical researcher, devoted to the study of clinical complexity and immune-mediated disorders of the gastrointestinal tract (h-index 23, 160 papers).&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - September 2022 - Autoimmunity Reviews\",\"displayDate\":\"20 September 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:14:24.835968865\",\"contentId\":234145,\"publishDate\":\"2022-06-24T12:00:00Z\",\"intro\":\"&lt;p&gt;Caffeine and rheumatoid arthritis: A complicated relationship&lt;/p&gt;\",\"url\":\"highlighted-article-july-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2022-06-24T10:57:39.487Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222000878\\\"&gt;Caffeine and rheumatoid arthritis: A complicated relationship&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Francesca Ingegnoli, Silvia Cavalli, Laura Giudice, Roberto Caporali&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Compelling evidence suggests a holistic approach should be incorporated into the management of rheumatoid arthritis (RA). Lifestyle interventions, including nutrition, are a relevant part of a multidimensional approach. This review examines how caffeine, one of the most important bioactive components of the most widely consumed beverages, may potentially interfere with RA. In particular, the mechanism by which caffeine affects RA pathogenesis, as a trigger for RA onset or flare, is outlined.&lt;/p&gt;\\n&lt;p&gt;We discuss how caffeine assumption interferes with rheumatic drug metabolism and with the most common RA comorbidities and constitutional symptoms such as fatigue and depressive symptoms, highlighting important knowledge gaps and unmet research needs.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\" https://admin1.journals.elsevier.com/media/04md4k4w/francesca-ingegnoli.png?width=137&amp;mode=max&amp;animationprocessmode=first\\\" alt=\\\"Ofira Einstein\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Francesca Ingegnoli, MD, PhD, Associate Professor of Rheumatology at the Università degli Studi of Milano (UNIMI), and Consultant Rheumatologist at the Clinical Rheumatology Unit at Gaetano Pini Hospital in Milan, Italy.&lt;/p&gt;\\n&lt;p&gt;After spending a year as a Research Fellow at the Department of Rheumatology, Guy’s Hospital (London), she completed her training at the UNIMI. She was awarded a PhD in Experimental Rheumatology by the University of Siena.&lt;/p&gt;\\n&lt;p&gt;She serves as health care provider representative of the Lombard network for rare diseases and of the European Reference Network on Rare CONnective tissue and complex musculoskeletal diseases NETwork (ERN- ReCONNET).&lt;/p&gt;\\n&lt;p&gt;Her publications are more than 150 (citations &gt;4500, h-index 36).&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - July 2022 - Autoimmunity Reviews\",\"displayDate\":\"24 June 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:13:22.863778937\",\"contentId\":225851,\"publishDate\":\"2022-03-29T12:00:00Z\",\"intro\":\"&lt;p&gt;Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care&lt;/p&gt;\",\"url\":\"highlighted-article-april-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2022-03-29T10:34:16.607Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997222000039\\\" target=\\\"_blank\\\"&gt;Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Ofira Einstein&lt;/em&gt;&lt;em&gt;, &lt;/em&gt;&lt;em&gt;Abram Katz&lt;/em&gt;&lt;em&gt;, &lt;/em&gt;&lt;em&gt;Tamir Ben-Hur&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;br&gt;&lt;/em&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Physical exercise (PE) positively impacts various autoimmune diseases. Accordingly, clinical trials indicate beneficial outcomes of PE in multiple sclerosis (MS) patients. There is also an increasing body of research on the beneficial effects of exercise in animal models of MS, including toxin- induced demyelination and experimental autoimmune encephalomyelitis, and various mechanisms underlying these effects were suggested. However, we still lack a thorough understanding of PE effects on autoimmune neuroinflammation and specific guidelines of PE therapy for MS patients are lacking. Here, current findings on the impact of PE on autoimmune neuroinflammation, both in human MS and animal models are reviewed. We show that training can alter disease progression by immunomodulation and point to the critical role of training intensity in inducing neuroprotection. The concept of personalized PE therapy for autoimmune neuroinflammation is discussed, and future research for paving the road for precise PE therapy in MS patients is described.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"https://admin1.journals.elsevier.com/media/tmxmvrek/ofira-einstein.jpg?width=137&amp;mode=max&amp;animationprocessmode=first\\\" alt=\\\"Ofira Einstein\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Ofira Einstein (B.P.T, Ph.D.) is a physiotherapist and a professor in neurobiology. Prof. Einstein’s research areas are neuroimmunology and neuroregeneration. Her scientific career started in cell therapy research. She studied neural stem cell biology and therapy for neurodegenerative diseases. Her current research focuses on the neurobiology of exercise training, primarily on the impact of exercise training on animal models of autoimmune neuroinflammation. She and her team, together with national and international collaborators study the effects and mechanisms of action of exercise training on neuroinflammation, neuroprotection and neuroregeneration.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - April 2022 - Autoimmunity Reviews\",\"displayDate\":\"29 March 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:13:01.930920042\",\"contentId\":222002,\"publishDate\":\"2022-02-22T12:00:00Z\",\"intro\":\"&lt;p&gt;Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication. Report of the 15&lt;sup&gt;th&lt;/sup&gt; Dresden Symposium on Autoantibodies&lt;/p&gt;\",\"url\":\"highlighted-article-march-2022-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:44:51.89Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221002998?pes=vor\\\"&gt;The influence of cytokines on the complex pathology of ulcerative colitis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Nakase, H.| Sato, N.| Mizuno, N.| Ikawa, Y.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Ulcerative colitis (UC) specifically affects the colon and rectum through multifactorial mechanisms associated with genetic alterations, environmental factors, microbiota, and mucosal immune dysregulation. In patients with corticosteroid-refractory UC, current therapies primarily employ antibodies against tumor necrosis factor-α, α4β7 integrin, and interleukin (IL)-12/23 p40; and a small-molecule Janus kinase inhibitor. Despite these revolutionary molecular targeting therapies introduced during the last two decades, 30%–55% of patients fail to respond such molecular targeting agents in the induction phase, requiring changes in treatment. Here we review basic and clinical research aimed to address this problem, focusing on the pathogenic effects of cytokines produced by innate and adaptive immune cells. For example, IL-1β, IL-6, tumor necrosis factor-α, T helper (Th) 1-, Th2-, and Th17-associated cytokines are expressed at relatively higher levels in the intestinal tissues of patients with UC. However, their expression levels depend on disease stage and patient characteristics. The complex pathology of UC may induce differences in responses to therapy. The findings of such studies strongly support the argument that future targeted therapies must focus on differences in cytokine levels associated with the stages of UC as well as on the distinct cytokine expression profiles of individual patients. © 2021 The Authors&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1568997221002949%3Fvia%253Dihub&amp;data=04%7C01%7Cs.vairavan%40elsevier.com%7C163d4eefac35417f5daa08d9f2b8545f%7C9274ee3f94254109a27f9fb15c10675d%7C0%7C0%7C637807696121845985%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=OB8PDZ8DtkDvEJPODQD2aGDwntSwW2sIiZpwbR331sc%3D&amp;reserved=0\\\"&gt;Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;em&gt;&lt;span class=\\\"text given-name\\\"&gt;Jan Damoiseaux, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Arad Dotan, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Marvin J.Fritzler, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Dimitrios P.Bogdanos, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Pier Luigi Meroni, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Dirk Roggenbuck, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Michel Goldman, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Nils Landegren, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Paul Bastard, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Yehuda Shoenfeld, &lt;/span&gt;&lt;span class=\\\"text given-name\\\"&gt;Karsten Conrad&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;span class=\\\"text given-name\\\"&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;\\n&lt;p&gt;The biannual Dresden meeting on autoantibodies addressed the relation between SARS-CoV2 infections and autoimmune manifestations. The main topics of the 15&lt;sup&gt;th&lt;/sup&gt; Dresden Symposium on Autoantibodies (2021) were summarized by the presenting authors in this publication. It was highlighted in several presentation that the apparent association between infection and the presence of autoantibodies, and even autoimmune diseases, does not necessarily imply a causal relation. Two major exceptions are autoantibodies to type I interferons and Kawasaki disease-like multisystem inflammatory syndrome in children (MIS-C). Autoantibodies to type I interferons were proven to be present before infection to contribute to severity of infectious complications. MIS-C is a new type of disease, only observed after SARS-CoV2 infection, that is associated with several autoantibodies. Although it is tempting to speculate that a strong immune activator, like SARS-CoV2, disturbs immuno homeostasis, further research is warranted to unravel if autoantibodies do precede infection, whether the presence of autoantibodies is an epiphenomenon of the ongoing cytokine storm, whether they are transient or long-lasting, and if they eventually result in autoimmune disease.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Author&lt;br&gt;&lt;br&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/rnaibja4/damoiseaux-jan-1000493-cdl.png?width=137&amp;height=190&amp;mode=max\\\" alt=\\\"\\\" width=\\\"137\\\" height=\\\"190\\\"&gt;&lt;br&gt;&lt;/strong&gt;&lt;em&gt;Jan Damoiseaux&lt;/em&gt; (PhD) is medical immunologist and as such involved in diagnostic testing for immune-mediated diseases. His career has started in basic immunology research and evolved, via research in animal models for autoimmune diseases, towards clinical immunology research. The research has predominantly been focussed on immune regulation via cytokines and/or T-lymphocytes, as well as on autoantibody testing. He is an active member of the College of Medical Immunologists (CMI), the European Autoantibody Standardisation Initiative (EASI), and the International Consensus on ANA Patterns (ICAP) working party. He has published more than 300 scientific papers in peer-reviewed journals. Many of these papers were the result of close collaboration with renowned  national and international scientists.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - March 2022 - Autoimmunity Reviews\",\"displayDate\":\"22 February 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:12:40.651096812\",\"contentId\":218437,\"publishDate\":\"2022-01-25T12:00:00Z\",\"intro\":\"&lt;p id=\\\"screen-reader-main-title\\\" class=\\\"Head u-font-serif u-h2 u-margin-s-ver\\\"&gt;Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies&lt;/p&gt;\",\"url\":\"highlighted-article-february-2022-autoimmunity-reviews-1\",\"lastModifiedDate\":\"2022-03-14T05:13:24.457Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221002688?via%3Dihub#!\\\"&gt;Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies&lt;/a&gt;&lt;br&gt;&lt;/strong&gt;&lt;em&gt;Nicolás Urriola, Stephen Adelstein&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;br&gt;&lt;/em&gt;&lt;strong&gt;About the Research&lt;br&gt;&lt;/strong&gt;Antibody-mediated nicotinic acetylcholine receptor (ACHR) autoimmunity currently encompasses two diseases: Myasthenia Gravis (MG) and the far less common Autoimmune Autonomic Ganglionopathy (AAG). The antibody target in AAG, the ganglionic α3-ACHR, is likely not one single receptor, but a variety of receptors due to various permissible subunit permutations. This complexity has hindered diagnostic immunoassay development, as has the lack of recognised clinical criteria for the diagnosis of AAG. Several immunoassays are available, but with little head-to-head comparison to allow an accurate assessment of their performance characteristics. This review highlights the immunobiology of AAG and assesses the likelihood of false positives of each available assay from previously published literature. Much like MG immunoassays, assays for AAG antibodies that employ whole receptor – rather than subunits – appear more clinically relevant.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;br&gt;&lt;br&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/jgadf1gl/nicolas.jpg?width=144&amp;height=181&amp;mode=max\\\" alt=\\\"\\\" width=\\\"144\\\" height=\\\"181\\\"&gt;&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Dr Nicolás Urriola MBBS, FRACP, FRCPA, is an early career clinician scientist who is Australia’s first, and thus far only, specialist with professional training and qualifications as a neurologist, clinical immunologist and immunopathologist. He works as a staff specialist in a large tertiary hospital, with expertise in directly translating novel neuroimmunological biomarker assays into the clinical environment.  His area of interest includes autoantibody-mediated neurological disease with particular emphasis on acetylcholine receptor autoimmunity.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - February 2022 - Autoimmunity Reviews (1)\",\"displayDate\":\"25 January 2022\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:12:23.955049227\",\"contentId\":214800,\"publishDate\":\"2021-12-22T12:00:00Z\",\"intro\":\"&lt;p&gt;Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis&lt;/p&gt;\",\"url\":\"highlighted-article-january-2022-autoimmunity-reviews-1\",\"lastModifiedDate\":\"2022-03-14T05:12:22.453Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1568997221002020%3Fvia%253Dihub&amp;data=04%7C01%7Cchennaimcateam%40elsevier.com%7C02b52b46d6a744059cfc08d9bee37f0b%7C9274ee3f94254109a27f9fb15c10675d%7C0%7C0%7C637750706562348095%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=b06ZlpXcVJBFv43rRFtLPQfpiWzO8o89RVwxsFGno3g%3D&amp;reserved=0\\\"&gt;&lt;strong&gt;Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Anuraag Jena, Shubhra Mishra, Parakkal Deepak, Praveen Kumar-M, Aman Sharma, Yusuf I. Patel, Nicholas A. Kennedy, Alfred H.J. Kim, Vishal Sharma, Shaji Sebastian&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Research&lt;br&gt;&lt;/strong&gt;Immune mediated inflammatory diseases (IMIDs) are a subgroup of diseases which share common inflammatory pathways.  There are concerns about the efficacy of COVID in IMIDs due to the underlying disease and immune modifying drugs. We performed this systematic review to address this issue and inform the clinical practice. Our analysis suggests that the seroconversion rates after SARS-CoV-2 vaccination are lower in IMID patients as compared to healthy controls. Further, the seroconversion rates improve considerably after the second dose. Certain classes of drugs (anti-CD20 eg rituximab, anti-CTLA-4) are associated with a poorer seroconversion rate even after two doses. The results suggest that there may be a need to monitor for seroconversion and possible additional doses in patients on these drugs. Due to limited data, the issues of decay in antibody titres, T cell responses and presence of neutralising antibodies were not addressed in this systaematic review.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;br&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/1kdlm3r4/image.jpg?width=198&amp;height=163&amp;mode=max\\\" alt=\\\"\\\" width=\\\"198\\\" height=\\\"163\\\"&gt;&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Vishal Sharma MD, DM is an associate professor in the department of gastroenterology at the prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He has trained at the University College of Medical Sciences (University of Delhi) prior to joining PGIMER. His work focuses on inflammatory bowel disease and gastrointestinal tuberculosis and he has &gt;300 publications. He has made significant contributions in discriminating gastrointestinal tuberculosis from Crohn’s disease. He has been awarded the Om Prakash memorial award for young physician-scientist and Dr SR Naik award of the Indian Society of Gastroenterology and Dr MJ Shah award of the Association of Physicians of India.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - January 2022 - Autoimmunity Reviews (1)\",\"displayDate\":\"22 December 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:11:38.145824678\",\"contentId\":207696,\"publishDate\":\"2021-10-18T12:00:00Z\",\"intro\":\"&lt;p id=\\\"screen-reader-main-title\\\" class=\\\"Head u-font-serif u-h2 u-margin-s-ver\\\"&gt;Post-COVID syndrome. A case series and comprehensive review&lt;/p&gt;\",\"url\":\"highlighted-article-november-2021-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-10-18T12:13:07.393Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221002226?via%3Dihub#!\\\"&gt;Post-COVID syndrome. A case series and comprehensive review&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Juan-Manuel Anaya, Manuel Rojas, Martha L.Salinas, Yhojan Rodríguez, Geraldine Roa, Marcela Lozano, Mónica Rodríguez-Jiménez, Norma Montoya, &lt;/em&gt;&lt;em&gt;Elizabeth Zapata, Post-COVID study group, Diana M.Monsalve, Yeny Acosta-Ampudia, Carolina Ramírez-Santana&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Research&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;In 2020, during the initial pandemic, we noticed that about one-third of patients had persistent COVID-19 symptoms or developed new ones after resolution of acute disease (either upon hospital discharge or after finishing quarantine at home). In order to gain insight into this new entity, an analysis of the first 100 patients with Post-COVID syndrome (PCS) was carried-out. Our findings, together with those of the literature, show that PCS is mainly characterized by musculoskeletal, pulmonary, neuro-psychiatric, and gastrointestinal systems involvement. One-third of PCS patients may actually present with all four systems complaints.&lt;/p&gt;\\n&lt;p&gt;Noteworthy, the severity of the acute disease is not associated with the development of PCS, nor is the magnitude of the humoral immune response against the virus.&lt;/p&gt;\\n&lt;p&gt;Currently, a national and open science &lt;em&gt;Post-COVID Alliance&lt;/em&gt; has been established to longitudinally investigate the clinical characteristics and immunopathological mechanisms of PCS and its relationship with autoimmunity.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/ttmixf0v/crea-cdo.jpg?width=434&amp;height=289&amp;mode=max\\\" alt=\\\"\\\" width=\\\"434\\\" height=\\\"289\\\"&gt;&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The Center for Autoimmune Diseases Research (CREA) at the Universidad del Rosario, in Bogota, Colombia, investigates the common mechanisms of these conditions (that is, the Autoimmune Tautology) throughout 10 premises, including female preponderance, shared subphenotypes, polyautoimmunity and co-aggregation, the effect of age at onset on severity, similar molecular mechanisms, common effects of environmental and genetic factors, the influence of ancestry, and the similar treatment for most of them.&lt;/p&gt;\\n&lt;p&gt;In addition to the comprehensive care of patients and their families, CREA's work has lead to the chair of Translational Medicine, training researchers, international networking, scientific papers and books.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - November 2021 - Autoimmunity Reviews\",\"displayDate\":\"18 October 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:11:25.391639187\",\"contentId\":205233,\"publishDate\":\"2021-09-21T12:00:00Z\",\"intro\":\"&lt;p id=\\\"screen-reader-main-title\\\" class=\\\"Head u-font-serif u-h2 u-margin-s-ver\\\"&gt;Autoimmune pancreatitis - What we know and what do we have to know?&lt;/p&gt;\",\"url\":\"highlighted-article-october-2021-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-09-21T11:27:39.423Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221001877?via%3Dihub\\\" data-anchor=\\\"?via%3Dihub\\\"&gt;Autoimmune pancreatitis - What we know and what do we have to know?&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;em&gt;Ammar Qureshi, Youssef Ghobrial, Joline De Castro, Koushan Siami-Namini, Kam A.Newman&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Research&lt;br&gt;&lt;/strong&gt;Autoimmune pancreatitis is a rare form of pancreatitis and its diagnosis and management remains very challenging to practicing physicians. We came across two patients with autoimmune pancreatitis, one of each type which is what inspired us to explore the current literature on autoimmune pancreatitis. Diagnosis can be challenging since there is no single test for diagnosis. Instead physicians have to rely on a set number of criteria to arrive at a correct diagnosis. The vast amount of literature available and the differing data amongst different societies across the world can be overwhelming. Much about diagnostic methods and treatment needs to be standardized. We aimed at consolidating all the opinions and guidelines in order to guide practicing physicians diagnose and manage autoimmune pancreatitis.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;br&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/x1sbxjxh/kam-a-newman.jpg?width=188&amp;height=283&amp;mode=max\\\" alt=\\\"\\\" width=\\\"188\\\" height=\\\"283\\\"&gt;&lt;br&gt;&lt;strong&gt;Kam A. Newman&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Ammar Qureshi specializes in Internal Medicine and is currently the chief resident at the Eisenhower Health Internal Medicine residency program. After completing his medical school from the Rajiv Gandhi University of Health Sciences he specialized in Orthopedics. He then went on to do a post-doctoral research fellowship at Marshall University in Huntington, West Virginia U.S.A. From there he moved on to complete his Internal Medicine residency training at Eisenhower Health in Rancho Mirage, California U.S.A. He is licensed to practice Internal Medicine in California. He has an interest in gastroenterology research and often collaborates with Gastroenterology, Rheumatology and Oncology for his research.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2021 - Autoimmunity Reviews\",\"displayDate\":\"21 September 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:11:21.104375979\",\"contentId\":204729,\"publishDate\":\"2021-09-14T12:00:00Z\",\"intro\":\"&lt;p&gt;Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis&lt;/p&gt;\",\"url\":\"highlighted-article-september-2021-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-09-21T10:43:40.577Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221001579?via%3Dihub#!\\\"&gt;Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Tsutomu Takeuchi, Hiroto Yoshida, Sakae Tanaka&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;This review outlined studies showing that therapeutics targeting interleukin-6 (IL-6) not only suppress bone and joint destruction but also promote bone repair in inflammatory arthritis. In particular, we highlighted basic and clinical researches, which added new findings on relationships between IL-6 and bone cells involved in bone formation such as osteoblasts and osteocytes.&lt;/p&gt;\\n&lt;p&gt;Although only few studies investigated the effect of anti-rheumatic drugs including biological agents on bone metabolism in RA, several studies convincingly demonstrated that the intervention targeting IL-6 exhibited bone anabolic effects in inflammatory diseases.&lt;/p&gt;\\n&lt;p&gt;In the future treatment of RA and inflammatory bone diseases, more and more attention should be paid to maintain and improve quality of life of the patients not only by suppressing progression of bone and joint destruction, but also by promoting bone regeneration in eroded joints.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/5aqhlo1n/竹内様プロフィール用3.jpg?width=167&amp;height=221&amp;mode=max\\\" alt=\\\"Dr. Tsutomu Takeuchi\\\" width=\\\"167\\\" height=\\\"221\\\"&gt;&lt;br&gt;Dr. Tsutomu Takeuchi&lt;br&gt;&lt;br&gt;&lt;/strong&gt;Dr. Tsutomu Takeuchi is Keio University School of Medicine in Tokyo, Japan. He was a research fellow, at Tumour Immunology, Dana-Farber Center Institute, Harvard University in United States, where his research centred on immunology. He served as Professor of Keio University School of Medicine, where he also acted as Professor of Internal Medicine, Chief of Rheumatology, Division of Rheumatology, Department of Internal Medicine from 2009 to 2021. He is now President of Japan College of Rheumatology, and Emeritus Professor of Keio University School of Medicine.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - September 2021 - Autoimmunity Reviews\",\"displayDate\":\"14 September 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:10:10.03980807\",\"contentId\":196218,\"publishDate\":\"2021-06-22T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221001178?via%3Dihub\\\"&gt;Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms - ScienceDirect&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Giuseppe Murdaca, Monica Greco, Matteo Borro, Sebastiano Gangemi&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"url\":\"highlighted-article-july-2021-autoimmunity-reviews-1\",\"lastModifiedDate\":\"2021-09-21T10:41:35.25Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;About the Research&lt;br&gt;&lt;/strong&gt;Within the “modern era” a growing interest towards the correlation between the hygiene conditions and allergic and autoimmune disorder incidence has rosen. Our research highlights that, not only in allergic diseases but also in autoimmune conditions, the improvement in socioeconomic conditions leads to the progressive depletion of the so-called “Old Friends”, such as microbes and parasites that co-evolved for thousands of years together with the human being, lifestyle changes including diet and vitamin D intake, and modifications in physiologic gut microbiome that in turn may contribute to the impairment the normal development of immune system. Further research in these multifactorial disorders, in order to better understand the role of genome and the correlation between genome, microbiome and environment may lead to a more specific precision medicine, especially in the current era characterized by an increasing interest in omics technology. &lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;br&gt;About the Author&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Prof Giuseppe Murdaca has received his PhD in Science and Space Engineering at University of Genova (Italy) in 2000-2003. Currently, he is working as Assistant professor in Internal Medicine at University of Genova (Italy).&lt;/p&gt;\\n&lt;p&gt;His research has included:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;Immunodeficiency&lt;/li&gt;\\n&lt;li&gt;Autoimmunity&lt;/li&gt;\\n&lt;li&gt;Neuro-endocrino-immunology&lt;/li&gt;\\n&lt;li&gt;Pharmacogenomics&lt;/li&gt;\\n&lt;li&gt;Vaccines&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;He is serving as editorial member of several journals including &lt;em&gt;International Journal of Molecular Sciences, Biomedicines, Disease markers.&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;He has authored of 149 research articles.&lt;/p&gt;\\n&lt;p&gt;He is a member of the following scientific societies:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;Italian Society of Immunology, Clinical Immunology and Allergy&lt;/li&gt;\\n&lt;li&gt;Italian Society of Internal Medicine&lt;/li&gt;\\n&lt;li&gt;Italian Society of Experimental Biology&lt;/li&gt;\\n&lt;li&gt;&lt;em&gt;European Academy of Allergy and Clinical Immunology&lt;/em&gt;&lt;/li&gt;\\n&lt;/ul&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - July 2021 - Autoimmunity Reviews (1)\",\"displayDate\":\"22 June 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.973921613\",\"contentId\":296245,\"publishDate\":\"2021-06-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000987?pes=vor\\\"&gt;Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Liu, Z.| Liao, Q.| Wen, H.| Zhang, Y.&lt;/p&gt;\",\"url\":\"highlighted-article-june-2021-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:49:43.437Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000987?pes=vor\\\"&gt;Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Liu, Z.| Liao, Q.| Wen, H.| Zhang, Y.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Objective: To compare the efficacy and compliance of up-to-date disease modifying therapies (DMTs) in patients with remitting-relapsing MS (RRMS). Methods: We searched PubMed, EMBASE and Cochrane Library for eligible studies. Annualized relapse rate, discontinuation due to adverse events (AEs) were assessed as primary outcomes. Sensitivity analysis and inconsistency detection were performed to evaluated whether exclusion of high-risk studies affected the validity. Risk of bias was assessed using Cochrane's Risk-of-Bias Tool 2. Surface under the cumulative ranking curve (SUCRA) was used to estimate the rankings among different DMTs. Results: 21 studies were included for main report. Seven studies were evaluated as “high risk” and were therefore excluded. Exclusion of high-risk studies did not affect the validity of evidence. The risk of relapses for most DMTs except Betaseron 50 μg was significantly lower comparing to placebo. Incompliance in patients treated with DMTs was not significantly increased comparing to placebo. Dimethyl fumarate and ocrelizumab had superiority in improving MRI outcomes. Ocrelizumab and ofatumumab had the largest reduction of risk in disability progression at 3 months. Referring to SUCRA, ofatumumab, alemtuzumab and natalizumab showed the best efficacy and compliance. Conclusion: The present study demonstrated the hierarchy of DMTs treating RRMS. Ofatumumab, alemtuzumab and natalizumab have superiority with respect to effectiveness and compliance. More studies are required to explore the long-term effect of DMTs. Our findings could provide helpful information and contribute to clinical treatment decision-making. © 2021 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S156899722100104X?pes=vor\\\"&gt;Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Privitera, G.| Pugliese, D.| Onali, S.| Petito, V.| Scaldaferri, F.| Gasbarrini, A.| Danese, S.| Armuzzi, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Background: Combining immunosuppressors has been proposed as a strategy to enhance treatment efficacy in Inflammatory Bowel Disease (IBD). Aim: To summarize current evidence on combinations of targeted therapies with traditional immunosuppressors or with other targeted therapies. Methods: A literature search on PubMed and Medline databases was performed to identify relevant articles. Results: Current evidence supports that the combination of infliximab and thiopurines is more effective than monotherapy with both agents in inducing remission in Crohn's Disease and Ulcerative colitis. Data on other combinations of other biologics and traditional immunosuppressors is lacking or show conflicting results. Vedolizumab seems a potentially effective maintenance regimen after calcineurin inhibitors-based rescue therapy in acute severe ulcerative colitis, as an alternative to thiopurines. Dual Targeted Therapy, which is the combination of 2 targeted therapies, might be a reasonable choice in patients with concomitant IBD and extraintestinal manifestations, or in patients with medical-refractory IBD who lack valid alternatives. Combinations with thiopurines are associated with an increased risk of infections and lymphoma. Data on other combinations is scarcer, but no specific safety issue has emerged so far. Conclusions: Combination therapies seem to be effective in selected patients, with an overall acceptable safety profile. © 2021 Elsevier B.V.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - June 2021 - Autoimmunity Reviews\",\"displayDate\":\"1 June 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:09:40.869829973\",\"contentId\":193147,\"publishDate\":\"2021-05-11T00:00:00Z\",\"intro\":\"&lt;p id=\\\"screen-reader-main-title\\\"&gt;\\r\\n\\tPrenatal and perinatal factors associated with developing multiple sclerosis later in life: A systematic review and meta-analysis&lt;/p&gt;\",\"url\":\"highlighted-article-may-2021\",\"lastModifiedDate\":\"2021-05-24T20:41:32.423Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000951?via%3Dihub\\\"&gt;Prenatal and perinatal factors associated with developing multiple sclerosis later in life: A systematic review and meta-analysis&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Negin Badihian, Roya Riahi, Parvin Goli, Shervin Badihian, Parnian Poursafa, Roya Kelishadi&lt;/em&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Research&lt;/strong&gt;&lt;br&gt;\\r\\n\\tBoth genetic and environmental factors play roles in Multiple Sclerosis (MS) etiopathogenesis. The relationship between prenatal/perinatal factors/exposures and future MS occurrence in the offspring remains controversial. We reviewed the available evidence on prenatal/perinatal factors associated with later MS occurrence. We found 100 prenatal/perinatal factors associated with an increased or decreased risk of MS occurrence in the offspring. In the meta-analyses, we found that prenatal smoking exposure, mode of delivery, birth order, and maternal age do not affect the risk of future MS development. Moreover, most of the other investigated factors including maternal age and parents&rsquo; marital status at the time of childbirth, maternal preeclampsia/toxemia, forceps use, birth weight, plurality, and preterm birth were reported not to affect MS risk. Based on findings from our study and previous meta-analyses, currently low gestational/neonatal vitamin D level is the most evident prenatal/perinatal factor that may increase the risk of MS in the offspring.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Author&lt;/strong&gt;&lt;br&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;img alt=\\\"\\\" src=\\\"https://api.journals.elsevier.com/media/pxcmfsfb/dr-roya-kelishadi-11062615.jpg\\\" style=\\\"width: 180px; height: 230px;\\\"&gt;&lt;br&gt;\\r\\n\\t&lt;strong&gt;Dr. Negin Badihian&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Negin Badihian is a medical researcher and M.D. graduate from Iran. As a medical student, she was actively involved in multiple research activities and projects. After her graduation in 2018, she joined the Institute for Primordial Prevention of Non-Communicable Disease at Isfahan University of Medical Sciences, as a research associate to professionally pursue her interests. Under supervision of Prof. Roya Kelishadi, she has been able to conduct more high-quality studies in her field of interest which is the etiopathogenesis and therapeutic options of neurologic and neuropsychiatric diseases. She aims to continue her educations to become a productive future clinician-scientist.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - May 2021\",\"displayDate\":\"11 May 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:09:26.769879835\",\"contentId\":191495,\"publishDate\":\"2021-04-12T00:00:00Z\",\"intro\":\"&lt;p id=\\\"screen-reader-main-title\\\"&gt;Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool?&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"url\":\"highlighted-article-april-2021\",\"lastModifiedDate\":\"2024-02-19T16:42:09.447Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000392?pes=vor\\\"&gt;Rheumatoid arthritis: Extra-articular manifestations and comorbidities&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Figus, F.A.| Piga, M.| Azzolin, I.| McConnell, R.| Iagnocco, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Although synovitis is the pathological hallmark of rheumatoid arthritis (RA), many extra-articular manifestations (EMs) and comorbidities likely occur due to the complex, chronic, inflammatory, and autoimmune features of RA. Cardiovascular (CV) disease is the most common cause of death in patients with RA. Compared to the general population, patients with RA have twice the risk of myocardial infarction and up to 50% increased CV mortality risk. Severe and prolonged disease activity, genetics, and inflammation (e.g. CRP, ACPA, cytokines, matrix-degrading enzymes) play important roles in CV disease and atheroscleroticdamage. The second major cause of death in patients with RA is respiratory disease, which occurs in 30–40% of patients. RA may affect the lung interstitium, airways, and pleurae, while pulmonary vascular involvement is less frequent. Central and peripheral nervous system involvement is usually due to small vessel vasculitis, joint damage, or drug toxicity. There is also evidence that microvascular cerebral damage caused by systemic inflammation is associated with the development of Alzheimer's disease and vascular dementia. Some observational studies have hinted how Disease Modified Anti-Rheumatic Drugs and biologics could reduce the incidence of dementia. Primary gastrointestinal and renal involvements are rare and often relate to drug therapy. To minimize morbidity and mortality, physicians must manage RA disease activity (treat-to-target) and monitor risk factors and concomitant conditions (e.g. smoking cessation; weight regulation; monitoring blood pressure, lipids, thyroid hormone, folic acid and homocysteine; screening for depression, anxiety, atlantoaxial instability, and atherosclerosis). This article aims to provide an overview of the most prevalent and important EMs and comorbidities associated with RA. © 2021&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000550\\\"&gt;The SARS-CoV-2 as an instrumental trigger of autoimmunity&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Dotan, A.| Muller, S.| Kanduc, D.| David, P.| Halpert, G.| Shoenfeld, Y.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state of the immune system. It had been established long ago that viruses are a substantial component of environmental factors that contribute to the production of autoimmune antibodies, as well as autoimmune diseases. Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) are viruses that withhold these autoimmune abilities. In a similar manner, SARS-CoV-2 may be counted to similar manifestations, as numerous records demonstrating the likelihood of COVID-19 patients to develop multiple types of autoantibodies and autoimmune diseases. In this review, we focused on the association between COVID-19 and the immune system concerning the tendency of patients to develop over 15 separate types of autoantibodies and above 10 distinct autoimmune diseases. An additional autoimmunity manifestation may be one of the common initial symptoms in COVID-19 patients, anosmia, the complete loss of the ability to sense smell, and other olfactory alterations. We summarize current knowledge on principal mechanisms that may contribute to the development of autoimmunity in the disease: the ability of SARS-CoV-2 to hyper-stimulate the immune system, induce excessive neutrophil extracellular traps formation with neutrophil-associated cytokine responses and the molecular resemblance between self-components of the host and the virus. Additionally, we will examine COVID-19 potential risk on the new-onsets of autoimmune diseases, such as antiphospholipid syndrome, Guillain-Barré syndrome, Kawasaki disease and numerous others. It is of great importance to recognize those autoimmune manifestations of COVID-19 in order to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period. Lastly, an effective vaccine against SARS-CoV-2 may be the best solution in dealing with the ongoing pandemic. We will discuss the new messenger RNA vaccination strategy with an emphasis on autoimmunity implications. © 2021 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000598?via%3Dihub\\\"&gt;Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool?&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Hila Greenbaum Bat-El Lugassy Galper Dean H.Decter Vered H.Eisenberg&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The need for non-invasive diagnostic tests for endometriosis is apparent to anyone who studies this disease. The average decade long delay to diagnosis costs women a reduced quality of life and possibly permanent infertility. Various anti-endometrial antibodies have been reported and studied and the goal of our review was to summarize the potential markers of disease that may aid an earlier diagnosis. We found that anti-SLP2, anti-TMOD3, and anti-TPM3 had both high sensitivity and specificity in mild to moderate disease, whereas anti-PDIK1L only showed high sensitivity in early disease stages. Others have shown their inability to act as potential tool due to their lack of sensitivity or specificity or absence of supporting data (ie. anti- α2-HS, anti-transferrin, anti-survivin, and anti-PEP). After our careful review of the literature, we concluded the possibility to use certain autoantibodies as a non-invasive diagnostic tool exists, especially with an added benefit of certain combination panels.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"width: 131px; height: 149px;\\\" src=\\\"https://api.journals.elsevier.com/media/uyef0qau/dr-vered-eisenberg-12054552.jpg\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Dr. Vered Eisenberg MD, MHA&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Chief Quality Officer, Sheba Medical Center, Tel Hashomer.&lt;br&gt;Obstetrician-Gynecologist. Specializes in obstetric and gynecological ultrasound particularly pelvic floor imaging and endometriosis-dedicated ultrasound. MHA from the Recanati/Coller School of Management, Tel Aviv University. Assistant Professor in Obstetrics and Gynecology, Sacker Faculty of Medicine, Tel Aviv University, and course chair: Introduction to healthcare management, School of public health. SQIL certificate from Harvard Medical School. Faculty member at the academic school of ultrasound in obstetrics and gynecology and chairs a course in gynecological and pelvic floor ultrasound, CME, Tel Aviv University. Editorial board member in the Journal of Ultrasound in Obstetrics and Gynecology.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - April 2021 - Autoimmunity Reviews\",\"displayDate\":\"12 April 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:08:57.945954663\",\"contentId\":183194,\"publishDate\":\"2021-03-04T00:00:00Z\",\"intro\":\"&lt;p&gt;The microbiome links between aging and lupus&lt;/p&gt;\",\"url\":\"ar-highlighted-article-march-2021\",\"lastModifiedDate\":\"2024-02-19T16:44:09.403Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000227?pes=vor\\\"&gt;Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Cavalli, G.| Colafrancesco, S.| Emmi, G.| Imazio, M.| Lopalco, G.| Maggio, M.C.| Sota, J.| Dinarello, C.A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The interleukin (IL)-1 family member IL-1α is a ubiquitous and pivotal pro-inflammatory cytokine. The IL-1α precursor is constitutively present in nearly all cell types in health, but is released upon necrotic cell death as a bioactive mediator. IL-1α is also expressed by infiltrating myeloid cells within injured tissues. The cytokine binds the IL-1 receptor 1 (IL-1R1), as does IL-1β, and induces the same pro-inflammatory effects. Being a bioactive precursor released upon tissue damage and necrotic cell death, IL-1α is central to the pathogenesis of numerous conditions characterized by organ or tissue inflammation. These include conditions affecting the lung and respiratory tract, dermatoses and inflammatory skin disorders, systemic sclerosis, myocarditis, pericarditis, myocardial infarction, coronary artery disease, inflammatory thrombosis, as well as complex multifactorial conditions such as COVID-19, vasculitis and Kawasaki disease, Behcet's syndrome, Sjogren Syndrome, and cancer. This review illustrates the clinical relevance of IL-1α to the pathogenesis of inflammatory diseases, as well as the rationale for the targeted inhibition of this cytokine for treatment of these conditions. Three biologics are available to reduce the activities of IL-1α; the monoclonal antibody bermekimab, the IL-1 soluble receptor rilonacept, and the IL-1 receptor antagonist anakinra. These advances in mechanistic understanding and therapeutic management make it incumbent on physicians to be aware of IL-1α and of the opportunity for therapeutic inhibition of this cytokine in a broad spectrum of diseases. © 2021 The Authors&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997221000240?via%3Dihub\\\"&gt;The microbiome links between aging and lupus&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;N. Katz-Agranov, G. Zandman-Goddard&lt;br&gt;Volume 20, Issue 3, March 2021, 102765 &lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Alterations in the microbiome (dysbiosis) are associated with autoimmune diseases, such as lupus, as well as with aging and frailty. We discovered the presence of shared features of dysbiosis in both conditions. Some significant similarities included the decreased abundance of microbes that have anti-inflammatory features and known to serve as protective bacteria (ie Lactobacillus, Bifidobacterium) while the abundance of pro-inflammatory bacteria (ie proteobacteria) increased in both conditions. Our biggest challenge was the array of studies that differed in subject population, geographical location, study design and outcomes. The significant inter-individual variability limited the ability to generalize several conclusions. &lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"height: 300px; width: 200px;\\\" src=\\\"https://api.journals.elsevier.com/media/rculu0bq/katz-05075039.jpg\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;Nurit Katz-Agranov, MD, LLB, is a physician scholar, who is currently an assistant professor of medicine at Tufts University, School of Medicine in Boston, MA. She has been focusing on clinical research and has diverse research interests; however, studying the gut microbiome has captured her interest and she has been working with Dr. Zandman-Goddard, focusing on the contribution of the microbiome to the various states of health and disease of its host. Alongside her research, Dr. Katz continues to spend a bulk of her time in direct patient care and education, both of which she is passionate about.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - March 2021 - Autoimmunity Reviews\",\"displayDate\":\"4 March 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:08:45.647012591\",\"contentId\":182725,\"publishDate\":\"2021-02-11T00:00:00Z\",\"intro\":\"&lt;p&gt;B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)&lt;/p&gt;\",\"url\":\"highlighted-article-february-2021\",\"lastModifiedDate\":\"2024-02-19T16:46:17.28Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220303177?pes=vor\\\"&gt;B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Möckel, T.| Basta, F.| Weinmann-Menke, J.| Schwarting, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The B cell activating factor (BAFF), or B lymphocyte stimulator (BLyS), is a B cell survival factor which supports autoreactive B cells and prevents their deletion. BAFF expression is closely linked with autoimmunity and is enhanced by genetic alterations and viral infections. Furthermore, BAFF seems to be involved in adipogenesis, atherosclerosis, neuro-inflammatory processes and ischemia reperfusion (I/R) injury. BAFF is commonly overexpressed in Systemic Lupus Erythematosus (SLE) and strongly involved in the pathogenesis of the disease. The relationship between BAFF levels, disease activity and damage accrual in SLE is controversial, but growing evidence is emerging on its role in renal involvement. Belimumab, a biologic BAFF inhibitor, has been the first biologic agent licensed for SLE therapy so far. As Rituximab (RTX) has been shown to increase BAFF levels following B cell depletion, the combination therapy of RTX plus belimumab (being evaluated in two RCT) seems to be a valuable option for several clinical scenarios. In this review we will highlight the growing body of evidence of immune and non-immune related BAFF expression in experimental and clinical settings. © 2020 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220303165?pes=vor\\\"&gt;Beyond the joints, the extra-articular manifestations in rheumatoid arthritis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Conforti, A.| Di Cola, I.| Pavlych, V.| Ruscitti, P.| Berardicurti, O.| Ursini, F.| Giacomelli, R.| Cipriani, P.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Rheumatoid arthritis (RA) is an inflammatory disease typically affecting the joints, but the systemic inflammatory process may involve other tissues and organs. Many extra-articular manifestations are recognized, which are related to worse long outcomes. Rheumatoid nodules are the most common extra-articular feature, found in about 30% of patients. Secondary Sjögren's syndrome and pulmonary manifestations are observed in almost 10% of patients, also in the early disease. Active RA with high disease activity has been associated with an increased risk of such features. Male gender, smoking habit, severe joint disease, worse function, high pro-inflammatory markers levels, high titer of rheumatoid factor, and HLA-related shared epitope have been reported as clinical predictors of occurrence of these rheumatoid complications. In addition, there is a little evidence deriving from randomized controlled trials in this field, thus the therapeutic strategy is mainly empiric and based on small case series and retrospective studies. However, considering that these extra-articular manifestations are usually related to the more active and severe RA, an aggressive therapeutic strategy is usually employed in view of the poor outcomes of these patients. The extra-articular features of RA remain, despite the improvement of joint damage, a major diagnostic and therapeutic challenge, since these are associated with a poor prognosis and need to be early recognized and promptly managed. © 2020 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220303177\\\" target=\\\"_blank\\\"&gt;B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Tamara Möckel, Fabio Basta, Julia Weinmann-Menke, Andrea Schwarting&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Volume 20, Issue 2, February 2021, 102736&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The B cell activating factor (BAFF), a cytokine of the tumor necrosis factor (TNF) family, mainly produced by hematopoietic cells, plays an essential role in activation, differentiation and survival of B cells. BAFF expression is a pivotal factor in autoimmunity, involved in the pathogenesis of Systemic Lupus Erythematosus (SLE) and seems to be associated with renal involvement as Lupus Nephritis (LN). Beyond its expression by myeloid cells and beside the involvement in inflammatory processes, BAFF is a very versatile cytokine, which exerts different regulatory functions in various pathways. The effectiveness of Belimumab, a biologic BAFF inhibitor and the first biologic agent licensed for SLE therapy so far, has been demonstrated in SLE patients by numerous controlled clinical and observational studies. Recently, a beneficial effect of Belimumab even in patients with active LN was reported. In addition, a combination with Rituximab (RTX) seems to be a very potent therapy option in refractory cases. Nevertheless, systemic function of BAFF in disease progression with regard to immune and non-immune related expression, which is highlighted in this review, needs to be further investigated.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the Authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;&lt;img style=\\\"margin-left: 12px; margin-right: 12px; float: left; width: 150px; height: 212px;\\\" src=\\\"https://api.journals.elsevier.com/media/j4sfbces/tamara-11065814.jpg\\\" alt=\\\"\\\"&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Tamara Möckel, M. Sc., is a biologist working in the research laboratory of Prof. Dr. Schwarting at the University Medical Center of the Johannes Gutenberg University Mainz, Germany. Special research focus of the Division of Rheumatology and Clinical Immunology lies on Systemic Lupus Erythematosus (SLE), especially renal involvement as Lupus Nephritis (LN) and neuropsychiatric lupus. Tamara Möckel’s main field of interest is the BAFF/BAFF-R system, which has bivalent effects on various autoimmune disorders. Objective of her doctoral thesis is the investigation of the BAFF system in the pathophysiology of renal injury by using different models of kidney damage (ischemic, obstructive and immunogenic) to evaluate BAFF as therapeutic approach and activity marker.&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"margin-left: 12px; margin-right: 12px; float: left; width: 200px; height: 199px;\\\" src=\\\"https://api.journals.elsevier.com/media/duwdi0qc/fabio-11065827.jpg\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Fabio Basta, MD, has interest in connective tissue diseases, particular Systemic Sclerosis and Systemic Lupus Erythematosus (SLE). He completed his residency in Allergology and Clinical Immunology at the University Campus Bio-medico of Rome in 2018 and worked as Pediatric Rheumatologist in Ospedale Pediatrico Bambino Gesù, Rome. Fabio Basta works as a Rheumatologist in Acura Rheumatology Center Rhineland Palatinate, Bad Kreuznach, Germany and is thereby involved in research in cooperation with the Johannes Gutenberg University Mainz. In the last year he conducted a cross-sectional study exploring the relationship between BAFF serum levels and fatigue in patients with SLE and Multiple Sclerosis.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - February 2021 - Autoimmunity Reviews\",\"displayDate\":\"11 February 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:08:27.954823723\",\"contentId\":181984,\"publishDate\":\"2021-01-06T00:00:00Z\",\"intro\":\"&lt;p&gt;Update in immunosuppressive therapy of myasthenia gravis&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"url\":\"highlighted-article-december-2020\",\"lastModifiedDate\":\"2024-02-19T16:50:11.523Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302664?pes=vor\\\"&gt;“Non-criteria” antiphospholipid syndrome: A nomenclature proposal&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Pires da Rosa, G.| Bettencourt, P.| Rodríguez-Pintó, I.| Cervera, R.| Espinosa, G.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a growing impression that certain patients not fulfilling these criteria might be inadequately excluded from the classification. Nonetheless, these “non-criteria” patients are heterogeneously defined across different publications. We reviewed the “non-criteria” APS subgroups depicted in the literature and attempted to organize these subsets in a nomenclature proposal that could be used for research purposes. We established four potential patient profiles, grouped under the broad term “non-criteria APS”: (A) “Seronegative APS”: patients fulfilling clinical criteria, plus “non-criteria” manifestations, with persistently negative antiphospholipid antibodies (aPL); (B) “Clinical non-criteria APS”: patients with “non-criteria” manifestations, plus aPL positivity fulfilling the classification criteria; (C) “Incomplete laboratory APS”: patients fulfilling clinical criteria, plus positive aPL, but not fulfilling the classification criteria (low titer aPL); and (D) “Laboratory non-criteria APS”: patients fulfilling clinical criteria, with negative or low titer criteria aPL, plus positive “non-criteria” aPL. This categorization could allow for a more homogeneous research approach to APS, enabling more sustained and universal conclusions. © 2020 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302913?via%3Dihub\\\"&gt;Update in immunosuppressive therapy of myasthenia gravis&lt;/a&gt;&lt;br&gt;&lt;br&gt;Agustina M.Lascano and Patrice H.Lalive&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Autoimmunity Reviews,&lt;/em&gt; Volume 20, Issue 1, January 2021, 102712&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Myasthenia gravis (MG) is a life-threatening autoimmune disease of the neuromuscular junction, which leads to weakness of the skeletal muscles. MG is generally caused by autoantibodies to the acetylcholine receptor or other antibodies targeting neuromuscular junction proteins.&lt;/p&gt;\\n&lt;p&gt;Immunosuppressive treatment in MG aims at controlling symptoms and preventing disease exacerbations. Therapeutic armamentarium has increased across time, ranging from “large spectrum” immunosuppressive treatments to drugs that target specific pathways of the autoimmune system (complement system, B cells, neonatal Fc receptor, etc.).&lt;/p&gt;\\n&lt;p&gt;In parallel, treatment goals were also redefined. Early clinical trials on immunosuppressive treatments were directed at their steroid-sparing capacity and their ability to decrease disease-related symptoms. Current treatment perspective aims at achieving minor MG clinical complaints and signs (i.e. so-called “minimal manifestation status”), while limiting the drug-related adverse events.&lt;/p&gt;\\n&lt;p&gt;Another challenge in MG is its heterogeneity in its antibody subtype, clinical presentation, management, and prognosis. This diversity could be a problem while performing clinical trials which includes all MG subgroups. Future research should include separate assessment of the different MG groups, and perform the analysis according to their antibody subtype, disease duration, generalized vs bulbar vs ocular presentation, refractory and history of thymectomy.&lt;/p&gt;\\n&lt;p&gt;In this review we will discuss the immunosuppressive therapies that are being administered in persons with MG, as well as the ongoing and completed clinical trials.&lt;/p&gt;\\n&lt;p&gt;&lt;br&gt;&lt;strong&gt;About the persons&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"data:image/png;base64,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\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;Dr Agustina M. Lascano, MD, PhD, is a neurologist at the University Hospitals of Geneva, Switzerland. Her main field of interest is clinical neurophysiology and neuroimmunology, with a particular focus on inflammatory disorders of the central and peripheral nervous system. During the past years, Dr Lascano has established several collaborations with different centres and experts on the field. She has recently begun a project on pain assessment in multiple sclerosis by means of laser evoked potentials.&lt;/p&gt;\\n&lt;p&gt;&lt;img src=\\\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAFoAAABwCAYAAACen2dSAAAgAElEQVR4AYy9dXiV17b/y733nO27Ql1ooQIFalC0hQLF3d1DggQIGiTubisrWUlW3N0FLS3Q0kKpAKW4S4grdO99zr2f+4z5rjdZpN3n/P6Yz1zrTQLP81nffMeYY445083VyRs3Zx88nH3xsMyeLn54uvji6erfMbzc/PFyD8DXMwhfjyB8PIPwk9dewfh5hxDgHUKQT5gagb7hBPmFE+xvINTfQFhAJGGBkUQER2EIicYQasIQGkNkWAyR4bHaiIjFGB5HVISZaBkGbZb3UZHxmIwJasREJSIjLioRc3QyZpOMFOJjUomPSSE+NoWEuGQS41JIMqeSZE4j2ZxBcnwGSeYMkuIzSE7IVCMlMQvrkZqUjT7kuf5an9OSc7Ae6Sm56CMjNY/fG/rXuwlodx2wsy+ezr54yXDxw8vVH2+3ADV83APw8QhUkAW0r2cw/jK8Q/DzEdChCnKwbzghfhGE+kVogAMiCQ80EhEkkE1EhpoU4KjwWGQIXGOEAI4jOjwOU4QZk0COjCfaEK/NFsix0UnoQyDHC2BTCokxMlJJiE0lIS6VRHMaieZ0BVWBjc8gNV6D+3uQu4KU99ZArb+ugxOo1q+7Qs5My0eG/rybqLljuPjiIYBd/PBw9cPTomJRsrd7IN4egQq2n0eQghzgFUKgdygBPmEE+oYRrFQcQbBfBCH+EYQGRBISGElokJHw4CgiFGhRsqZiBVhUbBm/AS2wu6jZGrSCHSMKTlEKVrO5E7TA1oH/HmBdzdYgu0K2Bi6vu8KV9zpM69kasrzuAO3u4os+BLK3qz9iF57uAcoyFGwBbWUX/j6hyFCW4RuuAAvkIP8IggMMHZAVaLGMEBPG0BiiwmI7RxfQMaJoHXDk43YhliGg40yamhMEckwqiXFpJColp5IYn0aSGhrkrqAFuA7Yev6fAHeFK0CtFau/7grX+rmyDlG0QBbA+vB09VOgvdwCkOFjUbR4tJ/Fl8WbBbSoWVN0hGYb/oYO0GFBRsKCogi3eLN4stiFqFeGUrNYh8U2Yg0JmHTLUGqOJyYqQfmyDrkDtFhFbCpJcekkCWyzQNZ8WIetvxfAuj9rgDXg1mq2Vq8O93HFino1BVtD/N9eZ+iKFo9W3qyC4O/ZhgZa1Cy+LIFPV3OAQBYFK7swECJKtlKzCoDB0R22YRQ1W4GWwKd8OcJMjCFeDVOkmWijBECBHE9sdAKx0YlKyeaYFGTEKz9OI0EB1i0ivSPQJSfI687Ap1uHDlabJeBlkpasebI1XP11p0o7LeLfgVXWkZaHgM1Ml1HQMbp5OGmQVaYhviywLd7sbfFmFQQ9g/Dx0oKfBD4BrSD7hSurCJEMIyCS0EDNl8WbRckRwZplSJZhDItRkMWblT8bzFqWYYhXdiGgYyMTiOnIMARwAnEmgZykAJtjUy2QxYt1wJ0qFsApiRmW0WkTOuCURD3QyawNHervzbpN6LMOOSu9gOyMQmTWnz02p+eTlVGghgBXoD0klfs3AdDXPRA/yTa6erPv46B1Tw4LNKrgJ5ZhCI4mPDSaCEnnwmIwqkwjTkvfdCULZMvQQccaE4lV6ZvATSI+LpkESdMSMkhLyiI5MZMkBVkAZ5ISr9uCNWQd9m/TtPQUCWra0AOcUqNVJiHQu8IVkAJWHwJah60/k7nr8w7QkjNLpiF5swQ9fUiWIamcvwWynjPrahZF64HPGrSkcyrLsKhZ8mWxDOXJkrpZcmQ9X1agIxMU3DjJh+M01QrwKEMcUQazSgnDfIMI8vDHEBxDkjmTjIwC0iQX7kjddLjWc+Zj+bAGthN0ekq2gp6RmvO/+m9WuqZgHWpXoPJcoGaJ0jMLtTmjUD3rpnuznmXokPUsw8+SL+uQJZXTLCOMQL9wNXTYyi4kZw6M6kjnJMtQQ9RsWYxIzhylAp4W+OKikog1JmEIjCLIKwjf3c5sWrQIu5nTWPjZp0wcPIhR773HjEHvMWVgP4a81ZMZIz9lwzIbIoKiyUjVVJaaLFYhqs4kVS04BLJ4sCw0cpVV6EoWxWq/6pJB6KNTsdZKzRaVpheSY7EKHXDX2VrN6uczixTwzEyxDskurNK5rqAlAGqrwGD0vFlfAQb5aqCt1SwLE/FlPct4LKWTzMIQR7QhDgl4Yg+yOAly8WLT4sUsGDWceZ8MYOGIgcwZ+h7zh/Vn9qC3mfpBL6YPeINln77HitEDmPJ+Tyb0fYVP33qZSUOHM/WzKay3dSDRnEFWRj4ZaXmkp+aQkqR5tG4PugdrltAJNzNNoOf9xhLkg9BhCmQZ+nvrOSezCBn6M/U+w/JMYGcV0k28WUDr6ZysBHU165BlVitBrxACJJ2zLFDUUlsyjkAtZw4XyBbQESGaN4s/R1pyZ5NkGxGxmIxmtYT23ePKxvmzWTJ6MJPf68mswe+wdNSHLB09kAWffIj9jM9YNmogy0Z/xNKRH7BweD8WDuvH/KHyAfRm6ruvM/6dHnz46tM8/Z//wYd93meXgyNhfmHERJqVCgW4BD3NIqx9V0ALYG1kSfCyWIMAUzZgBTo7s1DBzFGz5sM6YOtZfjYnq0gbAl9GVhHddG+WTEMg+8iS28OyCrSoWWzD3ytEDYGsrEPVMx5fmKhltqRywdFEhpiICItRQVALhKLkeFWXCPcLZ9WMaUwf0IfFIz9gztD+TPnwbaYN6I3thGFsnDoSmzEfseLTgYzv9zpj+7/BqHd6MuadHozo9TxDejzDoFefZfjrzzOhbw8WDOnLvCF9GfDqs/R65mk+eO1VRvbvj/3KtSpY5maXKB/OTLWoVi2PdcB5ZGeIcjvVq4NW0Cxq1WFaP8vNKkYfedkl6rWCnF1MTnYx8v/K++zsIrrpC5WOlM4CWS23rYKg1DTU4sRSOBLbkNxZ1CxpnWQbStEhGmSpaSjAerYhq7zIBPx2O7F41FAmf/gG0wa9w/SP+jFzcD8Wj/yI+cPeZdJ7rzOu/+tMH9ibuUP6M2VAb/o9/ySv/PWP9HzyL/R/oTsDejzPy3/5A68/8Wc+6vEMA196inF9XmXuwLcY1uMZhrz+HB/1eJYef/0T08ZMID4qkfTEbDJSckmISSIrTYpB2UrNWenWoDszBmugOmSZ5bkMHbCas0sQ0HlZJQpubk4J+hDgMroJYH3olqFDVpbhFYyvQPYOVXUNWQEKZL06J/4subMCrefMVsWj6DBZCcYSFWIkaK8zNpNGMHtwb2YM6sv0we/yWb+eTB/YhzmD+zFrUB9lH5Pff4sPX36Gd196mhG9X6Xnk3/m2T/+B8/84T947am/8M7zT/Hin/7AS3/9A/2e+zvvP/8E7z3/BB8+/3c+e+NFJr71EoN7Ps9rT/yFt57rzogPBjLqo+E42G0mKSaFZHM6kmWIbXSqWRTdCVqHqwPXwerP9ff6LJCVqkXZOSXk5ZaqoYBnl2jBUFezCoS/YxtqqS3FI4FtAR0s3uwfQYio2VI0khKoKLkz05AFipmYyESCXdyxmzaWie/3ZGSfHox+5zXmf/Iey0YNYN6Qfswe0pcZH73DtI/68WnvHrz/0lMK8Bvd/8brT/2F5//0//DCn/+DHn//A+888zd6d/8rvZ74EwNe6s7AF59k5OtPM+q1J/jklb8z7o1nGNHzOV77+x95s/vf6PnU33nhz39iwBtvsNfBEXNUAjkddiFwdeuQ1wUq6FmrV17nZulDswulYF3J2SXk55RqoEXNFsgCW1e2yjp00LISlFVgV0XrNQ1/WW5LStelaBQWbFRZhr4wUXmz1DQknYtMJMjVg1WTRvDJWy/S/8UnGfbmS0yU4PfR28wc+BZT3nuDGR/1Z+IHfXj7mSd5/o//Dy/85T955W9/oucTf2TAy0/y3vN/YVCPpxja4ymG93iaYT26M/ClJxj+6pOMfv0p1n7yDhs+eRO7ob1Y/P7LjOv1FG8+9Qfef/lp3nn27/T4+194t8erzBw9logAA0UFleRkiQ3kk5Mpo8AytGxBC3oCVwMrX9dga+8FbNch8PVneVb2IbB/B7SWzkkAlKFSOynsK8jaAkXyZr38KZW5sGBL0cgS/CJCo4kMM6l6c5CrN+tnjGXKB68z7I3nGfbm84x+51WG93qBAa88xYcvP8WIt15h1qD3mT/8Q4a/8TI9n/gTL/35P+j//N/4pOdTzP+oB+vHvsvqT95m1dC3WDG8N/MG9mLcG92Z0ec5bIe9ic/MYbiPfxe38e8QMW8QXlPeY0qfZ3nvub/S7/kneLv73+jzfHdee/opPhs6En+PQNKTsxCguRbgAl0D+7h65ZmAzssu1rzYCqgO9vdmXfXyNeXRHbmzXgb11CDrixQVBK0WJwJZvFkAyxAld6hZdkzCTMqXDYER7Fm9gEUj+jHkjRcY9uaLjOjzGu+98gw9n/yjAtrn2b8y8JUnGPnGc8z66B1mD+rLmLdf4uPXn2Ja/+dxGNefyNVjyduzhKDFo/CbP4LAxWPZPLov60f0xmFMfzynD8V1XH8i5g4gf+04SjdMoHLzJAV8Su/uDHz57/Tp/mcG9+jO293/ykt/+SMf9XqNHevsVXlVAmKu2IfMWV0CnUXR/w5yQW5Zh4ofg51bhvqa2EhX0N5WWYYOWW1T6ZYhhX2rypyuZB2yZBmqDBoRS5QxHv/du7CfOYppg3qr4DTindcY1PNF3nvpafo981fef+FJhr72LGPeeoE5g/qwcvRHrBkziE3jP8JxygBcprxH8rpxHPdbw8kge/IcZpK7bT6JayYQs/IzoleOJXjecMLnDCVv7USOOy/kq90LOOW0lJNOiziybQYJS0dgP7IPo3t1VzYzrs+LfPDSU/T42x8Z1udNDAHh5OcWk6c8WGyh6DHl6qq0tgUdrsy/eZ1bSr7Az9NBl5GXV0o3UbNsU+m+bA1Y9+aOmoZ/ZzFfhywrQB20Djk60kyYbwhbFkxm+WcDGdW3ByP6vE6/F59m4MtPM+zVJ/n41ScZ//ZzzB3wBiuG92Plx/3ZOvVjfJdOIHL1BPK2zqZ8xyy+dF3I+UgHfoncznf+GzjqZsNXXms45LyMql0LOLRnIV/uWcRJp2Wc9bLjvO86znnYctbDlu+dlvHl5ulk2Y7HZkgvpvXrwewPezF/8FsqBez59z8xcchgzIY48nMlayi2qFPmTr8VpRbkytDg/U+zQFbwrWaB3k0tUvRtKitFW0OWAKiUbNlo1fcAZWEikDtAS/nTEKeqdm4b17JuymBG9n6RYW+/Qs/uT9HjiT/zaa9nmPz2cyx47yXWftyLPZPfJ3jxp4QtHoVp1QQKd8xnv9NSvnFfyZkAO34J3sC9eBfuxjhzO9qZ+zEe3I5154bJhVtmd25G7eVK6DauBG7meuBWboVs46qvPZe913PF157TO5dwfMd8gucNYWrflxnf5xWWDu/Lyk/f59PerzDw1e7Yzp1PbkYRhXliA78HuJTCPGvQ8rrE8qzkNx9AYV45nUP7OaVoXc163iyQrUGr4CdqttScOxcnVpDFmyPiiIwwYwgIJWzLEmwnDOTDV56i1zNP8uyf/pOPX3uKVQNfw3F0P8LnDCfHdiL7HGZzbO8SvnVbzknX5ZySec8iTjsv5XLIJm4ZtlMX5Uy9yY0Gsw/1Zn8aEwJpSPCnPjGAxjg/6mN8qI/14n7EHu6G7OReyA5uBTpwzW8jl9zt+MlxKZ9vmcPKwa8z9KW/M+Xdniz55D3mDu3HoNeeZWCP59i7cSs5GZJZFCrYAlJTsQ5NlKrD1sALfPlw9O8TJeuAi/Ll5+R9KQViHQK5K2jdPvQgKKBVUV8K+0FSnevc1dbVbOhoGzCTHBGGaecypnz4Jn1feJJXnvgzA195kq1j3iN09giSl42l0GYyX26Zy0nHxfywdzlnXVdy0XM1V7xWc9F1Gb+4LONWyBYeGPdQG+lEg9GNRnMgTSnhNKWE0pQcQmOcP40COdqHepMPDwwuVEfs4X7ITu4Gb+d2gAPXfTZwwXkVvzitwDhvOFPeeZ6J/V5lfN8eTP3wTYb0eok+T/+FeWNGkp2aTV5OcYdaBZoGT4BZoCmYZRTl68/0Wf9AyinKr1BDg15GQV65BlpXsgC2htzhzXoAVLsmGuRwi23oAdAQHoMxIhbx5ygPJ9ZNGcoHrzzJh6+/wIBXu7PhswHE2swiZdVUsmymUrZmBsc2z+PUjiWc2bucX9xWc8V7Ldf91nE7aBP3QrdQY9xLY7wPjfF+1BvdaUmOoCkzioaUUBoSAmky+9EUF0CDyYf6KC/qotzUh1IdtpvqUEfu+jtw08eei642XPKw5QvnpSwe8Aoz3uvB2D6vMundXgx87Tk+6vkSY999C4NfUId9aGoVxWrK1MBqSpbX2vtOuLqSu84CuSC/nG6/B1lsQ8ubtW2qzkwjUqVzaufECrQGO0b5c3RwKC4rZzD+3dcY/taLjO7fixkD3iRphy25O+3I3rCIHNtZVK2fzfFN8/jBcRkXPWy47GnLrZDtSsW3g7dwN3wn9WYPmpL8lYJb0iNoSougNcdEc5qBxsRgGuICaY4Npjk2kAajF/WRbjwI30N1mCMPQnZwP2ALN702cNnFhgvua/gpcANbP+vLgkFvqOrf7CH9Gdn7VT56/UUmfdgXRxsbinJLKSwQgDpUUaeoVIOrz8UF5cjQLEKzkN9AFvvIr1Af1u+C1pUslqFD1hcoUv5UlTnrIKj8WQr78YQ7O7J93hgmv9+Lcf178lm/19g2fzyVoT7k7bYnf9tqCjbMZ9+GmXztMI+zTsu55GHDzcDN3I1w5E6QA9URjjTEe1OfGkRDWgjNmQI4hqa8WNpKUmnNiaMp3UhLuom2ZCNt8WG0RPtRF+FKTfge7gdt517gNu4FbFHjkpsN511WcSF4IxHLxjC9/4ssGt6XRR/LIul9VQmcNWwg3lu3kJGUQVFBGcUFFZZRqYAWq2edwHXQOmztw9Aso8M6LBZSJNahK/r3AqA16MdWgJbCvubPWjNMlCEWg6wQd9njvGwCs4f0VqXPqQPeIHLXeg5FhVLovJm8HbYUrp/PvnXT+c5xMef3ruSq5zruhGxXKr4d7EBttBPNyf40ZxtoyTHQnBlOU5aRlpI0WipzaC9Lo6U4hbaSDNrzkniUHEGLyYvmKA/qDc7UiG34bKY6UEA7cNnTjvOuqzjjbUvu1rksG/wGNqPex3bcEKZ92JuRb73EhP69cF6/lpy0bIrzSq1AC3BNvdZzSWEFjw/5QGToH1CFWuYrRRdUPA5agp91APw/Aa3lzrI1pVXojHs34LpsArMGv83Y/q8zc+CblMSG8UVsJAVOm8jZYUOu7WwO2c/mR6cVXHS15arHem4FblNZw/3IvdTGedCUFkxLbhTNuZE0ZYXRkmOktTSN5uJEmooSaanMpf1gCW1lOTzMjKM5USzEh4bwPdSF7+Se/2bu+W3mjt9GDbTLas562VK2cyHbJw1k/WcfsnXGKFWOnTrgLca98yoLRg0lLT6FksIqihTcTmgC2RpsaVEl+uh8XmWBrUOvVLClrtLNOvgJZGtvFrvQh65oZR2Wwr5qVFTFI613LiYihmjnjexd9BkzBr3NmL6vsuTjfpTEhvNFnJHcHevIdFhJts009m+Yyfd7l3PRbQ3XfTZyx7CHmmgXaqLdqI3zpCE9hOZ8E825RpoyQ2kW6KWpGuzyTNoOl9B6oIjWkixas820pEfSHO9PbcgOakO2K3++47eJW/6buOJuywVXG37xWce+XYvwmDuSrZOHs3veeFaPG6Y2HmYMeIvFo4dgDjdQWrzPyjY0lXbCrOgALKDleQfwgipKZBRWUVzYCblIFG0NWocsCxRRc1fI+mpQNStadrZVf4Zq4zITEx5DnOd2/O3nMenDnnzW9xXWjh1IRbyBLxKjydi0nNS1C8i1ncIB+xmc3LmQ866rue67iXuRTlTHeHAv1oOaOA8aBXReJC150TRnh9NaEENLeSqt5Wm0VmTQvi+LhxXpPCxKoSUzlrbUSJolxzY5UxPmSE3YTu4EbOZuoANXvdZy0cOOiz7r+MptFSabaawb9T4bJ33MuomfMntwP2Z+1Bv7OZNJjY2nuLAcgaNZRVeL0N7rcHXY2gehQe4AXVhBUWEFhf8baAmEomRdzWGy3NZ76Cz9c1pjYjwxkfHERJjICnXBbdV0Zg99R22obpn6MSWmEI7EG0iymUna2tnkrJ7IoXUzOLljERfc7bgTtot7RhfuRbtRbfamNsmP5qwIZRtK1TmRtBbG0rYvi5Z9mTSXp9FWmcHDijTa8uJpzTDRkhxKY7wvLWZPaqN288C4m3tBW7gXtFmBvuBpx89etpz0sCFz42w2jXmfhYN6s3L0EBZ/OpA5g95h48xxpMWYlRqtvdZazfrrfwe6uNAKdlHlb0HrbQS6qjv92UiIFPatuo5Uo2Ko1tql2m2lAcYYT6zBRGm0N5E7VrBi7EBWfTYQn9WzyQ/1Jt/XmaTVM0heNYW8VZP5fMNMvtk+n188bLkd4sidKDfuRrvxIMGfuuQgmnKiaCo0qdFSaKKtNFmpuLUqi1YJhoUJtOSZaMk10ZwRSXNqGM3yc/He1EXvpc7kxIPQndwL3Mhl77Vc9LTjrIcNx/YspWzXMpymf8ykt15gUt/XWfDJAFaMGcLGqaNIjoqmpEgPamINAk6zCH22hvy4onX1i3/vs1hIFUVFlXRTS21Lb7NADvDTivvWaV1IkJY/h4fo+4CxqiFGNY4bzJYmcek4iiE73INYJ1s2zxnDriVTMGxdRX6YNzlee0iymUXaqsnkrZ7EkU2z+G7XYs6723A7eDv3jM7UxPtQmxxIXWowTblRtJYkIJBbi6JpLU2gbV86LZVptJWn0laaQntJIq35cbRlG2nPi6Y1M4ymZG/qY52oj3PhgWEXN/3Wc8XHlqu+6/jJdQXfuK2geMs8XGeOYErfV5n67hvMGNiPpaMGs3HaaJIMkZSXCCQdmsydwIvleZEMLRiWFcsHofm0NsvrKgvoSvV9JcVVnaBVG4Gl5txRRFK9zRpkfWdbbVPpbbfSPG7VvxxriKE4JoAMv53sXTEL77WLMe22pyQ6mGyPnSSumEzKignkrJbl9xzOua/iopcdt0O28sC0l7okHxrSgmjKjqAp3wK62ExLUSxtZUm0lSbRLK+LE2gtilce3VqSyMMiE215Blqzw2jJ8KMu0Y36OGfqYnZzO9iey752XPFZxxnn5Zx0Xsq+XUtxnf4xCwa+zbyP+rL4k8HMGNAX2/EfEx9hpLz0QBfQOvRKSop1eJUIZOvRqXQNtAIuH0TJPrrJ7naQlaJl01W3DSkeRageuihVkZOFit51JEFQtXZZepmjpTnRYOJAWhT5Yc6YXB2IdFxHksdOsgI9yHbbTorNNDLWTCd37Qy+3D6PMx6ruRK4hbuRTtQl+tKQEU5TTiQtxfE0l8TRXGKmpSyJ5mIz7eXJNJckqYD48GA+bV+U0X58Hw+PFPPoYDZtpYm050k6aKApN4ymFB9qY524E+bAZe81XPGy5WeXFXyzewFVjovwXzAG25Efsnjoe8z6qB/TP+zDsk8HkxxlorzsEKVFFpV2pHGW7KK4klI1rCCX7OsAXl6yn7JiGQc6npWWVNFNlCydR6rHWcqh0kIQYCC4o1PfSESIdOtrZ0+kW1/abju6QTuaxqUjNJbPc5PJCNxNjJsDSd6OxLlsIyvEUyk6c8M88uznULZ1Pl86LeW0jx1XDLu5E+NBXWo4dZniyXG0VqargNdYnkrL/mxaqtJpLU2m9WAerUfLaT++n/YfvuLh6WO0nThE29Fy2o4U8fBgDs1FZs3bcyKojfdElvNXvO1UDeWCx2q+272QfVvnErJoHBtGD2TR4P5Me783E97pxapxI0mNMVNRqkHSFWqt2rKSKkpL9yl7KSvZh0CUWexGvk9mga0Ny/PSfRbQsrPtp509kVKoyjYsoLWNV227Si8gSTlUtRCozVftII+02kpPc2V2JpmhbirNi3HfRoKHI7nh/hQGeZK1bQUlO5Zx3N2W08EO/BC2ncsmV24m+lGTZaQuM5r6wjiayhJpkjRuXzZtB3Jp2ZdKc1kKbZ8XKqgtx/fT9t0R2k99QfNXB2g4UkLt/ixu5MRwO9vI3fQAqpN9aEj0UrZ0yWcdV/3WccF9Fedk98VlGYal47D5uB9Lhkj300CmfdCXNZM/Izs5Q8ESyDpgDZ4GTQEt3UdFiWWU7qfCMuRr+mttPkB56X7Ky/bTTQVAvYVAV7PsB1qaYrTc2aiK+7IK1IdStDSMK0VLR34Cpuh4clPSyIvyJ97bkRjXrcR77KYg3I9SQwDl/nsocrLjsJsd3wRu5puQbfwQvZcLyb5czwjlQZGZmuI46opMNBRG01aVQeu+TBrzIqkVhebHcCc3ihv5CVzIjuVyrpmfUiI4FR/EAd9tZGxZRrz9QpI3zuOk/2bqM/yojnHisr89l/3suOK7lvPOyznjvpLE1RPZNGYgy4bKJsBQprz7NktGf0xGfCoVZZqiuwK2fv840E7Y+nOBW1F60AJaFK0yjce7QkXR4QFyJKJzh1uvO3cuuXXIFkXL8YfoBFIT0kgMcNWsw9+JylQzRcYgSqNDKI/wIdxuPh5zP8W4ZgaZu1aRvG0ZmbtWU+C0llJ3e04b3biVHsz9dH+aiuNo/zyftooUqpO8uRnryoU4X8qd1xG8dDJe88eyefwQbEYPYtGQd3GYNIL1owewclg/HMcPpnj7Um7Fe3AtfDuX/ddxI2Qzlz3XctZlBcWbZ7N32gi2ThnJhokjmdC7BzMGvEuaOZnK8kNKsTrYDngWi7BWbmXZgcdULIA1yNagLYpWvRpWQVD5c6AOOpJw8Wi9xUu13JpVz7KmZg10bFQCZunMj0khzRhGktdWCmODOFFZREGID/kR/myfN5lFQ3qzYNBbLBvWhxLFyWEAACAASURBVLXjh6qaw+bxA9kwbhA7Jw0mdeMiTgQ48GPwJm7Fuqj8+dEXxbRXJXInZhc/+NuTt2E2YQvGsqD/q4x5tTujXnyCya93Z2HfV7Ef9g6BC8biN/tTAmcMpWjbQq7HuHA9xIFboZu5E7KV8+6rOe6yEv9F43Gc+Rkbxg5nYu8eLPrsU7WpWlZx+HdBdwC3sgt5psOWbEUf4vPlFkWXKY+27HDrmYaeP3esBoN10PoOd2cg7Ejt5IBldCLxMQI6mZzkFKJct1AYF8Kxwixy/FzICfdTLbdzPuiB3ej3WT7sHRZ88CaLP3qbyW+9zGc9nuHj5/7GrD4v4zRxIAkrx/KD9xpacsP59VAOvx7MoDkvgJ+8V5C1bBS7hvdmQa+nWdLzKWzfexWvmSMxLptM0OTBRM0dReXu1XzutZHirfM55WvP9cgd3Dbs4H60E1f87TnlaUuc/UJ2z57EjvGfYDOoL7mb13Ap3sTh3CLKyg50BDQdsJqtFFtZ+riay0oPUmaBrUCXHVTqlmCprEOvbSjI6hyKtuwOVY0xehdSJ2jpwO+AbNRPTCUqRcfHJJOelIE5wJ39WXHsT44jwWUr0XsdsBk9gF3TRuC5YDy7Jw5mxYA3GPrKcwzu/RbTB/ZjzeA+zHr7BYY991c2jujLSZcVWsk0O5r2nGiaMwI5b3SkarcdJZuXkD7vYwyLxzJ9yAeMHjwcm6njCV8ynvgFIwibNphj3ps4F+fOTxJ0I7Zzy7SL+3Gu3A7bwWnXlRS7byZk7QoqdtpRHekNWfGQEMil6DDKJHOQQNYlwOnBTVSsD/2DKC87SIUM+QAUZAF9AKXooMcUHaEaFtX+oPiz5dhaRGgUhjBTZ8+GFWj9yHCsso1kUuPT8LXfRJy7I58XpFASFULkFht87Rayd9YITLbTcZo8nJUDe2EzYTgf9H2X7s+9ztJFyzhakEbgzNGs6P8KKz58g8Pr53LfbwsNCSG0poRQHbGLi5FOXE8O4lq4C+c9NnOuIAGvPbt5o+c7TJ0whZQ9DsTO+5TIGUPJsJnMBdMebiR6cDvejbsJbjxI8uSOYZdaKH0ZtIdMj13cz46HA4XUmCP5auUKzjrt5HPJo0WdXUDrUDV1H6CiXKBq0PXXmpoPKeuQgCjQuwnojvpGgOTQkSrjkJYCvVqng9ZyZ+1MSefZbDmeJtaRQGxMEpU5eewYOZgAu0X8ePQg+SFeBK+ahffSKcTYTCJ9wyzsBvXEfkh/spy24O+4nZVzZpNvCONGUSZZa+ayd8IAto56j/3rZ1MdvI3aeF+aUoJ5YNjJ1fDt3E314LJxN9dCXbiTFslP2YkURIRwLD2FKxkJnHLdykn3tRzdu5pTkkMnuXA/05eadD9qk/2ojnLhktdavo/y5tuMBOpK0mksy+KGOZzj0+dzbtsWjlZUUdol0FlDrhS1i1dLdlGm+XR5uVUgVOoWazmAKL2bvlCxXnYryI+BjlaKls1X/fCOgO5Qc3QSZlMS8QkZJAUEsfWDPpi2r+WHo4fI8XTEsGIyYcvGkb5hKjl2kwiePhTj/ImUbV/L5647OOWzmwthHhzbvY7MNdPwnjsKp3EDqVw/Q+1kN8iqMT2EmshdXPNfx/XYPVxP8uOq0ZtLgU7civajIT+Je6nRXI4K4F58IHV5Ru7nGLmV5Mu9rCDqigzUZYfQkBpITbQzNwI38V2IEz8WZlFflkHbsSO0HztIa2I8NRkJHK6QX3nNg3WL6DpbgxdVd2YcovJDKnuptNhJt64Zh9Sg9b4NUbSebUSGmzBGxCjQuj+rWwaMiZijBLQcUUsn2RTPlrfeJHz1Ek4dLKPIewfZWxZS4bycQ05L+cJpJd/6b6PYYQlV25ZzSn79A7Zx1n8r33lvIXfDAnynDMFt3EBKbKdxw8ue2kg3GqI8qQ7cwQ2/9dwO3sSdyD1ci/HldqqB+5lGavJiqMkx0ZAfS0NJAo2V6TQdKaDpQCZNFUk0FkfRkBVMndmLe+GO3Arewle+W/gpK4HaknQeHdvPr6VZtMdFcTcvQ8skrHz4N5C7fE1UrSlcsxP5fmUlYi2l++km2YaecQhkvf4sZVF1hE3OoKhdFGkl0NoJtLROO3gZa0xATlXJeUA5m52enof3xHGY1iyjwmwg12UDFa52HPez57uAzZyPduV7gzPfBmzndPAOLpncuWJy53KsL6d8d1JgN4uwGZ/gNWkIhTbTuexiR22wC/Uh7tz3264V833tqYvYQVNqEDV5cdTuz6N2fwH1+zJpOlRA46FCGg8X03SkkKYDWbRWJtOUG05Dmj/VJhfuRThyPXATJ9ztOBviwU+O62kuyeTXoizaogO5lJdNWdnBjmBXVX4QGY/BKz9ApdXQ1axyaN2zLbDFUn4DWjWVB2ldoupklaVxUfYEoyOlWteZccQY9XszBHKyumVAji8Er17C9lFDCLZbTNKONRQ6reGwux0/hm7nstmTHyL2cipkF2ciXPgl2p2rZi/OhezhpJMdZetmEzLtY7ynDCVnxRR+3rWaukAXWiL8qQnYyU3/jap+UROyk9akANqyDLTmm2msyKRpfx7Nh0toPJBP44FcmvZl0F6VwcOyJFpyIqhP9ac6xoU74du55LueUx7ruJNs5Kb/XuoiQ2nNTKU1K4ZTudmUlh/qAC2AddBK2ZbcubLi4GPBUL4mebQeHNUHI8/KD/wWtJ4/i2V02oY0x8RYgY5TJ6u0c9ra8eH42GQSzamkJGSSGRDAmg/6sHXsMCI3LiNh01JKty3mJ397LoXu5OcwR7733cxP/tv4OXAr5/03c9HPgYveDuzfvJDgGSMJnPUJ+zfO46zjah4E7KEtIZxmkw/3/B20smroDloTfGnPiFSwWzIjaMqJpqXQTLNs3pYk0VqRSrtsf5Uk0JwTqYpMd427uRG6lXPe6/ghaButX5TTmp1Cgzma9uw0GkszOV5ablG0FuQUXN0qLCrWVV4hsPWviYLlN0HUX6FlIpLeacHQYh2P2YbV0TWDnEFR3iyB0KJqoxT7zaq+oW4csKg5Se7NSEinIDEd2/69mfHS84StW0TMllWU7lzFSdc1XArexsWQbZz33sjPHms567pK22UJc+RqwFYOOSzAc9JQouaP5qyrLZdc7Lnns5v2nCRaEw3UhzpzW/rrQh1pSvSnPT+BttwYBHRzhoG2LCMP82JpzzPRXhJPW2kCzQUm6jNDeRDryp1IRy76b+Ibp5WcCtxO+6FS2nOzaUuN458V+dzPSeVQUSXlFqvQgeqzQKyq0GAqlVdo76vKNHsR6BUVMnSrOaj+rW5Blvs1dNCdKZ2maM2ftXYvHXSMMV6dExTI8ZJtxCQjkJPkUpKEDLIS0rAf+C5D/6//G6eZY4jZbkv2Ths+d1zK9x62nHZZyRlprXVZzXk3G24EbeVepAs3w3ax32EezmMHkmM7k/POa7nj68iDIHdac9NoTYyiyeTPvVAnrvltpdbsSXt5Gu0VWTwsTlQ7LS1pobRnRNCea6RVdmcKo2nMiaAhI5B7pr1cD9nGOV97vtiznB/CnHhYnk9DTCRtGWb+qzSDGwlxSqFVZYeUXeiAf3cWmDpo3ccl+KlhAa2s4yDd5KYY62W3+LJ1z7OURnVFi0crJRvNmGXZbRJvTiIx1gp0fJo6Zua/cC4j/tCNRf16YXBYToz9Ioo3zeHL3cv4es8SvndfzS+etlwP3MyDaBcexHhzJ9KVgrUz8Jo6nKKN8zizaw0PAl1pyTTTtr+MlgQjTSHu1EZ4cidgD/cjnWgvT+HRoVIeVmXRXiTF/xhaZfNAdmnyjDRIEMwMpi7Ji9uRu7gSvIUfvddzxGkVV2L9aC/OoCUvkfbidB5lJvBNZi7lFZ//W8jKFixQqyoPIUNgK+DyW6CDfiwgHqSbXujXvVmHrPuzrAiNEaYO2xDQsVECWkvpBLIGOpVky+0vaal5mJ1dWNWnBzN6PEvA6tlEbVxM2trpVGxfxGHHJXzjsoJLgRu5LQ0zZi9q43w5H7ADw6wRBM4dT6rNDH5ytaMu2o+WrETaDlbQnBpLe0w4bUkR1BsDeBDuRmNqAK1FSbRV5fFrVS4Pi5JpLoylITeKJgmAkjtnBFKb5MVN4y5+9l3P957rOLJrBbX5cfzzy1IayrJ5lJfCpaxMymTxUf64mvdVdL7XUzbNh60AWzIMeS7fo/u6ll8LaKuDP11tQ4fdmd6JouO1Kx7kdi7x5lgZct2OBjolIZ3U5GxSwqPxnz0Nx4mfsnfWGEyblmFeO4uCbYs4uHsJ37it4nzARu4YnahPCuRBnA/7Ny7C/oPXCJg9AZ/pn3Jw5wpqYn2pjg+nLiuJu+mJfO/nyT4HG66Ge1Nt8qcp2Y+WtDDayjN5uD+P9rJUmgvNNBZE0ZQXTn1WoFoR1iV7c924i3P+m/jOfS0nPO1pKs/kUWUurTmJ1KQlclC8uUIWGprf/p5d6F/T4XcAtwqSCrYCL9Cl3iGg9ZZcS+3ZGrbYhmYdsuzWUjvJNKTIL8tudZdGrHYFmmQcouiUeLlXI5201BzMjrsIXjGfPdNHYbRfTOyGeaRvnk/ljgVqN/rngA3cMTlTHePJ3WgXquxnsfb9Hizp14tRL3Zn/ScfUbjVli/cdvKV514OOzqwz34l0WOHkL94Kg+SQnlYaqY1I5R22Q2vSqetIpnW4liaCyKozw2mJsOf++m+3Ev25FLods74buS0hy0/BTvy65EyHpXl8ig+mtOZuUh5dF8XNf8ebIEsQ7cM3Tasv1cpWalbU/1joLvah751JdU6vWKnXyCl329klvs1xKMFtNwzJ7DlFpiUbDKizCRud2DrZ8MJs5tPuM1sTKunkWM/g8+dlnA+bIuqOd8O28mNAAe+3buM+AWfsX5Qbyb3eoGRr3RnXv9e7B43lPil0zjhvIlzQW5cCPPkepQP9dlG2koSeVQSR0teOO2l8bSWxqsOp6acIOoz/ahJ9+V+uh93Ety5ECLp5EZOe9rxne9WHlbm8jAvk5/TMlS9okq3CH3uoux95QcVYAW6UoOtlG35ft0u9FnUXCGbCOWHNI+WbSt9RdhV0WIbGmhd0ZYL/tT1O2If2nVoAloNAZ2YQXJiBpnpuSTt3cumwe8TYbeA4JUzCVo8juhV46ncOZ/vfNZw2bCVqyGbuOC/idOeGyjfuIjY5dPxmjUar9mjSbSbQ56jDaU7bfglxptzJj+uZRipzo3jQU4cdTmxNBYl0FwUQ0u+tCkYaJQAmOVPXaqn2s66n+rDzRgnLoZu5ULgRn50t+FghC9flVRwrKhM/XoLZAEpqtQVqitWfc2iYl3NMu+vPNwBXv2cVT7dAdvi3d1kM/Z/Ai2FJK2YJCtCLXdWNQ4r0PFxKco29GCoXRwl9pFLssGE95yZGNctJmT1TPwWjCZkyWcUbJnFF86LOeW9ih99N/C9/06OuthzaJcthZuXUuK4mv1uGzgT4cr1zGh+inDjYqwPV9MiuJEdzW3ZiE03cVOgZ5moyY1VRaNG6evI9KcuO1BBrpV9wzQfrkft4kr4dq6FbeNHtzUcSE6kfN9RymQF+G8UrFuBNdx/91r/XuXZ1h+WqLpC0jvZiNXvQbKcgLVeFeqlUa2QpN/aJffPSXqnK7oz49Ahi6rTkjLVLS9ZydnEu+0hbOV0QhZ/RtCiMaSunUrRlhkc3ruYU16bOOq+meLtKynYvJhSh0V85b6Os3IWJTmUhrJM7mdEcTfdwN28GO5mR3EzLYKb5iAux/lz2RTInbRoqnNM1GaHUJPsTV1WMAL5QbI31cme3Ihy5Gb0Lm5FOXLSawPl6ZlUVUka15lR6LCUOq1s49/B7fpc/zn1m6D/dliyEOXRoR37g9pRYz3F6/RobfmtXY+m39wlhaRkdReo3DdnrWb9lq60ZO2qs8zMYhKDAglZOZ3QxWMIWDhGHXVLXz+ZfbuXckrU7LMF4+qpxNvOpsR+Pp9vWcapXeu56LeXmowYahIjuRXhzy2TP3fjArib4M/tpAAux3pw0mcz502+3MyM5m6uger0AGoEdHYQ1Sk+3DW7cjPKUcG+GurANz6bqcovpqpSy5f1X3PJgQWWNcCu762/pr/eL0FUfissebWarX5LpFRqAd15DcTjCxbryp11fSP+MTXLfaBdQWt3GWVpN7+k55EWE0f42nlEr5yI/8KxGFdNJmPjdKr2LOV0+G7Kdq9gzcA3sRv4LjuGD8Jv7GgSZ00jd+5sqlau4Mj6tZzYtJ4TDus5tmUdX2625XMHGw7stCVm/hhKtszhQnIgN/KN3MsJpyYziLrMQKqTvbkT58rN6D1cM+7gQsAGvvLeRlVhmapLCEjrocP732bdn2XWx+OgLf+uxbcfyzr0QKgUrfqfTUSpOodW29DqG9qOiq5mgSwjKV670E9dHKUujLJAllu41A1c2URuXUPUign4zR+FYeVUypyW83WAPT9G7OD7cAdyN80mcNLHmOdMI3vhAkpXrODwjh184eTEl3t38VNAANdizVwMDeWiuxtnd2/naoQHV+I82Ld7Ht9F7uRadjj38yOpzQunRnLoVD/uJ3pyS7a0jI5877OOb0Nc+O74d3z++deqVlxVdkBTpEXNOriuszV8+Zr1ex2yHkA75q6gVcHf4tG6dch1EALaFKFdNmUNWvNnsQ6p2qWotE7upftd0CnZZGeXEO/tRuTycQQuGIn/onGUO6/kh+hdfB+9lR8NmzjhZ0fxpllUblzIN1ttubh3N/VxZmrSUqlJT6OpoIja/AIeJJmpTTHRmGWgTbX0xlJTEMbPMbu5mOTNvSITDwqjqM4M5H6KL3fi3bhh2sNF4y5OeG/gbJQ3F89c5MK5a5z58aJaNleVa7AFXlfAXaHq3/MY6C55tW5DavGil0ll0WKdQ3eClj67WKItVTttsaJdYakvVvQbbkXR+t2fYhsy5Dod7T65HO1Ww8RUwmzn4L9gJG5zR5Mn/hy1k28MG/nSZyUnvFdzaO8Sihzmk79+Loe3LOf4TjuO79rI17s3cmy7HRfCXLmXGsr9rBBqC8JpKDDQkG+gOieYq0lunE9w5Wa+gdsFkVxP9+dWkjc3zG5cjnHhZOgezgRs42K8Pz+eOE2OIZarl25y5sxFtQm7/3dSuP/No3Xb6VCwpe6hluGWpbi87qbuera0GKhdb6vMQ7sUMIZoi6K1+rMWDDXQWrH/cdjabYq/AZ2WS05OCQleLvguGMXOmSOI2TiHo6EbORqwlsq9CznkvJSvfGw46LSIqt2LOLBnCYf2rmTf1iUc2baSz7ct5oTLaq7EuXEvL5y6fLGHAO5nBnAzzYdrSa5cTPHgfEYAv2SG8EuyD1eSvLiU4MF3ke58F+7BzbAdXE6N4Ptjpwi0XcvJI8dobHrEl4e/RjZcrVX6v73WIYv1qPKoXlCyzB1BtkxAyxlvy4JFPFr3aUnxtM7RTtCmKHPHXaEC2hq2LMFlVajfDdoVtLq/SG7cSs0haO0idkz/GNfFEyh0XsZBbxtydswja+tsDrgt4WSgLReid3Atxpmr0c5cCt/FNYMT9+O8uS8Nkdmh1ORF8EBUnR3M7axArmX6cyPNh8up3pxPD+BMUgDfx7pzIcWX0+ZAjod6cc3ozIOI7VzJiuVY+WH8lq/k8rmLtLb/F5d+uaFU3VXBXd9bw+8AbaldC1hRrxo6fLXrsl8DLdfDywVUskdoDVqrc+gbslpA1G6+TVCQrUFbQ5b0TkCnJXcGRO2yqBxys8tIiojEZcEktkwfiWnDbEpcl2Gyn06s/VSqXJdxKsyBn8N3cCl0F7fMPtxLCaQuK5ym3FgaC5OpL4qnvthMXZGZe1mR3MoK5Uq6H7ezgrieFcwvGcH8lOzPjwnenE4M4YsQD34O2UV9sic1pr1cSI2iMNqMeY8zdfUtNLc+oqHxESe+/l7BFpjWEK3hdn2tvk/soiNv1kFrbQh6/56W3lluLu+4hEpu+7L02ulL8M4cWhYrAlovKmn2oYpK6irh9N+FrLw6Tbw6X92JYfJ0Y+eccfgsm0rS5tkY104ics1EinYv4XNvO075rONi8HZumn24n2WkOieaunwzTZV51BQkUVsUT3VRHNfSQ7mRFcLVTH+uZwdwOc2Pn1MCOJscwA8pIRw1+HPKdzs1Kd40ZQdTn+jBmfgworY6cjAjm0f//P+ob2ihpe0f3L5dz6EDX1JRuu//GLT1h2JtFfpr2QGX3fHHQEtA1K6I/3egtcqdds1woso4JOsQj7ZW9O+rOZeOO+YyiyjMLsHouAWPJTPxXzmN4FUTCLOZTPrWuZTvWcrnrqu4GLGLW7He3MmM5G5OJDVymPNgAY0VGdzNNHAjNYgbqQHczAjkelYQF1O8OZPgw/dJwZxODOOYwZdv/XdwO9mHluIY6rPDqE0P4KTBl4hNO7h+4RItD/9FY1M7be3/pKnpVy5cuMW+ys9V2tdVvf/Te+vfAOvXOnC1lRUSIGcKIwgNknuStF47dYxC2gy6tH9pS29ZfmugrQOhdq27lnH8rkdbrj3LyyqkNL+c2N3bCbRZRNC6FXitmI3XssmErZpI7vZ57N+7lJ8CN3I93oM7WeHczQjhfpaBmoI47ucauZropwBfTvTiWoY/v6T5831iIN/Eh3DE4MXBgF2cCNjBrUQfmgoMNJfGUVtgpCEnnAPODsR7+fHo1/+ioamd5pZHtLQ+UvP9+02cO3eNA5VHLLAfz5f/HWxruNavO0BL1qHfYK5DlvSuc/lt1V6g6tDaxdmiZC2H/m0QtFa0fpGfdplfAVlpeRysOkiUbwgB621wnDYKr2WzMW5ZT6i9Df4rZxBjO4PMjfM54rGGM5E7uJ7gwdU4dwVNeqevpARxKVVsIpDzyX6cSw7mW3MwB4JcKHHbTJX7BtXkfinWleqMYFpKYmgojKFOzrjkRFKxcyVfV+3nH/8NDY1tNDS20tz6kLb2f1Df0M7t241cvHiHw4eOKdi/l0d3BS5w9WfyWgcss2qgEdB68b9rINT9ubMzSVI7WX4/7s9dbaMraB22zGVy0CavBDd7BwLWLsdt3kS2Tv4Ev9VziHRYQ/S2DURvXoN500oKnOz4PGALJ4J3ctbowqV4Ly4m+nEhJZQzKaEqmzgR40uFryO5jjbkbFtElZsNP0Tu4pLZhbtZgTQUGmkqjqEuP4qabAM1KX58G+ZMQ30TLW2/qmAoAbH94b9of/hPBbu2ro1795u5fv0Bx4+eUqAElg6y66x2xa02aa0hW4EO77jCRz+0qVXvtDZdbedbazbX+u00RVtnHNpfhpAleGcOrWccKgharqcUVR8/+hXx4bG42tqxa9Y4fJfOwGHiMHbNGY3bkin4r5lP9BY7khw3kblnMwVu2yj22M4Bv90cCtjD4YDdHAzYTZnnNgr22pG7YzmFO5ew3301J8K38HO8K9fTpTQaSF1OGA1FJuqKYqgtiKY+38itqD3cOLKf9n9Ac8tDamtbaGp+SHv7PxRkUXVb+680NT2ivv4hNTUtXLx4k6NfnqCseJ8KbFIksoYtoHXYqnvJui6tB0N1SMhyV5LWBma9C673dEjRX2Br9eg4k57eSSDU7trXah2/Ba1dJ5xNVnouleX7OVB+iEjfcFzX2LBk8LuqV3rbxCFsnTQM5/ljcVsyGa+l0/FZNoNw2/lEr19M3IYlxKxbROy6BZjXzSdx3VwyN8+nZM8yvpQdkyhHzie4cVkWLWm+3M8NobEwmoaiWOoLTTQUaIquS/PnfJwfjUrN/1CeLNYhcEXNuqJb2/5BS8s/VHCUANnY/Cv1jW2cP3+Fo0dPqCqdOoklG7mVAllLB2V1qIBbge7MOuQ0luXOJHWuUL9k27JfGBlunUfr+4WdoOWvR1gvVsQ2OsukWepKyrxsuYYyn88PfUluahHJRjNe6+0Z8+brOE4ahuuMT9k+fjB7Z32K15JJeC+fhvviyXgtnkzQ8mkYVs/EtHYuKQ6LydqyiNI9y/nCbz0/xTpxOd2Pqxl+3MwJ5m5+GA8KIqjJDaWhOJrGsgR1yqu+KE6Bv2Zy4cbJE/z6L1HzIxqb25VH64A7Yf+TlpZfaWh4SGPjI5qbH/Hw0b94+Oi/qKtv5dbtB5w9c4EvjnyldZCW7qdKgEsurbeJlXd2l2qN6Ja/BiSZh75oiQiRU1idzeeyBJc/dKBqHR1/RUJP7zpBa8C1m2zl0LocbCzKqyQlPpvU+Aw+P3iM7NRiynOL8dvqyDvdu7N6cB+85ozGefrHOM0YgdeiiQSunE7AyhmEr5lDnP180rYtpHDvKg742HM8eCs/RjtxMdWHq9nBXMsJ426hgerSKKrzBHIYdQURNJbG0ViaoBY3TWVJ1GSFcqkgmYe//kulcpJlNDW309jU1qFkzTb+gSi6qVmzDpnb2/+pMpSWlkdUVzdTX9+mPoCammYuXbzJsaPfakcoSvd19nWo3W+tX1qB7jxWYUnvJJe2Ai2XUumgO6t3nT4tXi0LGIEsV5kdOvAFx778lqNfnGR/5VHys6tIMWdRXlTFl0dOkZ1ewrFDRwl19uT5//wzU998STvYM380nrNG4rt4AgHLpxJqMwvThvmkbV9Ghec6vgrbwQ9xsqT243p2GLfzI7ieF8qNggjuFBq5X2SkOjuc+rxIGkpiaCyLp7E8iQY5hVsQx2W5XaymlvZ//rcKggJV8mfxaU2tncGwpfVXGhrbaWzUMhFJA0XtrSp4ttLY2E5dXRsPHjQrD39Q3cyVy7f5+uvvFPDSksqOXmnpLi3Vz7BobbsaaL2KJ2e/ZXUo1tEVtChb71qSP14gQeKbr09z5qeLnD17jdPfXeDr42c4uP8EBXn7SU3K4fiXJ9WzirIjnPn+HAmBUbz19EuMe/15wuaPwbR8CpFLJhK6ZJLa8jLYzSZu00Iydq7kkO8mfoh25VJqENdzgMlLFgAAGLtJREFUDdwoiOR2oZE7JVHcKTVxTyAXGqkviKRBupNK4mmsTKWlQu73SOFaQhA1ly7w6L+hte0RLW2PaHsoqpWFiubPupplluAo3i3A5UN49KvYhvZByG+C/BbU1rYq0AJcRm1ts3p/6ZIEzm8oL9tHsRzOL66itEQdf5Oz33JTY+cNutZpntY8I8FQG9KQLndz5GYW8MWRE5w9c4lLF69z6dINrly5y5Ur9zlz5hrffvMzhw+dpDD/ALlZJZz58RJffX2Owwe/5ub1u1RkFTP2/eGMff0FTEvHk7JuLtn2C0ndMJ9om5nErJtLypbF5DquYJ/Her4zOnE5JZAb2aFczw7ldkEE94oiuVto5EFhJDV5kdTlGlSW0VSZRrOArkrnepw/148f5leB/PBXpUodrh4IRakydNVKxqGpWbMMXfEyC/z6hlY1tIXOr8rv5dmDmibq5AOobuLKlTt8c+J7qioPq0tWLKey5Lri8MeuKrZetEgVLzzYqLKO4sIyvjv5E5cF6rVqLl66zYUL17lx4z737jWo3PPsueucPn2Rr46fIS+nioP7vuDatWq++uosXx37jnv3ajn7zRkWTZjF2FefJXnlZHI2zKPccSVlzrZkOCzBvG6uglyydxVlLrYcC9rGz2ZvrmUEcyMrjNvZ4dzLjlC7KffzInmQa6AmXwuAzQcyaT2YTXVmONcPFPPwX/8v7b/+k9Z2DagA05Ur4HTwGmiLpVgC4K//0NTcqehf1W+CKFv/gOTfkCG/CQJc8nJJCx88aOHWrVpOnz5PN385cO+nnQXXNwBUzUM1O0YRGhhBtNGsDpb/9NMv3Lz1gJs3H3D9ejVXr1Vz+fJd9bq6ulH96kiSf+7cDc6du8mJr38mM72UUyfPcO9eC0cOf8eZHy5SU9PE1fPXmTp8JAvefpEc2+mUbl3MwT2rOeK1QcHO3rGCoj027PPYwGF/B74K3MYPUU5cSfHnekYIdwVuUQz3ZTelJJYHBVHUlcbTUJVGy5FcHmSGcSUvkdbWR7T/81+0PfxV8+Y2zQ60YKh5sNQ5dNgCTLxbZrEMa9Aa7M58uyto+RmVzTS1UV/fSk1ti8rT6+patXOGHX8YQW8PC4xE/vSHMTyG8tJ9nD13kTt3arl7t54bN6q5evWumm/dquHatfvcv9+I/GPiW1ev3ufixbtcuHCHo1/+SEZaMed/vsq9+y2Ul37JL+ev0NDQypULN5jx4fvsHtmXkk1z2bdzGUfd13Hc255Dnuspdbaj0n0zR/x38I3BmdNRbpyJ8+JyWjC3C03cLYmjuiyB++WJVBfHUVuWROPBbFo+z6c218j5uEBq7z3g0b/+m4ePtEWIgNBTOAEi2YUAFt+W5wJcnosy5Wu//uO/VbYhwVCGgNaVLZDlZ2XIv2s99H9D/h350MSiuqk/+qgfT/Y3qL+xEuQXpm4AP3vmooJ7+24dt+/UqdcC9/r1+x2w79ypU8FAonS18qZ7XLtWo0Af2H+C4qJ93Lx5n5s366mqPMbNm/dUbeHG1TvsnTUFw+xP2LdjMV+62vGV10a+9t/Ccd9NHPz/O7uSJjeO9Nq/yWeffXL45KPDp/FysCNGMTO2RpZmNDOiFoqUuImkuIiLKHEV963Z7H1vNhqNfUehqgAUCoVCFYBGr9S8ifclshtDcTwOHyoKS1VW5vtevm/JRPdv/w1jh97B7BfvYvXMHxC7+ClSlw+jcP0EjNunYd4/j9qjy6g//Abe0ysIX3yPYPQGGjdPInfpKDzTwubej+hv7qD/hjaTzQSGYDHqIFgEkOASJB4EnUC/DWyt5cpIqh3VpmpXt0GgNdgj8kdR+B+CPjkm/6fw1PEzmJtdgm27CmSLAHsCIjW4VmvBslzk8zbyeQtOPRhYbQO25cEwXBQLDtJpG8+ezmJ+flWkJp+vY2x0Dl4rhO93YFsuLv/qP3HjZ/+AqQ9+hqVPfo6lw7/Awme/wOKnP8f07/8dkx/9BxaPvov4+UPIXzuG4q1TMO6chXX3a1QfX0Zj9AZaYzfRenFdgG7e/Rq5S4dRjMVRc30BuL+1jV6P7FWsJaAERYGhQCZw6nM19TXz3wa0DvU0m7V88HzQrm5fnQn2CP834WeHjso/H7t4/goymSLqjg/LaoJspVyQqYwZKRGNRiDfFwo1pFJl0SB2msG7aXool10Uiw4ScQOTk6+QTpdhVJqIrZewMB+FaTloemyvjYXzJzH6y3/CyuF3kPjqN4ge/x8sH/1vLJPFx9/D4pH/kveUjPTlz1G4cQKVW1+hevsMqvfOw3l8Bc3R7+E9/x7u3XOyr6OWTKDmhliapz9IoNPZEOYSBGruRl8lJJrRms0sKvEzjoXM5vu3Aa2lQwOtzprV6n7NaH3eB5p/Ef2rE2eQzZZQFcYqPSaDCbKOGeU1tdjrIJerIpksSUzJcIggk82VigvDaOLVqwxWlhOoVJowq21MTUYQW89jdXUdy4sraLa6yD5/iOXP3kHi9AfIX/kcqbO/R+TYe1j58tdIXfgY8fMfIXrqAyTOfYTMpcPIXDmM0vVjMG6egnnnDKr3z6P+6BIa984jdfZDWNElbOwBnW4fxYKJ6fE5xKLJfS0lSASGoGt9HgZaSwfPvFZr8zDg/FyDrXSdhns70DTcvnTwX+gdPnQEKyurqNV91Kq+MJkgk8FNL5T8ntkPQxYVQ7LAYiCbMxGGW6jVA5SMpiwF2VUfhVIDc7NRqXo13A6qtQBPHy9g4uU86k4L0y+n4HoBjNVlZL75DOUrR1C5eRKla8eQOP07rH7xa2QvfIzC9WPIXPoE+e++RPHGSeSvHkHhuy9QunUS5VsnYVKr755F+uyHiFw4grBDB6V0t9XuYn0thbnZZalpKHAUKBw82UagtGyQwd2ecoYETgM9DPKwQ9QSokGmcXjotmV2hExuVPY5wv+a/OL5GCy7AYLkSuxHffZFJrieRgYzCPc8lhQ3BOy1aFacIgvlpuWhYrUE0Go9wHqshPm5ddhVTwrpjttBPlfH/R8mUCzamJ+eQ6VkomlWUbzzNWp3zqH+8DLsBxeFuZHj7yN78RNYd85IhGHdPw/r8SWYDy4IsJXbp2Hd+QqV68dkzXDi3X9G4tkDKeTn03lU7Ro2t/dQKlmYm12R/hI4gkIgdKKi2ayM8HagNauHQdZGoJGGgdYM1pJBkHX2OfL9tZsoly3ki1U4DYZpHQndqM0M2dgpCcCbobyml+Z1K69S4iRrjQBmlU4yQNUJYdo+5maiIhP1RgCvtQFeQy9eLDexMJ/A/OwCivmCZF/1hUk07pxD88FVOE+uonTjFKIn3keGq98PLsB5elWOxvOrcJ59C5tg3zgF8+YpFK5+hsjxX+HWv/490rNT2NyDONrNrR3QCXp+B9OTCzDNujCUjOd4CASBI9Ca0b3+DjpdFXVoA2iQyWr9WgPO818CWstFO2CYqELKkUw6h2LJlkyPgDLQZmzMSIMyQavI5353MC36qJgulpcTcg0NQnloNLqoOSESqQqmJl7BqDTQavfhMiV1O/JAdrhYbEgR3TYraPk9+G4LfnwVzbH7aDy4IiAmT32I7IVDaD67Cn/6Hloz9+GN34A7+h1qjy6icv048pc+QeLMbzH+m3/B6X/8W0SeP8HOjwABIwCUgqrl4uKJc4hFU+ht7EqhiGPiFGdf1HVMs3UdQzkzDTSZ+ybIfxnog+xQx846dORzRjKZAool1iiqAipLgHzNiIPW500acKU/fUm76eio49Rt7Syr1TZmZ9Yl5fSl8EIDhAMvrgBoNnuYmlhGIZsV9rEz3c09hO0O/EoF9ZlnSJ79Awr805fPriBYeoru2iSClTF4M/fReH5NgKbzixz9pfzK69O/+xs8PH0C2wR6kESwz9HlOB58d09CVfadqyn8nMzVgBEEDTTZx+UtfkaQtUTw2rcdvE5ps47JlSYTNx4qpFSzZoTFoFzOQqFoSYG71dpALmcL0ARZHxpkJiZrkRxisfygatVVeT1rs7kqxkYXYJkuuO7GtFxPT3ZKhVY7WFlM4vaVm2g2WpIaBx0W2Hvw6Ty4vFQqojb9DM2xG+gsPcVGagm9xDLC5TF4E7dRvX8B6XO/w8qJDzB9+nM8PPklxm/eUiBJ+ZMlTB9WxUEuzZnDsib7GUqJk1HHm2w9AO1ATjS4b2M1vzu4RwFNjAgwjcnXB2PfxQj1ixFEqWTLjh1O50zOFlkgyLxBHSo1rTsBIpEcarU2aBQyVsfYi4tJLM7HhDmMxWltDojTWIHM+sFrcbRH3z+CYq6Ere09BAEL6T05hyzybO2hu7WHsOkiLCbRTa2gl15BGJ1BMHUX9g9nkH90HY1yReQpFU9j7PZtuE5TxsA43XXbyOcqamb6/UE/A/j+BrqDQtIwgOwjmd7rkc2K0RroN8+a6QpolYpzNlCTvZYCmsY8AHoHI/W6L/sYLNtVnWx1kM6YqNVbArCEKYP8n2wma4vF2j7IDAHJlJLhYuzFkizTM9oQxuy8FidIwPlQDkSA33yNx7efY20pit3Xf5Q0eFjPdAd723sCeq9uo5dcRLD8As2Xd+HEIghZa9h6LX2s11wsT06hUjSFTaylWGZDpE3XiymFTLbogywzkFCOAB6ANgB64/8GtIxjsGquxsZtZX2ZOaxXE3h+zuv4eoSOaj2ah+MoYPk+la5I5kbvrIEmuxnyJZPGIEMM95MZavRatIDZ2Sisagvzc2l8c/oRSsW6aBvb4EP1sb0HJNfyeHDtAdp+CG/AwKbbRsCoIOjBc3006SiDjmxyaaXX4Mw8gWeaCPt74LISZwKPVitEpWyh3QrR39iWohXjdG7zUrMtkNIB+0lGx6JVFAtNmU2cUVtbdIwKEPaRTNUGeJPN2jj8fhhsYkU1YCg8TJp9oJ1GiOXlpNQgKBH1WoB02pBEhQDx4OfUuGzWkpIoO38Q+vVgmi1MTa4iHi8gm3Nx9thjHP7gCiyzuQ80Wc0ByCC29oRZ44/nsDgVQXw1g3Qsj2yqBKNkw6k1UTWqMHIGTMMWGbBLFbg1F2FvBy0vAI3iOi3U7AZq1Sa8Zqhi/FYo71l7Zt+5xsdstWq3JZx0mwEy6QYmXmSRWK+KvO1I8YlAKzL8NaCHwea1NI5g1OpIhEbQtcH09yN2rY3FpZjSyLAvhWrWMJTXVOEOIwjDaCCTsYTFvs9lnk1ZgrfrAWIJA3Pz64iulzAxlsD3lydQLjbE4prF+swHU695MD0vFWqwrSacOpMlamsAgqE9d8Nrw3EcOA0HVtWBbTsol2wUsoYc3Ehes120WiqZYjGMy0pkEgfPsoEC2wMrj8x0q7UQK0sVvHicwtJcSWrliqGKCJzqfP82Ng+DzGs4HhqIM55t0xFq2VBjVYYY4WAjkQxC1k7DPgrFOjKZigT11FTV2bZIhm1TXlSRpun3UHdCGBUP6/EyXkXyiKyZiKwYSMRNtDtbMr2VIzworGsLE3iCSSbqo+mSqQHcRhv1WgtO3UO3x0VSH82mC78dyM5Pzwvh1Fuo1Tw0m4Fyop0+Go6PSrkmMkCHRjK4bheetyEzMZUyEQR9dLo7MMotRJYNzLzMYWY8j2y6IT6EUsK+8f5hZ6kBHj7z9T7Q7b7IBkmpgdaGYHsjuXxVpjynmR/2kUhz7c+WaSes9Xv7DpCZFa3ncCHS7aDutJHL15BKV7G+biKXaSCVtOC2VKjGNvkQNSUPwOZnPGhEOie/1UXL6wyOUMDLpIqo15rY2d1FGAZy9PssO27I954boN3uIuioWoIsJuQr+2xWkcMOml5X5JCFrkrFE5b2+7uyOaZaDZDNuIiu2VheNBBbs+F5g1XxvmL0MLP5evg4AFqtmjOx45j0+PS1fD+STFUQj+cEDI8xciwH03TkPa1Pb03JIGjbO6/h+5uose7h96WQlExXkU7VUMg3kEnXMfr0FVaXs3K96oiaXnyYnkra4jSkgMXEyFeAs1btOj7i0YwkNFu7e9jcZLWthzBUGxJ5DZ1mwDifQIcbMI06jHINvYEvUMtQexKGsmzLZIraScbq8I1FpJbfh1ULUTEDFAseMikHZqUl49/h6szWTyVEA8izYrQG+iB+5nj1dQL0+noJyWRBGnYYPaxn4TR8mXb00vFYCWuRjOxbyGYqEkNn0iYKxQbMShu2Hco0LBseIqslXLs0ho/fO4e710el5Lq9+8fBVFYdZs1DMV0VZLhbSABjui9gd1C1XWRShf01O9YuuD2AhqF0MXziPZQ7eniJmdOGzA49QBp5e2dPHGG57MmuIw6cn/OgLHDnEfvD3f4sF/S39kRmIqsGYuuWyM6GpOGMTHgP71fgEmANtKiBJCqqjsI+6H7oa0YikQLy+Yra8V71EY1mBpnNBmyGavNx3L7xDNevPcblC/dw8thVJOJF0Tnu4mk0O1K5My0f8biJR/cW8eWhazj28be4cOo+4utF7Oz+uD9lKSNaUtgZAkVGkqGUEOp1Rdhpg4za2tYZpVrB0EDzPg18qWBJ3KxnygGgu+IMXZe7kQ7W/Qiy1l8FNDPT/j4h6vUQsaiNlcUSEnEb3DNNf8UZrTScksh+KdA10PQ5w2OjQfeBfrWShWHUJAEoFGtIxAtgSswBVettpDMWotEiomtFTE+u49bNUZhmQ6YoPS0TFnp2Jgam3cLamoFvLz3D7evjuH7lJc4euwej3MDuj2S28tDsjN69qYEmm8lMOjezwqnuYnewsLrRV1qvgSWj5b5OX0K5Yt4UlrNOoZhER6ZA4C+uCIpm8oERFAg0vNpjp3aUaqkgsNy6m8u6SMZrSMYtFAoNkSDOdB3CsW2+JhbMDHkf+zDMeL4eYdmSIVHQ2UIiWZK0lT+e4UAYxtFrN1xVmYsnKnjyaFqkhY3TkRFk6pyUIH2CHeDZk0WsrGSxtlbBtYsv8d3F5zLNOZWZ/nalMyqUUs/pqrjYbQtglunI+60dgsWOK0f6Z0DTkXKlJ8sEyldRkoRlvJY/k1Alg86GKiBpdg0Drg3PcSpGqwKTZrywcWMXYYeJTxeG4YkfMoyWLHjo+zXQdITK8Sug+SxeI0DPTEcllPLafUTWMrJKzRt58EZOB1b0GGWsRvJ48mhKwhiynnGjyoTU0hCZ2vQ2MD+XlI00dbeLhfk8znz5Ax4/mJViPB/KegLB4ED4DLJYRRE92XnPGRa0u9jcUvH2T4Cm1IR9iaeLBRvB4KcRNARBIzHorLtdNb2HwR1+rYDirlH6CbXiwu+1rAhIUvc4mBHsy7A88LXGimfNZt6rZYOvR6YmInAcH/VGB69WkqjXPRkEb+JUUEBvwGkEstNocnxJpgnrHq4sBugAXVmu2ephaTEjLAu6W6hYbbx4voaLXz/E/EwCyrEphiqgVaAvzm0wkwrZsug2dxexkxpoarCSGhaJfKRTRekDZyAjpJbHgg7j/B3QifE+6iifo483gSZQAjR3jUrJ9A2gdTYrbVDn2ZbqP/vzU6BVn38C9OT4qkhBueLi1UpisFyl1tSoOwSUVTpW6yYnVrG4EBMNZwZErSKztBX7/R04bhfLyxmJX9kRP+gjk3Mw8XIdP9yYQTRSFL2kJHDwvIb+gGzk70iov7l0UaSmL6GY0lo+o8vCFAnADTh5U1aCSAhhFLW4p+vMBwbSA+az3gSZbRIoGke25/5VoJXBlPFVfqCBZh/4mm3y0EbT144QPDIznbWxupoQYAkeDxH4AdAV08PLsSVEVtPCKrUac+Bl9YDoQCNreSmwUK/ItqrTQTJpIpOu4uVoHLlsXby3sHuwKi1Ai1/ooFyy0NtgzVhlaGybhzZK1XKQTZeFiRwgmctQjWzT4ZeaBeq+t7FZA8KyLIlEH8NnaOngPfq5POs2eOa9ms3/G9C6DV4/wmUnFumj0TwS8ZyKad8o+LMjDPrHx5ZlnwZZR6BpCG093Sku1MZiRfmOU5hgOw21PYHVrbLRwuR4Uoo8DN8ICEHWQDO9tq3G/hTVA2T7HBxrzdm0gXr1oN6tNfXgWl0gOgBIs5lntqWAVhEDd/Hz+fz8TaD1+HTbPPMzOnWCrA8anP3Tbevr9fuRyYklWddbWIghmzP2f25AEMlqWlr9YMbG6LM5lEpVpds+Q5wD2ZAGe9viBJPJskxnTmUCzRCQdWyRmd4O0uk6JscS4rgYl2qQ2R4LSrblDIBWjGan2T7T7VLRRqlYFQMpUFR8zNfqOqXNyvv/FGgNlAJaLcb+f4BmGKdB1mdtFJ410GIU1qPHxxZFf2dmVmFU6mBRhPpLoNkALcU0nPE0l6kYQ/N7OklaUDdOIHgtFwV0yk62csDct8d90/q3IO1wG/MzecxPpwRQtiFObpDlsexJlurOsm2WPVkzT8bz0jcdgqmUelg71TP5XN6n26AhtDG490MZgj8IYglYjYXXD1/H9+ybHiPbkr7QCXYU0GznTaCJi36uvv5PXOVDaPwvqlUAAAAASUVORK5CYII=\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;Dr Patrice Lalive graduated at the University of Geneva, and obtained his board of Neurology in 2003. In 2002 he accomplished a research fellowship in Immunology, University Hospital Zurich, with a project on remyelinating factors in the animal model of multiple sclerosis (MS). From 2003 to 2005, he conducted a second fellowship in the MS research center at the University of California, San Francisco (UCSF), working on biomarkers in MS.&lt;/p&gt;\\n&lt;p&gt;Back in the division of Neurology in Geneva in 2006, he obtained in 2007 his Privat-Docent (PD) and in 2009 his habilitation as “Chargé de cours (CC)”. He was nominated Assistant Professor in 2014 and is Associate Professor since 2017.&lt;/p&gt;\\n&lt;p&gt;He is heading the Unit of Neuroimmunology and Neuromuscular diseases at the Geneva University Hospital and is leading a research group (basic and clinical research) focusing on neuroimmunology.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - December 2020 - Autoimmunity Reviews\",\"displayDate\":\"6 January 2021\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:08:01.243550646\",\"contentId\":181062,\"publishDate\":\"2020-10-20T00:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tHaematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives&lt;/p&gt;\",\"url\":\"highlighted-article-november-2020\",\"lastModifiedDate\":\"2021-03-21T02:51:41.367Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302378?via%3Dihub\\\"&gt;Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives&lt;/a&gt;&lt;br&gt;\\r\\n\\tPaola Di Benedetto, Piero Ruscitti, Paola Cipriani, Roberto Giacomelli&lt;br&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 19, Issue 11, November 2020, 102662&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tSystemic sclerosis is an autoimmune disease, in which an effective therapy is still lacking. At present, we can manage and treat the different visceral complications, and a disease modifying drug is a strongly unmet need. Many different immunosuppressive treatments have been proposed in the last 30 years but the results were generally inconclusive. Due to the improvement of the hematopoietic stem cells transplantation and the significant reduction of the mortality related to the procedure many well designed studies have been published, concerning the possibility to transplant stem cells in those patients with a rapidly progressive form. The main goal should be the possibility to remove autoreactive cells and resetting the immune system, thus re-establishing the self-tolerance. At present, although the results seem promising some critical issues may be considered such as the selection of patients, the conditioning regimen and the outcomes. This review highlights the state of art and focuses the possible future challenges in this field.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img src=\\\"https://api.journals.elsevier.com/media/qn3hxh2w/portrait-20211859.jpg\\\" style=\\\"height: 251px; width: 245px;\\\"&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tRoberto Giacomelli MD, PhD, is professor of Rheumatology at the University of Rome, Campus Biomedico,&nbsp; and head of the clinical department of Rheumatology and Clinical Immunology (italy). Before moving to this university, he was Professor of Rheumatology and Head of the department of Biotechnology and Applied Clinical Science at the University of L&rsquo;Aquila, Italy. He is Author of more than 400 papers, chapters in books and scientific communications in national and international congresses. His main fields of interestes are the pathogenesis of systemic sclerosis, the possibility of regenerative medicine to overcome the limits of the standard therapies and the role of immune system in different autoimmune and autoinflammatory diseases.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - November 2020\",\"displayDate\":\"20 October 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.950479497\",\"contentId\":296241,\"publishDate\":\"2020-10-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302202?pes=vor\\\"&gt;Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Ralli, M.| Angeletti, D.| Fiore, M.| D'Aguanno, V.| Lambiase, A.| Artico, M.| de Vincentiis, M.| Greco, A.&lt;/p&gt;\",\"url\":\"highlighted-article-october-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:42:36.987Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302184?pes=vor\\\"&gt;The role of TH17 cells in multiple sclerosis: Therapeutic implications&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Moser, T.| Akgün, K.| Proschmann, U.| Sellner, J.| Ziemssen, T.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) where immunopathology is thought to be mediated by myelin-reactive CD4&lt;sup&gt;+&lt;/sup&gt; T helper (TH) cells. The TH cells most commonly implicated in the pathogenesis of the disease are of TH1 and TH17 lineage, which are defined by the production of interferon-γ and interleukin-17, respectively. Moreover, there is emerging evidence for the involvement of TH17.1 cells, which share the hallmarks of TH1 and TH17 subsets. In this review, we summarise current knowledge about the potential role of TH17 subsets in the initiation and progression of the disease and put a focus on their response to approved immunomodulatory MS drugs. In this regard, TH17 cells are abundant in peripheral blood, cerebrospinal fluid and brain lesions of MS patients, and their counts and inflammatory mediators are further increased during relapses. Fingolimod and alemtuzumab induce a paramount decrease in central memory T cells, which harbour the majority of peripheral TH17 cells, while the efficacy of natalizumab, dimethyl fumarate and importantly hematopoietic stem cell therapy correlates with TH17.1 cell inhibition. Interestingly, also CD20 antibodies target highly inflammatory TH cells and hamper TH17 differentiation by IL-6 reductions. Moreover, recovery rates of TH cells best correlate with long-term efficacy after therapeutical immunodepletion. We conclude that central memory TH17.1 cells play a pivotal role in MS pathogenesis and they represent a major target of MS therapeutics. © 2020 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302202?pes=vor\\\"&gt;Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Ralli, M.| Angeletti, D.| Fiore, M.| D'Aguanno, V.| Lambiase, A.| Artico, M.| de Vincentiis, M.| Greco, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;Hashimoto's thyroiditis, characterized by thyroid-specific autoantibodies, is one of the commonest autoimmune disorders. Although the exact etiology has not been fully elucidated, Hashimoto's thyroiditis is related to an interaction among genetic elements, environmental factors and epigenetic influences. Cellular and humoral immunity play a key role in the development of the disease; thus, a T and B cells inflammatory infiltration is frequently found. Histopathologic features of the disease include lymphoplasmacytic infiltration, lymphoid follicle formation with germinal centers, and parenchymal atrophy. Moreover, the occurrence of large follicular cells and oxyphilic or Askanazy cells is frequently associated to Hashimoto's thyroiditis. Clinically, Hashimoto's thyroiditis is characterized mainly by systemic manifestations due to the damage of the thyroid gland, developing a primary hypothyroidism. Diagnosis of Hashimoto's thyroiditis is clinical and based on clinical characteristics, positivity to serum antibodies against thyroid antigens (thyroid peroxidase and thyroglobulin), and lymphocytic infiltration on cytological examination. The mainstream of treatment is based on the management of the hypothyroidism with a substitution therapy. A relationship between Hashimoto's thyroiditis and a possible malignant transformation has been proposed in several studies and involves immunological/hormonal pathogenic links although specific correlation is still debated and needs to be further investigated with prospective studies. © 2020 Elsevier B.V.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 October 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:07:48.533102876\",\"contentId\":180637,\"publishDate\":\"2020-09-20T00:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tLow-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis&lt;/p&gt;\",\"url\":\"highlighted-article-october-2020\",\"lastModifiedDate\":\"2021-03-21T01:46:40.267Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220302160?via%3Dihub\\\"&gt;Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis&lt;/a&gt;&lt;br&gt;\\r\\n\\tRuihe Wu, Na Li, Xiangcong Zhao, Tingting Ding, Hongwei Xue, Chong Gao, Xiaofeng Li, Caihong Wang&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews,&nbsp;&lt;/em&gt;Available online 13 August 2020, 102645&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Research&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tRheumatoid arthritis (RA) is a chronic aggressive arthritis and it is necessary to find effective treatment strategies from the pathogenesis of it. Some studies revealed the pleiotropic functions of interleukin-2 (IL-2) and the dose of it is a driver of the imbalance between autoimmunity and immune tolerance. Low-dose IL-2 plays the crucial function of controlling immune response and maintaining self-tolerance, therefore, it may be a potential treatment for RA. We summarize the biology characteristics of IL-2, IL-2R and the interaction between them and introduce the effects and mechanisms of IL-2 on Th17/Treg and Tfh/Tfr, which are the key factors to the pathogenesis of RA. Considering that it is difficult to achieve and maintain the balance between the pleiotropic functions of IL-2, thus, trying to achieve the function of IL-2 in order to maintain autoimmunity and avoid activating the effector arms of the immune system is the main problem that needs to be solved currently. But it needs further exploration to turn challenges into opportunities.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the Author&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img src=\\\"https://api.journals.elsevier.com/media/50rhnsxw/caihong-21082322.jpg\\\"&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tProfessor Caihong Wang (correspondence author) ，is chief physician, doctoral supervisor and the associate director of the department of rheumatology of the Second Hospital of Shanxi Medicine University. She is the communication review expert about projects of the Natural Science Foundation of China, the member of Chinese Medical Association Committee Rheumatology Branch, and chairman-designate of Shanxi Rheumatology Branch of Chinese Medical Association. Her main field of interest is the early diagnosis and immunoregulatory treatment of rheumatoid arthritis, and mechanism of drug resistant and therapy of overcoming drug resistant of rheumatic diseases.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2020\",\"displayDate\":\"20 September 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.96019817\",\"contentId\":296243,\"publishDate\":\"2020-09-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301853?pes=vor\\\"&gt;2020 international consensus on ANCA testing beyond systemic vasculitis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Moiseev, S.| Cohen Tervaert, J.W.| Arimura, Y.| Bogdanos, D.P.| Csernok, E.| Damoiseaux, J.| Ferrante, M.| Flores-Suárez, L.F.| Fritzler, M.J.| Invernizzi, P.| Jayne, D.| Jennette, J.C.| Little, M.A.| McAdoo, S.P.| Novikov, P.| Pusey, C.D.| Radice, A.| Salama, A.D.| Savige, J.A.| Segelmark, M.| Shoenfeld, Y.| Sinico, R.A.| Sousa, M.-J.| Specks, U.| Terrier, B.| Tzioufas, A.G.| Vermeire, S.| Zhao, M.-H.| Bossuyt, X.&lt;/p&gt;\",\"url\":\"highlighted-article-september-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:47:08.023Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301853?pes=vor\\\"&gt;2020 international consensus on ANCA testing beyond systemic vasculitis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Moiseev, S.| Cohen Tervaert, J.W.| Arimura, Y.| Bogdanos, D.P.| Csernok, E.| Damoiseaux, J.| Ferrante, M.| Flores-Suárez, L.F.| Fritzler, M.J.| Invernizzi, P.| Jayne, D.| Jennette, J.C.| Little, M.A.| McAdoo, S.P.| Novikov, P.| Pusey, C.D.| Radice, A.| Salama, A.D.| Savige, J.A.| Segelmark, M.| Shoenfeld, Y.| Sinico, R.A.| Sousa, M.-J.| Specks, U.| Terrier, B.| Tzioufas, A.G.| Vermeire, S.| Zhao, M.-H.| Bossuyt, X.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;This document follows up on a 2017 revised international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic polyangiitis and focuses on the clinical and diagnostic value of ANCA detection in patients with connective tissue diseases, idiopathic interstitial pneumonia, autoimmune liver diseases, inflammatory bowel diseases, anti-glomerular basement membrane (GBM) disease, infections, malignancy, and during drug treatment. Current evidence suggests that in certain settings beyond systemic vasculitis, ANCA may have clinical, pathogenic and/or diagnostic relevance. Antigen-specific ANCA targeting proteinase-3 and myeloperoxidase should be tested by solid phase immunoassays in any patient with clinical features suggesting ANCA-associated vasculitis and in all patients with anti-GBM disease, idiopathic interstitial pneumonia, and infective endocarditis associated with nephritis, whereas in patients with other aforementioned disorders routine ANCA testing is not recommended. Among patients with autoimmune liver diseases or inflammatory bowel diseases, ANCA testing may be justified in patients with suspected autoimmune hepatitis type 1 who do not have conventional autoantibodies or in case of diagnostic uncertainty to discriminate ulcerative colitis from Crohn's disease. In these cases, ANCA should be tested by indirect immunofluorescence as the target antigens are not yet well characterized. Many questions concerning the optimal use of ANCA testing in patients without ANCA-associated vasculitis remain to be answered. © 2020 Elsevier B.V.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - September 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 September 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.955336541\",\"contentId\":296242,\"publishDate\":\"2020-08-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?pes=vor\\\"&gt;Molecular mimicry may explain multi-organ damage in COVID-19&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Angileri, F.| Legare, S.| Marino Gammazza, A.| Conway de Macario, E.| JL Macario, A.| Cappello, F.&lt;/p&gt;\",\"url\":\"highlighted-article-august-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:45:51.193Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?pes=vor\\\"&gt;Molecular mimicry may explain multi-organ damage in COVID-19&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Angileri, F.| Legare, S.| Marino Gammazza, A.| Conway de Macario, E.| JL Macario, A.| Cappello, F.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/molecular-mimicry\\\"&gt;Molecular mimicry&lt;/a&gt; has been proposed as a cause of the autoimmune phenomena observed in COVID-19 [&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?via%3Dihub#bb0005\\\"&gt;[1]&lt;/a&gt;, &lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?via%3Dihub#bb0010\\\"&gt;[2]&lt;/a&gt;, &lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?via%3Dihub#bb0015\\\"&gt;[3]&lt;/a&gt;, &lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?via%3Dihub#bb0020\\\"&gt;[4]&lt;/a&gt;], the syndrome associated with the infection by &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/severe-acute-respiratory-syndrome-coronavirus-2\\\"&gt;severe acute respiratory syndrome coronavirus 2&lt;/a&gt; (SARS-CoV-2). Lucchese and Flöel [&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220301555?via%3Dihub#bb0020\\\"&gt;4&lt;/a&gt;] have recently reported three human proteins (namely DAB1, AIFM, and SURF1, as catalogued at &lt;a href=\\\"http://www.uniprot.org/\\\"&gt;www.uniprot.org&lt;/a&gt;) – that are present in neurons of the respiratory pacemaker in the &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/brainstem\\\"&gt;brainstem&lt;/a&gt; – that share potentially antigenic epitopes with SARS-CoV-2, as shown by &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/in-silico\\\"&gt;in silico&lt;/a&gt; analysis.&lt;/p&gt;\\n&lt;p&gt;Particularly, they postulated that damage to the &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/brainstem\\\"&gt;brainstem&lt;/a&gt; pacemaker may contribute to respiratory failure in COVID-19 as a consequence of molecular mimicry between neuronal and &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/viral-protein\\\"&gt;viral proteins&lt;/a&gt;, in turn causing the clinical dissociation between well-preserved &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/lung-mechanics\\\"&gt;lung mechanics&lt;/a&gt; and severity of &lt;a href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/hypoxemia\\\"&gt;hypoxemia&lt;/a&gt;.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - August 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 August 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.936441169\",\"contentId\":296239,\"publishDate\":\"2020-06-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220300926\\\"&gt;The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;McGonagle, D.| Sharif, K.| O'Regan, A.| Bridgewood, C.&lt;/p&gt;\",\"url\":\"highlighted-article-june-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:47:49.737Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220300860?pes=vor\\\"&gt;Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Scherlinger, M.| Mertz, P.| Sagez, F.| Meyer, A.| Felten, R.| Chatelus, E.| Javier, R.-M.| Sordet, C.| Martin, T.| Korganow, A.-S.| Guffroy, A.| Poindron, V.| Richez, C.| Truchetet, M.-E.| Blanco, P.| Schaeverbeke, T.| Sibilia, J.| Devillers, H.| Arnaud, L.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Aim: To describe changes in the 2001–2014 mortality of 6 autoimmune systemic diseases (AISDs), namely Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathies (IIM), Sjögren's Syndrome (SS), Mixed Connective Tissue Disease (MCTD) and ANCA-associated vasculitis (AAV) at the country-, continent-, and world-levels. Methods: Mortality data were retrieved from the World Health Organization (WHO) mortality database for each disease, based on ICD-10 codes. We computed age-standardized mortality rate (ASMR) as the estimated number of deaths per million inhabitants and its 95% confidence interval (95%CI). The association between gender, geographical areas and disease-specific mortality was analyzed using multivariate Poisson regression. The 2001–2014 temporal trends were analyzed using Jointpoint software. Results: In 2014, the worldwide ASMR for SLE was 2.68 (95%CI: 2.62–2.75) deaths/millions inhabitants, 1.46 (1.42–1.51) for SSc, 0.47 (0.44–0.49) for IIM, 0.17 (0.15–0.18) for SS, 0.11 (0.10–0.13) for MCTD and 0.53 (0.50–0.56) for AAV, with ASMRs generally lower in Europe than in North America, Latin America and Asia. Between 2001 and 2014, the worldwide ASMR decreased significantly for SSc (−0.71%/year), IIM (−1.65%/year) and AAV (−1.01%/year; p &lt; .001 for all) and increased for SS (+1.53%/year, p = .01). The worldwide ASMR of SLE decreased significantly between 2001 and 2003 (−6.37%, p &lt; .05) before increasing slightly between 2004 and 2014 (+0.58%, p &lt; .01). Conclusions: We observed a strong heterogeneity of standardized mortality rates across all countries analyzed for 6 autoimmune diseases. Those results further highlight the impact of world-wide inequities and major gaps in access to care and strategies for diagnosis and management of rare diseases, a crucial finding for world-wide physicians, patient associations and policy makers. © 2020&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S156899722030063X?pes=vor\\\"&gt;Exosomes: Effectual players in rheumatoid arthritis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Tavasolian, F.| Moghaddam, A.S.| Rohani, F.| Abdollahi, E.| Janzamin, E.| Momtazi-Borojeni, A.A.| Moallem, S.A.| Jamialahmadi, T.| Sahebkar, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Rheumatoid arthritis is a well-known chronic inflammatory joint disorder. It encompasses systemic inflammation, autoimmunity and development of several joint abnormalities leading to the lifelong disability and increased mortality. Exosomes are nano-sized (30–100 nm) mammalian extracellular particles with essential properties to regulate biological processes and cellular signaling by transferring protein and genetic materials. Understanding the diversity in the exosomal contents and their corresponding targets may contribute to better recognition of the processes that are implicated in the development and progression of diseases such as autoimmune disorders. Exosomes may act as a potential biomarker for the diagnosis of autoimmune disorders. In the present review, we aimed to bring together the relevant evidence on the biology of exosomes in rheumatoid arthritis, and also discuss the recent findings regarding the diagnostic, prognostic and therapeutic promise of these nanoparticles. © 2020 Elsevier B.V.&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220300926\\\"&gt;The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;McGonagle, D.| Sharif, K.| O'Regan, A.| Bridgewood, C.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Severe COVID-19 associated pneumonia patients may exhibit features of systemic hyper-inflammation designated under the umbrella term of macrophage activation syndrome (MAS) or cytokine storm, also known as secondary haemophagocytic lymphohistocytosis (sHLH). This is distinct from HLH associated with immunodeficiency states termed primary HLH -with radically different therapy strategies in both situations. COVID-19 infection with MAS typically occurs in subjects with adult respiratory distress syndrome (ARDS) and historically, non-survival in ARDS was linked to sustained IL-6 and IL-1 elevation. We provide a model for the classification of MAS to stratify the MAS-like presentation in COVID-19 pneumonia and explore the complexities of discerning ARDS from MAS. We discuss the potential impact of timing of anti-cytokine therapy on viral clearance and the impact of such therapy on intra-pulmonary macrophage activation and emergent pulmonary vascular disease. © 2020&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - June 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 June 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.969118128\",\"contentId\":296244,\"publishDate\":\"2020-03-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220300124?pes=vor\\\"&gt;Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Lee, K.H.| Ahn, B.S.| Cha, D.| Jang, W.W.| Choi, E.| Park, S.| Park, J.H.| Oh, J.| Jung, D.E.| Park, H.| Park, J.H.| Suh, Y.| Jin, D.| Lee, S.| Jang, Y.-H.| Yoon, T.| Park, M.-K.| Seong, Y.| Pyo, J.| Yang, S.| Kwon, Y.| Jung, H.| Lim, C.K.| Hong, J.B.| Park, Y.| Choi, E.| Shin, J.I.| Kronbichler, A.&lt;/p&gt;\",\"url\":\"highlighted-article-march-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:48:33.86Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997220300124?pes=vor\\\"&gt;Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Lee, K.H.| Ahn, B.S.| Cha, D.| Jang, W.W.| Choi, E.| Park, S.| Park, J.H.| Oh, J.| Jung, D.E.| Park, H.| Park, J.H.| Suh, Y.| Jin, D.| Lee, S.| Jang, Y.-H.| Yoon, T.| Park, M.-K.| Seong, Y.| Pyo, J.| Yang, S.| Kwon, Y.| Jung, H.| Lim, C.K.| Hong, J.B.| Park, Y.| Choi, E.| Shin, J.I.| Kronbichler, A.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Autoimmune diseases are clinical syndromes that result from pathogenic inflammatory responses driven by inadequate immune activation by T- and B-cells. Although the exact mechanisms of autoimmune diseases are still elusive, genetic factors also play an important role in the pathogenesis. Recently, with the advancement of understanding of the immunological and molecular basis of autoimmune diseases, gene modulation has become a potential approach for the tailored treatment of autoimmune disorders. Gene modulation can be applied to regulate the levels of interleukins (IL), tumor necrosis factor (TNF), cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4), interferon-γ and other inflammatory cytokines by inhibiting these cytokine expressions using short interfering ribonucleic acid (siRNA) or by inhibiting cytokine signaling using small molecules. In addition, gene modulation delivering anti-inflammatory cytokines or cytokine antagonists showed effectiveness in regulating autoimmunity. In this review, we summarize the potential target genes for gene or immunomodulation in autoimmune diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel diseases (IBD) and multiple sclerosis (MS). This article will give a new perspective on understanding immunopathogenesis of autoimmune diseases not only in animals but also in human. Emerging approaches to investigate cytokine regulation through gene modulation may be a potential approach for the tailored immunomodulation of some autoimmune diseases near in the future. © 2020 Elsevier B.V.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - March 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 March 2020\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:26:12.945017687\",\"contentId\":296240,\"publishDate\":\"2020-01-01T12:00:00Z\",\"intro\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997219302393?pes=vor\\\"&gt;Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Ruiz de Morales, J.M.G.| Puig, L.| Daudén, E.| Cañete, J.D.| Pablos, J.L.| Martín, A.O.| Juanatey, C.G.| Adán, A.| Montalbán, X.| Borruel, N.| Ortí, G.| Holgado-Martín, E.| García-Vidal, C.| Vizcaya-Morales, C.| Martín-Vázquez, V.| González-Gay, M.Á.&lt;/p&gt;\",\"url\":\"highlighted-article-january-2020-autoimmunity-reviews\",\"lastModifiedDate\":\"2024-02-19T16:40:43.693Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997219302393?pes=vor\\\"&gt;Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Ruiz de Morales, J.M.G.| Puig, L.| Daudén, E.| Cañete, J.D.| Pablos, J.L.| Martín, A.O.| Juanatey, C.G.| Adán, A.| Montalbán, X.| Borruel, N.| Ortí, G.| Holgado-Martín, E.| García-Vidal, C.| Vizcaya-Morales, C.| Martín-Vázquez, V.| González-Gay, M.Á.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. In this context, the present review in which a panel of 13 experts in immunology, dermatology, rheumatology, neurology, hematology, infectious diseases, hepatology, cardiology, ophthalmology and oncology have been involved, puts in common the mechanisms through which IL-17 is considered a molecular target for the development of novel biological therapies in these different fields. A comprehensive review of the literature and analysis of the most outstanding evidence have provided the basis for discussing the most relevant data related to IL-17A blocking agents for the treatment of different disorders, such as psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, cardiovascular disorders, non alcoholic fatty liver disease, multiple sclerosis, inflammatory bowel disease, uveitis, hematological and solid cancer. Current controversies are presented giving an opening line for future research. © 2019 The Authors&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - January 2020 - Autoimmunity Reviews\",\"displayDate\":\"1 January 2020\"},{\"summary\":\"Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld&#39;s syndrome): A new flame\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:07:28.009744161\",\"contentId\":179931,\"publishDate\":\"2018-11-30T09:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tAutoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld&#39;s syndrome): A new flame&lt;/p&gt;\",\"url\":\"highlighted-article-november-2018\",\"lastModifiedDate\":\"2021-03-20T23:57:45.693Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218302398\\\"&gt;Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld&#39;s syndrome): A new flame&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;i&gt;Autoimmunity Reviews&lt;/i&gt;,&nbsp;Volume 17, Issue 12,&nbsp;December 2018, Pages 1259-1264&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;b&gt;About the research&lt;/b&gt;&lt;br&gt;\\r\\n\\tAutoimmune/inflammatory syndrome by adjuvants (ASIA) may due to implantation of foreign bodies such as polypropylene meshes or silicone breast implants. Patients with ASIA present with complaints such as fatigue, cognitive impairment, arthralgias, myalgias, pyrexia, dry eyes and dry mouth. It has been postulated that these symptoms in these patients are due to a chronic inflammatory process and an adjuvant effect of the implanted biomaterial. Ultimately, these inflammatory reactions result in (an increase of) allergies, autoimmune diseases, immune deficiency and/or lymphomas.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tPre-existent allergic disease has been found to be an important risk factor for the development of ASIA after foreign body implantation. Explantation of the foreign body results in the majority of patients in an amelioration of the symptoms. Which percentage of patients will develop symptoms and/or diseases such as ASIA, immune deficiency, and/or autoimmune diseases after implant surgery is, however, at present unknown.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;b&gt;Background&lt;/b&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;b&gt;In 1992, an airplane crashed in Amsterdam (&ldquo;Bijlmer crash&rdquo;) killing 43 people.&lt;/b&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tAfter about a year many residents and service personnel started to develop physical health complaints. Symptoms were found to be very similar to the symptoms as found in the &ldquo;&lt;i&gt;Gulf War syndrome&lt;/i&gt;&rdquo;. In addition, an increased amount of patients developed vasculitis and/or other auto-immune diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIn a Dutch newspaper, I postulated that &lt;i&gt;silica&lt;/i&gt; may have been the trigger of these autoimmune diseases. In one sentence, however, I mentioned that similar findings are being observed in patients with silicone breast implants.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThis latter sentence caused a lot of correspondence (and even &ldquo;hate mail&rdquo;) from plastic surgeons telling me that I should stick to my own field (&ldquo;ANCA-associated vasculitis&rdquo;).&lt;br&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;b&gt;About the author&lt;/b&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img align=\\\"left\\\" height=\\\"282\\\" hspace=\\\"10\\\" src=\\\"https://api.journals.elsevier.com/media/elljmgvv/author-04160038.jpg\\\" vspace=\\\"10\\\" width=\\\"200\\\"&gt;Jan Willem Cohen Tervaert MD, PhD&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tCohen Tervaert studied Medicine at the University of Groningen where he obtained his MD in 1981. After training in Internal Medicine and Nephrology, he finished his thesis &lt;i&gt;cum laude&lt;/i&gt; in 1990 entitled &quot;ANCA: new class of autoantibodies in glomerulonephritis and vasculitis&quot;.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tSubsequently, he worked as a visiting researcher in the Vascular Biology Department, Harvard Medical School Boston, USA (Head: Prof. MA Gimbrone Jr.).&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIn 1993, he returned to Groningen (as a recipient of a fellowship of the Royal Netherlands Academy of Sciences), where he was a staff member at the Department of Clinical Immunology at the University Medical Center Groningen.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIn 2000, he was appointed Professor of Medicine and Immunology at the Maastricht University.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tUntil 2012, he was the chairman of the Division of Clinical and Experimental Immunology of the Department of Internal Medicine and head of the Immunology Laboratory at the Maastricht University Medical Center.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tFrom 2012 -2015, he was Research Director of the Sint Franciscus Vlietland Group in Rotterdam.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tCurrently, he is a Professor at the University of Alberta, Edmonton, Canada, where he is since November 1&lt;sup&gt;st&lt;/sup&gt;, 2017 the Director of the Division of Rheumatology.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tCohen Tervaert is a founding member of the Autoimmunity Consortium, of the North American Vascular Biology Organization and of the Dutch Vasculitis Study Group.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tFrom 2002 -2006, he was a member of the WHO committee assessing autoimmunity associated with exposure to chemicals.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHe is a former Chairman of the scientific advisory board of the Dutch Arthritis Foundation (&ldquo;Reumafonds&rdquo;), a former chairman of the Dutch Scientific Section of Nephrology and a former board member of the Dutch Federation of Nephrology and the Dutch Society of Immunology.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHe was (until recently) a member of the scientific advisory board of The National Health Care Institute that advises the Dutch Minister of Health, Welfare, and Sports on health care coverage and medications in the Netherlands, a member of the Netherlands National Institute for Public Health and the Environment committee on Chromium-VI and a member of the Health Council of the Netherlands committee on ME/CFS.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHis fields of interest are inflammation and autoimmunity of vascular disorders, such as atherosclerosis and vasculitis. Genes and the interplay with environmental factors such as vitamin D, &lt;i&gt;S. aureus&lt;/i&gt;, silica, and foreign body implantation such as silicones and polypropylene mesh in the development of autoimmunity have his special interest.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHe is (co) author of more than 420 scientific articles that are cited in over &gt; 26.000 publications. He is a member of Editorial Boards of 3 scientific journals. His Hirsch factor per 01-11-2018 is 80.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;u&gt;Key publications&lt;/u&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t1. Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses of Wegener&rsquo;s Granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336:709-711.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t2. Stegeman CA, Cohen Tervaert JW, De Jong PE, et al. Trimethoprimsulfamethoxazole (Co-trimoxazole) for the prevention of relapses of Wegener&rsquo;s granulomatosis. N Engl J Med 1996; 335:16-20.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t3. Jayne D, Rasmussen N, Andrassy K, Bacon P, Cohen Tervaert JW, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349:36-44.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t4. Jones RB, Cohen Tervaert JW, Hauser T et al. Rituximab versus cyclophosphamide in ANCA associated renal vasculitis. New Engl J Med 2010;363:211-220&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t5. Wilde B, Van Paassen P, Witzke O, Cohen Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 2011;79:599-612&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t6. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012 Jul 19;367(3):214-23.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t7. Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Revised 2017 International Consensus on testing of ANCA in small vessel vasculitis. Nature Rev Rheumatol 2017 Nov;13(11):683-692.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - November 2018\",\"displayDate\":\"30 November 2018\"},{\"summary\":\"The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:07:23.46948677\",\"contentId\":179753,\"publishDate\":\"2018-11-15T00:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tThe Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials&lt;/p&gt;\",\"url\":\"highlighted-article-october-2018-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-03-20T23:28:49.653Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218302179\\\"&gt;The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials&lt;/a&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 17, Issue 11,&nbsp;November 2018, Pages 1105-1114&lt;br&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;strong&gt;About the research&lt;/strong&gt;&lt;br&gt;\\r\\n\\tAs interest on whether nutrition and nutritional supplements can benefit rheumatoid arthritis (RA), is growing, we decided to take a closer look, specifically focusing on the Mediterranean diet (MD) and fish oil supplements. The MD is a dietary pattern rich in plant-based foods such as wholegrains, legumes, fruit, vegetables, high in monounsaturated, &lsquo;good&rsquo; fats such as olive oil, and low in saturated and trans-fats such as red meat and desserts. Although the evidence is currently limited, we found that the MD benefits pain, swollen and tender joints and we recommend that RA patients follow this way of eating both to improve their symptoms but also for its overall benefits including on the cardiovascular system. We also assessed research omega-3 polyunsaturated fatty acid (PUFA) supplements and found strong evidence that they can improve symptoms and progression of pharmacotherapy in RA patients especially at doses &ge;2.7 g/day. We recommend that in addition to the MD, RA patients consume &lsquo;fatty fish&rsquo; such as seabeam, seabass, trout, salmon, sardines or mackerel &ge;2/week and walnuts, flaxseeds and chia seeds daily which all provide different kinds of omega-3 fatty acids. Further research on dietary interventions for RA is needed to provide evidence on the best possible dietary pattern for a better quality of life.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img align=\\\"left\\\" src=\\\"https://api.journals.elsevier.com/media/motgtxha/elena-16145938.gif\\\" style=\\\"margin-right:8px;\\\"&gt; Dr Elena Philippou is an Assistant Professor in Nutrition-Dietetics at the University of Nicosia, Cyprus. Her research interests focus on the role of diet in chronic degenerative disease prevention and management; specifically the role of the Mediterranean diet, dietary glycaemic index and chrono-nutrition on cardiovascular disease, dementia, rheumatoid arthritis, diabetes, obesity and other diseases whose development includes abnormal glucose regulation and inflammation. She has published a number of papers and is the editor of the book &lsquo;The Glycemic Index&rsquo;, CRC Press (2017). In addition to her research activities, Dr Philippou teaches a number of nutrition and dietetics courses at BSc and MSc level and is a part-time lecturer of the Medical Program of the St&rsquo; George&rsquo;s Medical School delivered by the University of Nicosia. Additionally, since 2007, she consults children and adults on various diet-related issues such as weight management, cardiovascular disease, insulin resistance and diabetes, pregnancy and breastfeeding.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - October 2018\",\"displayDate\":\"15 November 2018\"},{\"summary\":\"Antiphospholipid syndrome: An update on risk factors for pregnancy outcome\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:07:18.395082645\",\"contentId\":179505,\"publishDate\":\"2018-10-24T00:00:00Z\",\"intro\":\"&lt;p&gt;Antiphospholipid syndrome: An update on risk factors for pregnancy outcome&lt;/p&gt;\",\"url\":\"highlighted-article-september-2018-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-06-09T21:51:46.14Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218301769\\\"&gt;Antiphospholipid syndrome: An update on risk factors for pregnancy outcome&lt;/a&gt;&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 17, Issue 10, October 2018, Pages 956-966&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the review&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Why about the 20–30% of women with APS remain unable to have successful pregnancy despite conventional treatment? In order to answer, we reviewed current literature to assess the role of the risk factors for poor pregnancy outcome. Among triple antiphospholipid antibodies positivity, lupus anticoagulant positivity, history of previous thrombosis and hypocomplementemia, the largest body of evidence confirms triple positivity being the most significant. In the mid-trimester, the abnormal values of uterine arteries Doppler velocimetry are conﬁrmed to be strongly associated with poor pregnancy outcomes. This tool is useful for pregnancy surveillance, but not as early indicator for pregnancy risk. In order to prevent obstetrical complications and establish the optimal combination therapy, the knowledge at preconception or at the beginning of pregnancy of risk factors associated with poor pregnancy outcome could be a crucial step for management and treatment of APS.&lt;/p&gt;\\n&lt;p&gt;Every clinician needs a smart and useful tool that can lead to the best management in APS patients, particularly during pregnancy. The majority of clinicians bases the choices on their knowledge, but a clear evidence-based guide is useful for the management.&lt;/p&gt;\\n&lt;p&gt;The task was not at all easy; in fact, we had to face with a different and heterogeneous group of studies. How to compare them? Table 3 is our great satisfaction! We compared not only the number of studies assessing risk factors, but also the numerosity of cases of each study. In our opinion, it was the best way to evaluate the effective role of risk factors. It was important to realize the significance of them, to do a risk-stratification in order to identify which patients could benefit additional treatment.&lt;/p&gt;\\n&lt;p&gt;What to do in the future? To find new treatments to help women to have successful pregnancy.&lt;/p&gt;\\n&lt;table border=\\\"0\\\" cellspacing=\\\"0\\\" cellpadding=\\\"6\\\" style=\\\"width: 100%;\\\"&gt;\\n&lt;tbody&gt;\\n&lt;tr&gt;\\n&lt;td width=\\\"110\\\"&gt;&lt;img style=\\\"width: 120px; height: 141px;\\\" src=\\\"https://api.journals.elsevier.com/media/04kezb4p/carolis-25124002.jpg\\\" alt=\\\"\\\"&gt;&lt;/td&gt;\\n&lt;td style=\\\"vertical-align: top;\\\"&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Prof. Sara De Carolis, MD is Adjunct Professor in Obstetrics at the Department of Obstetrics, Gynaecology and Pediatrics, F.Policlinico Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy. She has received several research awards. Her research tracks are investigation on the role of antiphospholipid antibodies in pregnancy (treatment, obstetrical management and outcome, risk factors), preeclampsia, autoimmune disease in pregnancy, pregnancy management of blood disorders (congenital thrombophilia, thrombocytopenia), and cancer in pregnancy. Coauthor of 150 peer-reviewed publications she has an H-index of 25, and 2044 citations (Scopus).&lt;/p&gt;\\n&lt;/td&gt;\\n&lt;/tr&gt;\\n&lt;/tbody&gt;\\n&lt;/table&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - September 2018 - Autoimmunity Reviews\",\"displayDate\":\"24 October 2018\"},{\"summary\":\"Therapy of scleroderma renal crisis: State of the art\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:07:14.693555426\",\"contentId\":179406,\"publishDate\":\"2018-10-11T00:00:00Z\",\"intro\":\"&lt;p&gt;Therapy of scleroderma renal crisis: State of the art&lt;/p&gt;\",\"url\":\"highlighted-article-august-2018-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-06-09T17:47:17.11Z\",\"description\":\"&lt;p&gt;&lt;br&gt;&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218301575?via%3Dihub\\\"&gt;Therapy of scleroderma renal crisis: State of the art&lt;/a&gt;&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 17, Issue 9, September 2018, Pages 882-889&lt;br&gt;&lt;br&gt;&lt;strong&gt;About this review&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Scleroderma renal crisis (SRC) is one of the most feared complication of systemic sclerosis, since the prognosis is not significantly improved after the introduction of ACE-inhibitors. The SRC therapy remains a challenge for rheumatologist and nephrologist and the aim of our review was to summarize the more recent findings on this topic. In particular, we focused on endothelin-1 (ET-1) inhibitors, drugs with a great rationale in both scleroderma and chronic kidney disease. We also reported our good experience with plasma exchange (PEx) in SRC with microangiopathic features; in our cohort, 5-year survival was significantly better in patients treated with PEx in addition to ACE-inhibitors than in those treated with ACE-inhibitors alone. Finally, we highlighted the most recent evidence on the role of the complement in the pathogenesis of SRC. Due to several similarities between SRC with microangiopathic features and the atypical uremic hemolytic syndrome, eculizumab (a C5-inhibitor) has been employed in few case reports, with encouraging results. Starting from literature data and the experience of our center, we proposed a possible treatment algorithm for SRC.&lt;/p&gt;\\n&lt;p&gt;In our opinion, an important future prospective will be to clarify the role and the appropriate timing for kidney biopsy in SRC. Another interesting topic will be try to identify in early stage patients who could benefit from ET-inhibitors or eculizumab before severe renal damage occurs.&lt;/p&gt;\\n&lt;table border=\\\"0\\\" cellspacing=\\\"0\\\" cellpadding=\\\"6\\\" style=\\\"width: 100%;\\\"&gt;\\n&lt;tbody&gt;\\n&lt;tr&gt;\\n&lt;td width=\\\"110\\\"&gt;&lt;img style=\\\"width: 110px;\\\" src=\\\"https://api.journals.elsevier.com/media/rrobgqrn/zanetti-12135518.jpg\\\" alt=\\\"\\\"&gt;&lt;/td&gt;\\n&lt;td style=\\\"vertical-align: top;\\\"&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Elisabetta Zanatta, MD, PhD student – Italy&lt;/p&gt;\\n&lt;p&gt;Elisabetta completed her residency in Rheumatology in 2017 and is now a Rheumatologist at the University Hospital of Padova, Italy. She is also a PhD student at University of Padova, Italy. Her major research interests include connective tissue diseases, in particular systemic sclerosis and pulmonary arterial hypertension.&lt;/p&gt;\\n&lt;/td&gt;\\n&lt;/tr&gt;\\n&lt;/tbody&gt;\\n&lt;/table&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - August 2018 - Autoimmunity Reviews\",\"displayDate\":\"11 October 2018\"},{\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:58.466911376\",\"contentId\":178580,\"publishDate\":\"2018-07-30T00:00:00Z\",\"intro\":\"&lt;p&gt;Immune checkpoint failures in inflammatory myopathies: An overview&lt;/p&gt;\",\"url\":\"highlighted-article-july-2018-autoimmunity-reviews\",\"lastModifiedDate\":\"2021-06-09T21:53:43.93Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S156899721830137X\\\" target=\\\"_blank\\\"&gt;Immune checkpoint failures in inflammatory myopathies: An overview&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"margin-right: 8px;\\\" src=\\\"https://api.journals.elsevier.com/media/jbnjnf1b/sandrine-30135922.jpg\\\" alt=\\\"\\\" align=\\\"left\\\"&gt; Sandrine Herbelet, DVM, spent 8 years in veterinary private practice and veterinary research, before taking the step to human medicine. Currently, she is PhD-student at the Lab for Neuropathology of Prof. Dr. J. L. De Bleecker, Division of Neurology, Department of Internal Medicine at Ghent University/Ghent University Hospital, Belgium. Her research focuses on the role of translocation factor NFAT5 in muscle disease (inflammatory myopathies and Duchenne muscular dystrophy). She dedicates 30% of her time to lecturing practical skills in First Aid and Resucitation as a teaching assistant at the Department of Anaesthesiology and Peri-operative Medicine at the Faculty of Medicine and Health Sciences at Ghent University, Belgium.&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"margin-right: 8px;\\\" src=\\\"https://api.journals.elsevier.com/media/m2ujlsnd/bleecker-30135912.jpg\\\" alt=\\\"\\\" align=\\\"left\\\"&gt; Jan De Bleecker, MD, PhD, is a neurologist trained at Ghent University Hospital, Belgium, and has a special interest in neuromuscular diseases. He did a research fellowship with Prof. A.G. Engel at Mayo Clinic Rochester from 1991 to 1993 and has continued to be doing clinical and basic research with a main focus on immunopathogenesis of the various types of inflammatory myopathy. He is currently a Professor of Neurology at Ghent University and heads the adult section of the Neuromuscular Reference Center at Ghent University Hospital. He co-authored about 200 research papers and presides over of a research commission at the Association Française contre les Myopathies (AFM, Paris).&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About this review&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;This review highlights all known immune checkpoint failures in inflammatory myopathies, more specifically in dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and immune mediated necrotizing myopathy (IMNM). Following summary can be provided from both innate and adaptive immunity checkpoint failures.&lt;/p&gt;\\n&lt;p&gt;Innate immunity research in DM:&lt;/p&gt;\\n&lt;p&gt;1) Neutrophils: increased neutrophils extracellular traps (NETs) formation with decreased NETs clearance in DM sera.&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;increase in neutrophils in DM compared to healthy controls.&lt;/li&gt;\\n&lt;li&gt;NETs are associated with interstitial lung disease (ILD) in DM.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;2) Macrophages: presence of late activated macrophages (25F9) around perimysial vessels, source of TGF-β and iNOS.&lt;/p&gt;\\n&lt;p&gt;3) Dendritic cells:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;mostly activated plasmacytoid DC (= type I interferon-producing cells= pDCs) in juvenile DM and adult DM.&lt;/li&gt;\\n&lt;li&gt;primary activated myeloid DCs in the perivascular infiltrates in juvenile DM and adult DM.&lt;/li&gt;\\n&lt;li&gt;DC maturation inside perivascular infiltrates and surrounding muscle fibers in DM muscle without lymphoid organ organization and concomitant presence of CD4&lt;sup&gt;+&lt;/sup&gt; T cells.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;Immune checkpoint research and subsequent checkpoint failures in adaptive immunity in DM:&lt;/p&gt;\\n&lt;p&gt;1) B cells:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;somatic hypermutation with absence of ectopic germinal centers (GCs).&lt;/li&gt;\\n&lt;li&gt;lymfoid organogenesis in juvenile DM.&lt;/li&gt;\\n&lt;li&gt;B cell reaction towards antigen &lt;em&gt;in situ&lt;/em&gt;.&lt;/li&gt;\\n&lt;li&gt;presence of autoantibodies (anti-histone e.a.) in DM.&lt;/li&gt;\\n&lt;li&gt;absence of B cell apoptosis in DM.&lt;/li&gt;\\n&lt;li&gt;decreased numbers of Bregs.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;2) T cells:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;lack of MHC expression in healthy myocytes (=&gt; partial absence of central T cell tolerance).&lt;/li&gt;\\n&lt;li&gt;absence of T cell apoptosis in DM.&lt;/li&gt;\\n&lt;li&gt;inefficient peripheral T cell anergy.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;CD4&lt;sup&gt;+&lt;/sup&gt;:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;presence of CD4&lt;sup&gt;+&lt;/sup&gt; activating co-stimulatory signals CD28 and ICOS in DM.&lt;/li&gt;\\n&lt;li&gt;absence of T cell apoptosis in DM. a) Th1 cells: IFN-γ production in DM. b) Th2 cells: increased in DM. c) Th17 cells: increased in DM, produing IL-17&lt;br&gt;d) Tregs: decreased number of Tregs in DM.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;CD8&lt;sup&gt;+&lt;/sup&gt;: absence of T cell apoptosis in DM. &lt;br&gt;&lt;br&gt;Innate immunity research in PM and IBM:&lt;/p&gt;\\n&lt;p&gt;1) Neutrophils: increased NETs formation with decreased NETs clearance in PM sera.&lt;br&gt;2) Macrophages: presence of macrophages correlates with the presence of respiratory-deficient fibers in IBM&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;presence of early-activated macrophages in PM .&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;3) Dendritic cells: mostly activated myeloid DC invading non-necrotic muscle fibers in PM and IBM.&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;DC maturation inside perivascular infiltrates and surrounding muscle&lt;/li&gt;\\n&lt;li&gt;fibers in PM muscle without lymphoid organ organization and concomitant presence of CD4&lt;sup&gt;+&lt;/sup&gt; T cells.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;Immune checkpoint research and subsequent checkpoint failures in adaptive immunity in PM and IBM:&lt;/p&gt;\\n&lt;p&gt;1) B cells:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;somatic hypermutation with absence of ectopic GCs in PM and IBM.&lt;/li&gt;\\n&lt;li&gt;rare presence of autoantibodies in IBM, large amounts in PM.&lt;/li&gt;\\n&lt;li&gt;presence of CD138+ plasma cells in IBM.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;2) T cells:&lt;/p&gt;\\n&lt;ul&gt;\\n&lt;li&gt;lack of MHC expression in healthy myocytes (=&gt; absence of central T cell tolerance).&lt;/li&gt;\\n&lt;li&gt;absence of T cell apoptosis in PM and IBM.&lt;/li&gt;\\n&lt;li&gt;inefficient peripheral T cell anergy in PM and IBM.&lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p&gt;CD4&lt;sup&gt;+&lt;/sup&gt;: absence of T cell apoptosis in PM and IBM. a) Th1 cells: IFN-γ production in IBM. b) Th17 cells: present in PM. c) Tregs: decreased number of Tregs in PM and IBM.&lt;/p&gt;\\n&lt;p&gt;CD8&lt;sup&gt;+&lt;/sup&gt;: absence of T cell apoptosis in PM and IBM.&lt;/p&gt;\\n&lt;p&gt;a) Th1 cells: IFN-γ production in IBM. b) Th17 cells: present in PM.&lt;br&gt;c) Tregs: decreased number of Tregs in PM and IBM.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - July 2018 - Autoimmunity Reviews\",\"displayDate\":\"30 July 2018\"},{\"summary\":\"Quality of life and neuropsychiatric disorders in patients with Graves&#39; Orbitopathy: Current concepts\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:46.802086587\",\"contentId\":178168,\"publishDate\":\"2018-06-13T23:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tQuality of life and neuropsychiatric disorders in patients with Graves&#39; Orbitopathy: Current concepts&lt;/p&gt;\",\"url\":\"highlighted-article-june2018\",\"lastModifiedDate\":\"2021-03-20T19:29:40.883Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218301022\\\"&gt;Quality of life and neuropsychiatric disorders in patients with Graves&#39; Orbitopathy: Current concepts&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThis paper highlights current evidence on neuropsychiatric abnormalities in Graves&rsquo; disease focusing on its impact on quality of life and psychosocial function.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img align=\\\"left\\\" height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/m5wnsk01/alice-18104341.jpg\\\" width=\\\"149\\\"&gt;&lt;strong&gt;Alice Bruscolini, MD, PhD,&lt;/strong&gt;&nbsp;is a Research Assistant at the Department of Sense Organs of the Sapienza University of Rome, Italy. She is an ophthalmologist and her research interests include the study of ocular manifestation, immunologic mechanisms and therapeutic approaches for several autoimmune diseases including Grave&rsquo;s disease.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/exgnbssu/marta-18104312.jpg\\\" width=\\\"144\\\"&gt;Marta Sacchetti, MD, PhD,&lt;/strong&gt;&nbsp;is a Research Assistant at the Department of Sense Organs of the Sapienza University of Rome, Italy. She is an ophthalmologist and her research is focus on allergic eye disease and neuro-immunologic system involvement of ocular diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/xt1f5dfo/marcella-18104418.jpg\\\" width=\\\"98\\\"&gt;Dr. Marcella Nebbioso&lt;/strong&gt;&nbsp;is an ophthalmologist doctor involved in clinical research at the Sapienza University of Rome. The main areas of interest include rare autoimmune ocular diseases. In particular, she studies the functional characteristics of the visual apparatus.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/f5okhxkn/angela-18104353.jpg\\\" width=\\\"174\\\"&gt;Angela Iannitelli, MD, PhD,&lt;/strong&gt;&nbsp;is a psychiatrist and postdoctoral researcher at the Department of Biotechnological and Applied Clinical Sciences, University of L&rsquo;Aquila, Italy. She is psychoanalyst of the International Psychoanalytical Association (IPA) and and her research focuses on complex interactions between mental disorders, psychopharmacology, psychoanalysis and brain plasticity.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/tpopq22u/antonio-18104405.png\\\" width=\\\"142\\\"&gt;Prof. Antonio Greco&lt;/strong&gt;&nbsp;is a Professor of Otolaryngology and the Director of the Department of Sense Organs at the Sapienza University of Rome, Italy. His main research interests include the role of autoimmune mechanisms in the development of many systemic autoimmune diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/wozb2vny/massimo-18105038.png\\\" width=\\\"131\\\"&gt;Dr. Massimo Ralli&lt;/strong&gt;&nbsp;is an otolaryngologist at the Sapienza University of Rome, Italy and a Research Assistant Professor in the Center for Hearing and Deafness, State University of New York at Buffalo, USA. His main areas of interest include hearing loss, tinnitus, inner ear disorders and otolaryngologic manifestations of many systemic autoimmune diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img height=\\\"160\\\" src=\\\"https://api.journals.elsevier.com/media/jw3grwfo/alessandro-18104330.jpg\\\" width=\\\"145\\\"&gt;Prof. Alessandro Lambiase, MD, PhD,&lt;/strong&gt;&nbsp;is Professor of Opthalmology at the Department of Sense Organs of the Sapienza University of Rome, Italy. His basic and clinical research is focused on the involvement of the nervous system in the pathophysiology of cornea and conjuctival diseases leading to the development of innovative drugs for treatment of challenging ocular diseases such as neurotrophic keratitis and highlighting novel therapeutic target for autoimmune diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tThis paper highlights current evidence on neuropsychiatric abnormalities in Graves&rsquo; disease focusing on its impact on quality of life and psychosocial function. Graves&rsquo; disease is an autoimmune chronic thyroiditis frequently associated with development of Graves&rsquo; orbitopathy characterized by proptosis, strabismus, impairment of visual function, ocular surface inflammation and dry eye. As consequence, patients with Graves&rsquo; orbitopathy could develop a neurobehavioral syndrome, ranging from anxious to depressive or psychotic disorders. To date, the pathogenic mechanism underlying neuropsychiatric disorders in patients with Graves&rsquo; disease has not been clearly understood. In fact, the development of neuropsychiatric disorders in patients with Graves&rsquo; orbitopathy has been associated with both the detrimental effects of the altered circulating thyroid hormones on the nervous system, and with the psychological discomfort caused by poor quality of life, reduced social interactions and relapsing course of the disease. The importance of a multidisciplinary approach in the management of Graves&rsquo; disease is emphasized and the potential benefit of neuropsychiatric approach on disease perception and patient compliance to medical and/or surgical treatment is discussed.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - June 2018\",\"displayDate\":\"13 June 2018\"},{\"summary\":\"Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:41.937618233\",\"contentId\":177875,\"publishDate\":\"2018-05-11T23:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tSolid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies&lt;/p&gt;\",\"url\":\"highlighted-article-may2018\",\"lastModifiedDate\":\"2021-03-20T18:51:41.337Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218300508\\\" target=\\\"_blank\\\"&gt;Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tJolien Claessens, Thibaut Belmondo, Ellen De Langhe, Rene Westhovens, Koen Poesen, Sophie H&uuml;e, Daniel Blockmans, Michael Mahler, Marvin J. Fritzler, Xavier Bossuyt&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218300508\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 15 August 2018&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDetection of antinuclear antibodies (ANAs) supports the clinical diagnosis of ANA-associated rheumatic diseases (AARDs), such as systemic lupus erythematosus, systemic sclerosis, primary Sj&ouml;gren&#39;s syndrome, idiopathic inflammatory myopathies and mixed connective tissue disease. Automated systems for indirect immunofluorescence (IIF) and solid phase assays (SPAs) are increasingly used to screen for ANAs. The goal of the study was to evaluate the performance of an automated IIF system and 2 automated solid phase assays (flouroenzyme immunoassay and chemiluminescence) for ANA detection. It was a multicenter study performed on 480 diagnostic samples from patients with AARDs and on 767 samples from diseased and healthy controls. Our results indicate that the performance of automated IIF and automated solid phase assays was assay- and disease-dependent. Taking into account antibody levels and combining IIF with SPA adds value.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img src=\\\"http://media.journals.elsevier.com/content/files/jc-14141434.jpg\\t\\\" style=\\\"float: left; width: 130px; height: 174px;\\\"&gt;In 2009&nbsp;&lt;strong&gt;Jolien Claessens&lt;/strong&gt;&nbsp;graduated &lsquo;magna cum laude&rsquo; as Pharmacist at the Catholic University of Leuven (Belgium). She obtained a PhD degree in Pharmaceutical Sciences in 2015 at the same university. After her PhD training she commenced an additional education in Laboratory Medicine at the University Hospital of Leuven, where she was involved in this study. In 2018, she graduated this additional education &lsquo;cum laude&rsquo; and at this moment she is working as a specialist in Laboratory Medicine in the CMA group (Centre for Medical Analysis, Belgium).&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/ngxl0glq/el-14141416.jpg\\\" style=\\\"float: left; width: 130px; height: 194px;\\\"&gt;Dr. Ellen De Langhe&lt;/strong&gt;&nbsp;received her MD in 2005 and her PhD in 2013 from the KU Leuven. In 2014, she became a rheumatologist at the University Hospital of Leuven, and is currently responsible for the clinical care program for patients suffering from systemic autoimmune rheumatic diseases. Since 2015 she is assistant professor at the KU Leuven. Her clinical and research activity is devoted to autoantibody testing, mechanisms of fibrosis and the role of environmental exposure in the pathophysiology of systemic autoimmune rheumatic diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/dstkefo1/rw-14141514.jpg\\\" style=\\\"float: left; width: 130px; height: 130px;\\\"&gt;Ren&eacute; Westhovens&lt;/strong&gt;&nbsp;is a rheumatologist since 1984 and full Professor at the medical faculty and the faculty of kinesiology and rehabilitation sciences of the KU Leuven, Belgium. He is also a past-president of the Royal Belgian Society of Rheumatology and currently deputy editor for Rheumatology Advances in Practice.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHis main scientific interests are in outcome assessment and the treatment of rheumatoid arthritis. A special research focus is on the multidisciplinary approach in RA and early therapy strategies. He participated in many EULAR recommendation initiatives. Dr Westhovens is author or co-author of &gt;270 papers in the international peer-reviewed literature. Since 2012 he is also president of the Orphan Drug Colleges and the Commission for advice on early treatment access and temporary reimbursement of a pharmaceutical product at the National Institute for Health and Disability Insurance Brussels Belgium.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/iqamhjlo/mm-14141501.jpg\\\" style=\\\"float: left; width: 130px; height: 130px;\\\"&gt;Michael Mahler&lt;/strong&gt;&nbsp;studied biology at the universities of Kaiserslautern and Heidelberg (both Germany). He received his Ph.D. from the institute of molecular genetics at the University of Heidelberg (Germany). During his Ph.D. thesis, Michael Mahler worked at the Scripps research institute in the laboratory of Prof. Eng Tan. Later on, he worked at different diagnostic companies and is currently Vice President of Research at Inova Diagnostics. His research is focused on the B-cell autoimmune response in autoimmune diseases and the discovery of novel autoantigens which resulted in more than 180 peer reviewed journal aricles. In addition, he works on the development and characterization of novel diagnostic assays for the diagnosis of autoimmune diseases.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/2i1nah0z/mf-14141448.jpg\\\" style=\\\"float: left; width: 130px; height: 152px;\\\"&gt;Dr. Marvin Fritzler&lt;/strong&gt;&nbsp;received his PhD in 1971 and MD in 1974 from the University of Calgary. In 1976, he went to The Scripps Research Institute in La Jolla, CA in and then to the University of Colorado as a research fellow under the mentorship of Dr. Eng M. Tan. After the post-doctoral fellowship at the University of Colorado, he joined the University of Calgary in 1978 where he is currently Professor in the Cumming School of Medicine. His clinical and research activity is devoted to biomarker identification and autoantibody testing. From 2001 to 2015, he served as Chair of the Alberta Research and Innovation Authority, a strategic policy advisory board of the Government of Alberta. He has published over 425 peer-reviewed manuscripts and over 11,000 citations. He has received numerous awards including most recently Master of the American College of Rheumatology (2013), Order of the University of Calgary (2014), Carl R Jolliff Award for Lifetime Achievement in Clinical and Diagnostic Immunology from the American Association of Clinical Chemistry (2016) and the Dunlop-Dottridge Lectureship of the Canadian Rheumatology Association (2018). He is the Director of Mitogen International Advanced Diagnostics at the University of Calgary.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/05phh5j2/xb-14141541.jpg\\\" style=\\\"float: left; width: 130px; height: 173px;\\\"&gt;Xavier Bossuyt&lt;/strong&gt;&nbsp;gained his medical qualification and PhD at the Catholic University of Leuven (Belgium). He spent two years at the department of Clinical Pharmacology and Toxicology of the University Hospital Z&uuml;rich as a post-doctoral researcher. He was trained in clinical pathology at the University Hospitals Leuven and at the National Institutes of Health, Bethesda, USA. He is a professor of medicine at the Catholic University of Leuven and a clinical laboratory immunologist at the Department of Laboratory Medicine at the University Hospitals Leuven. His research mainly focuses on protein chemistry, serologic markers in autoimmune diseases, the immune response to Streptococcus pneumoniae and immunodeficiencies.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - May 2018\",\"displayDate\":\"11 May 2018\"},{\"summary\":\"The role of capillaroscopy and thermography in the assessment and management of Raynaud&#39;s phenomenon\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:37.580581179\",\"contentId\":177820,\"publishDate\":\"2018-05-02T23:50:00Z\",\"intro\":\"&lt;p&gt;The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon&lt;/p&gt;\",\"url\":\"highlighted-article-april-2018\",\"lastModifiedDate\":\"2021-06-09T21:55:14.2Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997218300491?via%3Dihub\\\" target=\\\"_blank\\\"&gt;The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"float: left; width: 150px; height: 205px;\\\" src=\\\"https://api.journals.elsevier.com/media/uhxalyqk/herrick-07103748.jpg\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;Ariane Herrick is Professor of Rheumatology, University of Manchester, and Honorary Consultant Rheumatologist, Salford Royal NHS Foundation Trust. Her main clinical and research interests are Raynaud's phenomenon, systemic sclerosis-spectrum disorders, and assessment of the microvasculature (including capillaroscopy).&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;img style=\\\"width: 220px; height: 160px;\\\" src=\\\"http://media.journals.elsevier.com/content/files/andrea-07103803.jpg\\t\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;Andrea Murray (PhD) is a Research Fellow at the University of Manchester. She is a physicist with special interest in non-invasive imaging, particularly in studies of patients with systemic sclerosis.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Most patients with &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/raynauds-phenomenon\\\" target=\\\"_blank\\\" title=\\\"Learn more about Raynaud's phenomenon\\\"&gt;Raynaud's phenomenon&lt;/a&gt; (RP) have “benign” primary RP (PRP), but a minority have an underlying cause, for example a &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/connective-tissue-disease\\\" target=\\\"_blank\\\" title=\\\"Learn more about Connective tissue disease\\\"&gt;connective tissue disease&lt;/a&gt; such as &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/systemic-scleroderma\\\" target=\\\"_blank\\\" title=\\\"Learn more about Systemic scleroderma\\\"&gt;systemic sclerosis&lt;/a&gt; (SSc). Secondary RP can be associated with structural as well as functional digital vascular changes and can be very severe, potentially progressing to digital &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/ulcer\\\" target=\\\"_blank\\\" title=\\\"Learn more about Ulcer\\\"&gt;ulceration&lt;/a&gt; or gangrene. The first step in management is to establish why the patient has RP. This short review discusses the role of nailfold &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/capillaroscopy\\\" target=\\\"_blank\\\" title=\\\"Learn more about Capillaroscopy\\\"&gt;capillaroscopy&lt;/a&gt; and &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/thermography-medical\\\" target=\\\"_blank\\\" title=\\\"Learn more about Thermography (medical)\\\"&gt;thermography&lt;/a&gt; in the assessment of RP. Nailfold capillaroscopy examines microvascular structure, which is normal in PRP but abnormal in most patients with SSc: the inclusion of abnormal nailfold &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/capillary\\\" target=\\\"_blank\\\" title=\\\"Learn more about Capillary\\\"&gt;capillaries&lt;/a&gt; into the 2013 classification criteria for SSc behoves clinicians diagnosing connective tissue disease to be familiar with the technique. For those without access to the gold standard of high magnification videocapillaroscopy, a low magnification &lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/topics/medicine-and-dentistry/dermatoscopy\\\" target=\\\"_blank\\\" title=\\\"Learn more about Dermatoscopy\\\"&gt;dermatoscope&lt;/a&gt; or USB microscope can be used. Thermography measures surface temperature and is therefore an indirect measure of blood blow, assessing digital vascular function (abnormal in both PRP and SSc). Until now, the use of thermography has been mainly confined to specialist centres and used mainly in research: this may change with development of mobile phone thermography.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - April 2018 - Autoimmunity Reviews\",\"displayDate\":\"2 May 2018\"},{\"summary\":\"Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:25.16224585\",\"contentId\":177150,\"publishDate\":\"2018-01-27T23:50:00Z\",\"intro\":\"&lt;p&gt;Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis&lt;/p&gt;\",\"url\":\"highlighted-article-january-2018\",\"lastModifiedDate\":\"2021-06-09T17:49:32.753Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997217302926\\\" target=\\\"_blank\\\"&gt;Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Laura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, Carmen Espejo&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, available online 28 November 2017&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"https://www.sciencedirect.com/science/article/pii/S1568997217302926\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 30 April 2018&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Multiple sclerosis (MS) is a chronic, degenerative, autoimmune and demyelinating disease of the central nervous system (CNS) and one of the main causes of disability in young adults. Its precise pathogenesis is not fully known but MS is thought to occur in genetically predisposed individuals following exposition to environmental factors. Recently, as a result from research into experimental autoimmune encephalomyelitis (EAE) models, the commensal microbiota has been described as an essential player in triggering autoimmune demyelination which, consequently, has emerged as a novel environmental risk factor.&lt;/p&gt;\\n&lt;p&gt;In this review, we focus on the immunological modulation performed by commensal microbiota in EAE mice and how these microorganisms influence not only the local milieu but also peripheral responses of both innate and adaptive immune systems, host biological barriers and CNS-resident cells. Likewise, ongoing studies in MS patients are bringing to light that MS-related microbiota would be directing immune responses towards characteristic pathogenic profiles of the disease while under-represented populations seem to be related to immunoregulatory responses. As a result, microbiota modification is being contemplated as an immunomodulatory therapy for MS.&lt;/p&gt;\\n&lt;p&gt;In the light of this, we propose that microbiota modulation should be taken into account when developing adjuvant treatments that complement currently available therapeutic choices. In our opinion, combined strategies that consider the broad complexity of the disease would constitute a more comprehensive immunotherapeutic approach and improve the clinical outcome for MS patients.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;img style=\\\"float: left; width: 180px; height: 214px;\\\" src=\\\"https://api.journals.elsevier.com/media/rukhpqjl/laura-05105935.jpg\\\" alt=\\\"\\\"&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Laura Calvo-Barreiro (MsC)&lt;/em&gt; is a predoctoral researcher at the Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya - Vall d'Hebron Institute of Research, Barcelona, Spain. She is currently working on her PhD project regarding microbiota modulation as a therapeutic target in multiple sclerosis.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;img style=\\\"float: left; width: 180px; height: 222px;\\\" src=\\\"https://api.journals.elsevier.com/media/ibjnjbzu/herena-05105612.jpg\\\" alt=\\\"\\\"&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Herena Eixarch (PhD)&lt;/em&gt; is a postdoctoral researcher at the Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya - Vall d'Hebron Institute of Research in Barcelona. Her research is focused on the search of new therapeutic targets for multiple sclerosis treatment and on the study the pathogenesis of multiple sclerosis and its animal model.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;img style=\\\"float: left; width: 180px; height: 225px;\\\" src=\\\"https://api.journals.elsevier.com/media/jlgpaf3z/xavier-05105649.jpg\\\" alt=\\\"\\\"&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Xavier Montalban&lt;/em&gt; (MD, PhD) is the chairman of the Neuroimmunology Department and Research Group at Vall d’Hebron University Hospital in Barcelona, director of the Multiple Sclerosis Centre of Catalonia and is the Neurology Division director at University of Toronto and director of the BartLo Multiple Sclerosis Center in St. Michael’s Hospital in Toronto (Ontario) in Canada. Prof. Montalban’s main research interests focus on biomarkers, imaging markers, progressive forms of MS, paediatric MS and therapeutic innovation.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;&lt;img style=\\\"float: left; width: 180px; height: 222px;\\\" src=\\\"https://api.journals.elsevier.com/media/4c3f1kx4/carmen-05105555.jpg\\\" alt=\\\"\\\"&gt;&lt;/em&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Carmen Espejo&lt;/em&gt; (PhD) is a senior researcher at the Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya - Vall d'Hebron Institute of Research in Barcelona. Her research interests include the study of immunologic mechanisms of multiple sclerosis and the research for therapeutic targets and/or therapeutic approaches for multiple sclerosis patients.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - January 2018 - Autoimmunity Reviews\",\"displayDate\":\"27 January 2018\"},{\"summary\":\"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:17.580719466\",\"contentId\":176983,\"publishDate\":\"2018-01-02T17:40:00Z\",\"intro\":\"&lt;p&gt;The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)&lt;/p&gt;\",\"url\":\"highlighted-article-december-2017\",\"lastModifiedDate\":\"2021-06-09T21:57:09.25Z\",\"description\":\"&lt;p&gt;&lt;img style=\\\"width: 625px; height: 198px;\\\" src=\\\"http://media.journals.elsevier.com/content/files/banner-16113354.jpg\\t\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302859\\\" target=\\\"_blank\\\"&gt;The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Can-Jie Guo, Patrick S.C. Leung, Weici Zhang, Xiong Ma, M. Eric Gershwin&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, available online 4 November 2017&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302859\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 10 April 2018&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Autoimmune Polyglandular Syndrome type 1 (APS-1) is a rare and complex genetic disorder associated with abnormalities of the immune system, which affect multiple organ systems including endocrine and non-endocrine glands. APS-1 occurs in approximately 1 in 90,000 to 200,000 people in most populations studied. APS-1 presents as a constellation of symptoms, which usually begins in childhood or adolescence. While the symptoms of APS-1 are variable in each patient, three characteristic features: chronic mucocutaneous candidiasis (CMC), hypoparathyroidism and adrenal insufficiency (Addision’s disease) are common. The AIRE gene is responsible for APS-1. However, more than 126 mutations have been identified varying from single mutations to large deletions spread out across the coding sequence of the AIRE gene. Since it is a rare disease with a high degree of genetic and phenotypic variability, the diagnosis and management of APS-1 is challenging.&lt;/p&gt;\\n&lt;p&gt;Completing a comprehensive literature review on APS-1 is difficult as the syndrome has been described under various names, such as autoimmune polyendocrinopathy-candidiasis-ectodermal destrophy/dysplasia (APECED), Whitaker’s syndrome, polyglandular autoimmune disease type 1, or autoimmune polyendocrinopathy, candidosis, ectodermal dystrophy. A distinctive finding is the combined presence of IFN-a or IFN-w in addition to the organ-specific autoantibodies offering possibilities for early diagnostic markers and potentially therapeutic approaches. The work is the result of a long-term collaboration between Dr. Xiong Ma of Ren Ji Hospital, Shanghai Jiao-Tong University and Dr. M Eric Gershwin of the University of California at Davais. We hope this detailed overview of APS-1 will improve clinical care.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;From left to right: Can-Jie Guo, Patrick S. C. Leung, Weici Zhang, Xiong Ma and M. Eric Gershwin.&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Dr. Can-Jie Guo&lt;/em&gt;, is a hepatologist, currently working in the team directed by Professor Xiong Ma, the chair of the Department of Hepatology, Ren Ji Hospital, Shanghai Jiao-Tong University.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Dr. Patrick Leung&lt;/em&gt; is a professor at the Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis. He has applied his expertise in molecular biology and immunology to study primary biliary cholangitis (PBC) as a prototypic autoimmune disease for 30 years.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Dr. Weici Zhang&lt;/em&gt; is an assistant professor at the Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis. Her research focuses on immunologic mechanisms of autoimmunity. She has pioneered the study of plasmablasts in autoimmune liver disease.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Dr. Xiong Ma&lt;/em&gt; is Professor and Chief of Hepatology at Ren Ji Hospital, Shanghai Jiao-Tong University. His career has been focused on autoimmune diseases of the liver and he has developed and proposed rigorous Guidelines for the improved classification of autoimmune hepatitis and also the interesting overlap syndromes of immune mediated liver pathology.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Dr. M. Eric Gershwin&lt;/em&gt; is professor and division chief at the Division of Rheumatology, Allergen and Clinical Immunology, University of California Davis. The focus of his research has been the basis of loss of tolerance in patients who suffer from autoimmune disease he was the first person to clone an autoantigen (PDC-E2) in primary biliary cholangitis.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - December 2017 - Autoimmunity Reviews\",\"displayDate\":\"2 January 2018\"},{\"summary\":\"Zika virus and autoimmunity. One-step forward\",\"published\":true,\"url\":\"highlighted-article-november-2017-autoimmunity-reviews\",\"LAST_PROCESSED\":\"2024-05-19T23:06:12.902351283\",\"contentId\":176690,\"publishDate\":\"2017-11-26T00:00:00Z\",\"intro\":\"&lt;p&gt;Zika virus and autoimmunity. One-step forward&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/q4hpemyd/highlighted-article-november-27131206.jpg\",\"lastModifiedDate\":\"2021-06-09T17:02:50.437Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302586?via%3Dihub\\\" target=\\\"_blank\\\"&gt;Zika virus and autoimmunity. One-step forward&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Diana M. Monsalve, Yovana Pacheco, Yeny Acosta-Ampudia, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 16, Issue 12, December 2017, Pages 1237-1245&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302586?via%3Dihub\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 23 February 2018&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;ZIKA virus (ZIKV) is an arbovirus transmitted by mosquito bite. Until 2007, only sporadic cases of self-limited infections were reported. Nevertheless, in 2015-2016, a new outbreak was reported in the Caribbean and the Americas. These infections appeared with new complications never seen before such as congenital abnormalities or autoimmune manifestations in infected patients. We reviewed 272 cases in the current study in which Guillain-Barré Syndrome (GBS) was preceded by ZIKV-infection and 24 cases indicating idiopathic thrombocytopenic purpura after infection, which strongly suggests an association. Moreover, significant homology between ZIKV and human proteins has been described, thus implying that molecular mimicry might occur, and other autoimmune disorders could emerge after infection. Therefore, we investigated rheumatic and thyroid autoimmunity in ZIKV-infected patients and in healthy controls. No association between ZIKV infection and rheumatic and thyroid autoimmunity was found.&lt;/p&gt;\\n&lt;p&gt;Enrolling patients for this project on ZIKV and autoimmunity was the most difficult part of our work, since it was done in Cucuta, in the northeastern part of the country on the border between Colombia and Venezuela. This city is the one that has been most affected by arboviruses in the country. But, flying to Cucuta was an adventure. Flights were constantly plagued by turbulence and landing in high winds. Every trip ran into this problem - sometimes to the extent that the plane had to divert to a different airport and wait for better weather before trying to get to Cucuta again. Everyone on the team was a little upset thinking about all the not-so-fun things we have to do for science.&lt;/p&gt;\\n&lt;p&gt;Even if we did not find a significant difference in rheumatic and thyroid autoantibodies between groups, a high prevalence of anti-thyroid antibodies suggests a potential risk of developing thyroid autoimmune disease in the future.&lt;/p&gt;\\n&lt;p&gt;Let's continue having fun with this project.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;From left to right: Yeny Acosta-Ampudia, PhD, Immunologist; Yovana Pacheco, PhD, immunologist, Yhojan Rodríguez, MD, Carolina Ramirez-Santana, PhD, Immonologist, Juan-Manuel Anaya, MD, PhD, Diana M. Monsalve, PhD, immunologist.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - November 2017 - Autoimmunity Reviews\",\"displayDate\":\"26 November 2017\"},{\"summary\":\"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:06:08.521041163\",\"contentId\":176568,\"publishDate\":\"2017-11-15T02:40:00Z\",\"intro\":\"&lt;p&gt;Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review&lt;/p&gt;\",\"url\":\"highlighted-article-october-2017-autrev\",\"lastModifiedDate\":\"2021-06-09T17:03:08.687Z\",\"description\":\"&lt;p&gt;&lt;img src=\\\"https://api.journals.elsevier.com/media/cdzhxudx/1-15104606.jpg\\\" alt=\\\"\\\"&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302367?via%3Dihub\\\" target=\\\"_blank\\\"&gt;Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Keum Hwa Lee&lt;/strong&gt;, &lt;strong&gt;Andreas Kronbichler&lt;/strong&gt;, David Duck-Young Park, YoungMin Park, Hanwool Moon, Hyungdo Kim, Jun Hyug Choi, YoungSeo Choi, Songjoo Shim, Il Suk Lyu, Byung Hwan Yun, Yeonseung Han, Donghee Lee, Sang Yoon Lee, Byung Hun Yoo, Kyung Hwan Lee, Tai Lim Kim, Heonki Kim, Joo Sung Shim, Wonseok Nam, Heesung So, SooYeon Choi, Sangmok Lee, &lt;strong&gt;Jae Il Shin&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Autoimmunity Reviews, Volume 16, Issue 11, November 2017, Pages 1160-1173&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217302367\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 13 February 2018&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Neutrophil extracellular traps (NETs) are fibrous networks composed of nuclear and granular components released from activated neutrophils. NETs are found in a variety of conditions, such as bacterial, fungal, and parasitic infections. Recently, NETs are receiving growing attention since they are believed to be associated with various disorders including autoimmune diseases. However, few, if any, comprehensive reviews on the relationship between NETs and various autoimmune diseases have been published. In this review, we discuss the role of several inflammatory molecules (e.g. neutrophils, interleukin-8, and ANCA) in relation to NETs and describe the role of NETs in the pathogenesis of various autoimmune diseases. We also discuss previous studies of the association between aberrant NET formation and degradation and several autoimmune diseases such as ANCA-associated vasculitis, systemic lupus erythematosus (SLE), rheumatoid arthritis, psoriasis and antiphospholipid syndrome. In this point of view, this review also highlights the possibility of using targeted therapies directed to NETs for the treatment of autoimmune diseases in the future.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Dr. Keum Hwa Lee is a pediatrician at the Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea. Her research interests include Henoch-Schönlein purpura (HSP), SLE and vasculitis. She is a member of the Korean Society of Pediatrics.&lt;/p&gt;\\n&lt;p&gt;Dr. Andreas Kronbichler is an internal medicine physician at the Department of Internal Medicine IV (Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria). His research focuses on “personalized medicine” in autoimmune kidney diseases and comorbidities attributable to the treatment and disease manifestations of autoimmune disorders.&lt;/p&gt;\\n&lt;p&gt;Dr. Jae Il Shin is an associate professor at the Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea. He is a specialist in HSP, SLE and vasculitis. His research interests include the immunologic mechanisms of various autoimmune diseases and cancers, evidence-based medicine, meta-analysis, and genetic epidemiology.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - October 2017 - Autoimmunity Reviews\",\"displayDate\":\"15 November 2017\"},{\"summary\":\"Recent advances in our understanding of giant cell arteritis pathogenesis\",\"published\":true,\"url\":\"highlighted-article-june-201\",\"LAST_PROCESSED\":\"2024-05-19T23:05:39.665905587\",\"contentId\":175283,\"publishDate\":\"2017-06-26T00:00:00Z\",\"intro\":\"&lt;p&gt;Recent advances in our understanding of giant cell arteritis pathogenesis&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/bpthij5d/highlighted-article-june-26044433.jpg\",\"lastModifiedDate\":\"2021-06-09T22:01:41.873Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301386\\\" target=\\\"_blank\\\"&gt;&lt;strong&gt;Recent advances in our understanding of giant cell arteritis pathogenesis&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Maxime Samson&lt;/strong&gt;, Marc Corbera-Bellalta, Sylvain Audia, Ester Planas-Rigol, Laurent Martin, Maria Cinta Cid, Bernard Bonnotte&lt;br&gt;Autoimmunity Reviews, Available online 28 May 2017&lt;br&gt;&lt;br&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301386\\\" target=\\\"_blank\\\"&gt;Read full article on ScienceDirect, free access until 22 December 2017&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis usually affecting the aorta and its major branches, especially extracranial branches of the carotid artery. GCA is the most common vasculitis after 50 years. Its incidence increases progressively after 50 years with a peak occurring between 70 and 80 years. Its exact pathogenesis is not fully understood but major progress has been made in recent years, leading to new therapeutic targets like inhibition of the interleukin-6 pathway or the modulation of immune checkpoints.&lt;/p&gt;\\n&lt;p&gt;In this review, we particularly focus on the immunological mechanisms involved in the pathogenesis of GCA, thus providing a 4-step model implicating cells from innate and adaptive immunity. This model starts with the activation of adventitial dendritic cells, followed by the recruitment and activation of T cells and monocytes, thus triggering a severe remodeling process implicating vascular smooth muscles cells, which leads to vascular occlusion and ischemic symptoms of GCA. In particular, we comment new data about the implication of CD8&lt;sup&gt;+&lt;/sup&gt; T cells, the role of IFN-γ and IL-6 and the implication of the Th17/Treg balance. We also discuss recent data about vascular remodeling, especially the role of endothelin-1 in the control of the migration and the proliferation of vascular smooth muscles cells.&lt;/p&gt;\\n&lt;p&gt;Furthermore, we also comment the new data available about the implication of genetics and epignetics. We also provide our hypothesis concerning the involvement of a possible infectious trigger, with a particular focus on varicella zoster virus.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Maxime Samson (MD, PhD) is assistant professor – hospital practioner in the department of Internal Medicine and Clinical Immunology directed by Prof Bernard Bonnotte in Dijon University Hospital (France). He is currently working as a post-doctoral researcher in the team directed by Dr Maria-Cinta Cid (Vasculitis Research Unit, Hospital Clínic, University of Barcelona, IDIBAPS, Barcelona, Spain) which has been performing worldwide recognized research in the field of GCA and vasculitides for many years. Clinical and scientific work of Maxime Samson focuses on vasculitides, especially GCA and ANCA associated vasculitides. He has received several research grants for this scientific work.&lt;/p&gt;\\n&lt;p&gt; &lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - June 2017 - Autoimmunity Reviews\",\"displayDate\":\"26 June 2017\"},{\"summary\":\"Coffee and autoimmunity: More than a mere hot beverage!\",\"published\":true,\"url\":\"highlighted-article-may-2017-autoimmunity-reviews\",\"LAST_PROCESSED\":\"2024-05-19T23:05:35.370015296\",\"contentId\":175061,\"publishDate\":\"2017-05-29T00:00:00Z\",\"intro\":\"&lt;p&gt;Coffee and autoimmunity: More than a mere hot beverage!&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/neanfwhk/highlighted-article-may-30104331.jpg\",\"lastModifiedDate\":\"2021-06-09T22:01:57.307Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301271\\\" target=\\\"_blank\\\"&gt;Coffee and autoimmunity: More than a mere hot beverage!&lt;/a&gt;&lt;br&gt;Kassem Sharif, Abdulla Watad&lt;/strong&gt;, Nicola Luigi Bragazzi, Mohammad Adawi, Howard Amital, Yehuda Shoenfeld&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 4 May 2017&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301271\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 30 August 2017&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Summary&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Coffee is known to be one of the world’s most consumed beverage, therefore the impact of coffee consumption on health has been extensively studied. It has been proven that coffee intake leads to a decrease in overall mortality and cardiovascular mortality. In this review, current scientific evidence in regards to the immunoregulatory role of coffee intake and the possible influence of coffee consumption on autoimmune disease was studied. The association between coffee intake and autoimmune diseases appears to be disease specific. Additionally, in this study, not only the risk of disease occurrence was studied but also the influence of coffee intake on disease severity, progression as well as its effects of treatment modalities employed was also investigated. While this review highlights the influence of coffee on autoimmune disease, more scientific research and evidence is still required to better delineate the governing relationship between both entities.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors:&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Abdulla Watad&lt;/em&gt;, MD, is a fourth-year resident in internal medicine “B”, and researcher in the Autoimmune Diseases Center since 2013- at the largest hospital in Israel- the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University. His clinical and scientific works focusses on autoimmune / rheumatic diseases and following his internal medicine residency, he plans to specialize in rheumatology. Dr. Watad has published more than 30 papers in high impacted journals and several book chapters. He also received various awards such as excellence in residency and research in internal medicine – Israel, 2014, Shelbi award -2015, outstanding tutor of medical students-2016, and 1st prize for best basic clinical research -2016.&lt;/p&gt;\\n&lt;p&gt;&lt;em&gt;Kassem Sharif&lt;/em&gt;, MD, is an intern at Chaim Sheba medical centre and researcher in the Autoimmune Diseases Center at the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University. He has special interest in the field of Immunology.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - May 2017 - Autoimmunity Reviews\",\"displayDate\":\"29 May 2017\"},{\"summary\":\"Rituximab for immunologic renal disease: What the nephrologist needs to know\",\"published\":true,\"url\":\"highlighted-article-april-2017-autoimmunity-reviews\",\"LAST_PROCESSED\":\"2024-05-19T23:05:27.616790299\",\"contentId\":174820,\"publishDate\":\"2017-05-02T00:00:00Z\",\"intro\":\"&lt;p&gt;Rituximab for immunologic renal disease: What the nephrologist needs to know&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/qszpaswo/highlighted-article-april-02164633.jpg\",\"lastModifiedDate\":\"2021-06-09T17:51:16.907Z\",\"description\":\"&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301040\\\" target=\\\"_blank\\\"&gt;Rituximab for immunologic renal disease: What the nephrologist needs to know&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;Andreas Kronbichler, Martin Windpessl, Herwig Pieringer, David R.W. Jayne&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 13 April 2017&lt;br&gt;&lt;br&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217301040\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 2 August 2017&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;About the research&lt;br&gt;Rituximab, a chimeric, monoclonal anti-CD20 antibody, is increasingly used in immune-mediated kidney diseases. Information derived from either randomized, controlled trials or larger cohort studies have highlighted efficacy in licensed and off-label indications. Despite increasing evidence, little is known about specific side effects attributable to rituximab when used in kidney disorders. In this review, we focus on adverse events which might occur immediately (allergic reactions during or within hours of treatment) and in the long-term follow-up of patients (infections, late-onset neutropenia, hypogammaglobulinemia). Moreover, the aim of the current work was to summarize potential preventive strategies, strengthen the importance of specific tests ahead of treatment initiation (i.e. hepatitis screening) and highlight the role of vaccination ahead of therapy (if possible). In addition, patients should be counselled about potential strengths (efficacy in different clinical scenarios) and limitations (side effects) before rituximab administration and a consent form should be signed by the patient and by the treating physician. Taken together, this work should encourage the safe use of rituximab in renal indications and may provide information related to specific treatment-associated complications, especially for physicians who are not administering rituximab on a regular basis. &lt;/p&gt;\\n&lt;p&gt;Introducing the authors&lt;/p&gt;\\n&lt;p&gt;Dr. Andreas Kronbichler is specialty registrar in renal medicine in the Department of Internal Medicine IV (Nephrology and Hypertension) at the Medical University of Innsbruck. His research focuses on “personalized medicine” in autoimmune kidney diseases and co-morbidities attributable to treatment and disease manifestations of autoimmune disorders. &lt;br&gt;&lt;br&gt;Dr. Martin Windpessl is Consultant nephrologist in the Department of Internal Medicine IV (Nephrology and Oncology) at the academic teaching hospital Wels-Grieskirchen. He has a special interest in multisystem disorders involving the kidneys. He is a member of the Austrian peritoneal dialysis working group.&lt;/p&gt;\\n&lt;p&gt;Dr. David Jayne is Director of the Vasculitis and Lupus Clinic and Reader in Vasculitis in the School of Clinical Medicine at The University of Cambridge, UK. His research group focuses on clinical research in vasculitis, lupus and Behcet’s disease. He is President of the European Vasculitis Society and Chief Investigator of international clinical trials in vasculitis.&lt;/p&gt;\\n&lt;p&gt;About the research&lt;/p&gt;\\n&lt;p&gt;Rituximab, a chimeric, monoclonal anti-CD20 antibody, is increasingly used in immune-mediated kidney diseases. Information derived from either randomized, controlled trials or larger cohort studies have highlighted efficacy in licensed and off-label indications. Despite increasing evidence, little is known about specific side effects attributable to rituximab when used in kidney disorders. In this review, we focus on adverse events which might occur immediately (allergic reactions during or within hours of treatment) and in the long-term follow-up of patients (infections, late-onset neutropenia, hypogammaglobulinemia). Moreover, the aim of the current work was to summarize potential preventive strategies, strengthen the importance of specific tests ahead of treatment initiation (i.e. hepatitis screening) and highlight the role of vaccination ahead of therapy (if possible). In addition, patients should be counselled about potential strengths (efficacy in different clinical scenarios) and limitations (side effects) before rituximab administration and a consent form should be signed by the patient and by the treating physician. Taken together, this work should encourage the safe use of rituximab in renal indications and may provide information related to specific treatment-associated complications, especially for physicians who are not administering rituximab on a regular basis.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - April 2017 - Autoimmunity Reviews\",\"displayDate\":\"2 May 2017\"},{\"summary\":\"Regulatory immune cells and functions in autoimmunity and transplantation immunology\",\"published\":true,\"url\":\"highlighted-article-march-2017-autoimmunity-reviews\",\"LAST_PROCESSED\":\"2024-05-19T23:05:23.690009537\",\"contentId\":174549,\"publishDate\":\"2017-04-10T00:00:00Z\",\"intro\":\"&lt;p&gt;Regulatory immune cells and functions in autoimmunity and transplantation immunology&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/1achofac/highlighted-article-march-11140210.jpg\",\"lastModifiedDate\":\"2021-06-09T22:04:07.51Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217300666\\\" target=\\\"_blank\\\" data-mce-=\\\"\\\"&gt;Regulatory immune cells and functions in autoimmunity and transplantation immunology&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;&lt;strong&gt;Gabor Papp&lt;/strong&gt;, Peter Boros, Britt Nakken, Peter Szodoray, &lt;strong&gt;Margit Zeher&lt;/strong&gt;&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 7 March 2017&lt;/p&gt;\\n&lt;p&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217300666\\\" target=\\\"_blank\\\" data-mce-=\\\"\\\"&gt;Read the full article on ScienceDirect, free access until 10 July 2017&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Various tolerogenic mechanisms support the protection of self-structures during immune responses. However, quantitative and/or qualitative changes in regulatory cells and mediators can evoke auto-reactive immune responses. Better understanding of the alterations in immunological tolerance is crucial for developing effective therapies for autoimmune diseases. In transplant immunology, tolerogenic mechanisms are also critical, since the balance between alloantigen-reactive effector cells and the regulatory immune cells will ultimately determine whether a graft is accepted or rejected. Despite the potent immunosuppressive medications, induction of tolerance remains a major goal in transplantation, as well.&lt;/p&gt;\\n&lt;p&gt;We focused on the novel insights regarding the impaired immune regulation and other relevant factors contributing to the development of auto-reactive and graft-reactive immune responses in autoimmune diseases and transplant rejection, respectively. We also addressed some promising approaches for modification of immune-regulatory processes and tolerogenic mechanisms in autoimmunity and solid organ transplantation, which may be beneficial in future therapeutic strategies.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Prof. Margit Zeher&lt;/strong&gt; is the head of the Department of Clinical Immunology at the University of Debrecen. She is the president of the Hungarian Society of Allergology and Clinical Immunology. She specialized in systemic autoimmune and immune-inflammatory diseases, with a special emphasis on their both molecular and clinical aspects. She has over 300 publications in peer reviewed articles and books and has received several outstanding awards for her scientific works.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Dr. Gábor Papp&lt;/strong&gt; leads the research laboratory of the Department of Clinical Immunology at the University of Debrecen. His scientific work focuses mainly on the alterations in immune regulatory mechanisms in systemic autoimmune diseases. He has received several awards and research scholarships for his works.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - March 2017 - Autoimmunity Reviews\",\"displayDate\":\"10 April 2017\"},{\"summary\":\"Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature\",\"published\":true,\"url\":\"highlighted-article-february-2017-autrev\",\"LAST_PROCESSED\":\"2024-05-19T23:05:19.497763611\",\"contentId\":174305,\"publishDate\":\"2017-03-17T09:00:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tIntravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/2nhlmwv3/highlighted-article-february-11154656.jpg\",\"lastModifiedDate\":\"2021-03-20T11:08:30.427Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217300484\\\" target=\\\"_blank\\\"&gt;&lt;strong&gt;Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;br&gt;\\r\\n\\t&lt;strong&gt;S&eacute;bastien Sanges&lt;/strong&gt;, S&eacute;bastien Rivi&egrave;re, Ars&egrave;ne Mekinian, Thierry Martin, Alain Le Quellec, Emmanuel Chatelus, Alain Lescoat, Patrick Jego, Claire Cazalets, Thomas Qu&eacute;m&eacute;neur, No&eacute;mie Le Gouellec, Patricia Senet, Camille Franc&egrave;s, Alban Deroux, Bernard Imbert, Olivier Fain, Latifatou Boukari, Thomas Sen&eacute;, Christophe Deligny, Alexis Mathian, s, Christian Agard, Gr&eacute;gory Pugnet, Silvia Speca, Sylvain Dubucquoi, Pierre-Yves Hatron, &Eacute;ric Hachulla,&lt;strong&gt; David Launay&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 16, Issue 4, April 2017, Pages 377&ndash;384&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997217300484\\\" target=\\\"_blank\\\"&gt;Read the full article on ScienceDirect, free access until 13 June 2017&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tSystemic sclerosis (SSc) is a severe condition classified within the connective tissue diseases and associated with several debilitating complications (notably interstitial lung disease (ILD) and pulmonary hypertension and digestive tract fibrosis). Current standard of care is based on symptomatic treatments and immune-targeted therapies &nbsp;(from conventional immunosuppressants and biologics to hematopoietic stem cell transplantation). However, the latter are associated with side effects, especially infections, while their benefits are not constant and sometimes modest. There is a need for therapeutic options that are both more efficient and better tolerated.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIntravenous immunoglobulins (IVIG) have long been used to treat various autoimmune diseases. Their foremost advantage is an excellent safety profile&nbsp;including the absence of risk of infection. Although their precise mode of action remains debated, IVIG have been shown to display both immunomodulatory&nbsp;and antifibrotic properties. This gives a pathophysiological relevance to their use as a potential treatment in SSc.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tWe therefore performed a retrospective multicenter study and assessed the efficacy and safety of IVIG on several SSc organ involvements on a large nationwide patient cohort, as well as reviewed the available literature.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tWe showed in 46 patients from 19 French centers that IVIG may improve musculoskeletal involvement, systemic inflammation, digestive tract symptoms and could be corticosteroid sparing.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Introducing the authors&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img src=\\\"https://api.journals.elsevier.com/media/1xxfsj5y/1-17092742.jpg\\\" style=\\\"float:left;margin-right:10px\\\" width=\\\"80\\\"&gt; &lt;strong&gt;Prof David Launay&lt;/strong&gt; is professor in the Department of Internal Medicine and Clinical Immunology at the University of Lille. He is director of the &ldquo;Fibrosis and Inflammation/Immunology Resarch Group&rdquo; of the Lille Inflammation Research International Center (LIRIC) &ndash; INSERM UMR 995. He has authored over 200 publications. Pr. Launay focuses his research on understanding the mechanisms of fibrosis in systemic sclerosis and chronic graft-versus-host disease with a special interest in the immunological mechanisms.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;img src=\\\"https://api.journals.elsevier.com/media/flajlf4o/2-17092749.jpg\\\" style=\\\"float:left;margin-right:10px\\\" width=\\\"80\\\"&gt; &lt;strong&gt;Dr S&eacute;bastien Sanges&lt;/strong&gt; is a fellow in the Department of Internal Medicine and Clinical Immunology at the University Hospital of Lille. He obtained a master degree in immunological sciences in the University of Lille. He has been involved in several clinical and basic research projects focusing on systemic sclerosis and immunology, a dozen of which have been published so far. He presented the results of his works as oral and poster communications in more than 20 national and international rheumatology congresses.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - February 2017\",\"displayDate\":\"17 March 2017\"},{\"summary\":\"Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry\",\"published\":true,\"url\":\"autrev-highlighted-article-november-2016\",\"LAST_PROCESSED\":\"2024-05-19T23:04:54.916371533\",\"contentId\":173413,\"publishDate\":\"2016-11-14T13:30:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tCatastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/qtcikzvt/highlighted-article-november-14182824.jpg\",\"lastModifiedDate\":\"2021-03-20T09:23:22.093Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216302051\\\" target=\\\"_blank\\\"&gt;Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry analysis of 500 patients from the International CAPS Registry&lt;/a&gt;&lt;br&gt;\\r\\n\\tIgnasi Rodr&iacute;guez-Pint&oacute;&lt;/strong&gt;, Marta Moitinho, Irene Santacreu, Yehuda Shoenfeld, Doruk Erkan, Gerard Espinosa, Ricard Cervera&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 15 September 2016&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216302051\\\" target=\\\"_blank\\\"&gt;&lt;strong&gt;Full article on Science Direct - free access until 10 May 2017&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Summary&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tCatastrophic antiphospholipid syndrome (CAPS) is an autoimmune disease characterized by the development of multiple thrombotic events affecting several organs in a short period of time, together with the presence of circulating antiphospholipid antibodies. This situation leads to a life-threatening situation with a high mortality. The clinical picture of patients with CAPS is well known since the publication of the first series. However, some different clinical subsets can be distinguished. This study shows that in those patients in whom CAPS appears in their childhood, the disease is often triggered by infections while in adults and in elderly patients other precipitating factors, such as malignancies, are more often recognized. This work also shows that CAPS associated to SLE occurs in younger women with a higher virulence and mortality than CAPS in primary APS patients, while the later develops in older patients and is more often described in men with associated malignancies. Additionally, those patients that develop CAPS during their childhood present more typically venous thrombosis and heart failure, while the frequency of renal involvement is higher in elderly patients. Interestingly, no differences were found when comparing the mortality rate between kids, adults and elderly patients.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Ignasi Rodr&iacute;guez-Pint&oacute;&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIgnasi Rodriguez Pint&oacute;, M.D. is a research fellow at the Department of Autoimmune Diseases in the Hospital Cl&iacute;nic of Barcelona, Catalonia, Spain. He obtained a MSc in Autoimmune Diseases at the University of Barcelona and in Methodology of Research at the Autonomous University of Barcelona. His clinical and scientific work focuses on autoimmune diseases and, specially, the antiphospholipid syndrome. He is the data manager of the &ldquo;CAPS Registry&rdquo;, a web-based registry created by the European Forum on Antiphospholipid Antibodies, that aims to assemble all CAPS cases published or reported to the registry coordinators. He has received several research awards for this scientific work.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article – November 2016\",\"displayDate\":\"14 November 2016\"},{\"summary\":\"APS - Diagnostics and challenges for the future\",\"published\":true,\"url\":\"highlighted-article-october-2016-autrev\",\"LAST_PROCESSED\":\"2024-05-19T23:04:50.701631011\",\"contentId\":173159,\"publishDate\":\"2016-10-07T00:00:00Z\",\"intro\":\"&lt;p&gt;APS - Diagnostics and challenges for the future&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/yxthbun0/highlighted-article-october-07121021.jpg\",\"lastModifiedDate\":\"2021-06-09T21:44:51.2Z\",\"description\":\"&lt;p&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301732\\\" target=\\\"_self\\\"&gt;&lt;strong&gt;APS - Diagnostics and challenges for the future&lt;/strong&gt;&lt;/a&gt;&lt;br&gt;&lt;strong&gt;V. Pengo&lt;/strong&gt;, E. Bison, G. Zoppellaro, S. Padayattil Jose, G. Denas, A. Hoxha, A. Ruffatti, A. Banzato&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 31 July 2016&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301732\\\" target=\\\"_self\\\" class=\\\"cta-tertiary\\\"&gt;Full article on Science Direct - free access until 7 April 2017&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Main findings&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;An important message to doctors involved in the diagnosis of antiphospholipid syndrome (APS) is to check for all the three tests recommended by guidelines, i.e. Lupus Anticoagulant (LAC), anticardiolipin (aCL) and anti β2-glycoprotein I (aβGPI) antibodies, possibly in the same plasma sample. Obtaining an antiphospholipid antibody profile is mandatory for classifying patients at risk of thrombosis or pregnancy loss. Triple positive profile identify a high risk group of patients and does not need confirmation after 12 weeks. A specific subclass of aβ2GPI antibodies (those directed to Domain I of the molecule) is identified when all three tests are positive and together with the determination of antibodies directed to Domain 4/5 of the molecule might help to refine the diagnosis of APS. The target of pathogenic antibodies, β2GPI, is a high concentration protein in blood, whose physiological function is unknown. Moreover, it is not known why only a subgroup of these antibodies generate a hypercoagulable state.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the authors&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Vittorio Pengo M.D. is an Associate Professor of Cardiology at Padua University School of Medicine, Italy. His interest in antiphospholipid syndrome started in the eighties when during the period of residency in Internal Medicine he came across with a plasma with a very prolonged activated partial Thromboplastin Time (aPTT). Since that time, he studied the Lupus Anticoagulant phenomenon particularly at Jefferson Medical College in Phildelphia, USA, where he was the first to describe, together with Dr. Thiagarajan and Dr. Shapirofor, the most used assay for LAC, the diluted Russell Venom Time (dRVVT) in 1986. Since you never forget your first love, he is still active in this fascinating field&lt;strong&gt;.&lt;/strong&gt;&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article – October 2016 - Autoimmunity Reviews\",\"displayDate\":\"7 October 2016\"},{\"summary\":\"Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin D\",\"published\":true,\"url\":\"highlighted-article-september-2016-autrev\",\"LAST_PROCESSED\":\"2024-05-19T23:04:50.448549876\",\"contentId\":173076,\"publishDate\":\"2016-09-22T00:00:00Z\",\"intro\":\"&lt;p&gt;Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin D&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/vt2cpebw/highlighted-article-september-22131647.png\",\"lastModifiedDate\":\"2021-06-09T22:04:34.763Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a rel=\\\"noopener\\\" href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301604\\\" target=\\\"_blank\\\" data-mce-=\\\"\\\"&gt;Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin D&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Joanne Kwak-Kim&lt;/strong&gt;, Annie Skariah, Li Wu, Dinorah Salazar, Nayoung Sung, Kuniaki Ota&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 10, October 2016, Pages 943–947&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216301604\\\" target=\\\"_self\\\" data-mce-=\\\"\\\"&gt;&lt;strong&gt;Full article on Science Direct - free access until 16 February 2017&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Summary&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Recurrent pregnancy loss (RPL) has various underlying etiologies including autoimmune, cellular immune, thrombophilic, genetic, anatomical and infectious etiologies.  Approximately 20% of women with RPL have autoimmune conditions, such as antiphospholipid antibody (APA) and others, such as thyroperoxidase antibody, thyroglobulin antibody, and antinuclear antibody (ANA).&lt;/p&gt;\\n&lt;p&gt;Presence of autoimmunity is keenly associated with inflammatory immune responses, such as increased NK cell levels, cytotoxicity and increased Th1/Th2 cell ratios in women with reproductive failures.  Vitamin D deficiency is prevalent in women with RPL and women with low vitamin D have increased prevalence of autoimmune abnormalities. Vitamin D suppresses NK cytotoxicity through reduction of conjugation with target cells, polarization of perforin and pro-inflammatory cytokine secretion. Vitamin D effect on type 2 shift in NK and T cells is via TLR4/NF-kB pathway. It is speculated that appropriate level of vitamin D and vitamin D supplementation may have a pivotal role to maintain and succeed in early pregnancy.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author &lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Dr. Joanne Kwak-Kim is a Professor of Obstetrics and Gynecology, and Microbiology and Immunology, Chicago Medical School at Rosalind Franklin University of Medicine and Science, and the Director of Reproductive Medicine at Rosalind Franklin University Health Clinic. Her keen interest lies in Reproductive Immunology and her work in natural killer cell and Th1/Th2 immune responses in women with RPL and MIF is distinguished. The research work that she has done, which applies basic science techniques to clinical problems is cutting edge.  She has over 100 publications in peer reviewed articles and books, and has been awarded numerous times for her scientific work.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted Article - September 2016 - Autoimmunity Reviews\",\"displayDate\":\"22 September 2016\"},{\"summary\":\"IVIG in autoimmune disease — Potential next generation biologics\",\"published\":true,\"url\":\"highlighted-article-june-2016-autrev\",\"LAST_PROCESSED\":\"2024-05-19T23:04:29.88775909\",\"contentId\":172319,\"publishDate\":\"2016-06-14T02:30:00Z\",\"intro\":\"&lt;p&gt;IVIG in autoimmune disease — Potential next generation biologics&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/3mkbhvvd/highlighted-article-june-16113447.jpg\",\"lastModifiedDate\":\"2021-06-09T21:47:39.613Z\",\"description\":\"&lt;p&gt;&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216300751\\\"&gt;IVIG in autoimmune disease — Potential next generation biologics&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;Adrian W. Zuercher&lt;/strong&gt;, Rolf Spirig, Adriana Baz Morelli, Fabian Käsermann&lt;br&gt;&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 25 March 2016&lt;/p&gt;\\n&lt;p&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997216300751\\\"&gt;Full article on Science Direct - free access until 10 December 2016&lt;/a&gt;&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the research&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Intravenous or subcutaneous, plasma-derived immunoglobulins (IVIG/SCIG) are key therapeutics in the treatment of antibody-deficiency and autoantibody-mediated autoimmune disorders. However, manufacture of IVIG/SCIG comes with heavy logistics: it requires highly specialized processes and facilities and depends on the availability of sufficient human plasma. In addition, very high doses of 1-2 g/kg body weight need to be used for therapy. Therefore, efforts are underway to use recombinant technologies to develop next generation biologics that would ideally have the same efficacy as IVIG/SCIG but at lower doses.&lt;/p&gt;\\n&lt;p&gt;The therapeutic effect of IVIG/SCIG in autoimmune diseases depends primarily on the constant part of the IgG molecule – the so called “Fc domain”. Therefore, it has been hypothesized that IVIG/SCIG effects might be reproduced with a recombinant product based on the Fc domain of IgG only. More recently it has been realized that a certain degree of organized multimerization may increase the efficacy of recombinant Fc molecules. Several academic and industrial groups are now pursuing this hypothesis by using distinct strategies for expression of oligomerized recombinant Fc. The efficacy of various product candidates has been demonstrated in animal models of autoimmune diseases and some of the molecules are reviewed in the paper by Zuercher et al. In addition, alternative molecules that reproduce specific mechanisms of action of IVIG/SCIG are described as well.&lt;/p&gt;\\n&lt;p&gt;&lt;strong&gt;About the author&lt;/strong&gt;&lt;/p&gt;\\n&lt;p&gt;Adrian W. Zuercher earned his PhD/MDsci degree in Immunology/Allergy at the University of Bern, Switzerland in 1999. After postdoctoral studies in basic mucosal immunology at U Penn (Philadelphia, PA, USA) he held various positions in industrial R&amp;D environments in Switzerland and Australia. Currently he is leading CSL’s Research group in Bern. Adrian’s interests are in immunology and mucosal Immunology and particularly in auto-immune inflammatory diseases, and the application of plasma-derived and recombinant therapeutics in these conditions. Adrian has co-authored &gt;60 papers and patents.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article – June 2016 - Autoimmunity Reviews\",\"displayDate\":\"14 June 2016\"},{\"summary\":\"Association between stressful life events and autoimmune diseases: A systematic review and meta-analysis of retrospective case–control studies\",\"published\":true,\"url\":\"highlighted-article-march-2016\",\"LAST_PROCESSED\":\"2024-05-19T23:04:09.509434754\",\"contentId\":171330,\"publishDate\":\"2016-02-09T02:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tAssociation between stressful life events and autoimmune diseases: A systematic review and meta-analysis of retrospective case&ndash;control studies&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/ss5fcj22/highlighted-article-march-2016-09062255.jpg\",\"lastModifiedDate\":\"2021-03-20T00:27:49.647Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002621\\\"&gt;Association between stressful life events and autoimmune diseases: A systematic review and meta-analysis of retrospective case&ndash;control studies&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;\\r\\n\\tBrunetta Porcelli, Andrea Pozza, Nicola Bizzaro, Andrea Fagiolini, Maria-Cristina Costantini, Lucia Terzuoli, Fabio Ferretti&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 18 December 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002621\\\"&gt;Full article on Science Direct - free access until 8 August 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Brunetta Porcelli&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Brunetta Porcelli is Researcher of Biochemistry at University of Siena, Italy (Department of Medical Biotechnologies-Biochemistry Division) and non-doctor leading in Laboratory of Clinical Pathology (DAI Emergenza, Urgenza e Servizi Diagnostici, Azienda Ospedaliera Universitaria Senese, Siena), in which she is also responsible of Division of Organ Autoimmunity. Dr. Porcelli has a degree cum laude in Biological Science and PhD in Clinical Biochemistry at Siena University and 2nd level Master cum laude &ldquo;Coeliac Disease: from the clinic to the management&rdquo;, at Ancona University. She is a Professor and Coordinator at the department of Medical Biotechnologies, Siena University.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tSince 1984 she has been working at research both about General Biochemistry and Clinical Biochemistry, participating to several research programmes and projects. At present, her clinical and scientific work focuses on autoimmune diseases, particularly in the laboratory diagnosis and monitoring of organ autoimmune diseases, in development and standardization of methods for autoimmunity testing and autoantibodies detection, validation and clinical evaluation of novel biomarkers.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Porcelli is member of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL), the Study Group of Autoimmunity of the Italian Society of Clinical Pathology and Laboratory Medicine, and of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology. Associate Editor of the Italian Journal of Laboratory Medicine (RIMeL/IJLM). She has published more than 250 papers in peer-reviewed journals.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article -March 2016\",\"displayDate\":\"9 February 2016\"},{\"summary\":\"Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases\",\"published\":true,\"LAST_PROCESSED\":\"2024-05-19T23:04:01.936214239\",\"contentId\":171101,\"publishDate\":\"2016-01-27T02:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tLong-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases&lt;/p&gt;\",\"url\":\"highlighted-article-february-2016\",\"lastModifiedDate\":\"2021-03-20T00:03:34.603Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002608\\\"&gt;Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;\\r\\n\\t&lt;strong&gt;Patrick Cherin&lt;/strong&gt;, Cristina Belizna, Odile Cartry, Georgeta Lascu-Dubos, Christophe de Jaeger, Jean-Christophe Delain, Jean-Charles Crave, Eric Hachulla&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 15, Issue 3, March 2016, Pages 281&ndash;286&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002608\\\"&gt;Full article on Science Direct - free access until 25 July 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Pr CHERIN Patrick, MD, PhD&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tPr. Cherin Patrick M.D. is Professor of Internal Medicine at the University of Paris VI &ndash; Piti&eacute;-Salp&eacute;tri&egrave;re, Paris, France. Dr. Cherin has a PhD in Clinical Immunology at the State University of Paris. His clinical and scientific work focuses on autoimmune/rheumatic diseases, particularly on inflammatory myopathies, and the relationships between pathogenesis and immunomodulatory treatment. He first published the interest of Intravenous immunoglobulin in polymyositis and dermatomyositis. He has published more than 150 papers in peer-reviewed journals, and has authored and/or participated in 12 books. He has been chairman in several International Congresses on Internal medicine and on Autoimmunity. As a member of numerous Study Group and national or international Societies, he has organized and/or participated to a number of International collaborative studies.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&nbsp;&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article -February 2016\",\"displayDate\":\"27 January 2016\"},{\"summary\":\"Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)\",\"published\":true,\"url\":\"highlighted-article-january-2016\",\"LAST_PROCESSED\":\"2024-05-19T23:03:57.670425748\",\"contentId\":170788,\"publishDate\":\"2015-12-09T01:30:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tClinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/0ssfczvw/highlighted-article-january-2016-11114713.jpg\",\"lastModifiedDate\":\"2021-03-19T23:29:41.727Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002165\\\"&gt;Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;\\r\\n\\t&lt;strong&gt;Antonella Radice&lt;/strong&gt;, Barbara Trezzi, Umberto Maggiore, Francesca Pregnolato, Tiziana Stellato, Pietro Napodano, Davide Rolla, Gianpaola Pesce, Marco D&#39;Amico, Domenico Santoro, Francesco Londrino, Federica Ravera, Giuseppe Ortisi, Renato Alberto Sinico&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 23 October 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215002165\\\"&gt;Full article on Science Direct - free access until 9 June 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Dr Antonella Radice&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Antonella Radice is Consultant for Immunology and Infectious Diseases, in charge of Laboratory Diagnosis of Autoimmune Disorders, at Microbiology Institute, San Carlo Borromeo Hospital in Milan, Italy (since 2007). Previously she was Research Fellow at the &ldquo;Associazione per la Ricerca sulle Malattie Renali&rdquo; (1987- 1991) and Head of Laboratory at Nephrology and Clinical Immunology Department, San Carlo Borromeo Hospital in Milan (1992- 2007).&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Radice has a University Degree in Biological Sciences and a PhD in Biotechnology at the State University of Milan. She has implemented her postgraduate specialization with continuous training and updating through participation to national and international stages, courses, workshops and meetings on Nephrology, Rheumatology, Clinical Immunology &amp; Autoimmunity, and Laboratory Medicine as a learner, teacher, speaker and mentor.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tShe focused her activity and research interests on the pathogenesis of autoimmune conditions, with special reference to the immunological mediated renal diseases. Her particular interest goes out to the laboratory diagnosis and monitoring of systemic autoimmune diseases, in development and standardization of methods for autoimmunity testing and autoantibodies detection, validation and clinical evaluation of novel biomarkers. She has been involved in vasculitis research and ANCA detection since 1989, taking part into the EC-BCR historical projects on ANCA Assays Standardization.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tAs a member of the Scientific Committee and of the Autoimmunology Study Group of the Italian Society of Pathology and Laboratory Medicine (SIPMeL), of the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) and the European Autoimmunity Standardization Initiative (EASI) she has participated to a number of International collaborative studies&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article -January 2016\",\"displayDate\":\"9 December 2015\"},{\"summary\":\"The critical role of toll-like receptors — From microbial recognition to autoimmunity: A comprehensive review\",\"published\":true,\"url\":\"highlighted-article-december-2015\",\"LAST_PROCESSED\":\"2024-05-19T23:03:53.567186485\",\"contentId\":170618,\"publishDate\":\"2015-11-16T02:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tThe critical role of toll-like receptors &mdash; From microbial recognition to autoimmunity: A comprehensive review&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/lzddkfum/highlighted-article-december-27091705.jpg\",\"lastModifiedDate\":\"2021-03-19T03:08:53.5Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215001846\\\"&gt;The critical role of toll-like receptors &mdash; From microbial recognition to autoimmunity: A comprehensive review&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;\\r\\n\\t&lt;strong&gt;Maximiliano Javier Jim&eacute;nez-Dalmaroni&lt;/strong&gt;, M. Eric Gerswhin, &lt;strong&gt;Iannis E. Adamopoulos&lt;/strong&gt;&lt;br&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 20 August 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215001846\\\"&gt;Full article on Science Direct - free access until 13 May 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Iannis E Adamopoulos&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tIannis E Adamopoulos received his BSc (Hons) from Surrey University and his MPhil from the University College London before completing his DPhil at Wolfson College, at the University of Oxford where he was also the recipient of a research into aging Scholarship. He subsequently moved to the USA to undertake post-doctoral training at Washington University of Saint Louis, and DNAX research Institute at Palo alto California. His research efforts have been focused on cytokine signaling in autoimmunity with specific emphasis on the activation and differentiation of myeloid subsets leading to tissue destruction in inflammatory arthritis. His work has defined novel signaling networks of pro-inflammatory mediators that are critical in the pathogenesis of autoimmune diseases including rheumatoid arthritis and psoriasis. In 2011 he was named the Arthritis National Research foundation Sontag Fellow for his pioneering work on the activation of myeloid cells by IL-23. Dr Adamopoulos has received numerous awards from the National Institute of Health, Shriners, and the National Psoriasis Foundation for his research on inflammation. His work has been published and highlighted in leading journals including Journal of Immunology, Journal of Experimental Medicine, Nature Reviews Rheumatology, and Nature communications. He is currently an Associate professor at the University of California at Davis, and an Associate Investigator at Shriners Hospitals for Children-Northern California. Dr Adamopoulos is an ad hoc reviewer and member of the editorial boards for leading journals in rheumatology as well as serving in the scientific advisory board of biotechnology companies.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Maximiliano Javier Jim&eacute;nez Dalmaroni&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tMaximiliano Javier Jim&eacute;nez Dalmaroni is currently a Visiting Scientist at the Faculty of Medicine, The University of La Plata (UNLP), Argentina. He received a B.Sc. in Chemistry (UNLP) in 1998, and a M.Sc. in Biochemistry (UNLP) in 2000. He received his D.Phil. in Biochemistry from the University of Oxford in 2008. From 2000 to 2001 he did a post-graduate research in the development of adenoviral vectors for gene therapy in the Department of Medicine, The University of Manchester (UK) and from 2001 to 2003 and Cedars Sinai Medical Center (CS), Los Angeles (USA). He did a postdoctoral research in Cincinnati Children&rsquo;s Hospital (CCHMC) from 2003 to 2009, in the role of novel cadherins in cell adhesion in&nbsp;&nbsp; development and diseases. His research interests center on understanding the role of innate immunity in microbial infections and chronic inflammatory diseases. In 2003, he was granted a highly prestigious Oxford/Scripps scholarship to pursue his D.Phil. at Oxford University (UK) and at The Scripps Research Institute (TSRI) (USA). During that time, his research was focused on one of the most important family of innate immunity receptors, the toll-like receptors (TLRs). He also established an independent collaboration with Prof Bruce Beutler, Nobel Prize of Medicine 2011, to investigate the role of the TLR2 co-receptors CD36 and CD14 in the modulation of TLR2 signaling pathway. His work established a hierarchy among these co-receptors and it uncovered novel properties of CD36 in terms of its interaction with TLR2.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - December 2015\",\"displayDate\":\"16 November 2015\"},{\"summary\":\"Auto-reactions, autoimmunity and psoriatic arthritis\",\"published\":true,\"url\":\"highlighted-article-november-2015\",\"LAST_PROCESSED\":\"2024-05-19T23:03:49.420721697\",\"contentId\":170414,\"publishDate\":\"2015-10-19T02:20:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tAuto-reactions, autoimmunity and psoriatic arthritis&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/m3dddlwb/highlighted-article-november-20051221.png\",\"lastModifiedDate\":\"2021-03-19T02:06:51.31Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721500169X\\\"&gt;Auto-reactions, autoimmunity and psoriatic arthritis&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tMaria Sole Chimenti, Paola Triggianese, Marzia Nuccetelli, Chiara Terracciano, Anna Crisanti, Maria Domenica Guarino, Sergio Bernardini, &lt;strong&gt;Roberto Perricone&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 5 August 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721500169X\\\"&gt;Full article on Science Direct - free access until 16 April 2016&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Roberto Perricone&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Roberto Perricone M.D. is Professor of Rheumatology and of Allergy and Clinical Immunology at the University of Rome Tor Vergata and head of the Department of Rheumatology at the Fondazione Policlinico Tor Vergata Hospital, Rome, Italy. He is a member of the Autoimmunity Network and of the Autoimmunity Consortium. He completed medical studies and qualifying course in Allergy and Clinical Immunology at Sapienza University of Rome where he worked for several years as assistant professor and then he moved to the University of Rome Tor Vergata.&nbsp; His clinical and scientific work focuses on autoimmune/rheumatic diseases, particularly on the relationships between complement and autoimmunity, new activators of the complement system, complement deficiencies, systemic autoimmune diseases pathogenesis and treatment. He has published more than 350 papers in peer-reviewed journals, and has authored and edited 10 books. He has been chairman in EULAR Congress and in several International Congresses on Autoimmunity.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - November 2015\",\"displayDate\":\"19 October 2015\"},{\"summary\":\"Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors\",\"published\":true,\"url\":\"highlighted-article-october-2015\",\"LAST_PROCESSED\":\"2024-05-19T23:03:41.177750969\",\"contentId\":170128,\"publishDate\":\"2015-09-02T11:50:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tGene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/pscprhzz/highlighted-article-october-02165941.jpg\",\"lastModifiedDate\":\"2021-03-19T00:46:29.68Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721500155X\\\" target=\\\"_blank\\\"&gt;Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tElena Gianchecchi,&lt;strong&gt; Alessandra Fierabracci&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Available online 13 July 2015&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S156899721500155X\\\" target=\\\"_blank\\\"&gt;Full article on Science Direct - free access until 2 March 2016 &lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Alessandra Fierabracci&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tDr. Alessandra Fierabracci is Senior Scientist at the Immunology and Pharmcotherapy Area of Children&rsquo;s Hospital Bambino Ges&ugrave; in Rome (Italy) since 2001. Previously she was Lecturer in Immunology at Queen Mary Westfield College, University of London (UK, 1997-2000) and Visiting Scholar at the Department of Pediatrics, Division of Immunogenetics, University of Pittsburgh (PA, USA) in 1999. She earned her MD degree at the University of Pisa (Italy) in 1986, her PhD in Immunology at Queen Mary Westfield College in1996 and her Research Doctorate in Experimental Pathology at the University of Florence (Italy) in 1997.&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tHer research interests are related to the pathogenesis of autoimmune disorders with special reference to insulin-dependent diabetes mellitus (Type 1 diabetes), polyendocrine syndromes and associated conditions of autoimmunity and immunodeficiency. A special interest is related to the immunoregulatory activity of microvescicles derived from mesenchymal stem cells. She is Inventor of the European Patent 1748296 &lsquo;Method for the detection of GAD65 autoreactive T cells in newly diagnosed Type 1 diabetic patients and in the prediabetic period&rsquo; and the PCT/IT2012/000232 &lsquo;Microvescicles isolated from mesenchymal stem cells for use as immunosuppressive agents&rsquo;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tBetween 2004 and 2012 she was Contract Professor at the University of Pisa and Siena (Italy) for Research Doctorate and Specialist training. Since 2012 she is Board member and Vice-President of the Italian Women Inventors and Innovators Network (ITWIIN) and member of the European Association for the Studies on Diabetes. She was awarded the 2011 EUWIIN Award Best Woman Inventor, Category High Education (Third Prize), Reykjavik (Island), 6-9th September 2011, the 2014 BFIIN Special recognition Award, BFIIN Exhibition &amp; Award and British Invention Show (BSI), London 22-25th October 2014 and the 2014 World Invention Awards BSI Silver Medal.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - October 2015\",\"displayDate\":\"2 September 2015\"},{\"summary\":\"Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?\",\"published\":true,\"url\":\"highlighted-article-september-2015\",\"LAST_PROCESSED\":\"2024-05-19T23:03:41.061336046\",\"contentId\":170100,\"publishDate\":\"2015-08-26T10:40:00Z\",\"intro\":\"&lt;p&gt;\\r\\n\\tIs there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?&lt;/p&gt;\",\"thumbnail\":\"https://api.journals.elsevier.com/media/ejabgnyt/highlighted-article-september-26154142.jpg\",\"lastModifiedDate\":\"2021-03-19T00:38:22.343Z\",\"description\":\"&lt;p&gt;\\r\\n\\t&lt;strong&gt;&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000920\\\" target=\\\"_blank\\\"&gt;Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?&lt;/a&gt;&nbsp;&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;S. De Carolis&lt;/strong&gt;, A. Botta, S. Salvi, E. di Pasquo, G. Del Sordo, C. Garufi, &lt;strong&gt;A. Lanzone&lt;/strong&gt;, M.P. De Carolis&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;em&gt;Autoimmunity Reviews&lt;/em&gt;, Volume 14, Issue 9, September 2015, Pages 760&ndash;762&lt;em&gt;&nbsp;&lt;/em&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;a href=\\\"http://www.sciencedirect.com/science/article/pii/S1568997215000920\\\" target=\\\"_blank\\\"&gt;Full article on Science Direct - free access until 24 February 2016&lt;/a&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Sara De Carolis&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tProf. Sara De Carolis, MD is Adjunct Professor in Obstetrics and Gynaecology and Researcher at the High Risk Pregnancies Centre in the Department of Obstetrics and Gynaecology at the Catholic University of Rome. She has received several research awards. Her research tracks are investigation on the role of antiphospholipid antibodies in pregnancy&nbsp; (treatment, management, risk factors for pregnancy outcome),&nbsp; preeclampsia, autoimmune diseases in pregnancy,&nbsp; pregnancy management of&nbsp; blood disorders (congenital thrombophilia, thrombocytopenia), cancer in pregnancy. Coauthor of 101 peer-reviewed publications she has an H-index of 20, and 1683 citations (Scopus).&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\t&lt;strong&gt;Antonio Lanzone&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;\\r\\n\\tProf. Antonio Lanzone is head of the Institute of Obstetrics and Gynecology, President of the master&rsquo;s degree in Medicine and Surgery and head of Obstetric division, Catholic University of the Sacred Heart, Rome. Author of more than 500 publications, 287 manuscripts International Scientific Journals with impact factor, he has an H index of 33 (Scopus). He has received several outstanding research awards and patents for reproductive medicine and gynecological endocrinology. His research tracks are the polycystic ovary syndrome, reproductive endocrinology, metabolic issues in reproduction, mini-invasive gynecological surgery and recently also high risk pregnancy.&lt;/p&gt;\",\"type\":\"highlighted-articles\",\"title\":\"Highlighted article - September 2015\",\"displayDate\":\"26 August 2015\"}]}}},\"topCitedArticles\":{},\"topSocialArticles\":{},\"recommendedJournals\":{},\"guideForAuthorsContent\":{},\"guideForAuthorsTableOfContents\":{},\"openAccessOptions\":{},\"serverRenderError\":null}"</script></div>
<script src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/54/js/react/16.12.0/react.production.min.js" type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/54/js/react-dom/16.12.0/react-dom.production.min.js" type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/shared-assets/54/js/react-dom-server/16.12.0/react-dom-server.browser.production.min.js" type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script async src="https://sdfestaticassets-eu-west-1.sciencedirectassets.com/prod/7ba758f35c085605b3a44408553251401be17045-jhp/client.js" type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script async="async" src="https://www.googletagservices.com/tag/js/gpt.js" type="4a85e47efd71a21c1bf3c9f1-text/javascript"></script>
<script type="4a85e47efd71a21c1bf3c9f1-text/javascript">
    const pendoData = {"visitor":{"pageName":"sd:browse:journal:about:aims-and-scope","pageType":"CP-CR","pageProduct":"sd","pageLanguage":"en","pageEnvironment":"prod","accessType":"ae:ANON_GUEST","countryCode":"NL"},"account":{"id":"ae:228598","name":"ae:ScienceDirect Guests"},"events":{}};;
    pendoData.events = {
      ready: function () {
        pendo.addAltText();
      },
    };
    function runPendo(data, options) {
  const {
    firstDelay,
    maxRetries,
    urlPrefix,
    urlSuffix,
    apiKey
  } = options;
  (function (apiKey) {
    (function (p, e, n, d, o) {
      var v, w, x, y, z;
      o = p[d] = p[d] || {};
      o._q = [];
      v = ['initialize', 'identify', 'updateOptions', 'pageLoad'];
      for (w = 0, x = v.length; w < x; ++w) (function (m) {
        o[m] = o[m] || function () {
          o._q[m === v[0] ? 'unshift' : 'push']([m].concat([].slice.call(arguments, 0)));
        };
      })(v[w]);
      y = e.createElement(n);
      y.async = !0;
      y.src = urlPrefix + apiKey + urlSuffix;
      z = e.getElementsByTagName(n)[0];
      z.parentNode.insertBefore(y, z);
    })(window, document, 'script', 'pendo');
    pendo.addAltText = function () {
      var target = document.querySelector('body');
      var observer = new MutationObserver(function (mutations) {
        mutations.forEach(function (mutation) {
          if (mutation?.addedNodes?.length) {
            if (mutation.addedNodes[0]?.className?.includes("_pendo-badge")) {
              const badge = mutation.addedNodes[0];
              const altText = badge?.attributes['aria-label'].value ? badge?.attributes['aria-label'].value : 'Feedback';
              const pendoBadgeImage = pendo.dom(`#${badge?.attributes?.id.value} img`);
              if (pendoBadgeImage.length) {
                pendoBadgeImage[0]?.setAttribute('alt', altText);
              }
            }
          }
        });
      });
      var config = {
        attributeFilter: ['data-layout'],
        attributes: true,
        childList: true,
        characterData: true,
        subtree: false
      };
      observer.observe(target, config);
    };
  })(apiKey);
  (function watchAndSetPendo(nextDelay, retryAttempt) {
    if (typeof pageDataTracker === 'object' && typeof pageDataTracker.getVisitorId === 'function' && pageDataTracker.getVisitorId()) {
      data.visitor.id = pageDataTracker.getVisitorId();
      console.debug(`initializing pendo`);
      pendo.initialize(data);
    } else {
      if (retryAttempt > 0) {
        return setTimeout(function () {
          watchAndSetPendo(nextDelay * 2, retryAttempt - 1);
        }, nextDelay);
      }
      pendo.initialize(data);
      console.debug(`gave up ... pendo initialized`);
    }
  })(firstDelay, maxRetries);
}
    window.addPendoScript = () => {
      runPendo(pendoData, {
        firstDelay: 300,
        maxRetries: 4,
        urlPrefix: 'https://cdn.pendo.io/agent/static/',
        urlSuffix: '/pendo.js',
        apiKey: 'd6c1d995-bc7e-4e53-77f1-2ea4ecbb9565',
      });
      window.addPendoScript = () => {};
    };
    addEventListener('load', () => window.addPendoScript());
  </script>
<script data-cfasync="false">
      (function initOneTrust()  {
        const monitor = {
  init: () => {},
  loaded: () => {},
};
        function enableGroup(group) {
  document.querySelectorAll(`script[type*="ot-${group}"]`).forEach(script => {
    script.type = 'text/javascript';
    document.head.appendChild(script);
  });
}
        function runOneTrustCookies(doClear, monitor) {
  const oneTrustConsentSdkId = 'onetrust-consent-sdk';
  const emptyNodeSelectors = 'h3.ot-host-name, h4.ot-host-desc, button.ot-host-box';
  const ariaLabelledByButtonNodes = 'div.ot-accordion-layout > button';
  const ariaAttribute = 'aria-labelledby';
  function adjustOneTrustDOM() {
    const oneTrustRoot = document.getElementById('onetrust-consent-sdk');

    /* remove empty nodes */
    [...(oneTrustRoot?.querySelectorAll(emptyNodeSelectors) ?? [])].filter(e => e.textContent === '').forEach(e => e.remove());

    /* remove invalid aria-labelledby values */
    oneTrustRoot?.querySelectorAll(ariaLabelledByButtonNodes).forEach(e => {
      const presentIdValue = e.getAttribute(ariaAttribute)?.split(' ').filter(label => document.getElementById(label)).join(' ');
      if (presentIdValue) {
        e.setAttribute(ariaAttribute, presentIdValue);
      }
    });
  }
  function observeOneTrustLoaded(shouldSetOTDefaults, isConsentPresent) {
    const cb = (mutationList, observer) => {
      const oneTrustRoot = mutationList.filter(mutationRecord => mutationRecord.type === 'childList' && mutationRecord.addedNodes.length).map(mutationRecord => [...mutationRecord.addedNodes]).flat().find(e => e.id === oneTrustConsentSdkId);
      if (oneTrustRoot && typeof OneTrust !== 'undefined') {
        monitor.loaded(true);
        OneTrust.OnConsentChanged(() => {
          const perfAllowed = decodeURIComponent(document.cookie.match('(^| )OptanonConsent=([^;]+)')?.[2])?.match('groups=([0-9:0|1,?]+)&?')?.[1]?.match('2:([0|1])')[1] === '1';
          if (perfAllowed) {
            enableGroup('performance');
          }
        });
        if (!isConsentPresent && (shouldSetOTDefaults || OneTrust.GetDomainData().ConsentModel.Name === 'implied consent')) {
          OneTrust.AllowAll();
        }
        document.dispatchEvent(new CustomEvent('@sdtech/onetrust/loaded', {}));
        observer.disconnect();
        adjustOneTrustDOM();
      }
    };
    const observer = new MutationObserver(cb);
    observer.observe(document.querySelector('body'), {
      childList: true
    });
  }
  if (doClear) {
    document.cookie = 'OptanonAlertBoxClosed=; expires=Thu, 01 Jan 1970 00:00:00 UTC; samesite=lax; path=/';
  }
  const isConsentPresent = !!decodeURIComponent(document.cookie.match('(^| )OptanonConsent=([^;]+)')?.[2])?.match('groups=([0-9:0|1,?]+)&?')?.[1];
  const shouldSetOTDefaults = 'true' === 'false' && !document.cookie?.match('OptanonAlertBoxClosed=');
  if (shouldSetOTDefaults) {
    const date = new Date();
    date.setFullYear(date.getFullYear() + 1);
    document.cookie = `OptanonAlertBoxClosed=${new Date().toISOString()}; expires=${date.toUTCString()}; samesite=lax; path=/; domain=sciencedirect.com`;
  }
  observeOneTrustLoaded(shouldSetOTDefaults, isConsentPresent, monitor);
  window.addOTScript = () => {
    const otSDK = document.createElement('script');
    otSDK.setAttribute('data-cfasync', 'false');
    otSDK.setAttribute('src', 'https://cdn.cookielaw.org/scripttemplates/otSDKStub.js');
    otSDK.setAttribute('data-document-language', 'true');
    otSDK.setAttribute('data-domain-script', '865ea198-88cc-4e41-8952-1df75d554d02');
    window.addOTScript = () => {};
    document.head.appendChild(otSDK);
    monitor.init();
  };
  window.addEventListener('load', () => window.addOTScript());
}
        if (document.location.host.match(/.sciencedirect.com$/)) {
          runOneTrustCookies(true, monitor);
        }
        else {
          window.addEventListener('load', (event) => {
            enableGroup('performance');
          });
        }
      }());
    </script>
<script src="/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js" data-cf-settings="4a85e47efd71a21c1bf3c9f1-|49" defer></script></body>
</html>